,symbol,name,description__profile,ceo__profile,industry__profile,price__profile,currency__profile,mktCap__profile,image__profile,volAvg__profile,pe__quote,change__quote,volume__quote,ebitda__income_statement,netIncome__income_statement,annual_earnings,quaterly_earnings,eps__income_statement,epsdiluted__income_statement,totalAssets__balance_sheet_statement,totalCurrentAssets__balance_sheet_statement,cashAndShortTermInvestments__balance_sheet_statement,totalLiabilities__balance_sheet_statement,netReceivables__balance_sheet_statement,longTermInvestments__balance_sheet_statement,totalCurrentLiabilities__balance_sheet_statement,cashAndCashEquivalents__balance_sheet_statement,freeCashFlow__cash_flow_statement,growthEBITDA__income_statement_growth,growthNetIncome__income_statement_growth,growthEPS__income_statement_growth,dividend__historical-price-full/stock_dividend,date__historical-price-full/stock_dividend,derived__netIncomeMargin,derived__debtRatio
0,MFIN,Medallion Financial Corp. Common Stock,"Medallion Financial Corp., together with its subsidiaries, operates as a finance company in the United States. The company operates through four segments: Recreation Lending, Home Improvement Lending, Commercial Lending, and Medallion Lending. It provides loans that finance consumer purchases of recreational vehicles, boats, and trailers; consumer home improvements; commercial businesses; and taxi medallions to individuals, and small to mid-size businesses. The company also offers commercial loans for purchase of equipment and related assets necessary to open a new business, or purchase or improvement of an existing business; and medallion loans. In addition, it provides debt, mezzanine, and equity investment capital to companies in various industries; and raises deposits and conducts other banking activities. Medallion Financial Corp. was incorporated in 1995 and is headquartered in New York City, New York.",Mr. Alvin  Murstein,Financial - Credit Services,8.29,USD,191231233,https://images.financialmodelingprep.com/symbol/MFIN.png,43047,5.45,0,27958,0,35878000,"[{'period': '2024', 'revenue': 290.7, 'unit': 'M', 'net_profit': 35.88}, {'period': '2023', 'revenue': 264.06, 'unit': 'M', 'net_profit': 55.08}, {'period': '2022', 'revenue': 156.93, 'unit': 'M', 'net_profit': 43.84}, {'period': '2021', 'revenue': 148.07, 'unit': 'M', 'net_profit': 54.11}]","[{'period': ""Q4 '24"", 'revenue': 97.55, 'unit': 'M', 'net_profit': 10.14}, {'period': ""Q3 '24"", 'revenue': 48.88, 'unit': 'M', 'net_profit': 8.61}, {'period': ""Q2 '24"", 'revenue': 71.8, 'unit': 'M', 'net_profit': 7.1}, {'period': ""Q1 '24"", 'revenue': 72.47, 'unit': 'M', 'net_profit': 10.02}, {'period': ""Q4 '23"", 'revenue': 70.57, 'unit': 'M', 'net_profit': 14.32}, {'period': ""Q3 '23"", 'revenue': 49.04, 'unit': 'M', 'net_profit': 11.23}]",1.59,1.52,2868606000,168357000,153043000,2429648000,17445000,0,84123000,98238000,115513000,-1,-0.34860836253381505,-0.3510204081632653,"[0.11, 0.2]","['2025-03-17', '1996-11-08']",__nan__,0.8469786370104504
1,MFNC,Mackinac Financial Corporation Common Stock,"Mackinac Financial Corp. is a bank holding company, which engages in the provision of commercial banking services through its subsidiary, mBank. The company is headquartered in Manistique, Michigan and currently employs 294 full-time employees. The Company, through the Bank, is engaged in the general commercial banking business. The Bank provides a range of loan and deposit products. These banking services include customary retail and commercial banking services, including checking and savings accounts, time deposits, interest bearing transaction accounts, safe deposit facilities, real estate mortgage lending, commercial lending, commercial and governmental lease financing, and direct and indirect consumer financing. The funds for the Bank's operation are also provided by brokered deposits and through borrowings from the Federal Home Loan Bank (FHLB) system, proceeds from the sale of loans and mortgage-backed and other securities, funds from repayment of outstanding loans and earnings from operations. The Bank has over 13 branch offices located in the Upper Peninsula of Michigan and four branch offices located in Michigan's Lower Peninsula.",Mr. Paul Tobias,Banks - Regional,21.5,USD,0,https://images.financialmodelingprep.com/symbol/MFNC.png,51880,0.0,0.12000084,194294,27176000,13473000,"[{'period': '2020', 'revenue': 63.04, 'unit': 'M', 'net_profit': 13.47}, {'period': '2019', 'revenue': 58.31, 'unit': 'M', 'net_profit': 13.85}, {'period': '2018', 'revenue': 50.23, 'unit': 'M', 'net_profit': 8.37}, {'period': '2017', 'revenue': 40.64, 'unit': 'M', 'net_profit': 5.48}]","[{'period': ""Q2 '21"", 'revenue': 15.27, 'unit': 'M', 'net_profit': 2.94}, {'period': ""Q1 '21"", 'revenue': 15.73, 'unit': 'M', 'net_profit': 3.88}, {'period': ""Q4 '20"", 'revenue': 15.91, 'unit': 'M', 'net_profit': 3.64}, {'period': ""Q3 '20"", 'revenue': 15.76, 'unit': 'M', 'net_profit': 3.32}, {'period': ""Q2 '20"", 'revenue': 16.42, 'unit': 'M', 'net_profit': 3.45}, {'period': ""Q1 '20"", 'revenue': 14.95, 'unit': 'M', 'net_profit': 3.05}]",1.28,1.28,242843000,218901000,333654000,1333866000,0,111836000,0,221818000,13279000,-0.12524543728071588,-0.027220216606498194,-0.007751937984496131,"[0.14, 0.0024]","['2021-07-01', '2000-04-14']",__nan__,5.492709281305205
2,MGEE,MGE Energy Inc,"MGE Energy, Inc., through its subsidiaries, operates as a public utility holding company primarily in Wisconsin. It operates through Regulated Electric Utility Operations; Regulated Gas Utility Operations; Nonregulated Energy Operations; Transmission Investments; and All Other. The company generates, purchases, and distributes electricity; owns or leases electric generation facilities located in Wisconsin and Iowa; and plans, constructs, operates, maintains, and expands transmission facilities to provide transmission services. It also generates electricity from coal-fired, gas-fired, and renewable energy sources, as well as purchases power under short and long-term commitments. As of December 31, 2021, the company generated and distributed electricity to 159,000 customers in Dane County, Wisconsin; and purchased and distributed natural gas to 169,000 customers in seven Wisconsin counties. MGE Energy, Inc.is headquartered in Madison, Wisconsin.",Mr. Jeffrey M. Keebler,Diversified Utilities,86.85,USD,3170659005,https://images.financialmodelingprep.com/symbol/MGEE.png,160762,26.08,-0.17,148945,272676000,120569000,"[{'period': '2024', 'revenue': 676.94, 'unit': 'M', 'net_profit': 120.57}, {'period': '2023', 'revenue': 690.43, 'unit': 'M', 'net_profit': 117.7}, {'period': '2022', 'revenue': 714.52, 'unit': 'M', 'net_profit': 110.95}, {'period': '2021', 'revenue': 606.58, 'unit': 'M', 'net_profit': 105.76}]","[{'period': ""Q4 '24"", 'revenue': 171.41, 'unit': 'M', 'net_profit': 22.02}, {'period': ""Q3 '24"", 'revenue': 168.48, 'unit': 'M', 'net_profit': 40.94}, {'period': ""Q2 '24"", 'revenue': 145.71, 'unit': 'M', 'net_profit': 23.79}, {'period': ""Q1 '24"", 'revenue': 191.34, 'unit': 'M', 'net_profit': 33.81}, {'period': ""Q4 '23"", 'revenue': 164.65, 'unit': 'M', 'net_profit': 20.08}, {'period': ""Q3 '23"", 'revenue': 160.53, 'unit': 'M', 'net_profit': 37.86}]",3.33,3.33,2827959000,227265000,21302000,1597821000,51277000,118035000,125563000,21302000,40859000,-0.013055454009113843,0.024384234360529826,0.024615384615384636,"[0.45, 0.59]","['2025-02-28', '1987-02-26']",__nan__,0.5650085450319471
3,MGI,Moneygram International Inc. Common Stock,"MoneyGram International, Inc., together with its subsidiaries, provides cross-border peer-to-peer payments and money transfer services in the United States and internationally. The company operates through two segments, Global Funds Transfer and Financial Paper Products. The Global Funds Transfer segment offers money transfer services and bill payment services through third-party agents, including retail chains, independent retailers, post offices, banks, and other financial institutions; and digital solutions, such as moneygram.com, account deposit, and kiosk-based services, as well as mobile app solutions. The Financial Paper Products segment provides money orders to consumers through its agents and financial institutions under the MoneyGram brand and on a private label or co-branded basis with various agents and financial institutions; and official check outsourcing services for banks and credit unions. MoneyGram International, Inc. was incorporated in 2003 and is based in Dallas, Texas.",Mr. W. Alexander Holmes,Financial - Credit Services,10.99,USD,1074114244,https://images.financialmodelingprep.com/symbol/MGI.png,3394929,32.3235294117647,0,4045697,140900000,34200000,"[{'period': '2022', 'revenue': 1310.0, 'unit': 'M', 'net_profit': 34.2}, {'period': '2021', 'revenue': 1280.0, 'unit': 'M', 'net_profit': -37.9}, {'period': '2020', 'revenue': 1220.0, 'unit': 'M', 'net_profit': -7.9}, {'period': '2019', 'revenue': 1290.0, 'unit': 'M', 'net_profit': -60.3}]","[{'period': ""Q1 '23"", 'revenue': 337.5, 'unit': 'M', 'net_profit': 5.0}, {'period': ""Q4 '22"", 'revenue': 342.1, 'unit': 'M', 'net_profit': 21.8}, {'period': ""Q3 '22"", 'revenue': 330.8, 'unit': 'M', 'net_profit': 4.2}, {'period': ""Q2 '22"", 'revenue': 329.6, 'unit': 'M', 'net_profit': 3.1}, {'period': ""Q1 '22"", 'revenue': 307.6, 'unit': 'M', 'net_profit': 5.1}, {'period': ""Q4 '21"", 'revenue': 324.6, 'unit': 'M', 'net_profit': 4.2}]",0.35,0.34,4505200000,172100000,172100000,4651000000,0,0,159700000,172100000,31900000,0.1094488188976378,1.9023746701846966,1.8333333333333335,"[0.05, 0.01]","['2007-12-12', '2004-09-14']",__nan__,1.0323626032140638
4,MGIC,Magic Software Enterprises Ltd. Ordinary Shares,"Magic Software Enterprises Ltd. provides proprietary application development, business process integration, vertical software solutions, and information technologies (IT) outsourcing software services in Israel and internationally. The company's Software Services segment develops, markets, sells, and supports application platform, software applications, and business and process integration solutions and related services. Its IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, and supplemental outsourcing services. The company offers proprietary application platforms, such as Magic xpa for developing and deploying business applications; AppBuilder for building, deploying, and maintaining high-end and mainframe-grade business applications; Magic xpi for application integration; FactoryEye for virtualization of production data; BusinessEye for organizational business intelligence; and Magic SmartUX for cross-platform mobile business applications. It also provides vertical software solutions comprising Clicks, a software solution for healthcare providers; Leap, a software solution for business support systems; Hermes Cargo, a packaged software solution for managing air cargo ground handling; HR Pulse, a single-tenant software as a service tool; MBS Solution, a system for managing TV broadcast management; Nativ, a system for management of rehabilitation centers; and Mobisale, a system for sales and distribution field activities for consumer goods manufacturers and wholesalers. In addition, the company provides software maintenance, support, training, and consulting services. The company was formerly known as Mashov Software Export (1983) Ltd. and changed its name to Magic Software Enterprises Ltd. in 1991. Magic Software Enterprises Ltd. was incorporated in 1983 and is headquartered in Or Yehuda, Israel.",Mr. Yakov  Tsaroya,Information Technology Services,12.57,USD,617178201,https://images.financialmodelingprep.com/symbol/MGIC.png,76165,16.76,0.23,83471,82060000,36883000,"[{'period': '2024', 'revenue': 552.52, 'unit': 'M', 'net_profit': 36.88}, {'period': '2023', 'revenue': 535.05, 'unit': 'M', 'net_profit': 37.03}, {'period': '2022', 'revenue': 566.79, 'unit': 'M', 'net_profit': 40.47}, {'period': '2021', 'revenue': 480.32, 'unit': 'M', 'net_profit': 29.77}]","[{'period': ""Q4 '24"", 'revenue': 142.58, 'unit': 'M', 'net_profit': 10.62}, {'period': ""Q3 '24"", 'revenue': 142.97, 'unit': 'M', 'net_profit': 8.43}, {'period': ""Q2 '24"", 'revenue': 136.25, 'unit': 'M', 'net_profit': 9.03}, {'period': ""Q1 '24"", 'revenue': 130.72, 'unit': 'M', 'net_profit': 8.8}, {'period': ""Q4 '23"", 'revenue': 125.55, 'unit': 'M', 'net_profit': 8.48}, {'period': ""Q3 '23"", 'revenue': 129.48, 'unit': 'M', 'net_profit': 7.15}]",0.75,0.75,540331000,276199000,112830000,239262000,139569000,0,170287000,112779000,73158000,-0.0025768183586153248,-0.003996651454187032,0.0,"[0.327, 0.4]","['2025-04-22', '2003-02-11']",__nan__,0.44280635388308276
5,MGLN,Magellan Health Inc. Common Stock,"Magellan Health, Inc., together with its subsidiaries, provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans; and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Further, it offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions. In addition, the company provides services to health plans and managed care organizations, employers, labor unions, third party administrators, state governments, military and governmental agencies, exchanges, brokers, and consultants. Magellan Health, Inc. was incorporated in 1969 and is headquartered in Phoenix, Arizona. As of January 4, 2022, Magellan Health, Inc. operates as a subsidiary of Centene Corporation.",Mr. Kenneth Fasola,Medical - Healthcare Plans,94.99,USD,0,https://images.financialmodelingprep.com/symbol/MGLN.png,143016,8.485795962122566,94.99,832178,487414000,4046000,"[{'period': '2020', 'revenue': 4580.0, 'unit': 'M', 'net_profit': 4.05}, {'period': '2019', 'revenue': 7160.0, 'unit': 'M', 'net_profit': 55.9}, {'period': '2018', 'revenue': 7310.0, 'unit': 'M', 'net_profit': 24.18}, {'period': '2017', 'revenue': 5840.0, 'unit': 'M', 'net_profit': 110.14}]",[],0.16,0.16,3359855000,2156397000,1285297000,1489883000,743502000,2612000,737579000,1144450000,375281000,0.9615903154793766,-0.9276233408464813,-0.9298245614035087,__nan__,__nan__,__nan__,0.44343669592884216
6,MGNI,Magnite Inc. Common Stock,"Magnite, Inc. operates an independent sell-side advertising platform in the United States and internationally. The company's platform offers applications and services for sellers of digital advertising inventory or publishers that own and operate CTV channels, applications, websites, and other digital media properties, to manage and monetize their inventory; and provides applications and services for buyers, including advertisers, agencies, agency trading desks, and demand side platforms to buy digital advertising inventory. It markets its technology solutions to buyers and sellers through a sales teams that operate from various locations. The company was formerly known as The Rubicon Project, Inc. and changed name to Magnite, Inc. in July 2020. Magnite, Inc. was incorporated in 2007 and is headquartered in New York, New York.",Mr. Michael G. Barrett,Advertising Agencies,9.0,USD,1286559000,https://images.financialmodelingprep.com/symbol/MGNI.png,2724900,56.25,-0.15,3034322,51087000,22786000,"[{'period': '2024', 'revenue': 668.17, 'unit': 'M', 'net_profit': 22.79}, {'period': '2023', 'revenue': 619.71, 'unit': 'M', 'net_profit': -159.18}, {'period': '2022', 'revenue': 577.07, 'unit': 'M', 'net_profit': -130.32}, {'period': '2021', 'revenue': 468410.0, 'unit': 'K', 'net_profit': 65.0}]","[{'period': ""Q4 '24"", 'revenue': 193.97, 'unit': 'M', 'net_profit': 36.41}, {'period': ""Q3 '24"", 'revenue': 162.0, 'unit': 'M', 'net_profit': 5.21}, {'period': ""Q2 '24"", 'revenue': 162.88, 'unit': 'M', 'net_profit': -1.08}, {'period': ""Q1 '24"", 'revenue': 149.32, 'unit': 'M', 'net_profit': -17.76}, {'period': ""Q4 '23"", 'revenue': 186.93, 'unit': 'M', 'net_profit': 30.91}, {'period': ""Q3 '23"", 'revenue': 150.09, 'unit': 'M', 'net_profit': -17.48}]",0.16,0.16,2854768000,1703180000,483220000,2086550000,1200046000,0,1495984000,483220000,202391000,-0.5582314384047319,1.1431425268871243,1.1367521367521367,__nan__,__nan__,__nan__,0.730900024100032
7,MGNX,MacroGenics Inc. Common Stock,"MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The company's pipeline of immuno-oncology product candidates includes MGC018, an antibody drug conjugate (ADC), which targets solid tumors expressing B7-H3; Enoblituzumab, a monoclonal antibody that targets B7-H3; and MGD024, an investigational bispecific CD123 × CD3 DART molecule to minimize cytokine-release syndrome for patients with hematologic malignancies. It also develops Lorigerlimab, a monoclonal antibody that targets the immune checkpoints PD-1 and cytotoxic T-lymphocyte-associated protein 4; Tebotelimab, an investigational tetravalent DART molecule for PD-1 and lymphocyte-activation gene 3; Retifanlimab, an investigational monoclonal antibody targeting metastatic squamous cell carcinoma of the anal canal and metastatic non-small cell lung cancer; and IMGC936, an ADC that targets ADAM9, a cell surface protein over-expressed in various solid tumor types. Further, the company develops MGD014 and MGD020, a DART molecule to target the envelope protein of human immunodeficiency virus infected cells and CD3 on T cells; Teplizumab for the treatment of type 1 diabetes; and PRV-3279, a CD32B × CD79B DART molecule for the treatment of autoimmune indications. It has collaborations with Incyte Corporation; Zai Lab Limited; I-Mab Biopharma; and Janssen Biotech, Inc. The company was incorporated in 2000 and is headquartered in Rockville, Maryland.","Dr. Scott  Koenig M.D., Ph.D.",Biotechnology,1.1,USD,69399330,https://images.financialmodelingprep.com/symbol/MGNX.png,754126,-1.03,0,1709451,-57367000,-66966000,"[{'period': '2024', 'revenue': 149.96, 'unit': 'M', 'net_profit': -66.97}, {'period': '2023', 'revenue': 58.75, 'unit': 'M', 'net_profit': -9.06}, {'period': '2022', 'revenue': 151.94, 'unit': 'M', 'net_profit': -120.02}, {'period': '2021', 'revenue': 75.64, 'unit': 'M', 'net_profit': -190.86}]","[{'period': ""Q4 '24"", 'revenue': 17.73, 'unit': 'M', 'net_profit': -15.42}, {'period': ""Q3 '24"", 'revenue': 110.71, 'unit': 'M', 'net_profit': 56.31}, {'period': ""Q2 '24"", 'revenue': 10.8, 'unit': 'M', 'net_profit': -55.66}, {'period': ""Q1 '24"", 'revenue': 9.1, 'unit': 'M', 'net_profit': -52.19}, {'period': ""Q4 '23"", 'revenue': 10.72, 'unit': 'M', 'net_profit': -46.07}, {'period': ""Q3 '23"", 'revenue': 10.4, 'unit': 'M', 'net_profit': 17.55}]",-1.07,-1.07,261655000,217490000,201667000,145598000,4309000,0,55530000,182840000,-72079000,-29.44174516608825,-6.393022742327225,-6.133333333333334,__nan__,__nan__,__nan__,0.5564502875924404
8,MGPI,MGP Ingredients Inc.,"MGP Ingredients, Inc., together with its subsidiaries, produces and supplies distilled spirits, branded spirits, and food ingredients. It operates through three segments: Distillery Products; Branded Spirits; and Ingredient Solutions. The Distillery Products segment provides food grade alcohol for beverage applications that include bourbon and rye whiskeys, as well as grain neutral spirits, including vodka and gin; and food-grade industrial alcohol, which is used as an ingredient in foods, personal care products, cleaning solutions, pharmaceuticals, and various other products. This segment also provides fuel-grade alcohol for blending with gasoline; distillers feed and related co-products, such as distillers feed and corn oil; and warehouse services, including barrel put away, storage, and retrieval services, as well as blending services. The Branded Spirits segment provides ultra-premium, premium, mid, and value branded distilled spirits. The Ingredient Solutions segment provides specialty wheat starches for food applications under the Fibersym, Resistant Starch, and FiberRite RW Resistant Starch names; specialty wheat proteins for food applications under the Arise and Proterra names; gluten-free textured pea proteins; commodity wheat starch for food and non-food applications; and commodity wheat proteins. The company sells its products directly or through distributors to manufacturers and processors of finished packaged goods or to bakeries primarily in the United States, the United Kingdom, Japan, Thailand, Mexico, and Canada. MGP Ingredients, Inc. was founded in 1941 and is headquartered in Atchison, Kansas.",Mr. Brandon M. Gall CPA,Beverages - Wineries & Distilleries,26.51,USD,563875653,https://images.financialmodelingprep.com/symbol/MGPI.png,401796,16.99,-0.5,442537,98870000,34663000,"[{'period': '2024', 'revenue': 703.62, 'unit': 'M', 'net_profit': 34.66}, {'period': '2023', 'revenue': 836.52, 'unit': 'M', 'net_profit': 107.47}, {'period': '2022', 'revenue': 782.36, 'unit': 'M', 'net_profit': 109.46}, {'period': '2021', 'revenue': 626.72, 'unit': 'M', 'net_profit': 91.31}]","[{'period': ""Q4 '24"", 'revenue': 180.8, 'unit': 'M', 'net_profit': -41.96}, {'period': ""Q3 '24"", 'revenue': 161.46, 'unit': 'M', 'net_profit': 23.65}, {'period': ""Q2 '24"", 'revenue': 190.81, 'unit': 'M', 'net_profit': 32.09}, {'period': ""Q1 '24"", 'revenue': 170.56, 'unit': 'M', 'net_profit': 20.64}, {'period': ""Q4 '23"", 'revenue': 214.89, 'unit': 'M', 'net_profit': 31.07}, {'period': ""Q3 '23"", 'revenue': 211.62, 'unit': 'M', 'net_profit': 13.21}]",1.56,1.56,1405785000,546136000,25273000,573242000,0,7024000,92450000,25273000,31097000,-0.42013770776394965,-0.6774784833682251,-0.6763485477178424,"[0.12, 0.1]","['2025-03-14', '1988-12-16']",__nan__,0.40777359269020513
9,MGRC,McGrath RentCorp Common Stock,"McGrath RentCorp operates as a business to business rental company in the United States and internationally. It rents and sells relocatable modular buildings, portable storage containers, electronic test equipment and related accessories, and liquid and solid containment tanks and boxes. The company operates through four segments: Mobile Modular, TRS-RenTelco, Adler Tanks, and Enviroplex. The Mobile Modular segment rents and sells modular buildings designed for use as classrooms, temporary offices adjacent to existing facilities, sales offices, construction field offices, restroom buildings, health care clinics, child care facilities, office spaces, and various other purposes; and portable storage containers. The TRS-RenTelco segment rents and sells general purpose electronic test equipment, such as oscilloscopes, amplifiers, analyzers, signal source, and power source test equipment primarily to aerospace, defense, electronics, industrial, research, and semiconductor industries. It also provides communications test equipment, including network and transmission test equipment for various fiber, copper, and wireless networks to the manufacturers of communications equipment and products, electrical and communications installation contractors, field technicians, and service providers. The Adler Tanks segment rents fixed axle steel tanks for storing groundwater, wastewater, volatile organic liquids, sewage, slurry and bio sludge, oil and water mixtures, and chemicals; vacuum containers for sludge and solid materials; dewatering boxes for the separation of water contained in sludge and slurry; and roll-off and trash boxes for temporary storage and transportation of solid waste. The Enviroplex segment manufactures and sells portable classrooms directly to public school districts and other educational institutions in California. The company was incorporated in 1979 and is headquartered in Livermore, California.",Mr. Joseph F. Hanna,Rental & Leasing Services,101.45,USD,2490719240,https://images.financialmodelingprep.com/symbol/MGRC.png,153560,10.76,-3.21,175947,468345000,231727000,"[{'period': '2024', 'revenue': 910.94, 'unit': 'M', 'net_profit': 231.73}, {'period': '2023', 'revenue': 831.84, 'unit': 'M', 'net_profit': 174.62}, {'period': '2022', 'revenue': 733.82, 'unit': 'M', 'net_profit': 115.14}, {'period': '2021', 'revenue': 616.83, 'unit': 'M', 'net_profit': 89.7}]","[{'period': ""Q4 '24"", 'revenue': 243.75, 'unit': 'M', 'net_profit': 38.95}, {'period': ""Q3 '24"", 'revenue': 266.76, 'unit': 'M', 'net_profit': 149.32}, {'period': ""Q2 '24"", 'revenue': 212.61, 'unit': 'M', 'net_profit': 20.62}, {'period': ""Q1 '24"", 'revenue': 187.83, 'unit': 'M', 'net_profit': 22.85}, {'period': ""Q4 '23"", 'revenue': 221.59, 'unit': 'M', 'net_profit': 32.02}, {'period': ""Q3 '23"", 'revenue': 243.51, 'unit': 'M', 'net_profit': 40.37}]",9.44,9.43,2277584000,234453000,807000,1154216000,219342000,0,283879000,807000,334147000,0.5642942314051242,0.32702824975232075,0.3221288515406162,"[0.485, 1.28]","['2025-04-16', '1990-04-10']",__nan__,0.5067720883181477
10,MGTA,Magenta Therapeutics Inc. Common Stock,"Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that cause acute myeloid leukemia and myelodysplastic syndromes, which is under Phase I/II clinical trial; CD45-antibody drug conjugate that targets HSCs and immune cells, which is in investigational new drug application enabling studies for potential use as a single-agent in autoimmune diseases and hematology-oncology transplants; and MGTA-145 that is in Phase II clinical trial for use in autologous and allogeneic transplants. The company also has a cell therapy program, E478, which is a small molecule aryl hydrocarbon receptor antagonist for stem cell-based gene therapy and genome editing. Magenta Therapeutics, Inc. has a research and clinical collaboration agreement with AVROBIO, Inc. for the treatment of lysosomal storage disorders; and Beam Therapeutics, Inc. to evaluate the potential utility of MGTA-117 for conditioning of patients with sickle cell disease and beta-thalassemia. The company was formerly known as HSCTCo Therapeutics, Inc. and changed its name to Magenta Therapeutics, Inc. in February 2016. Magenta Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.","Mr. Stephen F. Mahoney J.D., MBA",Biotechnology,0.6996,USD,42441024,https://images.financialmodelingprep.com/symbol/MGTA.png,247981,-0.6083478260869565,-0.0587,375912,-78977000,-72022000,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -72.02}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -65.56}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -69.19}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -68.73}]","[{'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.76}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.28}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -26.21}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -23.06}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -17.25}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -17.27}]",-23.05,-23.05,146645000,115602000,112041000,40687000,0,0,14549000,57626000,-67404000,-0.0573689283992931,-0.09856619890176938,-0.01676224084693423,__nan__,__nan__,__nan__,0.27745235091547615
11,MGTX,MeiraGTx Holdings plc Ordinary Shares,"MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.",Dr. Alexandria  Forbes Ph.D.,Biotechnology,5.24,USD,413199676,https://images.financialmodelingprep.com/symbol/MGTX.png,539322,-2.47,-0.51,925442,-121838000,-147791000,"[{'period': '2024', 'revenue': 33.28, 'unit': 'M', 'net_profit': -147.79}, {'period': '2023', 'revenue': 14.02, 'unit': 'M', 'net_profit': -84.03}, {'period': '2022', 'revenue': 15.92, 'unit': 'M', 'net_profit': -142.88}, {'period': '2021', 'revenue': 37.7, 'unit': 'M', 'net_profit': -71.98}]","[{'period': ""Q4 '24"", 'revenue': 21.39, 'unit': 'M', 'net_profit': -39.4}, {'period': ""Q3 '24"", 'revenue': 10.91, 'unit': 'M', 'net_profit': -39.33}, {'period': ""Q2 '24"", 'revenue': 0.28200000000000003, 'unit': 'M', 'net_profit': -48.62}, {'period': ""Q1 '24"", 'revenue': 0.6970000000000001, 'unit': 'M', 'net_profit': -20.44}, {'period': ""Q4 '23"", 'revenue': 2.04, 'unit': 'M', 'net_profit': 20.21}, {'period': ""Q3 '23"", 'revenue': 5.1, 'unit': 'M', 'net_profit': -44.3}]",-2.12,-2.12,269751000,123518000,103659000,201924000,707000,6749000,60783000,103659000,-109450000,-1.1355605412606045,-0.7588513215990098,-0.4228187919463088,__nan__,__nan__,__nan__,0.7485570025690359
12,MGYR,Magyar Bancorp Inc. Common Stock,"Magyar Bancorp, Inc. operates as the holding company for Magyar Bank that provides various consumer and commercial banking services to individuals, businesses, and nonprofit organizations in New Jersey, the United States. It accepts various deposit accounts, including demand, savings, NOW, money market, and retirement accounts, as well as certificates of deposit. The company also provides residential mortgage loans, multi-family and commercial real estate mortgage loans, home equity loans and lines of credit, commercial business loans, and construction loans, as well as small business administration loans. In addition, it offers non-deposit investment products and financial planning services, including insurance products, fixed and variable annuities, and retirement planning for individual and commercial customers; and buys, sells, and holds investment securities. The company has seven branch offices located in New Brunswick, North Brunswick, South Brunswick, Branchburg, Bridgewater, and Edison, New Jersey. Magyar Bancorp, Inc. was founded in 1922 and is headquartered in New Brunswick, New Jersey.",Mr. John S. Fitzgerald,Banks - Regional,13.79,USD,89353960,https://images.financialmodelingprep.com/symbol/MGYR.png,2265,10.53,0.19,2344,11100000,7783000,"[{'period': '2024', 'revenue': 31.5, 'unit': 'M', 'net_profit': 7.78}, {'period': '2023', 'revenue': 30.42, 'unit': 'M', 'net_profit': 7.71}, {'period': '2022', 'revenue': 0.231, 'unit': 'M', 'net_profit': 7.92}, {'period': '2021', 'revenue': 29.0, 'unit': 'M', 'net_profit': 6.12}]","[{'period': ""Q1 '25"", 'revenue': 8.4, 'unit': 'M', 'net_profit': 2.08}, {'period': ""Q4 '24"", 'revenue': 14.74, 'unit': 'M', 'net_profit': 2.54}, {'period': ""Q3 '24"", 'revenue': 12.74, 'unit': 'M', 'net_profit': 1.69}, {'period': ""Q2 '24"", 'revenue': 12.54, 'unit': 'M', 'net_profit': 1.9}, {'period': ""Q1 '24"", 'revenue': 12.11, 'unit': 'M', 'net_profit': 1.65}, {'period': ""Q4 '23"", 'revenue': 7.84, 'unit': 'M', 'net_profit': 2.19}]",1.23,1.23,951918000,20672000,15616000,841370000,5056000,0,0,0,5506000,-0.04153354632587859,0.009599169801530678,0.025000000000000022,"[0.06, 0.12]","['2025-02-06', '2021-11-29']",__nan__,0.883868148306892
13,MHLD,Maiden Holdings Ltd.,"Maiden Holdings, Ltd., through its subsidiaries, provides property and casualty reinsurance solutions to regional and specialty insurers in Europe, the United States, and internationally. It operates in two segments: Diversified Reinsurance and AmTrust Reinsurance. The company writes treaties on a quota share basis and excess of loss basis. It also offers auto and credit life insurance products through its insurer partners to retail clients; and a range of legacy services to small insurance companies. The company was founded in 2007 and is headquartered in Pembroke, Bermuda.",Mr. Patrick Joseph Haveron CPA,Insurance - Reinsurance,0.8698,USD,86537098,https://images.financialmodelingprep.com/symbol/MHLD.png,160390,-0.43,-0.0802,222924,-187608000,-200969000,"[{'period': '2024', 'revenue': 56.44, 'unit': 'M', 'net_profit': -200.97}, {'period': '2023', 'revenue': 89.23, 'unit': 'M', 'net_profit': -38.57}, {'period': '2022', 'revenue': 8.26, 'unit': 'M', 'net_profit': -59.84}, {'period': '2021', 'revenue': 106.41, 'unit': 'M', 'net_profit': 18.9}]","[{'period': ""Q4 '24"", 'revenue': 27.69, 'unit': 'M', 'net_profit': -157.99}, {'period': ""Q3 '24"", 'revenue': 14.48, 'unit': 'M', 'net_profit': -34.47}, {'period': ""Q2 '24"", 'revenue': 20.49, 'unit': 'M', 'net_profit': -9.97}, {'period': ""Q1 '24"", 'revenue': 28.9, 'unit': 'M', 'net_profit': 1.46}, {'period': ""Q4 '23"", 'revenue': 25.21, 'unit': 'M', 'net_profit': -20.78}, {'period': ""Q3 '23"", 'revenue': 26.35, 'unit': 'M', 'net_profit': -3.53}]",-2.01,-2.01,1316006000,55544000,251363000,1270813000,20809000,327047000,0,25651000,-67449000,-6.430608365019012,-4.210635484456429,-4.289473684210526,"[0.05, 0.05]","['2018-09-28', '2008-06-27']",__nan__,0.965658971159706
14,MICT,MICT Inc. Common Stock,"MICT, Inc., through its subsidiaries, engages in the financial technology and insurance business in China, Singapore, and Hong Kong. It primarily develops platforms for insurance products, and financial products and services. The company also deals in securities, futures, and options; and provides securities advisory and asset management services, as well as the Magpie Invest app that allows to trade in securities on various stock exchanges. In addition, it conducts insurance brokerage and agency businesses; and offers a range of insurance products, including automobile, property and liability, life, and health insurance products. The company was formerly known as Micronet Enertec Technologies, Inc. and changed its name to MICT, Inc. in July 2018. MICT, Inc. was incorporated in 2002 and is based in Montvale, New Jersey.",Mr. Darren  Mercer,Computer Hardware,0.9261,USD,118009293,https://images.financialmodelingprep.com/symbol/MICT.png,315910,-2.9874193548387096,0.0261,186060,-11792000,37474000,"[{'period': '2022', 'revenue': 146.03, 'unit': 'M', 'net_profit': 37.47}, {'period': '2021', 'revenue': 55.68, 'unit': 'M', 'net_profit': -37.16}, {'period': '2020', 'revenue': 1.17, 'unit': 'M', 'net_profit': -22.99}, {'period': '2019', 'revenue': 0.47700000000000004, 'unit': 'M', 'net_profit': -4.22}]","[{'period': ""Q3 '23"", 'revenue': 586.22, 'unit': 'M', 'net_profit': 20.75}, {'period': ""Q2 '23"", 'revenue': 977.17, 'unit': 'M', 'net_profit': 96.51}, {'period': ""Q1 '23"", 'revenue': 851.25, 'unit': 'M', 'net_profit': 176.63}, {'period': ""Q4 '22"", 'revenue': 110.76, 'unit': 'M', 'net_profit': 68.89}, {'period': ""Q3 '22"", 'revenue': 13.76, 'unit': 'M', 'net_profit': -8.13}, {'period': ""Q2 '22"", 'revenue': 11.96, 'unit': 'M', 'net_profit': -14.44}]",0.29,0.29,1151182000,531176000,500316000,14708000,11541000,0,13850000,500316000,6366000,0.6605251036388761,2.008504225200495,1.8787878787878787,__nan__,__nan__,__nan__,0.01277643326598227
15,MIDD,Middleby Corporation (The) Common Stock,"The Middleby Corporation designs, manufactures, markets, distributes, and services a range of foodservice, food processing, and residential kitchen equipment in the United States, Canada, Asia, Europe, the Middle East, and Latin America. Its Commercial Foodservice Equipment Group segment offers conveyor, combi, convection, baking, proofing, deck, speed cooking, and hydrovection ovens; ranges, fryers, rethermalizers; steam cooking, food warming, catering, induction cooking, and countertop cooking equipment; heated cabinets, charbroilers, ventless cooking systems, kitchen ventilation, toasters, griddles, charcoal grills, professional mixers, stainless steel fabrication, custom millwork, professional refrigerators, blast chillers, cold rooms, ice machines, and freezers; and soft serve ice cream, coffee and beverage dispensing, home and professional craft brewing equipment, fry dispensers, bottle filling and canning equipment, and IoT solutions. The company's Food Processing Equipment Group segment provides batch, baking, proofing, conveyor belt, and continuous processing ovens; frying and automated thermal processing systems; tumblers, massagers, grinders, slicers, reduction and emulsion systems, mixers, formers, and blenders; battering, breading, and seeding equipment; water cutting systems, food presses, food suspension equipment, filling and depositing solutions, and forming equipment; and food safety, food handling, freezing, and defrosting and packaging equipment for customers producing hot dog, dinner sausage, poultry, and lunchmeat, as well as muffin, cookie, and bread products. Its Residential Kitchen Equipment Group segment offers kitchen equipment comprising cookers, stoves, dishwashers, microwaves, cooktops, wine coolers, ice machines, and ventilation and outdoor equipment. The company was formerly known as Middleby Marshall Oven Company and changed its name to The Middleby Corporation in 1985. The company was founded in 1888 and is based in Elgin, Illinois.",Mr. James K. Pool III,Industrial - Machinery,125.14,USD,6713285468,https://images.financialmodelingprep.com/symbol/MIDD.png,867160,15.84,-4.13,1795648,796723000,428433000,"[{'period': '2024', 'revenue': 3880.0, 'unit': 'M', 'net_profit': 428.43}, {'period': '2023', 'revenue': 4040.0, 'unit': 'M', 'net_profit': 400.88}, {'period': '2022', 'revenue': 4030.0000000000005, 'unit': 'M', 'net_profit': 436.57}, {'period': '2021', 'revenue': 3250.0, 'unit': 'M', 'net_profit': 488.49}]","[{'period': ""Q4 '24"", 'revenue': 1010.0, 'unit': 'M', 'net_profit': 112.3}, {'period': ""Q3 '24"", 'revenue': 942.81, 'unit': 'M', 'net_profit': 114.17}, {'period': ""Q2 '24"", 'revenue': 991.55, 'unit': 'M', 'net_profit': 115.39}, {'period': ""Q1 '24"", 'revenue': 926.93, 'unit': 'M', 'net_profit': 86.57}, {'period': ""Q4 '23"", 'revenue': 1010.0, 'unit': 'M', 'net_profit': 76.29}, {'period': ""Q3 '23"", 'revenue': 980.65, 'unit': 'M', 'net_profit': 108.65}]",7.97,909.62,7283151000,2330043000,689533000,3644720000,643355000,0,829322000,689533000,637506000,-0.0007825952816026147,0.06872595925983208,0.06550802139037423,"[0.4, 0.05]","['2004-06-02', '1988-11-14']",__nan__,0.5004317499390031
16,MILE,Metromile Inc. Common Stock,"Metromile, Inc. provides insurance policies for automobile owners in the United States. It operates through two segments, Insurance Services and Enterprise Business Solutions. The company offers pay-per-mile auto insurance policies. It also provides The Pulse, a device that plugs into the diagnostic port of its customer's car and transmits data, such as miles driven, driving habits, phone use, speeding, hard braking, accelerating, cornering, and location over wireless cellular networks. In addition, the company offers access to its technology under software as a service arrangement, as well as professional services to third-party customers. Metromile, Inc. was founded in 2011 and is headquartered in San Francisco, California. As of July 28, 2022, Metromile, Inc. operates as a subsidiary of Lemonade, Inc..",Mr. Dan  Preston,Insurance - Property & Casualty,1.05,USD,0,https://images.financialmodelingprep.com/symbol/MILE.png,932105,-0.9122502172024327,0,1490173,-183264000,-232433000,"[{'period': '2021', 'revenue': 102.3, 'unit': 'M', 'net_profit': -232.43}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -571.09}, {'period': '2019', 'revenue': 0.0, 'unit': '', 'net_profit': -976.0}]","[{'period': ""Q1 '22"", 'revenue': 20.7, 'unit': 'M', 'net_profit': -34.32}, {'period': ""Q4 '21"", 'revenue': 35.06, 'unit': 'M', 'net_profit': -44.81}, {'period': ""Q3 '21"", 'revenue': 41.02, 'unit': 'M', 'net_profit': -26.76}, {'period': ""Q2 '21"", 'revenue': 35.08, 'unit': 'M', 'net_profit': -41.26}, {'period': ""Q1 '21"", 'revenue': -8.86, 'unit': 'M', 'net_profit': -103.63}, {'period': ""Q4 '20"", 'revenue': -57.95, 'unit': 'M', 'net_profit': -83.68}]",-1.83,-1.83,313415000,137779000,120940000,127027000,16839000,0,11160000,120940000,-121936000,-319.9004487885511,-405.9967588466327,-27.504672897196265,__nan__,__nan__,__nan__,0.40529968252955345
17,MILEW,Metromile Inc. Warrant ,"Metromile, Inc. provides pay-per-mile car insurance service. It also licenses artificial intelligence claims platform to automate claims, reduce losses associated with fraud, and unlock the productivity of insurance carriers' employees; and offers Metromile Pulse, a wireless device that is plugged into the car's diagnostics port and transmits data over wireless cellular networks. The company was founded in 2011 and is based in San Francisco, California.",Mr. Dan  Preston,Insurance - Property & Casualty,0.0586,USD,0,https://images.financialmodelingprep.com/symbol/MILEW.png,0,0.0,-0.010399997,,-183264000,-232433000,"[{'period': '2021', 'revenue': 102.3, 'unit': 'M', 'net_profit': -232.43}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -571.09}, {'period': '2019', 'revenue': 0.0, 'unit': '', 'net_profit': -976.0}]","[{'period': ""Q1 '22"", 'revenue': 20.7, 'unit': 'M', 'net_profit': -34.32}, {'period': ""Q4 '21"", 'revenue': 35.06, 'unit': 'M', 'net_profit': -44.81}, {'period': ""Q3 '21"", 'revenue': 41.02, 'unit': 'M', 'net_profit': -26.76}, {'period': ""Q2 '21"", 'revenue': 35.08, 'unit': 'M', 'net_profit': -41.26}, {'period': ""Q1 '21"", 'revenue': -8.86, 'unit': 'M', 'net_profit': -103.63}, {'period': ""Q4 '20"", 'revenue': -57.95, 'unit': 'M', 'net_profit': -83.68}]",-1.83,-1.83,313415000,137779000,120940000,127027000,16839000,0,11160000,120940000,-121936000,-319.9004487885511,-405.9967588466327,-27.504672897196265,__nan__,__nan__,__nan__,0.40529968252955345
18,MIME,Mimecast Limited Ordinary Shares,"Mimecast Limited provides cloud security and risk management services for corporate information and email. The company offers Mimecast Email Security solution, which protects against the delivery of malware, malicious URLs and attachments, spam, viruses, impersonation attacks, phishing, and spear-phishing attacks, including business email compromise, identity theft, extortion, fraud, and other attacks, while also preventing data leaks and other internal threats, as well as provides awareness training services. It also provides Cyber Resilience Extensions, such as Mimecast Enterprise Information Archiving that unifies email data to support e-discovery, forensic analysis, and compliance initiatives; Mimecast Business Continuity and Sync & Recover, which protects email and data against the threat of downtime as a result of system failure, natural disasters, planned maintenance, system upgrades, and migrations; and Mimecast Web Security service that protects against malicious web activity initiated by user action or malware and blocks access to inappropriate websites based on acceptable use policies. In addition, the company's Cyber Resilience Extensions also comprise Mimecast Secure Messaging, a secure and private channel to share sensitive information; Mimecast Health Care Pack, which prevents breaches and protects against data exfiltration transmissions; and Mimecast Large File Send that enables employees to create security and compliance risks when they turn to file sharing services. Further, it offers Threat Intelligence Dashboard, which displays cyber threat data specific to an organization by identifying users who pose the greatest cyber risk; and Mimecast Mobile and Desktop Apps for mobile, PC, and Mac users, as well as engages in data center operations. The company sells its services through direct sales and channel partners. Mimecast Limited was founded in 2003 and is headquartered in London, the United Kingdom. As of May 19, 2022, Mimecast Limited was taken private.",Mr. Peter Bauer,Software - Infrastructure,79.92,USD,0,https://images.financialmodelingprep.com/symbol/MIME.png,1387382,0.0,0,2047351,102723000,29745000,"[{'period': '2021', 'revenue': 501.4, 'unit': 'M', 'net_profit': 29.75}, {'period': '2020', 'revenue': 426.96, 'unit': 'M', 'net_profit': -2.2}, {'period': '2019', 'revenue': 340.38, 'unit': 'M', 'net_profit': -7.0}, {'period': '2018', 'revenue': 261.9, 'unit': 'M', 'net_profit': -12.39}]","[{'period': ""Q4 '21"", 'revenue': 151.6, 'unit': 'M', 'net_profit': 13.82}, {'period': ""Q3 '21"", 'revenue': 147.23, 'unit': 'M', 'net_profit': 17.58}, {'period': ""Q2 '21"", 'revenue': 142.55, 'unit': 'M', 'net_profit': 10.07}, {'period': ""Q1 '21"", 'revenue': 133.89, 'unit': 'M', 'net_profit': 5.77}, {'period': ""Q4 '20"", 'revenue': 129.64, 'unit': 'M', 'net_profit': 10.79}, {'period': ""Q3 '20"", 'revenue': 122.69, 'unit': 'M', 'net_profit': 10.05}]",0.45,0.45,934707000,443425000,292949000,573838000,114280000,0,345772000,292949000,88437000,0.4919609010762371,14.520454545454545,13.67605633802817,__nan__,__nan__,__nan__,0.613922865668065
19,MIND,MIND Technology Inc. Common Stock (DE),"MIND Technology, Inc., together with its subsidiaries, provides technology to the oceanographic, hydrographic, defense, seismic, and maritime security industries. The company's products include the GunLink seismic source acquisition and control systems that provide operators of marine seismic surveys with precise monitoring and control of energy sources; the BuoyLink RGPS tracking system, which is used to offer precise positioning of marine seismic energy sources and streamers; Digishot energy source controllers; Sleeve Gun energy sources; and SeaLink product line of marine sensors and solid streamer systems. It also provides streamer weight collars, depth and pressure transducers, air control valves, and source array systems; spare and replacement parts; and repair and engineering services, training and field service operations, and umbilical terminations, as well as side scan sonar equipment and systems. The company markets its products to governmental and commercial customers through internal sales organization and a network of distributors and representatives. It operates in the United States, Europe, Canada, Latin America, the Asia/South Pacific, Eurasia, and internationally. The company was formerly known as Mitcham Industries, Inc. MIND Technology, Inc. was incorporated in 1987 and is headquartered in The Woodlands, Texas.",Mr. Robert P. Capps CPA,"Hardware, Equipment & Parts",4.64,USD,36978109,https://images.financialmodelingprep.com/symbol/MIND.png,298349,0.77,-0.19,163269,2034000,-2069000,"[{'period': '2024', 'revenue': 36.51, 'unit': 'M', 'net_profit': -2.07}, {'period': '2023', 'revenue': 35.09, 'unit': 'M', 'net_profit': -7.43}, {'period': '2022', 'revenue': 23.11, 'unit': 'M', 'net_profit': -13.58}, {'period': '2021', 'revenue': 21.21, 'unit': 'M', 'net_profit': -14.0}]","[{'period': ""Q3 '25"", 'revenue': 12.11, 'unit': 'M', 'net_profit': 1.29}, {'period': ""Q2 '25"", 'revenue': 10040.0, 'unit': 'K', 'net_profit': 798.0}, {'period': ""Q1 '25"", 'revenue': 9680.0, 'unit': 'K', 'net_profit': 954.0}, {'period': ""Q4 '24"", 'revenue': 13.38, 'unit': 'M', 'net_profit': 1.44}, {'period': ""Q3 '24"", 'revenue': 4970.0, 'unit': 'K', 'net_profit': 568.0}, {'period': ""Q2 '24"", 'revenue': 8.75, 'unit': 'M', 'net_profit': -1.49}]",-2.5,-2.5,33491000,28339000,5289000,10850000,6566000,0,10277000,5289000,-5257000,1.5022222222222221,0.7215717938366303,0.536178107606679,"[0.0563, 0.0563]","['2018-10-12', '2018-10-12']",__nan__,0.3239676330954585
20,MINDP,MIND Technology Inc. Series A 9.00% Series A Cumulative Preferred Stock (DE),"MIND Technology, Inc., together with its subsidiaries, provides technology to the oceanographic, hydrographic, defense, seismic, and maritime security industries. The company's products include the GunLink seismic source acquisition and control systems that provide operators of marine seismic surveys with precise monitoring and control of energy sources; the BuoyLink RGPS tracking system, which is used to offer precise positioning of marine seismic energy sources and streamers; Digishot energy source controllers; Sleeve Gun energy sources; and SeaLink product line of marine sensors and solid streamer systems. It also provides streamer weight collars, depth and pressure transducers, air control valves, and source array systems; spare and replacement parts; and repair and engineering services, training and field service operations, and umbilical terminations, as well as side scan sonar equipment and systems. The company markets its products to governmental and commercial customers through internal sales organization and a network of distributors and representatives. It operates in the United States, Europe, Canada, Latin America, the Asia/South Pacific, Eurasia, and internationally. The company was formerly known as Mitcham Industries, Inc. MIND Technology, Inc. was incorporated in 1987 and is headquartered in The Woodlands, Texas.",Mr. Robert P. Capps,"Hardware, Equipment & Parts",13.3,USD,5299784,https://images.financialmodelingprep.com/symbol/MINDP.png,11868,-10.892710892710893,-0.19,9029,2034000,-2069000,"[{'period': '2024', 'revenue': 36.51, 'unit': 'M', 'net_profit': -2.07}, {'period': '2023', 'revenue': 35.09, 'unit': 'M', 'net_profit': -7.43}, {'period': '2022', 'revenue': 23.11, 'unit': 'M', 'net_profit': -13.58}, {'period': '2021', 'revenue': 21.21, 'unit': 'M', 'net_profit': -14.0}]","[{'period': ""Q3 '25"", 'revenue': 12.11, 'unit': 'M', 'net_profit': 1.29}, {'period': ""Q2 '25"", 'revenue': 10040.0, 'unit': 'K', 'net_profit': 798.0}, {'period': ""Q1 '25"", 'revenue': 9680.0, 'unit': 'K', 'net_profit': 954.0}, {'period': ""Q4 '24"", 'revenue': 13.38, 'unit': 'M', 'net_profit': 1.44}, {'period': ""Q3 '24"", 'revenue': 4970.0, 'unit': 'K', 'net_profit': 568.0}, {'period': ""Q2 '24"", 'revenue': 8.75, 'unit': 'M', 'net_profit': -1.49}]",-2.5,-2.5,33491000,28339000,5289000,10850000,6566000,0,10277000,5289000,-5257000,1.5022222222222221,0.7215717938366303,0.536178107606679,"[0.5625, 0.35625]","['2023-10-12', '2016-07-13']",__nan__,0.3239676330954585
21,MIRM,Mirum Pharmaceuticals Inc. Common Stock,"Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California.",Mr. Christopher  Peetz,Biotechnology,39.32,USD,1927238344,https://images.financialmodelingprep.com/symbol/MIRM.png,532593,-21.25,-1.68,504993,-48972000,-87942000,"[{'period': '2024', 'revenue': 336.89, 'unit': 'M', 'net_profit': -87.94}, {'period': '2023', 'revenue': 186.37, 'unit': 'M', 'net_profit': -163.41}, {'period': '2022', 'revenue': 77.06, 'unit': 'M', 'net_profit': -135.66}, {'period': '2021', 'revenue': 19.14, 'unit': 'M', 'net_profit': -83.99}]","[{'period': ""Q4 '24"", 'revenue': 99.41, 'unit': 'M', 'net_profit': -23.79}, {'period': ""Q3 '24"", 'revenue': 90.38, 'unit': 'M', 'net_profit': -14.23}, {'period': ""Q2 '24"", 'revenue': 77.88, 'unit': 'M', 'net_profit': -24.64}, {'period': ""Q1 '24"", 'revenue': 69.22, 'unit': 'M', 'net_profit': -25.28}, {'period': ""Q4 '23"", 'revenue': 69.55, 'unit': 'M', 'net_profit': -33.15}, {'period': ""Q3 '23"", 'revenue': 47.73, 'unit': 'M', 'net_profit': -23.59}]",-1.85,-1.85,670754000,392788000,280315000,445114000,78286000,12526000,126551000,222503000,9332000,0.6412044838449703,0.4618486675029832,0.5375,__nan__,__nan__,__nan__,0.6636024533584592
22,MIST,Milestone Pharmaceuticals Inc. Common Shares,"Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in Montréal, Canada.",Mr. Joseph G. Oliveto M.B.A.,Biotechnology,0.6529,USD,34834827,https://images.financialmodelingprep.com/symbol/MIST.png,2288167,-0.97,-0.0292,1155262,-42102000,0,"[{'period': '2024', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': '2023', 'revenue': 1.0, 'unit': 'M', 'net_profit': -59.69}, {'period': '2022', 'revenue': 5.0, 'unit': 'M', 'net_profit': -57.13}, {'period': '2021', 'revenue': 15.0, 'unit': 'M', 'net_profit': -42.63}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.36}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.44}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.36}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.35}, {'period': ""Q4 '23"", 'revenue': -0.868, 'unit': 'M', 'net_profit': -13.61}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.08}]",-0.67,-0.67,75499000,73926000,69695000,62352000,1490000,0,8126000,25314000,-28848000,0.25935438473040723,1.0,0.5179856115107913,__nan__,__nan__,__nan__,0.8258652432482549
23,MITC,MeaTech 3D Ltd. American Depositary Shares,"MeaTech 3D Ltd., a deep-tech food company, engages in the development of cultivated meat technologies to manufacture cultivated meat without animal slaughter. The company develops a three-dimensional bioprinter to deposit layers of differentiated stem cells, scaffolding, and cell nutrients in a three-dimensional form of structured cultured meat. It intends to license its production technology; provide associated products, such as cell lines, printheads, bioreactors, and incubators; and offer services, such as technology implementation, training, and engineering support directly and through contractors to food processing and food retail companies. The company is headquartered in Rehovot, Israel.",Mr. Sharon  Fima,Packaged Foods,3.34,USD,57471714,https://images.financialmodelingprep.com/symbol/MITC.png,0,-2.1548387096774193,-0.05000019,115786,-13690630,-16864000,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -16.86}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -41.55}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -18.04}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -18.53}]","[{'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.17}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.17}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.25}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.25}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.52}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.52}]",-0.66,-0.66,10823000,4966000,4599000,4941000,0,0,2485000,4248000,-12997000,0.467766089256379,0.5941373252147962,0.7843137254901961,__nan__,__nan__,__nan__,0.4565277649450245
24,MITK,Mitek Systems Inc. Common Stock,"Mitek Systems, Inc. develops, markets, and sells mobile image capture and digital identity verification solutions in the United States, Europe, Latin America, and internationally. The company's solutions are embedded in native mobile apps and web browsers to facilitate digital consumer experiences. It offers Mobile Deposit that enables individuals and businesses to remotely deposit checks using their camera-equipped smartphone or tablet; and Mobile Verify, an identity verification solution that is integrated into mobile apps, mobile websites, and desktop applications. The company also provides Mobile Fill, which includes automatic image capture, minimizes the numbers of clicks, and expedites form fill completion; and MiSnap, a mobile-capture software development kit that enables an intuitive user experience and instant capture of quality images of identity documents and checks. In addition, it offers CheckReader that enables financial institutions to automatically extract data from checks; Check Fraud Defender, an AI-powered and cloud-hosted model for fighting check fraud; and Check Intelligence that enables financial institutions to automatically extract data from a check image received across any deposit channel, including branch, ATM, remote deposit capture, and mobile. Further, the company provides ID_CLOUD, an automated identity verification solution that is integrated into a customers' application to read and validate identity documents; IDLive Face, a passive facial liveness detection product; IDVoice, a robust AI-driven voice biometric engine; IDLive Voice that helps stop spoofing attacks on voice biometric systems; and IDLive Doc that works to fight fraud related to digitally displayed document images. Mitek Systems, Inc. was incorporated in 1986 and is based in San Diego, California.",Mr. Edward H. West,Software - Application,7.11,USD,321682707,https://images.financialmodelingprep.com/symbol/MITK.png,516709,71.1,-0.06,636527,25261000,3278000,"[{'period': '2024', 'revenue': 172.08, 'unit': 'M', 'net_profit': 3.28}, {'period': '2023', 'revenue': 172.55, 'unit': 'M', 'net_profit': 8.03}, {'period': '2022', 'revenue': 143.94, 'unit': 'M', 'net_profit': 3.69}, {'period': '2021', 'revenue': 119.8, 'unit': 'M', 'net_profit': 7.98}]","[{'period': ""Q1 '25"", 'revenue': 37.25, 'unit': 'M', 'net_profit': -4.61}, {'period': ""Q4 '24"", 'revenue': 43.22, 'unit': 'M', 'net_profit': 8.57}, {'period': ""Q3 '24"", 'revenue': 44980.0, 'unit': 'K', 'net_profit': 216.0}, {'period': ""Q2 '24"", 'revenue': 46970.0, 'unit': 'K', 'net_profit': 282.0}, {'period': ""Q1 '24"", 'revenue': 36.92, 'unit': 'M', 'net_profit': -5.79}, {'period': ""Q4 '23"", 'revenue': 37.66, 'unit': 'M', 'net_profit': -1.44}]",0.07,0.0691,413753000,185051000,130340000,198952000,47500000,11410000,42147000,93456000,30250000,-0.36246624435302727,-0.591628254640588,-0.611111111111111,__nan__,__nan__,__nan__,0.4808472687811327
25,MITO,Stealth BioTherapeutics Corp. ADS,"Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate is Elamipretide that is in phase 3 clinical trial to treat barth syndrome, phase 2/3 clinical trial for the treatment of duchenne cardiomyopathy, phase 2a clinical trial to treat friedreich's ataxia, phase 2 clinical trial for the treatment of dry age-related macular degeneration, phase 2 clinical trial to treat leber's hereditary optic neuropathy, and phase 3 clinical trial for the treatment of replisome myopathies. The company's product candidates also include SBT-20 to treat complications of diabetes, renal diseases, ocular diseases, neurodegenerative, Parkinson's, Alzheimer's, Huntington's, and ALS diseases; SBT-550 for rare neurological indications; and SBT-272, a peptidomimetic that targets the mitochondria and stabilizing mitochondrial function under conditions of oxidative stress, as well as SBT 550. Stealth BioTherapeutics Corp was incorporated in 2006 and is based in George Town, the Cayman Islands.",Ms. Irene P. McCarthy J.D.,Biotechnology,0.32,USD,0,https://images.financialmodelingprep.com/symbol/MITO.png,201870,-0.3463203463203463,0,1299739,-51208000,-53769000,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -53.77}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -57.46}, {'period': '2019', 'revenue': 21.09, 'unit': 'M', 'net_profit': -71.73}, {'period': '2018', 'revenue': 0.0, 'unit': 'M', 'net_profit': -96.71}]","[{'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.66}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -26.93}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.3}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -18.41}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.69}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -18.34}]",-1.16,-1.16,50226000,49602000,47135000,95521000,0,0,10828000,47135000,-45038000,0.07595142284858437,0.06418713124597525,0.06451612903225812,__nan__,__nan__,__nan__,1.9018237566200773
26,MKD,Molecular Data Inc. American Depositary Shares,"Molecular Data Inc., through its subsidiaries, operates in the chemical e-commerce business in the People's Republic of China. The company operates technology-driven platform that connects participants along the chemical value chain through its integrated solutions. It delivers e-commerce solutions, financial solutions, warehousing and logistics solutions, and software-as-a-service suites for participants in the traditional chemical industry. The company offers its e-commerce solutions through online platform that consists of molbase.com and molbase.cn websites; Moku Data Weixin account; Chemical Community app; and other ancillary platforms. Molecular Data Inc. was founded in 2013 and is headquartered in Shanghai, the People's Republic of China.",Dr. Zheng Wang,Chemicals,0.41,USD,0,https://images.financialmodelingprep.com/symbol/MKD.png,0,-0.10638297872340426,0.00999999,422231,-188797000,-328038000,"[{'period': '2020', 'revenue': 7600.0, 'unit': 'M', 'net_profit': -328.04}, {'period': '2019', 'revenue': 13210.0, 'unit': 'M', 'net_profit': -193.55}, {'period': '2018', 'revenue': 9050.0, 'unit': 'M', 'net_profit': -254.64}, {'period': '2017', 'revenue': 4200.0, 'unit': 'M', 'net_profit': -107.81}]","[{'period': ""Q4 '20"", 'revenue': 2900.0, 'unit': 'M', 'net_profit': -51.2}, {'period': ""Q2 '20"", 'revenue': 2220.0, 'unit': 'M', 'net_profit': -52.47}, {'period': ""Q4 '19"", 'revenue': 4059.9999999999995, 'unit': 'M', 'net_profit': -60.33}, {'period': ""Q3 '19"", 'revenue': 4019.9999999999995, 'unit': 'M', 'net_profit': -29.55}, {'period': ""Q2 '19"", 'revenue': 5120.0, 'unit': 'M', 'net_profit': -103.67}, {'period': ""Q4 '18"", 'revenue': 2970.0, 'unit': 'M', 'net_profit': -166.6}]",-2.62,-2.62,684821000,663186000,347349000,712700000,92043000,353000,692606000,11311000,-234164000,-4.140231529223912,-0.6948663897327795,-0.40106951871657753,__nan__,__nan__,__nan__,1.0407099081365787
27,MKGI,Monaker Group Inc. Common Stock,"Monaker Group, Inc. is a technology-driven travel company, which is focused on delivering innovation to alternative lodging rentals. The company is headquartered in Weston, Florida and currently employs 8 full-time employees. The firm operates NextTrip.com, an online marketplace for the alternative lodging rental (ALR) industry. The company operates through a segment consisting of various products and services related to its online marketplace of travel and related logistics, including destination tours/activities, accommodation rental listings, hotel listings, air and car rental. Its NextTrip.com has a capacity of uniting a range of travelers seeking ALR online with property owners and managers. As of February 29, 2016, the Company operated its online marketplace through 115 Websites in 16 languages, with Websites in Europe, Asia, South America and the United States. As of February 29, 2016, its global marketplace included approximately 100,000 paid listings on subscriptions and contracted with over 1.1 million listings under the performance based listing arrangement ALRs.",Mr. William Kerby,Travel Services,2.27,USD,13483550,https://images.financialmodelingprep.com/symbol/MKGI.png,234815,0.0,0.1500001,149868,-7775716,-16508655,"[{'period': '2021', 'revenue': 0.04834, 'unit': 'M', 'net_profit': -16.51}, {'period': '2020', 'revenue': 0.44177, 'unit': 'M', 'net_profit': -9.45}, {'period': '2019', 'revenue': 0.50519, 'unit': 'M', 'net_profit': 4.3}, {'period': '2018', 'revenue': 0.4308, 'unit': 'M', 'net_profit': -10.04}]","[{'period': ""Q2 '21"", 'revenue': 0.01073, 'unit': 'M', 'net_profit': -7.47}, {'period': ""Q1 '21"", 'revenue': 0.0376, 'unit': 'M', 'net_profit': -9.01}, {'period': ""Q2 '20"", 'revenue': 0.00787, 'unit': 'M', 'net_profit': -2.05}, {'period': ""Q1 '20"", 'revenue': 82.95, 'unit': 'K', 'net_profit': -747.14}, {'period': ""Q2 '19"", 'revenue': 0.02182, 'unit': 'M', 'net_profit': -1.44}, {'period': ""Q1 '19"", 'revenue': 0.048990000000000006, 'unit': 'M', 'net_profit': 2.15}]",-1.4,-1.4,25997520,12902118,2905872,6835073,0,4912111,6835073,2640988,-7356216,0.13555361275300656,-0.7460817842073232,-0.7499999999999998,__nan__,__nan__,__nan__,0.26291250088469975
28,MKSI,MKS Instruments Inc. Common Stock,"MKS Instruments, Inc. provides instruments, systems, subsystems, and process control solutions that measure, monitor, deliver, analyze, power, and control critical parameters of manufacturing processes worldwide. Its Vacuum & Analysis segment offers pressure and vacuum control solutions, including direct and indirect pressure measurement; materials delivery solutions comprising flow and valve technologies, as well as integrated pressure measurement and control subsystems, which provide customers with precise control capabilities; power solutions products, such as microwave, power delivery systems, radio frequency matching networks, and metrology products used in providing energy to etching, stripping, and deposition processes; and plasma and reactive gas products. Its Light & Motion segment offers laser products, such as continuous wave and pulsed nanosecond, diode and diode-pumped solid-state, and fiber laser technologies; and photonics products comprising motion control, optical tables and vibration isolation systems, photonic instruments, optics and optical assemblies, opto-mechanical components, temperature sensing products for wafer fabrication systems, and laser and LED measurement products, including laser power and energy meters, laser beam profilers, and optical and photonic subsystems. Its Equipment & Solutions segment provides laser-based systems for printed circuit board (PCB) manufacturing, including flexible interconnect PCB processing systems and high-density interconnect solutions for rigid PCB manufacturing and substrate processing, and multi-layer ceramic capacitor test systems. It serves semiconductor, industrial technologies, life and health sciences, research, and defense markets. It sells its products and services through its direct sales organization, independent distributors, and sales representatives, as well as through its websites and product catalogs. The company was incorporated in 1961 and is headquartered in Andover, Massachusetts.",Dr. John T. C. Lee Ph.D.,"Hardware, Equipment & Parts",58.78,USD,3964546416,https://images.financialmodelingprep.com/symbol/MKSI.png,1232627,20.92,-4.21,2614725,870000000,190000000,"[{'period': '2024', 'revenue': 3590.0, 'unit': 'M', 'net_profit': 190.0}, {'period': '2023', 'revenue': 3.62, 'unit': 'B', 'net_profit': -1.84}, {'period': '2022', 'revenue': 3550.0, 'unit': 'M', 'net_profit': 333.0}, {'period': '2021', 'revenue': 2950.0, 'unit': 'M', 'net_profit': 551.0}]","[{'period': ""Q4 '24"", 'revenue': 935.0, 'unit': 'M', 'net_profit': 90.0}, {'period': ""Q3 '24"", 'revenue': 896.0, 'unit': 'M', 'net_profit': 62.0}, {'period': ""Q2 '24"", 'revenue': 887.0, 'unit': 'M', 'net_profit': 23.0}, {'period': ""Q1 '24"", 'revenue': 868.0, 'unit': 'M', 'net_profit': 15.0}, {'period': ""Q4 '23"", 'revenue': 893.0, 'unit': 'M', 'net_profit': -68.0}, {'period': ""Q3 '23"", 'revenue': 932.0, 'unit': 'M', 'net_profit': 39.0}]",2.82,2.81,8590000000,2474000000,714000000,6268000000,615000000,0,775000000,714000000,410000000,1.7404255319148936,1.1032047800108638,1.1023222060957911,"[0.22, 0.15]","['2025-02-24', '2011-02-25']",__nan__,0.7296856810244471
29,MKTX,MarketAxess Holdings Inc. Common Stock,"MarketAxess Holdings Inc., together with its subsidiaries, operates an electronic trading platform for institutional investor and broker-dealer companies worldwide. It offers the access to liquidity in the U.S. investment-grade bonds, U.S. high-yield bonds, and U.S. Treasuries, as well as municipal bonds, emerging market debts, Eurobonds, and other fixed income securities. The company, through its Open Trading protocols, executes bond trades between and among institutional investor and broker-dealer clients in an all-to-all anonymous trading environment for corporate bonds. It also offers trading-related products and services, including composite+ pricing and other market data products to assist clients with trading decisions; auto-execution and other execution services for clients requiring specialized workflow solutions; connectivity solutions that facilitate straight-through processing; and technology services to optimize trading environments. In addition, the company provides various pre-and post-trade services, such as trade matching, trade publication, regulatory transaction reporting, and market and reference data across a range of fixed-income and other products. MarketAxess Holdings Inc. was incorporated in 2000 and is headquartered in New York, New York.",Mr. Christopher Robert Concannon J.D.,Financial - Capital Markets,206.27,USD,7774976364,https://images.financialmodelingprep.com/symbol/MKTX.png,700190,28.33,-1.65,792335,432769000,274181000,"[{'period': '2024', 'revenue': 817.1, 'unit': 'M', 'net_profit': 274.18}, {'period': '2023', 'revenue': 752.55, 'unit': 'M', 'net_profit': 258.06}, {'period': '2022', 'revenue': 718.3, 'unit': 'M', 'net_profit': 250.22}, {'period': '2021', 'revenue': 698.95, 'unit': 'M', 'net_profit': 257.89}]","[{'period': ""Q4 '24"", 'revenue': 202.4, 'unit': 'M', 'net_profit': 65.14}, {'period': ""Q3 '24"", 'revenue': 206.72, 'unit': 'M', 'net_profit': 71.49}, {'period': ""Q2 '24"", 'revenue': 197.25, 'unit': 'M', 'net_profit': 64.94}, {'period': ""Q1 '24"", 'revenue': 211.66, 'unit': 'M', 'net_profit': 72.61}, {'period': ""Q4 '23"", 'revenue': 196.75, 'unit': 'M', 'net_profit': 69.63}, {'period': ""Q3 '23"", 'revenue': 172.28, 'unit': 'M', 'net_profit': 54.94}]",7.29,7.28,1789216000,1145935000,649255000,400556000,341921000,60483000,259848000,544478000,375295000,0.09534319246568582,0.062490554339191255,0.06113537117903929,"[0.76, 0.07]","['2025-02-19', '2009-11-06']",__nan__,0.22387235526621715
30,MKTY,Mechanical Technology Incorporated Common Stock (Nevada),"Mechanical Technology, Incorporated, through its subsidiary, MTI Instruments, Inc., designs, manufactures, and markets precision linear displacement solutions, vibration measurement and system balancing solutions, and wafer inspection tools worldwide. It offers electronic gauging instruments for position, displacement, and vibration applications in the industrial manufacturing/production markets, as well as the research, design, and process development market. The company also provides engine vibration analysis systems for military and commercial aircraft; capacitance, laser systems, and fiber optic sensors for non-contact measurement; and vibration and balancing systems, engine signal conditioning, and charge amplifiers for turbine engine/rotating machine measurement and balancing. In addition, it offers portable precision signal generator; manual semiconductor metrology system, semi-automated metrology system, and photovoltaic/solar metrology system; and rapid-deployment custom measurement solutions to OEMs. The company serves manufacturing, electronics, semiconductor, solar, commercial and military aviation, automotive, and data storage industries. Mechanical Technology, Incorporated was founded in 1961 and is based in Albany, New York.",Mr. Michael M. Toporek,Industrial - Machinery,12.66,USD,256306764,https://images.financialmodelingprep.com/symbol/MKTY.png,206241,63.3,-0.1800003,87544,1713000,1946000,"[{'period': '2020', 'revenue': 9.6, 'unit': 'M', 'net_profit': 1.95}, {'period': '2019', 'revenue': 6570.0, 'unit': 'K', 'net_profit': 323.0}, {'period': '2017', 'revenue': 7060.0, 'unit': 'K', 'net_profit': 582.0}, {'period': '2016', 'revenue': 7060.0, 'unit': 'K', 'net_profit': -359.0}]","[{'period': ""Q3 '21"", 'revenue': 5070.0, 'unit': 'K', 'net_profit': -610.0}, {'period': ""Q2 '21"", 'revenue': 3.3, 'unit': 'M', 'net_profit': -1.17}, {'period': ""Q1 '21"", 'revenue': 2330.0, 'unit': 'K', 'net_profit': -666.0}, {'period': ""Q4 '20"", 'revenue': 9.6, 'unit': 'K', 'net_profit': 1.95}, {'period': ""Q3 '20"", 'revenue': 3.69, 'unit': 'M', 'net_profit': 1.51}, {'period': ""Q2 '20"", 'revenue': 2440.0, 'unit': 'K', 'net_profit': 602.0}]",0.2,0.2,8647000,4779000,3380000,2731000,975000,750000,1637000,2630000,787000,3.4842931937172774,5.024767801857585,4.952380952380953,"[0.37, 0.37]","['2019-03-21', '2019-03-21']",__nan__,0.31583208049034345
31,MLAB,Mesa Laboratories Inc. Common Stock,"Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.",Mr. Gary M. Owens,"Hardware, Equipment & Parts",105.235,USD,571805948,https://images.financialmodelingprep.com/symbol/MLAB.png,41388,-2.27,-3.805,69983,-238376999,-254246000,"[{'period': '2024', 'revenue': 216.19, 'unit': 'M', 'net_profit': -254.25}, {'period': '2023', 'revenue': 219080.0, 'unit': 'K', 'net_profit': 930.0}, {'period': '2022', 'revenue': 184.34, 'unit': 'M', 'net_profit': 1.87}, {'period': '2021', 'revenue': 133.94, 'unit': 'M', 'net_profit': 3.27}]","[{'period': ""Q3 '25"", 'revenue': 62.84, 'unit': 'M', 'net_profit': -1.68}, {'period': ""Q2 '25"", 'revenue': 57.83, 'unit': 'M', 'net_profit': 3.43}, {'period': ""Q1 '25"", 'revenue': 58.17, 'unit': 'M', 'net_profit': 3.39}, {'period': ""Q4 '24"", 'revenue': 58.9, 'unit': 'M', 'net_profit': -254.58}, {'period': ""Q3 '24"", 'revenue': 53.47, 'unit': 'M', 'net_profit': 2.12}, {'period': ""Q2 '24"", 'revenue': 53.16, 'unit': 'M', 'net_profit': -1.23}]",-47.2,-47.2,446796000,109352000,28214000,301403000,39055000,0,44312000,28214000,41566000,-7.539117764854337,-274.3827956989247,-278.6470588235294,"[0.16, 0.2]","['2025-02-28', '2003-11-26']",__nan__,0.674587507497829
32,MLAC,Malacca Straits Acquisition Company Limited Class A Ordinary Shares,"Mountain Lake Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.",Paul J Grinberg,Shell Companies,10.05,USD,311474615,https://images.financialmodelingprep.com/symbol/MLAC.png,129534,-59.12,0,20688,-6256494,7775629,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.78}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.05}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -179.61}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 487.88}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -44.76}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -18.95}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.66}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -277.12}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -352.81}]",1.95,1.95,233231190,1499561,1383392,8067334,0,0,17334,1383392,-1388732,0.2969334853377369,0.2851289470926702,4.735294117647058,__nan__,__nan__,__nan__,0.03458943034162798
33,MLACU,Malacca Straits Acquisition Company Limited Units,"Malacca Straits Acquisition Company Limited does not have significant business. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the media, food processing, renewable energy, and healthcare industries. The company was formerly known as Bilbao Street Limited and changed its name to Malacca Straits Acquisition Company Limited in February 2020. Malacca Straits Acquisition Company Limited was incorporated in 2019 and is based in Central, Hong Kong.",Mr. Gordon  Lo,Shell Companies,10.18,USD,315503650,https://images.financialmodelingprep.com/symbol/MLACU.png,18863,33.05,-0.04,46,-6256494,7775629,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.78}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.05}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -179.61}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 487.88}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -44.76}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -18.95}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.66}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -277.12}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -352.81}]",1.95,1.95,233231190,1499561,1383392,8067334,0,0,17334,1383392,-1388732,0.2969334853377369,0.2851289470926702,4.735294117647058,__nan__,__nan__,__nan__,0.03458943034162798
34,MLACW,Malacca Straits Acquisition Company Limited Warrants,,,Shell Companies,0.0014,USD,0,https://images.financialmodelingprep.com/symbol/MLACW.png,0,0.0,-0.001,7031,-6256494,7775629,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.78}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.05}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -179.61}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 487.88}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -44.76}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -18.95}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.66}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -277.12}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -352.81}]",1.95,1.95,233231190,1499561,1383392,8067334,0,0,17334,1383392,-1388732,0.2969334853377369,0.2851289470926702,4.735294117647058,__nan__,__nan__,__nan__,0.03458943034162798
35,MLCO,Melco Resorts & Entertainment Limited American Depositary Shares,"Melco Resorts & Entertainment Limited develops, owns, and operates casino gaming and resort facilities in Asia and Europe. It owns and operates City of Dreams, an integrated casino resort that has approximately 511 gaming tables and 572 gaming machines; approximately 770 rooms, and suites and villas; approximately 25 restaurants and bars, and 165 retail outlets; and health and fitness clubs, three swimming pools, spa and salons, and banquet and meeting facilities. The company also operates Altira Macau, a casino hotel, which has approximately 101 gaming tables and 121 gaming machines; 230 hotel rooms; various dining and casual restaurants, and recreation and leisure facilities; and various non-gaming amenities comprising a spa, gymnasium, outdoor garden podium, and sky terrace lounge. In addition, it operates Studio City, a cinematically themed integrated resort with gaming facilities, hotel, entertainment, retail, and food and beverage outlets that comprises 290 gaming tables and 645 gaming machines in Cotai, Macau. Further, the company owns and operates seven Mocha Clubs with 813 gaming machines, as well as Grand Dragon casino in Taipa Island, Macau. Additionally, it operates and manages City of Dreams Manila, an integrated resort in the Entertainment City complex in Manila; a casino in Limassol and three satellite casinos in Nicosia, Ayia Napa, and Paphos in Cyprus. The company was formerly known as Melco Crown Entertainment Limited and changed its name to Melco Resorts & Entertainment Limited in April 2017. The company was incorporated in 2004 and is headquartered in Central, Hong Kong. Melco Resorts & Entertainment Limited is a subsidiary of Melco Leisure and Entertainment Group Limited.",Mr. Yau Lung  Ho,"Gambling, Resorts & Casinos",4.61,USD,644958616,https://images.financialmodelingprep.com/symbol/MLCO.png,4286390,46.1,-0.02,6122071,1028022999,43543000,"[{'period': '2024', 'revenue': 4640.0, 'unit': 'M', 'net_profit': 43.54}, {'period': '2023', 'revenue': 3780.0, 'unit': 'M', 'net_profit': -326.92}, {'period': '2022', 'revenue': 1.35, 'unit': 'B', 'net_profit': -1.1}, {'period': '2021', 'revenue': 2009.9999999999998, 'unit': 'M', 'net_profit': -956.46}]","[{'period': ""Q4 '24"", 'revenue': 1190.0, 'unit': 'M', 'net_profit': -20.27}, {'period': ""Q3 '24"", 'revenue': 1180.0, 'unit': 'M', 'net_profit': 27.26}, {'period': ""Q2 '24"", 'revenue': 1160.0, 'unit': 'M', 'net_profit': 21.39}, {'period': ""Q1 '24"", 'revenue': 1110.0, 'unit': 'M', 'net_profit': 15.17}, {'period': ""Q4 '23"", 'revenue': 1090.0, 'unit': 'M', 'net_profit': -156.55}, {'period': ""Q3 '23"", 'revenue': 1020.0, 'unit': 'M', 'net_profit': -16.3}]",0.1,0.1,7985343000,1429167000,1147193000,8925307000,144211000,0,1190864000,1147193000,325475000,0.6700044332102518,1.1331916065092378,1.4004004004004003,"[0.16512, 0.34418]","['2020-02-28', '2014-04-02']",__nan__,1.1177111615618764
36,MLHR,Herman Miller Inc. Common Stock,"Herman Miller, Inc. engages in the research, design, manufacture, and distribution of office furniture systems, seating products, other freestanding furniture elements, textiles, home furnishings, and related services worldwide. The company offers seating products under the Embody, Aeron, Mirra2, Setu, Sayl, Verus, Cosm, Lino, Verus, Celle, Equa, Taper, and Ergon names; and modular systems under the Canvas Office Landscape, Locale, Public Office Landscape, Layout Studio, Action Office, Ethospace, Arras, Prospect, Overlay, and Resolve names. It also provides storage products under the Meridian and Tu names; wood case goods under the Geiger name; freestanding furniture products under the Abak, Intent, Sense, and Envelop names; healthcare products under the Palisade, Compass, Nala, Ava, and Nemschoff names; Thrive portfolio of ergonomic solutions, ergonomic, and technology support products under the Colebrook Bosson Saunders name; and textiles under the Maharam name, as well as Live Platform system of cloud-connected furnishings, applications, and dashboards. In addition, the company offers products for residential settings under the Eames, Eames Soft Pad, HAY, Nelson, Bubble Lamps, Airia, Ardea, Bumper, Burdick Group, Everywhere, Claw, Caper, Distil, Envelope, Formwork, Full Round, H Frame, I Beam, Landmark, Logic Mini, Logic Power Access Solutions, Renew, Rolled Arm, Scissor, Sled, Soft Pad, Swoop, Tone, Twist, Ward Bennett, and Wireframe names. Its products are used in offices and related conference, lobby, and lounge areas; transportation terminals; hospitals, clinics, and other healthcare facilities; industrial and educational settings; and residential and other environments. The company markets its products through its sales staff, own dealer network, independent dealers and retailers, and independent contract office furniture dealers, as well as through e-commerce Website. Herman Miller, Inc. was founded in 1905 and is headquartered in Zeeland, Michigan.",Ms. Andrea Owen,Home Improvement,38.66,USD,2922197441,https://images.financialmodelingprep.com/symbol/MLHR.png,564696,0.0,0.0299988,201186,331000000,82300000,"[{'period': '2024', 'revenue': 3630.0, 'unit': 'M', 'net_profit': 82.3}, {'period': '2023', 'revenue': 4090.0, 'unit': 'M', 'net_profit': 42.1}, {'period': '2022', 'revenue': 3950.0, 'unit': 'M', 'net_profit': -19.7}, {'period': '2021', 'revenue': 2470.0, 'unit': 'M', 'net_profit': 174.6}]","[{'period': ""Q3 '25"", 'revenue': 876.2, 'unit': 'M', 'net_profit': -12.7}, {'period': ""Q2 '25"", 'revenue': 970.4, 'unit': 'M', 'net_profit': 34.1}, {'period': ""Q1 '25"", 'revenue': 861.5, 'unit': 'M', 'net_profit': -1.2}, {'period': ""Q4 '24"", 'revenue': 888.9, 'unit': 'M', 'net_profit': 9.9}, {'period': ""Q3 '24"", 'revenue': 872.3, 'unit': 'M', 'net_profit': 22.2}, {'period': ""Q2 '24"", 'revenue': 949.5, 'unit': 'M', 'net_profit': 33.5}]",1.12,1.11,4043600000,1069599999,230400000,2584600000,330500000,63900000,697700000,230400000,273900000,-0.1078167115902965,0.9548693586698337,1.0,"[0.1875, 0.4416]","['2021-11-24', '1984-11-26']",__nan__,0.6391829063211
37,MLND,Millendo Therapeutics Inc. Common Stock,"Millendo Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing novel treatments for orphan endocrine diseases in the United States. Its lead product candidates include livoletide, a potential treatment for Prader-Willi syndrome; nevanimibe, a potential treatment for patients with classic congenital adrenal hyperplasia; and MLE-301, a neurokinin 3-receptor antagonist for the treatment of vasomotor symptoms in menopausal women. The company is headquartered in Ann Arbor, Michigan.",Dr. Julia Owens,Biotechnology,1.06,USD,11148126,https://images.financialmodelingprep.com/symbol/MLND.png,140975,0.0,-0.06000006,1912625,-35302000,-36406000,"[{'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -36.41}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -44.57}, {'period': '2018', 'revenue': 0.0, 'unit': 'M', 'net_profit': -27.19}, {'period': '2017', 'revenue': 0.295, 'unit': 'M', 'net_profit': -50.98}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.06}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.39}, {'period': ""Q2 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.67}, {'period': ""Q1 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.0}, {'period': ""Q2 '19"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.87}, {'period': ""Q1 '19"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.37}]",-28.95,-28.95,43409000,40901000,38174000,9683000,314000,0,7987000,38174000,-30461000,0.20765812272747677,0.18313588224735236,0.40639737543571874,__nan__,__nan__,__nan__,0.22306434149600313
38,MLVF,Malvern Bancorp Inc. Common Stock,"Malvern Bancorp, Inc. operates as the bank holding company for Malvern Bank that provides various banking products and services to consumer and business customers in Pennsylvania. It offers personal and business checking accounts, retirement accounts, money market accounts, and time and savings accounts; safe deposit boxes, credit cards, wire transfers, access to automated teller services, Internet banking, ACH origination, telephone banking, and mobile banking services. The company also provides loans, such as commercial construction and real estate loans, consumer loans, unsecured overdraft lines of credit, and personal loans, as well as loans secured by savings accounts and certificates of deposit on deposit; residential mortgages; and one- to four-family first mortgage loans, as well as investment advisory services to individuals, families, businesses, and non-profits. In addition, it offers life and health insurance, long term care, automobile, homeowners, and liability insurance services. Malvern Bancorp, Inc. was incorporated in 1887 and is headquartered in Paoli, Pennsylvania.",Mr. Anthony Charles Weagley,Banks - Regional,16.97,USD,129731577,https://images.financialmodelingprep.com/symbol/MLVF.png,11112,18.64835164835165,-0.05,44597,15712000,6951000,"[{'period': '2022', 'revenue': 31.64, 'unit': 'M', 'net_profit': 6.95}, {'period': '2021', 'revenue': 31820.0, 'unit': 'K', 'net_profit': -92.0}, {'period': '2020', 'revenue': 29.79, 'unit': 'M', 'net_profit': 6.38}, {'period': '2019', 'revenue': 31.67, 'unit': 'M', 'net_profit': 9.33}]","[{'period': ""Q2 '23"", 'revenue': 7260.0, 'unit': 'K', 'net_profit': 571.0}, {'period': ""Q1 '23"", 'revenue': 8.24, 'unit': 'M', 'net_profit': 1.91}, {'period': ""Q4 '22"", 'revenue': 8.47, 'unit': 'M', 'net_profit': 2.58}, {'period': ""Q3 '22"", 'revenue': 7.78, 'unit': 'M', 'net_profit': 1.83}, {'period': ""Q2 '22"", 'revenue': 7510.0, 'unit': 'K', 'net_profit': 522.0}, {'period': ""Q1 '22"", 'revenue': 7.88, 'unit': 'M', 'net_profit': 2.02}]",0.92,0.92,1044360000,4252000,103111000,897915000,4252000,109985000,543000,53267000,5819000,12.148117154811715,76.55434782608695,76.40983606557377,"[0.03, 0.04]","['2010-12-29', '2008-09-26']",__nan__,0.8597753648167299
39,MMAC,MMA Capital Holdings Inc. Common Stock,"MMA Capital Holdings, Inc. engages in investing in debt associated with renewable energy infrastructure and real estate. The company is headquartered in Baltimore, Maryland and currently employs 216 full-time employees. The firm operates through three segments: United States (U.S.) Operations, International Operations and Corporate Operations. The U.S. Operations segment consists of three business lines: Leveraged Bonds, Low-Income Housing Tax Credits (LIHTC) and Energy Capital and Other Investments. In Leveraged Bonds business line, it owns and manages bonds that finance housing and infrastructure in the United States. In LIHTC business line, it owns and manages limited partner and general partner investments in affordable housing communities in the United States. In Energy Capital and Other Investments business line, it provides project capital necessary to develop and build renewable energy systems. The company manages International Operations segment through a subsidiary, International Housing Solutions S.a r.l. (IHS).",Mr. Michael Falcone,Financial - Mortgages,27.77,USD,11261012700,https://images.financialmodelingprep.com/symbol/MMAC.png,83513,23.08395677472984,0,22665,9501008,8.374,"[{'period': '2020', 'revenue': 2.18, 'unit': '', 'net_profit': 8.37}, {'period': '2019', 'revenue': 22.64, 'unit': 'M', 'net_profit': 100.98}, {'period': '2018', 'revenue': 27.86, 'unit': 'M', 'net_profit': 61.0}, {'period': '2017', 'revenue': 4.07, 'unit': 'M', 'net_profit': 19.4}]","[{'period': ""Q2 '21"", 'revenue': 1740.0, 'unit': 'K', 'net_profit': 138.0}, {'period': ""Q1 '21"", 'revenue': 2.27, 'unit': 'M', 'net_profit': -8.08}, {'period': ""Q4 '20"", 'revenue': 0.02, 'unit': '', 'net_profit': 3.63}, {'period': ""Q3 '20"", 'revenue': -3.96, 'unit': 'M', 'net_profit': 2.94}, {'period': ""Q2 '20"", 'revenue': -14.07, 'unit': 'M', 'net_profit': -3.51}, {'period': ""Q1 '20"", 'revenue': -6.18, 'unit': 'M', 'net_profit': -3.06}]",0.0,0.0,87727000,28644000,28644000,540531000,0,409699000,540531000,28644000,17967000,-0.786273271246682,-0.999999917070224,-1.0,"[0.33, 0.112]","['2008-02-01', '1996-12-27']",__nan__,6.161512419209593
40,MMLP,Martin Midstream Partners L.P. Limited Partnership,"Martin Midstream Partners L.P., together with its subsidiaries, engages in terminalling, processing, storage, and packaging of petroleum products and by-products primarily in the United States Gulf Coast region. The company's Terminalling and Storage segment owns or operates 15 marine shore-based terminal facilities and 13 specialty terminal facilities that provide storage, refining, blending, packaging, and handling services for producers and suppliers of petroleum products and by-products. This segment also offers land rental services to oil and gas companies, as well as storage and handling services for lubricants and fuels. Its Transportation segment operates a fleet of 570 tank trucks and 1,200 trailers; and 29 inland marine tank barges, 14 inland push boats, and 1 articulated offshore tug and barge unit to transport petroleum products and by-products, petrochemicals, and chemicals. The company's Sulfur Services segment processes molten sulfur into prilled or pelletized sulfur, which is used in the production of fertilizers and industrial chemicals. Its Natural Gas Liquids segment stores, distributes, and transports natural gas liquids for wholesale deliveries to refineries, industrial NGL users, and propane retailers, as well as owns approximately 2.1 million barrels of underground storage capacity for NGLs. Martin Midstream GP LLC serves as a general partner of the company. Martin Midstream Partners L.P. was incorporated in 2002 and is based in Kilgore, Texas.",Mr. Robert D. Bondurant CPA,Oil & Gas Midstream,2.77,USD,108182627,https://images.financialmodelingprep.com/symbol/MMLP.png,97326,-21.31,-0.16,82556,104402000,-5207000,"[{'period': '2024', 'revenue': 707.62, 'unit': 'M', 'net_profit': -5.21}, {'period': '2023', 'revenue': 797.96, 'unit': 'M', 'net_profit': -4.55}, {'period': '2022', 'revenue': 1020.0, 'unit': 'M', 'net_profit': -10.33}, {'period': '2021', 'revenue': 882430.0, 'unit': 'K', 'net_profit': -211.0}]","[{'period': ""Q4 '24"", 'revenue': 171.33, 'unit': 'M', 'net_profit': -8.94}, {'period': ""Q3 '24"", 'revenue': 170.93, 'unit': 'M', 'net_profit': -3.32}, {'period': ""Q2 '24"", 'revenue': 184.53, 'unit': 'M', 'net_profit': 3.78}, {'period': ""Q1 '24"", 'revenue': 180.83, 'unit': 'M', 'net_profit': 3.27}, {'period': ""Q4 '23"", 'revenue': 181100.0, 'unit': 'K', 'net_profit': 517.0}, {'period': ""Q3 '23"", 'revenue': 176.7, 'unit': 'M', 'net_profit': -1.06}]",-0.14,-0.14,1179804000,130479000,55000,608948000,53569000,7314000,115501000,55000,6343000,-0.06411244778313642,-0.1446471752033414,-0.2727272727272728,"[0.005, 0.3077]","['2025-02-07', '2003-01-29']",__nan__,0.5161433594054605
41,MMSI,Merit Medical Systems Inc. Common Stock,"Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.",Mr. Fred P. Lampropoulos,Medical - Instruments & Supplies,88.48,USD,5226257008,https://images.financialmodelingprep.com/symbol/MMSI.png,663424,43.59,-4.03,1176834,295944000,120357000,"[{'period': '2024', 'revenue': 1360.0, 'unit': 'M', 'net_profit': 120.36}, {'period': '2023', 'revenue': 1260.0, 'unit': 'M', 'net_profit': 94.41}, {'period': '2022', 'revenue': 1150.0, 'unit': 'M', 'net_profit': 74.52}, {'period': '2021', 'revenue': 1070.0, 'unit': 'M', 'net_profit': 48.45}]","[{'period': ""Q4 '24"", 'revenue': 355.16, 'unit': 'M', 'net_profit': 27.95}, {'period': ""Q3 '24"", 'revenue': 339.85, 'unit': 'M', 'net_profit': 28.44}, {'period': ""Q2 '24"", 'revenue': 337.58, 'unit': 'M', 'net_profit': 35.73}, {'period': ""Q1 '24"", 'revenue': 323.51, 'unit': 'M', 'net_profit': 28.24}, {'period': ""Q4 '23"", 'revenue': 323.29, 'unit': 'M', 'net_profit': 27.63}, {'period': ""Q3 '23"", 'revenue': 315.23, 'unit': 'M', 'net_profit': 25.83}]",2.07,2.03,2418603000,923774000,376715000,1039244000,209166000,22832000,216402000,0,220799000,0.278696174419509,0.2748196714365911,0.26219512195121947,__nan__,__nan__,__nan__,0.4296877164214218
42,MMYT,MakeMyTrip Limited Ordinary Shares,"MakeMyTrip Limited, an online travel company, sells travel products and solutions in India, the United States, Singapore, Malaysia, Thailand, the United Arab Emirates, Peru, Colombia, Vietnam, and Indonesia. The company operates through three segments: Air Ticketing, Hotels and Packages, and Bus Ticketing. Its services and products include air tickets; hotels; packages; rail tickets; bus tickets; and car hire, as well as ancillary travel requirements, such as visa processing and facilitating access to travel insurance. The company allows travelers to research, plan, book, and purchase travel services and products through its websites, such as makemytrip.com, goibibo.com, redbus.in, makemytrip.com.sg, and makemytrip.ae; and other technology-enhanced distribution channels, such as call centers, travel stores, and travel agents' network, as well as mobile service platform. As of March 31, 2022, it had approximately 125 franchisee-owned travel stores. The company serves leisure and corporate travelers. MakeMyTrip Limited was incorporated in 2000 and is based in Gurugram, India.",Mr. Rajesh  Magow,Travel Services,88.1,USD,9671837369,https://images.financialmodelingprep.com/symbol/MMYT.png,902903,46.13,-2.94,966885,138772000,216801000,"[{'period': '2024', 'revenue': 782.52, 'unit': 'M', 'net_profit': 216.8}, {'period': '2023', 'revenue': 593.04, 'unit': 'M', 'net_profit': -11.17}, {'period': '2022', 'revenue': 303.92, 'unit': 'M', 'net_profit': -45.57}, {'period': '2021', 'revenue': 163.44, 'unit': 'M', 'net_profit': -56.04}]","[{'period': ""Q3 '25"", 'revenue': 267.36, 'unit': 'M', 'net_profit': 27.02}, {'period': ""Q2 '25"", 'revenue': 210.99, 'unit': 'M', 'net_profit': 17.85}, {'period': ""Q1 '25"", 'revenue': 254.52, 'unit': 'M', 'net_profit': 21.03}, {'period': ""Q4 '24"", 'revenue': 202.89, 'unit': 'M', 'net_profit': 172.01}, {'period': ""Q3 '24"", 'revenue': 214.22, 'unit': 'M', 'net_profit': 24.26}, {'period': ""Q2 '24"", 'revenue': 168.69, 'unit': 'M', 'net_profit': 2.07}]",1.95,1.83,1660077000,857278000,606787000,543659000,97174000,12045000,297574000,327065000,112916000,3.2704332840965042,20.41269699140401,20.499999999999996,__nan__,__nan__,__nan__,0.3274902308748329
43,MNDO,MIND C.T.I. Ltd. Ordinary Shares,"MIND C.T.I. Ltd., together with its subsidiaries, designs, develops, markets, supports, implements, and operates billing and customer care systems in the Americas, Europe, Israel, the Asia Pacific, and Africa. It operates in two segments, Billing and Related Services and Messaging. The company offers billing and customer care solutions that support various services, such as voice, data, and content services, as well as prepaid, postpaid, and pay-in-advance payment models in a single platform. Its solutions also include a workflow engine to support the implementation of business processes, including subscriber registration, order management, trouble ticket, and debt collection; and an integral point of sale solution that covers all dealer, store and cashier management, and sales cycle related activities. In addition, the company offers professional services comprising turnkey project delivery, customer support and maintenance, integration, customizations, and project management, as well as managed services, including day to day billing operational tasks to its billing and customer care customers. Further, it provides PhonEX ONE, a call management system that collects, records, and stores call information, which is used by organizations for telecom expense management, call accounting, traffic analysis, and fraud detection. The company offers its products directly, as well as through distributors and resellers primarily to communication service providers, such as traditional wireline and wireless, voice over IP, broadband IP network operators, wireless internet service providers, LTE operators, cable operators, and mobile virtual network operators. MIND C.T.I. Ltd. was incorporated in 1995 and is headquartered in Yokne'am Illit, Israel.",Mr. Ariel  Glassner,Software - Application,1.69,USD,34419047,https://images.financialmodelingprep.com/symbol/MNDO.png,78236,7.68,0.01,50915,4563000,4630000,"[{'period': '2024', 'revenue': 21.45, 'unit': 'M', 'net_profit': 4.63}, {'period': '2023', 'revenue': 21.61, 'unit': 'M', 'net_profit': 5.17}, {'period': '2022', 'revenue': 21.55, 'unit': 'M', 'net_profit': 5.29}, {'period': '2021', 'revenue': 26.33, 'unit': 'M', 'net_profit': 5.95}]","[{'period': ""Q4 '24"", 'revenue': 5.2, 'unit': 'M', 'net_profit': 1.24}, {'period': ""Q3 '24"", 'revenue': 5210.0, 'unit': 'K', 'net_profit': 929.0}, {'period': ""Q2 '24"", 'revenue': 5.27, 'unit': 'M', 'net_profit': 1.13}, {'period': ""Q1 '24"", 'revenue': 5.76, 'unit': 'M', 'net_profit': 1.33}, {'period': ""Q4 '23"", 'revenue': 5.61, 'unit': 'M', 'net_profit': 1.43}, {'period': ""Q3 '23"", 'revenue': 5.26, 'unit': 'M', 'net_profit': 1.25}]",0.23,0.22,30702000,18919000,15753000,6406000,2498000,0,3275000,4452000,4104000,-0.07724974721941355,-0.10392877878846526,-0.11538461538461538,"[0.22, 0.14]","['2025-03-25', '2003-11-07']",__nan__,0.20865090222135366
44,MNKD,MannKind Corporation Common Stock,"MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California.",Dr. Michael E. Castagna Pharm.D.,Biotechnology,4.62,USD,1403814720,https://images.financialmodelingprep.com/symbol/MNKD.png,2095122,46.2,-0.07,2325199,77538000,27588000,"[{'period': '2024', 'revenue': 285.5, 'unit': 'M', 'net_profit': 27.59}, {'period': '2023', 'revenue': 198.96, 'unit': 'M', 'net_profit': -11.94}, {'period': '2022', 'revenue': 99.77, 'unit': 'M', 'net_profit': -112.17}, {'period': '2021', 'revenue': 75.44, 'unit': 'M', 'net_profit': -91.79}]","[{'period': ""Q4 '24"", 'revenue': 76.78, 'unit': 'M', 'net_profit': 7.42}, {'period': ""Q3 '24"", 'revenue': 70.08, 'unit': 'M', 'net_profit': 11.55}, {'period': ""Q2 '24"", 'revenue': 72.39, 'unit': 'M', 'net_profit': -2.01}, {'period': ""Q1 '24"", 'revenue': 66.26, 'unit': 'M', 'net_profit': 10.63}, {'period': ""Q4 '23"", 'revenue': 58.47, 'unit': 'M', 'net_profit': 1.4}, {'period': ""Q3 '23"", 'revenue': 51.25, 'unit': 'M', 'net_profit': 1.72}]",0.1,0.1,393843000,268306000,197256000,472659000,11804000,5482000,81837000,46339000,32818000,4.1251239341661705,3.310939855922265,3.237136465324385,__nan__,__nan__,__nan__,1.2001203525262605
45,MNMD,Mind Medicine (MindMed) Inc. Subordinate Voting Shares,"Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company is headquartered in Vancouver, Canada.",Mr. Robert  Barrow,Biotechnology,4.89,USD,368551280,https://images.financialmodelingprep.com/symbol/MNMD.png,2006772,-3.18,-0.54,1606242,-103916000,-108679000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -108.68}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -95.73}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -47.26}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -93.04}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -34.74}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.68}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.85}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -54.4}, {'period': ""Q4 '23"", 'revenue': 4.84, 'unit': 'M', 'net_profit': -23.86}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -17.92}]",-1.54,-0.15,302151000,281620000,273741000,60703000,0,0,38849000,273741000,-79129000,-0.12256670627633143,-0.13524213429156395,0.3688524590163934,__nan__,__nan__,__nan__,0.20090285982836395
46,MNOV,Medicinova Inc Common Stock,"MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. Its product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic diseases, including nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. The company has collaboration agreements with Kissei Pharmaceutical Co., Ltd.; Kyorin Pharmaceutical Co., Ltd; Angiogene Pharmaceuticals Ltd.; and Meiji Seika Kaisha Ltd. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.","Dr. Yuichi  Iwaki M.D., Ph.D.",Biotechnology,1.24,USD,60817288,https://images.financialmodelingprep.com/symbol/MNOV.png,18863,-5.39,0.04,20202,-9879970,-8571516,"[{'period': '2023', 'revenue': 1.0, 'unit': 'M', 'net_profit': -8.57}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.07}, {'period': '2021', 'revenue': 4.04, 'unit': 'M', 'net_profit': -10.13}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.85}]","[{'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.81}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'B', 'net_profit': -2.85}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.63}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.75}, {'period': ""Q3 '23"", 'revenue': -999.77, 'unit': 'M', 'net_profit': -2.06}, {'period': ""Q2 '23"", 'revenue': 1000000.0, 'unit': 'K', 'net_profit': -723.11}]",-0.17,-0.17,55875926,41074279,40359738,3372375,0,0,2959123,40359738,-10643859,0.2868419779945329,0.3907551757282262,0.4137931034482758,__nan__,__nan__,__nan__,0.06035470445715745
47,MNPR,Monopar Therapeutics Inc. Common Stock,"Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. Its lead product candidate in development is Validive, a clonidine hydrochloride mucobuccal tablet that is in Phase 2b/3 clinical trial for the prevention of chemoradiotherapy induced severe oral mucositis in patients with oropharyngeal cancer. The company also engages in developing Camsirubicin, an analog of doxorubicin, which is in Phase 1b clinical trial for the treatment of advanced soft tissue sarcoma; MNPR-101, a urokinase plasminogen activator receptor targeted antibody for the treatment of various cancers; MNPR-101 RIT, a radioimmunotherapeutic based on MNPR-101 for the potential treatment of cancer and severe COVID-19; and MNPR-202, an analog of camsirubicin to potentially treat doxorubicin-and camsirubicin-resistant cancers. Monopar Therapeutics Inc. has collaborations with the Grupo Español de Investigación en Sarcomas for the development of camsirubicin in patients with advanced soft tissue sarcoma; NorthStar Medical Radioisotopes, LLC to develop radio-immuno-therapeutics targeting severe COVID-19; and the Cancer Science Institute of Singapore to evaluate the activity of MNPR-202 and related analogs in various types of cancer. The company was incorporated in 2014 and is headquartered in Wilmette, Illinois.","Dr. Chandler D. Robinson M.B.A., M.D., M.Sc., MBA, MSc",Biotechnology,28.92,USD,176776103,https://images.financialmodelingprep.com/symbol/MNPR.png,50932,-7.04,0.03,15236,-16161721000,-15586419000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'B', 'net_profit': -15.59}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.4}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.49}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.08}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.93}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'B', 'net_profit': -1.3}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.72}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.64}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.81}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.95}]",-411.23,-411.23,60291071000,60291071,60212202,5254300000,0,0,5254300000,45816289,-6404139000,-37670.58481629875,-1854.0411106810648,-708.0172413793105,__nan__,__nan__,__nan__,0.08714889141710552
48,MNRO,Monro Inc. Common Stock,"Monro, Inc. provides automotive undercar repair, and tire sales and services in the United States. It offers replacement tires and tire related services; routine maintenance services on passenger cars, light trucks, and vans; products and services for brakes; mufflers and exhaust systems; and steering, drive train, suspension, and wheel alignment. The company also provides automotive undercar repair services, including tire replacement sales, and tire related service. The company operates its stores under the brand names of Monro Auto Service and Tire Centers, Tire Choice Auto Service Centers, Mr. Tire Auto Service Centers, Car-X Tire & Auto, Tire Warehouse Tires for Less, Ken Towery's Tire & Auto Care, Mountain View Tire & Auto Service, Tire Barn Warehouse, and Free Service Tire & Auto Centers. As of March 26, 2022, it operated 1,304 company-operated stores, 76 Car-X franchised locations, seven wholesale locations, and three retread facilities in 32 states. The company was formerly known as Monro Muffler Brake, Inc. and changed its name to Monro, Inc. in August 2017. Monro, Inc. was founded in 1957 and is headquartered in Rochester, New York.",Mr. Nicholas P. Hawryschuk,Auto - Parts,14.46,USD,433068324,https://images.financialmodelingprep.com/symbol/MNRO.png,931285,22.59,-1.07,1044439,144089000,37571000,"[{'period': '2024', 'revenue': 1280.0, 'unit': 'M', 'net_profit': 37.57}, {'period': '2023', 'revenue': 1330.0, 'unit': 'M', 'net_profit': 39.05}, {'period': '2022', 'revenue': 1360.0, 'unit': 'M', 'net_profit': 61.57}, {'period': '2021', 'revenue': 1130.0, 'unit': 'M', 'net_profit': 34.32}]","[{'period': ""Q3 '25"", 'revenue': 305.77, 'unit': 'M', 'net_profit': 4.58}, {'period': ""Q2 '25"", 'revenue': 301.39, 'unit': 'M', 'net_profit': 5.65}, {'period': ""Q1 '25"", 'revenue': 293.18, 'unit': 'M', 'net_profit': 5.86}, {'period': ""Q4 '24"", 'revenue': 310.08, 'unit': 'M', 'net_profit': 3.7}, {'period': ""Q3 '24"", 'revenue': 317.65, 'unit': 'M', 'net_profit': 12.17}, {'period': ""Q2 '24"", 'revenue': 322.09, 'unit': 'M', 'net_profit': 12.87}]",1.22,1.14,1692814000,253289000,6561000,1036039000,41093000,0,455156000,6561000,99716000,-0.0809888574945627,-0.037825240729358736,0.016666666666666684,"[0.28, 0.05]","['2025-02-25', '2005-07-15']",__nan__,0.612021757854082
49,MNSB,MainStreet Bancshares Inc. Common Stock,"MainStreet Bancshares, Inc. operates as the bank holding company for MainStreet Bank that provides various banking products and services for individuals, small to medium-sized businesses, and professional service organizations. The company offers demand, NOW, money market, savings, and sweep accounts, as well as certificates of deposit; business and consumer checking, interest-bearing checking, business account analysis, and other depository services; and cash management, wire transfer, check imaging, remote deposit capture, and courier services. It also provides commercial loans, including government contract receivables, plant and equipment, general working capital, contract administration, and acquisition loans; commercial real estate, real estate construction, and residential real estate loans; and consumer loans comprising term loans and overdraft protection, as well as debit and credit cards. In addition, the company provides deposit insurance solutions; remote deposit of checks; and internet bill payment, online cash management, and online and mobile banking services. As of March 18, 2022, it operated six branches in Herndon, Fairfax, McLean, Leesburg, Clarendon, and Washington D.C., as well as 55,000 automated teller machines. MainStreet Bancshares, Inc. was incorporated in 2003 and is headquartered in Fairfax, Virginia.",Mr. Jeff W. Dick,Banks - Regional,15.27,USD,118008240,https://images.financialmodelingprep.com/symbol/MNSB.png,10880,-9.54,-0.35,11595,0,-9980000,"[{'period': '2024', 'revenue': 134.62, 'unit': 'M', 'net_profit': -9.98}, {'period': '2023', 'revenue': 124.12, 'unit': 'M', 'net_profit': 26.59}, {'period': '2022', 'revenue': 74.84, 'unit': 'M', 'net_profit': 26.67}, {'period': '2021', 'revenue': 59.65, 'unit': 'M', 'net_profit': 22.17}]","[{'period': ""Q4 '24"", 'revenue': 16.85, 'unit': 'M', 'net_profit': -16.17}, {'period': ""Q3 '24"", 'revenue': 33590.0, 'unit': 'K', 'net_profit': 265.0}, {'period': ""Q2 '24"", 'revenue': 34.2, 'unit': 'M', 'net_profit': 2.62}, {'period': ""Q1 '24"", 'revenue': 33.27, 'unit': 'M', 'net_profit': 3.31}, {'period': ""Q4 '23"", 'revenue': 33.94, 'unit': 'M', 'net_profit': 5.15}, {'period': ""Q3 '23"", 'revenue': 19.54, 'unit': 'M', 'net_profit': 6.34}]",-1.6,-1.6,2228098000,103300000,103300000,2020107000,11311000,0,0,47553000,8951000,0,-1.3753996614632311,-1.4923076923076921,"[0.1, 0.05]","['2025-02-10', '2022-02-02']",__nan__,0.9066508744229383
50,MNSBP,MainStreet Bancshares Inc. Depositary Shares,"MainStreet Bancshares, Inc. operates as the bank holding company for MainStreet Bank that provides various banking products and services for individuals, small to medium-sized businesses, and professional service organizations. The company offers demand, NOW, money market, savings, and sweep accounts, as well as certificates of deposit; business and consumer checking, interest-bearing checking, business account analysis, and other depository services; and cash management, wire transfer, check imaging, remote deposit capture, and courier services. It also provides commercial loans, including government contract receivables, plant and equipment, general working capital, contract administration, and acquisition loans; commercial real estate, real estate construction, and residential real estate loans; and consumer loans comprising term loans and overdraft protection, as well as debit and credit cards. In addition, the company provides deposit insurance solutions; remote deposit of checks; and internet bill payment, online cash management, and online and mobile banking services. As of March 18, 2022, it operated six branches in Herndon, Fairfax, McLean, Leesburg, Clarendon, and Washington D.C., as well as 55,000 automated teller machines. MainStreet Bancshares, Inc. was incorporated in 2003 and is headquartered in Fairfax, Virginia.",Mr. Jeff W. Dick,Banks - Regional,24.32,USD,187947635,https://images.financialmodelingprep.com/symbol/MNSBP.png,1386,9.24,0.01,2502,0,-9980000,"[{'period': '2024', 'revenue': 134.62, 'unit': 'M', 'net_profit': -9.98}, {'period': '2023', 'revenue': 124.12, 'unit': 'M', 'net_profit': 26.59}, {'period': '2022', 'revenue': 74.84, 'unit': 'M', 'net_profit': 26.67}, {'period': '2021', 'revenue': 59.65, 'unit': 'M', 'net_profit': 22.17}]","[{'period': ""Q4 '24"", 'revenue': 16.85, 'unit': 'M', 'net_profit': -16.17}, {'period': ""Q3 '24"", 'revenue': 33590.0, 'unit': 'K', 'net_profit': 265.0}, {'period': ""Q2 '24"", 'revenue': 34.2, 'unit': 'M', 'net_profit': 2.62}, {'period': ""Q1 '24"", 'revenue': 33.27, 'unit': 'M', 'net_profit': 3.31}, {'period': ""Q4 '23"", 'revenue': 33.94, 'unit': 'M', 'net_profit': 5.15}, {'period': ""Q3 '23"", 'revenue': 19.54, 'unit': 'M', 'net_profit': 6.34}]",-1.6,-1.6,2228098000,103300000,103300000,2020107000,11311000,0,0,47553000,8951000,0,-1.3753996614632311,-1.4923076923076921,"[0.46875, 0.552]","['2025-03-14', '2020-12-11']",__nan__,0.9066508744229383
51,MNST,Monster Beverage Corporation,"Monster Beverage Corporation, through its subsidiaries, engages in development, marketing, sale, and distribution of energy drink beverages and concentrates in the United States and internationally. The company operates through three segments: Monster Energy Drinks, Strategic Brands, and Other. It offers carbonated energy drinks, non-carbonated, ready-to-drink iced teas, lemonades, juice cocktails, single-serve juices and fruit beverages, ready-to-drink dairy and coffee drinks, energy drinks, sports drinks and single-serve still waters, and sodas that are considered natural, sparkling juices, and flavored sparkling beverages. The company sells its products to bottlers, full-service beverage distributors, as well as sells directly to retail grocery and speciality chains, wholesalers, club stores, mass merchandisers, convenience chains, drug stores, foodservice customers, value stores, e-commerce retailers, and the military; and concentrates and/or beverage bases to authorized bottling and canning operations. It provides its products under the Monster Energy, Monster Energy Ultra, Monster Rehab, Monster Energy Nitro, Java Monster, Muscle Monster, Espresso Monster, Punch Monster, Juice Monster, Monster Hydro Energy Water, Monster Hydro Super Sport, Monster HydroSport Super Fuel, Monster Super Fuel, Monster Dragon Tea, Reign Total Body Fuel, and Reign Inferno Thermogenic Fuel, as well as NOS, Full Throttle, Burn, Mother, Nalu, Ultra Energy, Play and Power Play (stylized), Relentless, BPM, BU, Gladiator, Samurai, Live+, Predator, Fury, and True North brands. The company was formerly known as Hansen Natural Corporation and changed its name to Monster Beverage Corporation in January 2012. Monster Beverage Corporation was founded in 1985 and is headquartered in Corona, California.","Mr. Rodney Cyril Sacks H.Dip.Law, H.Dip.Tax",Beverages - Non-Alcoholic,55.01,USD,53533476590,https://images.financialmodelingprep.com/symbol/MNST.png,6898191,36.92,-2.1,19020238,2010728000,1509048000,"[{'period': '2024', 'revenue': 7.49, 'unit': 'B', 'net_profit': 1.51}, {'period': '2023', 'revenue': 7.14, 'unit': 'B', 'net_profit': 1.63}, {'period': '2022', 'revenue': 6.31, 'unit': 'B', 'net_profit': 1.19}, {'period': '2021', 'revenue': 5.54, 'unit': 'B', 'net_profit': 1.38}]","[{'period': ""Q4 '24"", 'revenue': 1810.0, 'unit': 'M', 'net_profit': 270.71}, {'period': ""Q3 '24"", 'revenue': 1880.0, 'unit': 'M', 'net_profit': 370.92}, {'period': ""Q2 '24"", 'revenue': 1900.0, 'unit': 'M', 'net_profit': 425.37}, {'period': ""Q1 '24"", 'revenue': 1900.0, 'unit': 'M', 'net_profit': 442.05}, {'period': ""Q4 '23"", 'revenue': 1730.0, 'unit': 'M', 'net_profit': 366.98}, {'period': ""Q3 '23"", 'revenue': 1860.0, 'unit': 'M', 'net_profit': 452.69}]",1.49,1.49,7719089000,3641504000,1533287000,1761371000,1221646000,0,1097519000,1533287000,1622099000,-0.005699089085292493,-0.07476449857387056,-0.04487179487179491,"[0.5, 0.5]","['1990-11-08', '1990-11-08']",__nan__,0.2281837921547478
52,MNTK,Montauk Renewables Inc. Common Stock,"Montauk Renewables, Inc., a renewable energy company, engages in recovery and processing of biogas from landfills and other non-fossil fuel sources. It operates in two segments, Renewable Natural Gas and Renewable Electricity Generation. The company develops, owns, and operates renewable natural gas (RNG) projects that capture methane and prevents it from being released into the atmosphere by converting it into either RNG or electrical power for the electrical grid. Its customers for RNG and renewable identification numbers (RIN) include long-term owner-operators of landfills and livestock farms, local utilities, and refiners in the natural gas and refining sectors. The company was founded in 1980 and is headquartered in Pittsburgh, Pennsylvania.","Mr. Sean F. McClain B.S., CPA, M.B.A.",Diversified Utilities,1.84,USD,262080400,https://images.financialmodelingprep.com/symbol/MNTK.png,202936,26.29,-0.08,198736,40969000,9734000,"[{'period': '2024', 'revenue': 175.74, 'unit': 'M', 'net_profit': 9.73}, {'period': '2023', 'revenue': 174.9, 'unit': 'M', 'net_profit': 14.95}, {'period': '2022', 'revenue': 205.56, 'unit': 'M', 'net_profit': 35.19}, {'period': '2021', 'revenue': 148.13, 'unit': 'M', 'net_profit': -4.53}]","[{'period': ""Q4 '24"", 'revenue': 27.69, 'unit': 'M', 'net_profit': -8.45}, {'period': ""Q3 '24"", 'revenue': 65.92, 'unit': 'M', 'net_profit': 17.05}, {'period': ""Q2 '24"", 'revenue': 43340.0, 'unit': 'K', 'net_profit': -712.0}, {'period': ""Q1 '24"", 'revenue': 38.79, 'unit': 'M', 'net_profit': 1.85}, {'period': ""Q4 '23"", 'revenue': 46.81, 'unit': 'M', 'net_profit': 4.8}, {'period': ""Q3 '23"", 'revenue': 55.69, 'unit': 'M', 'net_profit': 12.93}]",0.0684,0.0684,349015000,57224000,45621000,91598000,8172000,0,33528000,45621000,-18528000,-0.0920796028720858,-0.3488092052448488,-0.3781818181818182,__nan__,__nan__,__nan__,0.26244717275761786
53,MNTX,Manitex International Inc. Common Stock,"Manitex International, Inc. provides engineered lifting solutions in the United States, Italy, Canada, France, Chile, and internationally. It designs, manufactures, and distributes products that are used in various industries. The company also offers boom trucks, truck cranes, aerial platforms, and sign cranes products primarily for use in industrial projects, energy exploration, and infrastructure development comprising roads, bridges, and commercial construction. In addition, it manufactures and sells rough terrain cranes and material handling products for construction, municipality, and railroad industries; and truck mounted hydraulic knuckle boom cranes. The company provides its products under the Manitex, PM, MAC, PM-Tadano, Oil & Steel, Badger, and Valla brands. It also sells its products through dealers and rental distribution channel. The company was formerly known as Veri-Tek International, Corp. and changed its name to Manitex International, Inc. in May 2008. Manitex International, Inc. was founded in 1993 and is headquartered in Bridgeview, Illinois.",Mr. J. Michael Coffey,Agricultural - Machinery,5.8,USD,118304920,https://images.financialmodelingprep.com/symbol/MNTX.png,101165,12.608695652173912,0,216922,24656000,7356000,"[{'period': '2023', 'revenue': 291.39, 'unit': 'M', 'net_profit': 7.36}, {'period': '2022', 'revenue': 273.85, 'unit': 'M', 'net_profit': -4.3}, {'period': '2021', 'revenue': 211.54, 'unit': 'M', 'net_profit': -4.57}, {'period': '2020', 'revenue': 167.5, 'unit': 'M', 'net_profit': -12.72}]","[{'period': ""Q3 '24"", 'revenue': 66540.0, 'unit': 'K', 'net_profit': 427.0}, {'period': ""Q2 '24"", 'revenue': 76.23, 'unit': 'M', 'net_profit': 1.49}, {'period': ""Q1 '24"", 'revenue': 73.34, 'unit': 'M', 'net_profit': 2.28}, {'period': ""Q4 '23"", 'revenue': 78.65, 'unit': 'M', 'net_profit': 5.2}, {'period': ""Q3 '23"", 'revenue': 71.33, 'unit': 'M', 'net_profit': 1.7}, {'period': ""Q2 '23"", 'revenue': 73530.0, 'unit': 'K', 'net_profit': 404.0}]",0.36,0.36,255731000,145573000,9269000,176047000,49671000,0,92791000,9269000,-4940000,1.0775193798449612,2.711493718008376,2.714285714285714,__nan__,__nan__,__nan__,0.6884069588747551
54,MODV,ModivCare Inc. Common Stock,"ModivCare Inc., a technology-enabled healthcare services company, provides a suite of integrated supportive care solutions for public and private payors and patients. The company operates through four segments: Non-Emergency Medical Transportation (NEMT), Personal Care, Remote Patient Monitoring (RPM), and the Matrix Investment. The NEMT segment offers contact center management, network credentialing, claims management, and non-emergency medical transport management services for Medicaid or Medicare eligible members, whose limited mobility or financial resources hinder their ability to access necessary healthcare and social services. The Personal Care segment provides bathing, personal hygiene, grooming, oral care, dressing, medication reminders, meal planning, preparation and feeding, housekeeping, transportation services, prescription reminders, and assistance with dressing and ambulation services through placing non-medical personal care assistants, home health aides, and skilled nurses primarily to Medicaid patients in need of care monitoring and assistance in performing daily living activities, including senior citizens and disabled adults. The RPM segment offers personal emergency response systems, vitals monitoring, medication management, and data-driven patient engagement solutions. The Matrix Investment segment provides in-home and on-site care services, as well as a fleet of mobile health clinics that offers community-based care with advanced diagnostic capabilities and care options. It serves federal, state, and local government agencies, MCOs, commercial insurers, private individuals, and health systems. The company was formerly known as The Providence Service Corporation and changed its name to ModivCare Inc. in January 2021. ModivCare Inc. was incorporated in 1996 and is headquartered in Denver, Colorado.",Mr. L. Heath Sampson CPA,Medical - Care Facilities,1.1,USD,15723290,https://images.financialmodelingprep.com/symbol/MODV.png,643052,-0.08,0.015,422001,4881000,-201278000,"[{'period': '2024', 'revenue': 2790.0, 'unit': 'M', 'net_profit': -201.28}, {'period': '2023', 'revenue': 2750.0, 'unit': 'M', 'net_profit': -204.46}, {'period': '2022', 'revenue': 2500.0, 'unit': 'M', 'net_profit': -1.84}, {'period': '2021', 'revenue': 2000.0, 'unit': 'M', 'net_profit': 31.96}]","[{'period': ""Q4 '24"", 'revenue': 702.8, 'unit': 'M', 'net_profit': -23.49}, {'period': ""Q3 '24"", 'revenue': 702.04, 'unit': 'M', 'net_profit': -26.6}, {'period': ""Q2 '24"", 'revenue': 698.3, 'unit': 'M', 'net_profit': -128.88}, {'period': ""Q1 '24"", 'revenue': 684.45, 'unit': 'M', 'net_profit': -22.3}, {'period': ""Q4 '23"", 'revenue': 702.83, 'unit': 'M', 'net_profit': -5.25}, {'period': ""Q3 '23"", 'revenue': 686.92, 'unit': 'M', 'net_profit': -4.3}]",-14.14,-14.14,1654332000,495379000,112581000,1692806000,356844000,0,624494000,112581000,-34038000,1.2092066349492092,0.015562946297564316,0.020097020097020038,__nan__,__nan__,__nan__,1.0232565168297536
55,MOFG,MidWestOne Financial Gp Common Stock,"MidWestOne Financial Group, Inc. operates as the bank holding company for MidWestOne Bank that provides commercial and retail banking products and services to individuals, businesses, governmental units, and institutional customers. It offers deposit products, such as noninterest bearing and interest-bearing demand deposit accounts, interest checking accounts, savings accounts, money market accounts, certificates of deposit, and time deposits. The company also provides commercial and industrial, commercial and residential real estate, agricultural, and credit card loans, as well as consumer loans, such as secured and unsecured personal, and automobile loans. In addition, it offers various trust and investment services, including administering estates, personal trusts, and conservatorships, as well as property management, farm management, investment advisory, retail securities brokerage, and financial planning and custodial services, as well as investment-related services, including securities trading, mutual funds sales, fixed and variable annuities, tax-exempted, and conventional unit trusts. Further, the company provides other products and services comprising treasury management, debit cards, automated teller machines, online and mobile banking, and safe deposit boxes. It offers its products and services primarily through a network of 56 banking offices located in central and eastern Iowa, the Minneapolis/St. Paul metropolitan area of Minnesota, southwestern Wisconsin, southwestern Florida, and Denver, Colorado. MidWestOne Financial Group, Inc. was incorporated in 1983 and is headquartered in Iowa City, Iowa.",Mr. Charles N. Reeves,Banks - Regional,26.29,USD,547244753,https://images.financialmodelingprep.com/symbol/MOFG.png,102252,-7.43,-0.11,76549,0,-60289000,"[{'period': '2024', 'revenue': 294.27, 'unit': 'M', 'net_profit': -60.29}, {'period': '2023', 'revenue': 162.59, 'unit': 'M', 'net_profit': 20.86}, {'period': '2022', 'revenue': 213.88, 'unit': 'M', 'net_profit': 60.84}, {'period': '2021', 'revenue': 198.73, 'unit': 'M', 'net_profit': 69.49}]","[{'period': ""Q4 '24"", 'revenue': 78.27, 'unit': 'M', 'net_profit': 16.33}, {'period': ""Q3 '24"", 'revenue': -92.87, 'unit': 'M', 'net_profit': -95.71}, {'period': ""Q2 '24"", 'revenue': 94.2, 'unit': 'M', 'net_profit': 15.82}, {'period': ""Q1 '24"", 'revenue': 78.88, 'unit': 'M', 'net_profit': 3.27}, {'period': ""Q4 '23"", 'revenue': 69.2, 'unit': 'M', 'net_profit': 2.73}, {'period': ""Q3 '23"", 'revenue': 44.44, 'unit': 'M', 'net_profit': 9.14}]",-3.54,-3.54,6236329000,1400236000,1400236000,5676633000,34749000,0,3186000,71803000,63184000,0,-3.890311136679611,-3.661654135338346,"[0.2425, 0.1525]","['2025-03-03', '2008-05-29']",__nan__,0.9102523295355328
56,MOGO,Mogo Inc. Common Shares,"Mogo Inc. operates as a financial technology company in Canada and internationally. The company provides digital solutions to the consumers to get in control of their financial health. It offers Mogo app to access a digital spending account with Mogo Visa Platinum Prepaid Card; MogoCrypto that enables the buying and selling of bitcoin; MogoProtect, a free ID fraud protection and monthly credit score monitoring; MogoMortgage, a digital mortgage experience; and MogoMoney that provides access to personal loans. The company also offers Mogo Trade, a free stock trading platform with real-time stock quotes and funding; and Mogo Ventures to manage its existing investments in strategic partners and companies. In addition, it operates Carta, a digital payments software platform that enable financial technology companies, banks, and corporations to issue payment products to consumers via multiple channels, including physical, virtual, and tokenized cards, as well as payment switching and routing services. Mogo Inc. was founded in 2003 and is headquartered in Vancouver, Canada.",Mr. David Marshall Feller,Software - Infrastructure,0.75,USD,18354300,https://images.financialmodelingprep.com/symbol/MOGO.png,59875,-1.92,-0.0959,39739,-2198000,-17887000,"[{'period': '2023', 'revenue': 64.83, 'unit': 'M', 'net_profit': -17.89}, {'period': '2022', 'revenue': 68.95, 'unit': 'M', 'net_profit': -165.68}, {'period': '2021', 'revenue': 57.52, 'unit': 'M', 'net_profit': -33.21}, {'period': '2020', 'revenue': 44.24, 'unit': 'M', 'net_profit': -26.98}]","[{'period': ""Q3 '24"", 'revenue': 17.53, 'unit': 'M', 'net_profit': -8.11}, {'period': ""Q2 '24"", 'revenue': 17.48, 'unit': 'M', 'net_profit': -12.35}, {'period': ""Q1 '24"", 'revenue': 17.9, 'unit': 'M', 'net_profit': -3.6}, {'period': ""Q4 '23"", 'revenue': 17.23, 'unit': 'M', 'net_profit': 8.51}, {'period': ""Q3 '23"", 'revenue': 16.18, 'unit': 'M', 'net_profit': -9.5}, {'period': ""Q2 '23"", 'revenue': 16.01, 'unit': 'M', 'net_profit': -10.01}]",-0.72,-0.72,207763000,92653000,16133000,114039000,0,38996000,7209000,16133000,-12587000,0.949501447410743,0.8920375668465337,0.8894009216589862,"[0.0748, 0.0748]","['2019-03-21', '2019-03-21']",__nan__,0.5488898408282514
57,MOHO,ECMOHO Limited American Depositary Shares,"ECMOHO Limited, an investment holding company, operates as an integrated solution provider in the health and wellness market. The company offers health supplements and food, mother and child care products, personal care products, and household healthcare equipment and cleaning products. It sells its products through flagship stores of its brand partners, self-operated branded stores on third-party e-commerce platforms; and other small and medium-sized online and offline retailers. The company is also involved in the provision of bonded area warehousing; online store operating services; and promotion and marketing services to its brand partners and other brand customers. It serves consumers and retailers. The company was founded in 2011 and is headquartered in Shanghai, the People's Republic of China.",Ms. Zoe Wang,Specialty Retail,0.0999,USD,0,https://images.financialmodelingprep.com/symbol/MOHO.png,0,-0.07135714285714286,-0.0745,53639022,-54507698,-55685017,"[{'period': '2021', 'revenue': 130.75, 'unit': 'M', 'net_profit': -55.69}, {'period': '2020', 'revenue': 304.94, 'unit': 'M', 'net_profit': -13.3}, {'period': '2019', 'revenue': 329.48, 'unit': 'M', 'net_profit': 2.3}, {'period': '2018', 'revenue': 199.02, 'unit': 'M', 'net_profit': 6.12}]","[{'period': ""Q4 '21"", 'revenue': 32.61, 'unit': 'M', 'net_profit': -42.28}, {'period': ""Q3 '21"", 'revenue': 28.25, 'unit': 'M', 'net_profit': -3.75}, {'period': ""Q2 '21"", 'revenue': 42.8, 'unit': 'M', 'net_profit': -3.56}, {'period': ""Q1 '21"", 'revenue': 27.09, 'unit': 'M', 'net_profit': -6.07}, {'period': ""Q4 '20"", 'revenue': 71850.0, 'unit': 'K', 'net_profit': -399.91}, {'period': ""Q3 '20"", 'revenue': 71.45, 'unit': 'M', 'net_profit': -4.12}]",-1.6,-1.6,93554436,87127092,43623588,64667810,19206657,4197,63891668,43623588,3804811,-5.555388092718823,-3.187185914155985,-3.2105263157894743,__nan__,__nan__,__nan__,0.6912318941241867
58,MOMO,Momo Inc. American Depositary Shares,"Hello Group Inc. provides mobile-based social and entertainment services in the People's Republic of China. It operates Momo platform that includes its Momo mobile application, as well as various related properties, features, functionalities, tools, and services. The company's Momo mobile application connects people and facilitates interactions based on location and interests; and various recreational activities, including live talent shows, short videos, and social games, as well as other video- and audio-based interactive experiences, such as online parties, mobile karaoke, and user participated reality shows. It also operates Tantan, a social and dating application, which enables users to find and establish romantic connections, and meet interesting people; and provides live video, quick chat, value-added, mobile marketing, and other services, as well as mobile games and audio chatrooms. In addition, it allows its platform's users to livestream a variety of content and activities that comprise talent shows, such as singing, dancing, and talk shows, as well as casual chatting, and other forms of interactions between broadcasters and viewers. The company was formerly known as Momo Inc. and changed its name to Hello Group Inc. in August 2021. Hello Group Inc. was incorporated in 2011 and is headquartered in Beijing, the People's Republic of China.",Mr. Yan  Tang,Internet Content & Information,5.39,USD,884461184,https://images.financialmodelingprep.com/symbol/MOMO.png,1221575,7.09,-0.15,2226965,1591503000,1039573000,"[{'period': '2024', 'revenue': 10.56, 'unit': 'B', 'net_profit': 1.04}, {'period': '2023', 'revenue': 12.0, 'unit': 'B', 'net_profit': 1.96}, {'period': '2022', 'revenue': 12.7, 'unit': 'B', 'net_profit': 1.48}, {'period': '2021', 'revenue': 14.58, 'unit': 'B', 'net_profit': -2.92}]","[{'period': ""Q4 '24"", 'revenue': 2640.0, 'unit': 'M', 'net_profit': 187.24}, {'period': ""Q3 '24"", 'revenue': 2670.0, 'unit': 'M', 'net_profit': 449.37}, {'period': ""Q2 '24"", 'revenue': 2690.0, 'unit': 'M', 'net_profit': 397.79}, {'period': ""Q1 '24"", 'revenue': 2560.0, 'unit': 'M', 'net_profit': 5.18}, {'period': ""Q4 '23"", 'revenue': 3000.0, 'unit': 'M', 'net_profit': 452.47}, {'period': ""Q3 '23"", 'revenue': 3040.0, 'unit': 'M', 'net_profit': 546.43}]",2.78,2.785,18382970000,12011870000,6148904000,6950297000,192317000,3885393000,6398532000,4122658999,1354453000,-0.43042460933250115,-0.4689501992510144,-0.43495934959349597,"[0.28, 0.62]","['2025-04-11', '2019-04-04']",__nan__,0.378083465294237
59,MON,Monument Circle Acquisition Corp. Class A Common Stock,"Monument Circle Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on businesses in the media, technology, sports and entertainment sectors, and related industries. The company was incorporated in 2020 and is based in Indianapolis, Indiana.",None,Shell Companies,10.07,USD,0,https://images.financialmodelingprep.com/symbol/MON.png,66056,0.0,0.02,26349,6533337,14196768,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 14.2}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.42}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.29}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 10.91}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.07}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.93}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.87}]",0.46,0.46,250804,780.774,250630,19166,0,250023702,468.737,607.255,-0.8381130000000001,0,0.0,0.0,__nan__,__nan__,__nan__,0.07641823894355752
60,MONCU,Monument Circle Acquisition Corp. Unit,"Monument Circle Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on businesses in the media, technology, sports and entertainment sectors, and related industries. The company was incorporated in 2020 and is based in Indianapolis, Indiana.",,Shell Companies,10.05,USD,0,https://images.financialmodelingprep.com/symbol/MONCU.png,3193,0.0,-0.04,1400,6533337,14196768,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 14.2}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.42}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.29}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 10.91}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.07}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.93}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.87}]",0.46,0.46,250804,780.774,250630,19166,0,250023702,468.737,607.255,-0.8381130000000001,0,0.0,0.0,__nan__,__nan__,__nan__,0.07641823894355752
61,MONCW,Monument Circle Acquisition Corp. Warrant,"Monument Circle Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on businesses in the media, technology, sports and entertainment sectors, and related industries. The company was founded in 2020 and is Indianapolis, Indiana.",Mr. Jeffrey H. Smulyan,Shell Companies,0.0002,USD,0,https://images.financialmodelingprep.com/symbol/MONCW.png,0,0.0,0,97025,6533337,14196768,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 14.2}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.42}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.29}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 10.93}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 17.25}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.09}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.4}]",0.6,0.6,250804,780.774,250630,19166,0,250023702,468.737,607.255,-838113,0,0.0,0.0,__nan__,__nan__,__nan__,0.07641823894355752
62,MOR,MorphoSys AG American Depositary Shares,"MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, follicular lymphoma, and marginal zone lymphoma. The company also develops Pelabresib, a small molecule that is in Phase II clinical trial to treat myelofibrosis; Felzartamab, an antibody directed against CD38, which is in Phase I/II clinical trials for the treatment of anti-PLA2R-positive membranous nephropathy, an autoimmune disease; and CPI-0209, a small molecule that is in Phase I/II designed to promote anti-tumor activity by inhibiting EZH2. In addition, it develops Gantenerumab, an antibody for the treatment of Alzheimer's diseases through its pharmaceutical partners; Otilimab, an antibody for rheumatoid arthritis; Tremfya, an antibody to treat psoriasis, psoriatic arthritis, and palmoplantar pustulosis; and MOR210/TJ210, an antibody to treat immuno-oncology and autoimmune diseases. MorphoSys AG has a regional licensing agreement with I-Mab Biopharma to develop and commercialize felzartamab in China, Taiwan, Hong Kong, and Macau; a strategic alliance with the LEO Pharma; a joint collaboration and license agreement with Incyte Corporation to develop and commercialize MorphoSys investigational compound tafasitamab; and a clinical collaboration with Incyte Corporation and Xencor, Inc. to investigate the combination of tafasitamab, plamotamab, and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma, and relapsed or refractory follicular lymphoma. The company was founded in 1992 and is headquartered in Planegg, Germany.","Mr. Arkadius  Pichota M.B.A., Ph.D.",Biotechnology,18.96,USD,2856343112,https://images.financialmodelingprep.com/symbol/MOR.png,47073,-12.64,0.45,19165,-97738116,-189734199,"[{'period': '2023', 'revenue': 238.28, 'unit': 'M', 'net_profit': -189.73}, {'period': '2022', 'revenue': 278.27, 'unit': 'M', 'net_profit': -151.06}, {'period': '2021', 'revenue': 179.6, 'unit': 'M', 'net_profit': -514.5}, {'period': '2020', 'revenue': 327.7, 'unit': 'M', 'net_profit': 97.89}]","[{'period': ""Q1 '24"", 'revenue': 27.54, 'unit': 'M', 'net_profit': -314.96}, {'period': ""Q4 '23"", 'revenue': 59.08, 'unit': 'M', 'net_profit': 48.27}, {'period': ""Q3 '23"", 'revenue': 63.8, 'unit': 'M', 'net_profit': -119.6}, {'period': ""Q2 '23"", 'revenue': 53.17, 'unit': 'M', 'net_profit': -73.97}, {'period': ""Q1 '23"", 'revenue': 62.32, 'unit': 'M', 'net_profit': -43.89}, {'period': ""Q4 '22"", 'revenue': 81.67, 'unit': 'M', 'net_profit': 329.44}]",-1.38,-1.38,2026311213,814021511,682755659,1977261974,42654713,3551950,264310744,158500000,-298709634,-1.56562278450735,-0.2560388242918557,-0.24324324324324303,__nan__,__nan__,__nan__,0.9757938273818356
63,MORF,Morphic Holding Inc. Common Stock,"Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; and preclinical trial to treat idiopathic pulmonary fibrosis and fibrosis diseases. The company is also developing avß6 for the treatment of fibrotic diseases, and avß8 to treat solid tumors, as well as various other products. Morphic Holding, Inc. has a research collaboration with Engitix Ltd for the identification of Morphic integrin technology amenable targets in fibrostenotic IBD; a collaboration agreement with Schrödinger, LLC for integrin targets; and a license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. It also has collaboration agreements with AbbVie Biotechnology Ltd and Janssen Pharmaceuticals, Inc. to discover or develop integrin-based therapeutics. Morphic Holding, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.","Dr. Praveen P. Tipirneni M.B.A., M.D.",Biotechnology,56.99,USD,2862305653,https://images.financialmodelingprep.com/symbol/MORF.png,2453038,-14.879895561357703,0.02,1739150,-177595000,-152095000,"[{'period': '2023', 'revenue': 0.521, 'unit': 'M', 'net_profit': -152.09}, {'period': '2022', 'revenue': 70.81, 'unit': 'M', 'net_profit': -59.04}, {'period': '2021', 'revenue': 19.79, 'unit': 'M', 'net_profit': -94.24}, {'period': '2020', 'revenue': 44.95, 'unit': 'M', 'net_profit': -45.0}]","[{'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -57.59}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -45.29}, {'period': ""Q4 '23"", 'revenue': -60.24, 'unit': 'M', 'net_profit': -40.73}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -36.21}, {'period': ""Q2 '23"", 'revenue': 60.24, 'unit': 'M', 'net_profit': -39.01}, {'period': ""Q1 '23"", 'revenue': 0.521, 'unit': 'M', 'net_profit': -36.13}]",-3.59,-3.59,722514000,716928000,704349000,25492000,0,560000,24776000,58577000,-113553000,-1.8464842685643763,-1.5760911908673634,-1.3161290322580645,__nan__,__nan__,__nan__,0.03528236131064588
64,MORN,Morningstar Inc. Common Stock,"Morningstar, Inc. provides independent investment research services in North America, Europe, Australia, and Asia. The company offers web-based tools; investment data, fundamental equity and manager research, private capital markets research, credit and fund rating, and index, as well as environmental, social, and governance (ESG) rating services; and investment offerings, including managed investment products, publicly listed and private companies, fixed income securities, and real-time global market data for financial advisors, asset managers, retirement plan providers and sponsors, and individual and institutional investors. It also provides Morningstar Data, an investment data spanning various databases, including equity fundamentals, managed investments, ESG factors, and market data; Morningstar Direct, an investment-analysis platform; Morningstar Managed Portfolios, an advisor service consisting of model portfolio that offers services for independent financial advisors, as well as offers asset allocation services for asset managers, broker/dealers, and insurance providers; Morningstar Advisor Workstation, a web-based research, financial planning, and proposal generation platform; and Morningstar.com, a website for individual investors. In addition, the company offers Morningstar Enterprise Components; Morningstar Credit Ratings that provides issuance and surveillance services for structured finance products and instruments; corporate credit estimates and operational risk assessment rankings; Morningstar Indexes for creating investment products; Morningstar workplace solutions, such as retirement accounts, fiduciary services, allocation funds, and custom models; and PitchBook Platform, research and analysis workstation for investment and research professionals. Further, its PitchBook provides a mobile application, excel plug-in, data feeds, and data solutions. The company was incorporated in 1984 and is headquartered in Chicago, Illinois.",Mr. Michael John Holt C.F.A.,Financial - Data & Stock Exchanges,255.31,USD,10920400161,https://images.financialmodelingprep.com/symbol/MORN.png,171845,29.72,-2.54,222153,731600000,369900000,"[{'period': '2024', 'revenue': 2280.0, 'unit': 'M', 'net_profit': 369.9}, {'period': '2023', 'revenue': 2040.0, 'unit': 'M', 'net_profit': 141.1}, {'period': '2022', 'revenue': 1870.0, 'unit': 'M', 'net_profit': 70.5}, {'period': '2021', 'revenue': 1700.0, 'unit': 'M', 'net_profit': 193.3}]","[{'period': ""Q4 '24"", 'revenue': 591.0, 'unit': 'M', 'net_profit': 116.9}, {'period': ""Q3 '24"", 'revenue': 569.4, 'unit': 'M', 'net_profit': 119.7}, {'period': ""Q2 '24"", 'revenue': 570.5, 'unit': 'M', 'net_profit': 69.1}, {'period': ""Q1 '24"", 'revenue': 544.0, 'unit': 'M', 'net_profit': 64.2}, {'period': ""Q4 '23"", 'revenue': 542.4, 'unit': 'M', 'net_profit': 73.5}, {'period': ""Q3 '23"", 'revenue': 515.5, 'unit': 'M', 'net_profit': 39.1}]",8.64,8.58,3548900000,1014100000,551000000,1930300000,370500000,85300000,967300000,502700000,448900000,0.7431498689540148,1.621545003543586,1.6102719033232629,"[0.455, 0.05]","['2025-10-03', '2010-12-29']",__nan__,0.543915015920426
65,MOSY,MoSys Inc. Common Stock,"MoSys, Inc. is a provider of semiconductor solutions. The company is headquartered in San Jose, California and currently employs 21 full-time employees. The firm has developed approximately two IC product lines under the Bandwidth Engine and LineSpeed product names. Bandwidth Engine ICs integrate its 1T-SRAM high-density embedded memory with its integrated macro function technology and a serial interface protocol resulting in a monolithic memory IC solution optimized for transaction performance. The LineSpeed IC product line consists of non-memory, high-speed serialization-deserialization (SerDes), input/output (I/O) physical layer (PHY) devices with clock data recovery, gearbox and retimer functionality, which convert lanes of data received on line cards or by optical modules into various configurations and/or ensure signal integrity.",Mr. Daniel Lewis,Semiconductors,4.5,USD,63332550,https://images.financialmodelingprep.com/symbol/MOSY.png,433915,0.0,0.28999996,298854,-3394000,-3780000,"[{'period': '2020', 'revenue': 6.79, 'unit': 'M', 'net_profit': -3.78}, {'period': '2019', 'revenue': 10.09, 'unit': 'M', 'net_profit': -2.58}, {'period': '2018', 'revenue': 16.6, 'unit': 'M', 'net_profit': -11.41}, {'period': '2017', 'revenue': 8.84, 'unit': 'M', 'net_profit': -10.67}]","[{'period': ""Q3 '21"", 'revenue': 1.34, 'unit': 'M', 'net_profit': -1.71}, {'period': ""Q2 '21"", 'revenue': 1.17, 'unit': 'M', 'net_profit': -1.21}, {'period': ""Q1 '21"", 'revenue': 1.34, 'unit': 'M', 'net_profit': -1.37}, {'period': ""Q4 '20"", 'revenue': 1.6, 'unit': 'M', 'net_profit': -1.03}, {'period': ""Q3 '20"", 'revenue': 1970.0, 'unit': 'K', 'net_profit': -707.0}, {'period': ""Q2 '20"", 'revenue': 1970.0, 'unit': 'K', 'net_profit': -639.0}]",-1.75,-1.75,8298000,7857000,5889000,5366000,701000,0,1836000,5889000,-2662000,-0.5604597701149425,-0.46511627906976744,-0.4705882352941177,__nan__,__nan__,__nan__,0.6466618462280067
66,MOTN,Motion Acquisition Corp. Class A Common Stock,,,,,,,,,,,,0,0,"[{'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 544.49}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.04}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",0.0,0.0,116067608,1047530,878653,4184850,0,0,159850,878653,,0,0.0,0.0,__nan__,__nan__,__nan__,0.03605527909216497
67,MOTNU,Motion Acquisition Corp. Unit,,,Asset Management,11.4406,USD,0,https://images.financialmodelingprep.com/symbol/MOTNU.png,2985,0,-0.3194,1401,41704693000000,42137424000000,"[{'period': '2024', 'revenue': 616.56, 'unit': 'T', 'net_profit': 42.14}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q4 '24"", 'revenue': 616.56, 'unit': 'T', 'net_profit': 42.14}, {'period': ""Q3 '24"", 'revenue': 138.68, 'unit': 'T', 'net_profit': 13.52}, {'period': ""Q2 '24"", 'revenue': 164.95, 'unit': 'T', 'net_profit': 13.28}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 544.49}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.04}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.99}]",411517.0,385088.0,455621132000000,304486263000000,89241695000000,140442002000000,210899926000000,5547979000000,121806577000000,89241695000000,70337070000000,0,0.0,0.0,__nan__,__nan__,__nan__,0.3082429504169706
68,MOTNW,Motion Acquisition Corp. Warrants to purchase one Class A common,,,,,,,,,,,,0,0,"[{'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 544.49}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.04}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",0.0,0.0,116067608,1047530,878653,4184850,0,0,159850,878653,,0,0.0,0.0,__nan__,__nan__,__nan__,0.03605527909216497
69,MOTS,Motus GI Holdings Inc. Common Stock,"Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.",Ms. Ravit  Ram,Medical - Devices,0.0001,USD,639,https://images.financialmodelingprep.com/symbol/MOTS.png,2817,,3.0000000015651188e-12,511,-11429000,-12867000,"[{'period': '2023', 'revenue': 0.319, 'unit': 'M', 'net_profit': -12.87}, {'period': '2022', 'revenue': 0.592, 'unit': 'M', 'net_profit': -18.09}, {'period': '2021', 'revenue': 0.391, 'unit': 'M', 'net_profit': -18.91}, {'period': '2020', 'revenue': 0.098, 'unit': 'M', 'net_profit': -19.6}]","[{'period': ""Q1 '24"", 'revenue': 0.064, 'unit': 'M', 'net_profit': -2.11}, {'period': ""Q4 '23"", 'revenue': 0.064, 'unit': 'M', 'net_profit': -2.81}, {'period': ""Q3 '23"", 'revenue': 0.08600000000000001, 'unit': 'M', 'net_profit': -2.68}, {'period': ""Q2 '23"", 'revenue': 0.113, 'unit': 'M', 'net_profit': -3.0}, {'period': ""Q1 '23"", 'revenue': 0.056, 'unit': 'M', 'net_profit': -4.39}, {'period': ""Q4 '22"", 'revenue': 0.109, 'unit': 'M', 'net_profit': -3.92}]",-15.89,-15.89,7223000,5757000,4958000,4536000,76000,0,3270000,4958000,-11298000,0.30766900896535015,0.28876236802830135,0.8104044863381458,__nan__,__nan__,__nan__,0.6279939083483317
70,MOVE,Movano Inc. Common Stock,"Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medtech and consumer devices. Its platform uses radiofrequency technology, which enables the creation of sensors that are small enough to fit into wearable devices and other small form factors. The company develops Movano Ring that measures heart rate, heart rate variability, sleep, respiration, temperature, blood oxygen saturation, steps, and calories, as well as incorporates women-centric features and design. It is also developing non-invasive continuous glucose monitoring and cuffless blood pressure monitoring features to its technology platform. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.",Dr. John  Mastrototaro Ph.D.,Medical - Devices,1.105,USD,7330029,https://images.financialmodelingprep.com/symbol/MOVE.png,16147,-0.23,-0.075,31211,-29125000,-29283000,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -29.28}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -30.2}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -22.58}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.04}]","[{'period': ""Q3 '24"", 'revenue': 0.05, 'unit': 'M', 'net_profit': -7.2}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.19}, {'period': ""Q1 '24"", 'revenue': 0.852, 'unit': 'M', 'net_profit': -5.72}, {'period': ""Q4 '23"", 'revenue': 0.224, 'unit': 'M', 'net_profit': -5.96}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.96}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.27}]",-9.51,-9.51,9421000,8523000,6118000,5972000,450000,0,5899000,6118000,-26241000,0.03543633051829773,0.03023579282024109,0.30634573304157553,__nan__,__nan__,__nan__,0.6339029826982273
71,MOXC,Moxian Inc. Common Stock,"Moxian (BVI) Inc provides internet media marketing and bitcoin mining services. The company operates an online-to-offline business that provides an online platform for small and medium-sized enterprises with physical stores to conduct business online, interact with existing customers, and obtain new ones. It also operates the Games Channel, an application that develops contacts with the mobile gaming industry in China. Moxian (BVI) Inc was incorporated in 2010 and is headquartered in Beijing, the People's Republic of China.",Mr. Conglin  Deng,Advertising Agencies,1.01,USD,35910247,https://images.financialmodelingprep.com/symbol/MOXC.png,14283,-1.3835616438356164,-0.01,65290,-12891347,-25933339,"[{'period': '2022', 'revenue': 0.16443000000000002, 'unit': 'M', 'net_profit': -25.93}, {'period': '2021', 'revenue': 0.21933000000000002, 'unit': 'M', 'net_profit': -2.79}, {'period': '2020', 'revenue': 946.47, 'unit': 'K', 'net_profit': 72.72}, {'period': '2019', 'revenue': 370.41, 'unit': 'K', 'net_profit': 300.45}]","[{'period': ""Q2 '23"", 'revenue': 0.00364, 'unit': 'M', 'net_profit': -1.75}, {'period': ""Q1 '23"", 'revenue': 0.00364, 'unit': 'M', 'net_profit': -1.75}, {'period': ""Q4 '22"", 'revenue': 0.062, 'unit': 'M', 'net_profit': -10.81}, {'period': ""Q3 '22"", 'revenue': 0.062, 'unit': 'M', 'net_profit': -10.81}, {'period': ""Q4 '21"", 'revenue': 0.00235, 'unit': 'M', 'net_profit': -1.02}, {'period': ""Q2 '21"", 'revenue': 194.09, 'unit': 'K', 'net_profit': 342.13}]",-0.76,-0.76,24531417,4890262,2505286,613455,2384976,0,613455,2505286,-39905826,-3.814060741945133,-8.278757672415798,-4.066666666666666,__nan__,__nan__,__nan__,0.025006912564406694
72,MPAA,Motorcar Parts  of America Inc. Common Stock,"Motorcar Parts of America, Inc. manufactures, remanufactures, and distributes heavy-duty truck, industrial, marine, and agricultural application replacement parts. The company offers rotating electrical products, including alternators and starters; wheel hub assemblies and bearings; and brake-related products comprising brake calipers, brake boosters, brake rotors, brake pads, and brake master cylinders. It also offers test solutions and diagnostic equipment for electric vehicle powertrain development and manufacturing, including electric motor test systems, e-axle test systems, advanced power emulators, and charging unit test systems, as well as test systems for alternators, starters, belt starter generator, and bench-top testers, as well as turbochargers and test services for electric vehicle inverters. The company sells its products to automotive retail chain stores and warehouse distributors, as well as various automobile manufacturers for their aftermarket programs and warranty replacement programs in North America. Motorcar Parts of America, Inc. was founded in 1968 and is headquartered in Torrance, California.",Mr. Selwyn H. Joffe CPA,Auto - Parts,8.47,USD,165873939,https://images.financialmodelingprep.com/symbol/MPAA.png,127501,-9.62,-0.43,69110,58591000,-49244000,"[{'period': '2024', 'revenue': 717.68, 'unit': 'M', 'net_profit': -49.24}, {'period': '2023', 'revenue': 683.07, 'unit': 'M', 'net_profit': -4.21}, {'period': '2022', 'revenue': 650.31, 'unit': 'M', 'net_profit': 7.36}, {'period': '2021', 'revenue': 540.78, 'unit': 'M', 'net_profit': 21.48}]","[{'period': ""Q3 '25"", 'revenue': 186.18, 'unit': 'M', 'net_profit': 2.29}, {'period': ""Q2 '25"", 'revenue': 208.19, 'unit': 'M', 'net_profit': -2.95}, {'period': ""Q1 '25"", 'revenue': 169.89, 'unit': 'M', 'net_profit': -18.09}, {'period': ""Q4 '24"", 'revenue': 189.48, 'unit': 'M', 'net_profit': 1.34}, {'period': ""Q3 '24"", 'revenue': 171.86, 'unit': 'M', 'net_profit': -47.21}, {'period': ""Q2 '24"", 'revenue': 196.64, 'unit': 'M', 'net_profit': -1.96}]",-2.51,-2.51,1012002000,560459000,15811000,726892000,129118000,0,404425000,13974000,38172000,0.6076112604949788,-10.705253149512718,-10.409090909090907,__nan__,__nan__,__nan__,0.7182713077642139
73,MPACU,Model Performance Acquisition Corp. Units,"Model Performance Acquisition Corp. intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Central, Hong Kong.",Mr. Sze Wai  Tsang CFA,Shell Companies,7.97,USD,0,https://images.financialmodelingprep.com/symbol/MPACU.png,2180,0,-2.07,34697,0,0,"[{'period': '2021', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -108.16}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -359.73}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -155.01}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -195.22}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -65.32}]",0.0,0.0,58464685,386105,336852,2682542,0,58078580,617891,336852,-235155,0,0.0,0.0,__nan__,__nan__,__nan__,0.045883117304061416
74,MPB,Mid Penn Bancorp Common Stock,"Mid Penn Bancorp, Inc. operates as the bank holding company for Mid Penn Bank that provides commercial banking services to individuals, partnerships, non-profit organizations, and corporations. The company offers various time and demand deposit products, including checking accounts, savings accounts, clubs, money market deposit accounts, certificates of deposit, and IRAs. It also provides a range of loan products comprising mortgage and home equity loans, secured and unsecured commercial and consumer loans, lines of credit, construction financing, farm loans, community development loans, loans to non-profit entities, and local government loans. In addition, the company offers online banking, telephone banking, cash management, and automated teller services, as well as safe deposit boxes; and trust and wealth management services. As of December 31, 2021, it operated sixty full-service retail banking locations in Berks, Blair, Bucks, Centre, Chester, Clearfield, Cumberland, Dauphin, Fayette, Huntingdon, Lancaster, Lehigh, Luzerne, Lycoming, Montgomery, Northumberland, Perry, Schuylkill, and Westmoreland counties, Pennsylvania. The company was founded in 1868 and is headquartered in Harrisburg, Pennsylvania.",Mr. Rory G. Ritrievi,Banks - Regional,24.36,USD,471512160,https://images.financialmodelingprep.com/symbol/MPB.png,81393,8.4,-0.32,268602,0,49437000,"[{'period': '2024', 'revenue': 286.58, 'unit': 'M', 'net_profit': 49.44}, {'period': '2023', 'revenue': 163.36, 'unit': 'M', 'net_profit': 37.4}, {'period': '2022', 'revenue': 169.31, 'unit': 'M', 'net_profit': 54.81}, {'period': '2021', 'revenue': 127.56, 'unit': 'M', 'net_profit': 29.32}]","[{'period': ""Q4 '24"", 'revenue': 73.31, 'unit': 'M', 'net_profit': 13.23}, {'period': ""Q3 '24"", 'revenue': 44.78, 'unit': 'M', 'net_profit': 12.3}, {'period': ""Q2 '24"", 'revenue': 76.53, 'unit': 'M', 'net_profit': 11.77}, {'period': ""Q1 '24"", 'revenue': 74.03, 'unit': 'M', 'net_profit': 12.13}, {'period': ""Q4 '23"", 'revenue': 66.12, 'unit': 'M', 'net_profit': 12.1}, {'period': ""Q3 '23"", 'revenue': 63.42, 'unit': 'M', 'net_profit': 9.24}]",2.9,2.9,5470936000,63848000,37002000,4815918000,26846000,0,15484000,37002000,44472000,-1,0.32195095863304546,0.26637554585152834,"[0.2, 0.19]","['2025-02-07', '1998-02-09']",__nan__,0.8802731379054699
75,MPWR,Monolithic Power Systems Inc. Common Stock,"Monolithic Power Systems, Inc. engages in the design, development, marketing, and sale of semiconductor-based power electronics solutions for the computing and storage, automotive, industrial, communications, and consumer markets. The company provides direct current (DC) to DC integrated circuits (ICs) that are used to convert and control voltages of various electronic systems, such as portable electronic devices, wireless LAN access points, computers and notebooks, monitors, infotainment applications, and medical equipment. It also offers lighting control ICs for backlighting that are used in systems, which provide the light source for LCD panels in notebook computers, monitors, car navigation systems, and televisions, as well as for general illumination products. The company sells its products through third-party distributors and value-added resellers, as well as directly to original equipment manufacturers, original design manufacturers, electronic manufacturing service providers, and other end customers in China, Taiwan, Europe, South Korea, Southeast Asia, Japan, the United States, and internationally. Monolithic Power Systems, Inc. was incorporated in 1997 and is headquartered in Kirkland, Washington.",Mr. Michael R. Hsing,Semiconductors,455.19,USD,21788124540,https://images.financialmodelingprep.com/symbol/MPWR.png,977519,12.44,-33.43,1587493,575788000,1786700000,"[{'period': '2024', 'revenue': 2.21, 'unit': 'B', 'net_profit': 1.79}, {'period': '2023', 'revenue': 1820.0, 'unit': 'M', 'net_profit': 427.37}, {'period': '2022', 'revenue': 1790.0, 'unit': 'M', 'net_profit': 437.67}, {'period': '2021', 'revenue': 1210.0, 'unit': 'M', 'net_profit': 242.02}]","[{'period': ""Q4 '24"", 'revenue': 0.62166, 'unit': 'B', 'net_profit': 1.45}, {'period': ""Q3 '24"", 'revenue': 620.12, 'unit': 'M', 'net_profit': 144.43}, {'period': ""Q2 '24"", 'revenue': 507.43, 'unit': 'M', 'net_profit': 100.37}, {'period': ""Q1 '24"", 'revenue': 457.88, 'unit': 'M', 'net_profit': 92.54}, {'period': ""Q4 '23"", 'revenue': 454.01, 'unit': 'M', 'net_profit': 96.91}, {'period': ""Q3 '23"", 'revenue': 474.87, 'unit': 'M', 'net_profit': 121.16}]",36.76,36.59,3617097000,1565053000,862946000,471330000,172518000,0,294567000,691816000,642292000,0.10324504123363684,3.1806473954896646,3.0935412026726055,"[1.56, 1]","['2025-03-31', '2012-12-19']",__nan__,0.1303061543552744
76,MRAC,Marquee Raine Acquisition Corp. Class A Ordinary Shares,"Marquee Raine Acquisition Corp., a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2020 and is based in New York, New York.",Mr. Crane H. Kenney,Shell Companies,10.92,USD,0,https://images.financialmodelingprep.com/symbol/MRAC.png,308685,0,1,294228,-127691,-127691,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -127.69}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.98}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -127.69}]",-0.0034,-0.0034,376847694,3097694,2266049,14148976,0,0,1067726,2266049,,0,0.0,0.0,__nan__,__nan__,__nan__,0.03754560854497361
77,MRACU,Marquee Raine Acquisition Corp. Unit,,,,,,,,,,,,-127691,-127691,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -127.69}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.98}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -127.69}]",8.43,0.0,376847694,3097694,2266049,14148976,0,0,1067726,2266049,,0,0.0,0.0,__nan__,__nan__,__nan__,0.03754560854497361
78,MRACW,Marquee Raine Acquisition Corp. Warrant,"Marquee Raine Acquisition Corp., a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2020 and is based in New York, New York.",Mr. Crane H. Kenney,Shell Companies,1.435,USD,0,https://images.financialmodelingprep.com/symbol/MRACW.png,54745,0,0.105,35817,-127691,-127691,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -127.69}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.98}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -127.69}]",-0.0034,-0.0034,376847694,3097694,2266049,14148976,0,0,1067726,2266049,,0,0.0,0.0,__nan__,__nan__,__nan__,0.03754560854497361
79,MRAM,Everspin Technologies Inc. Common Stock,"Everspin Technologies, Inc. manufactures and sells magnetoresistive random access memory (MRAM) products in the United States, Hong Kong, Japan, China, Canada, and internationally. It offers Toggle MRAM, spin-transfer torque MRAM, and tunnel magneto resistance sensor products, as well as foundry services for embedded MRAM. The company provides its products for applications, including data center, industrial, medical, automotive/transportation, and aerospace markets. It serves original equipment manufacturers and original design manufacturers through a direct sales channel and a network of representatives and distributors. Everspin Technologies, Inc. was incorporated in 2008 and is headquartered in Chandler, Arizona.",Dr. Sanjeev  Aggarwal Ph.D.,Semiconductors,4.4,USD,97420400,https://images.financialmodelingprep.com/symbol/MRAM.png,106906,110,-0.17,147662,2472000,781000,"[{'period': '2024', 'revenue': 50400.0, 'unit': 'K', 'net_profit': 781.0}, {'period': '2023', 'revenue': 63.77, 'unit': 'M', 'net_profit': 9.05}, {'period': '2022', 'revenue': 59.98, 'unit': 'M', 'net_profit': 6.13}, {'period': '2021', 'revenue': 55.15, 'unit': 'M', 'net_profit': 4.34}]","[{'period': ""Q4 '24"", 'revenue': 13.24, 'unit': 'M', 'net_profit': 1.21}, {'period': ""Q3 '24"", 'revenue': 12.09, 'unit': 'M', 'net_profit': 2.27}, {'period': ""Q2 '24"", 'revenue': 10.64, 'unit': 'M', 'net_profit': -2.5}, {'period': ""Q1 '24"", 'revenue': 14430.0, 'unit': 'K', 'net_profit': -202.0}, {'period': ""Q4 '23"", 'revenue': 16.71, 'unit': 'M', 'net_profit': 1.97}, {'period': ""Q3 '23"", 'revenue': 16.47, 'unit': 'M', 'net_profit': 2.44}]",0.0361,0.0352,77789000,64201000,42097000,15196000,11722000,0,9914000,42097000,4050000,-0.6513399153737659,-0.9137207247017234,-0.9179545454545454,__nan__,__nan__,__nan__,0.19534895679337697
80,MRBK,Meridian Corporation Common Stock,"Meridian Corporation operates as the holding company for Meridian Bank that provides commercial banking products and services in Pennsylvania, New Jersey, Delaware, and Maryland. The company offers various deposit products, such as demand non-interest bearing, demand interest bearing, savings accounts, money market accounts, and time deposits. It also provides commercial and industrial loans comprising business lines of credit, term loans, small business lending, lease financing, and shared national credits; commercial real estate, and land development and construction loans for residential and commercial projects; and consumer and home equity lending, private banking, merchant, and title and land settlement services. In addition, the company operates and originates mortgage loans for 1-4 family dwellings; and offers real estate holding, investment advisory, and equipment leasing services. It operates through a network of 6 full-service branches, and 19 other offices. The company was founded in 2004 and is headquartered in Malvern, Pennsylvania.",Mr. Christopher J. Annas,Banks - Regional,12.67,USD,142984751,https://images.financialmodelingprep.com/symbol/MRBK.png,58649,8.74,-0.02,45918,0,16346000,"[{'period': '2024', 'revenue': 156.03, 'unit': 'M', 'net_profit': 16.35}, {'period': '2023', 'revenue': 94.09, 'unit': 'M', 'net_profit': 13.24}, {'period': '2022', 'revenue': 111.85, 'unit': 'M', 'net_profit': 21.83}, {'period': '2021', 'revenue': 151.1, 'unit': 'M', 'net_profit': 35.59}]","[{'period': ""Q4 '24"", 'revenue': 28.59, 'unit': 'M', 'net_profit': 5.6}, {'period': ""Q3 '24"", 'revenue': 29.07, 'unit': 'M', 'net_profit': 4.74}, {'period': ""Q2 '24"", 'revenue': 47.62, 'unit': 'M', 'net_profit': 3.33}, {'period': ""Q1 '24"", 'revenue': 45.3, 'unit': 'M', 'net_profit': 2.68}, {'period': ""Q4 '23"", 'revenue': 43720.0, 'unit': 'K', 'net_profit': 570.0}, {'period': ""Q3 '23"", 'revenue': 25.31, 'unit': 'M', 'net_profit': 4.0}]",1.47,1.45,2385867000,189860000,179902000,2214345000,83469000,0,6860000,5598000,9029000,0,0.2343124669636789,0.23529411764705885,"[0.125, 0.125]","['2025-02-10', '2020-08-07']",__nan__,0.9281091527733943
81,MRCC,Monroe Capital Corporation Common Stock,"Monroe Capital Corporation is a business development company specializing in customized financing solutions in senior, unitranche and junior secured debt, subordinated debt financing and to a lesser extent, unsecured debt and equity, including equity co-investments in preferred and common stock and warrants. It also provides financing primarily to leveraged buyouts in lower middle-market companies. It focuses to invest in the United States and Canada. The fund prefers to invest in companies with EBITDA between $3 and $35 million. Its makes minority equity investments.",Mr. Lewis W. Solimene Jr.,Asset Management,6.66,USD,144297558,https://images.financialmodelingprep.com/symbol/MRCC.png,68009,14.8,-0.12,93642,0,9704000,"[{'period': '2024', 'revenue': 46.44, 'unit': 'M', 'net_profit': 9.7}, {'period': '2023', 'revenue': 27280.0, 'unit': 'K', 'net_profit': 371.0}, {'period': '2022', 'revenue': 4.49, 'unit': 'M', 'net_profit': -2.79}, {'period': '2021', 'revenue': 40.16, 'unit': 'M', 'net_profit': 32.46}]","[{'period': ""Q4 '24"", 'revenue': -0.461, 'unit': 'M', 'net_profit': -1.72}, {'period': ""Q3 '24"", 'revenue': 12.13, 'unit': 'M', 'net_profit': 4.97}, {'period': ""Q2 '24"", 'revenue': 16.13, 'unit': 'M', 'net_profit': 3.26}, {'period': ""Q1 '24"", 'revenue': 15.19, 'unit': 'M', 'net_profit': 3.19}, {'period': ""Q4 '23"", 'revenue': 15.79, 'unit': 'M', 'net_profit': 1.58}, {'period': ""Q3 '23"", 'revenue': 948.0, 'unit': 'K', 'net_profit': -236.0}]",0.45,0.45,490671000,32555000,9044000,298909000,23511000,457048000,6934000,9044000,35959000,0,25.15633423180593,25.31578947368421,"[0.25, 0.34]","['2025-03-14', '2012-12-12']",__nan__,0.6091841580203435
82,MRCY,Mercury Systems Inc Common Stock,"Mercury Systems, Inc., a technology company, manufactures and sells components, products, modules, and subsystems for aerospace and defense industries in the United States, Europe, and the Asia Pacific. Its products and solutions are deployed in approximately 300 programs with 25 defense contractors and commercial aviation customers. The company offers components, including power amplifiers and limiters, switches, oscillators, filters, equalizers, digital and analog converters, chips, monolithic microwave integrated circuits, and memory and storage devices; modules and sub-assemblies, such as embedded processing modules and boards, switched fabric boards, digital receiver boards, multi-chip modules, integrated radio frequency and microwave multi-function assemblies, tuners, and transceivers, as well as graphics and video processing, and Ethernet and input-output boards; and integrated subsystems. It also designs and develops digital radio frequency memory units for various modern electronic warfare applications; radar environment simulation and test systems for defense and intelligence applications; and signals intelligence payloads and EO/IR technologies for small UAV platforms, as well as onboard UAV processor systems for real-time wide area motion imagery. The company was formerly known as Mercury Computer Systems, Inc. and changed its name to Mercury Systems, Inc. in November 2012. Mercury Systems, Inc. was incorporated in 1981 and is headquartered in Andover, Massachusetts.",Dr. William L. Ballhaus,Aerospace & Defense,42.96,USD,2563904352,https://images.financialmodelingprep.com/symbol/MRCY.png,544786,-27.9,1.44,761168,-66230000,-137640000,"[{'period': '2024', 'revenue': 835.27, 'unit': 'M', 'net_profit': -137.64}, {'period': '2023', 'revenue': 973.88, 'unit': 'M', 'net_profit': -28.34}, {'period': '2022', 'revenue': 988.2, 'unit': 'M', 'net_profit': 11.28}, {'period': '2021', 'revenue': 924.0, 'unit': 'M', 'net_profit': 62.04}]","[{'period': ""Q2 '25"", 'revenue': 223.12, 'unit': 'M', 'net_profit': -17.58}, {'period': ""Q1 '25"", 'revenue': 204.43, 'unit': 'M', 'net_profit': -17.52}, {'period': ""Q4 '24"", 'revenue': 248.56, 'unit': 'M', 'net_profit': -10.78}, {'period': ""Q3 '24"", 'revenue': 208.26, 'unit': 'M', 'net_profit': -44.57}, {'period': ""Q2 '24"", 'revenue': 197.46, 'unit': 'M', 'net_profit': -45.58}, {'period': ""Q1 '24"", 'revenue': 180.99, 'unit': 'M', 'net_profit': -36.71}]",-2.38,-2.38,2378905000,953784000,180521000,906130000,415470000,0,234416000,180521000,26091000,-1.895653585048549,-3.857596611964002,-3.76,"[0.6175, 0.6175]","['2015-03-13', '2015-03-13']",__nan__,0.3809021377482497
83,MREO,Mereo BioPharma Group plc American Depositary Shares,"Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor. The company is also developing Navicixizumab (OMP-305B83), which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Acumapimod (BCT-197), a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole (BGS-649), an oral aromatase inhibitor for the treatment of hypogonadotropic hypogonadism. In addition, it develops rare disease product candidates, including Setrusumab (BPS-804), a novel antibody for the treatment of osteogenesis imperfecta; and Alvelestat (MPH-966), an oral small molecule that is in Phase II clinical trial to treat Alpha-1 antitrypsin deficiency. The company has a collaboration with The University of Texas MD Anderson Cancer Center to evaluate anti-TIGIT therapeutic antibody candidate, etigilimab. Mereo BioPharma Group plc was incorporated in 2015 and is based in London, the United Kingdom.",Dr. Denise Vera Scots-Knight Ph.D.,Biotechnology,1.76,USD,273056267,https://images.financialmodelingprep.com/symbol/MREO.png,1357167,-5.87,-0.07,3283418,-47364000,-43253000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -43.25}, {'period': '2023', 'revenue': 10.0, 'unit': 'M', 'net_profit': -29.47}, {'period': '2022', 'revenue': 1.51, 'unit': 'M', 'net_profit': -34.2}, {'period': '2021', 'revenue': 36.46, 'unit': 'M', 'net_profit': 12.72}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.05}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.0}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.26}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.95}, {'period': ""Q4 '23"", 'revenue': 0.36110000000000003, 'unit': 'M', 'net_profit': -6.05}, {'period': ""Q3 '23"", 'revenue': 0.53343, 'unit': 'M', 'net_profit': -6.56}]",-0.0585,-0.0585,76390000,74763000,69802000,15421000,0,0,13848000,69802000,-32834000,-0.8177770954866441,-0.46789520124889705,0.9997341440802748,__nan__,__nan__,__nan__,0.20187197277130514
84,MRIN,Marin Software Incorporated Common Stock,"Marin Software Incorporated, together with its subsidiaries, provides enterprise marketing software for advertisers and agencies in the United States, the United Kingdom, and internationally. It offers MarinOne, a search, social, and eCommerce advertising platform; Marin Search to manage advertising campaigns for advertisers and agencies; and Marin Social that enables advertisers to manage their Facebook, Instagram, and Twitter advertising, as well as managed services. The company markets and sells its solutions to advertisers directly, and through advertising agencies that use its platform on behalf of their customers. Marin Software Incorporated was incorporated in 2006 and is headquartered in San Francisco, California.",Mr. Christopher A. Lien,Software - Application,1.13,USD,3552098,https://images.financialmodelingprep.com/symbol/MRIN.png,19478,-0.29,0.03,33582,-16282000,-21917000,"[{'period': '2023', 'revenue': 17.73, 'unit': 'M', 'net_profit': -21.92}, {'period': '2022', 'revenue': 20.02, 'unit': 'M', 'net_profit': -18.23}, {'period': '2021', 'revenue': 24.42, 'unit': 'M', 'net_profit': -12.94}, {'period': '2020', 'revenue': 29.98, 'unit': 'M', 'net_profit': -14.05}]","[{'period': ""Q3 '24"", 'revenue': 4.28, 'unit': 'M', 'net_profit': -2.33}, {'period': ""Q2 '24"", 'revenue': 4.04, 'unit': 'M', 'net_profit': -2.02}, {'period': ""Q1 '24"", 'revenue': 4.03, 'unit': 'M', 'net_profit': -2.41}, {'period': ""Q4 '23"", 'revenue': 4.35, 'unit': 'M', 'net_profit': -5.26}, {'period': ""Q3 '23"", 'revenue': 4.44, 'unit': 'M', 'net_profit': -4.95}, {'period': ""Q2 '23"", 'revenue': 4.36, 'unit': 'M', 'net_profit': -5.92}]",-7.45,-7.45,19315000,16775000,11363000,5676000,3864000,0,4281000,11363000,-16390000,0.17534440842787682,-0.2024469194052779,-0.0797101449275362,__nan__,__nan__,__nan__,0.2938648718612477
85,MRKR,Marker Therapeutics Inc. Common Stock,"Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens and kill tumor cells expressing tumor-associated antigens. The company's MultiTAA-specific T cell therapies include autologous T cells for the treatment of lymphoma, and various solid tumors; allogeneic T cells for the treatment of acute myeloid leukemia and acute lymphoblastic leukemia; and off-the-shelf products in various indications. It is also developing TPIV100/110, a peptide-based immunotherapeutic vaccines for the treatment of breast and ovarian cancer cells; and TPIV200, which is in Phase 2 clinical trial for the treatment of breast and ovarian cancers. The company was founded in 1999 and is headquartered in Houston, Texas.",Dr. Juan F. Vera M.D.,Biotechnology,1.05,USD,11244450,https://images.financialmodelingprep.com/symbol/MRKR.png,134116,-0.88,0.04,45764,-11118372000000,-10731315,"[{'period': '2024', 'revenue': 6590000.0, 'unit': 'M', 'net_profit': -10.73}, {'period': '2023', 'revenue': 3.31, 'unit': 'M', 'net_profit': -14.05}, {'period': '2022', 'revenue': 9.0, 'unit': 'M', 'net_profit': -29.92}, {'period': '2021', 'revenue': 1.24, 'unit': 'M', 'net_profit': -41.87}]","[{'period': ""Q4 '24"", 'revenue': 6.59, 'unit': 'T', 'net_profit': -10.73}, {'period': ""Q3 '24"", 'revenue': 1.93, 'unit': 'M', 'net_profit': -2.31}, {'period': ""Q2 '24"", 'revenue': 1.17, 'unit': 'M', 'net_profit': -2.19}, {'period': ""Q1 '24"", 'revenue': 1.24, 'unit': 'M', 'net_profit': -2.39}, {'period': ""Q4 '23"", 'revenue': 1.06, 'unit': 'M', 'net_profit': -2.74}, {'period': ""Q3 '23"", 'revenue': 0.25761, 'unit': 'M', 'net_profit': -2.98}]",-1.19,-1.19,22022860000000,22022860000000,19192440000000,3464454000000,2346703000000,0,3464454000000,19192440,-10910324000000,-942851.4036758989,0.23598211434728794,0.383419689119171,__nan__,__nan__,__nan__,0.157311720639372
86,MRLN,Marlin Business Services Corp. Common Stock,"Marlin Business Services Corp. provides credit products and services to small and mid-sized businesses in the United States. The company's products and services include loans and leases for the acquisition of commercial equipment and working capital loans. It offers lease finance to approximately 100 categories of equipment. As of December 31, 2020, the company had a portfolio of approximately 80,000 equipment finance leases and loans. It also offers reinsurance services; and operates a commercial bank that issues certificates of deposit and money market deposit accounts. The company provides its solutions through a network of independent commercial equipment dealers and national account programs, as well as through direct solicitation and relationships with select lease and loan brokers. Marlin Business Services Corp. was founded in 1997 and is based in Mount Laurel, New Jersey.",Mr. Jeffrey Hilzinger,Financial - Credit Services,23.49,USD,0,https://images.financialmodelingprep.com/symbol/MRLN.png,64090,0,0,0,20670000,342000,"[{'period': '2020', 'revenue': 102300.0, 'unit': 'K', 'net_profit': 342.0}, {'period': '2019', 'revenue': 141.62, 'unit': 'M', 'net_profit': 27.12}, {'period': '2018', 'revenue': 116.89, 'unit': 'M', 'net_profit': 24.98}, {'period': '2017', 'revenue': 107.87, 'unit': 'M', 'net_profit': 25.29}]","[{'period': ""Q3 '21"", 'revenue': 20.55, 'unit': 'M', 'net_profit': 5.48}, {'period': ""Q2 '21"", 'revenue': 20.65, 'unit': 'M', 'net_profit': 10.26}, {'period': ""Q1 '21"", 'revenue': 21.03, 'unit': 'M', 'net_profit': 6.85}, {'period': ""Q4 '20"", 'revenue': 22.01, 'unit': 'M', 'net_profit': 15.3}, {'period': ""Q3 '20"", 'revenue': 24.6, 'unit': 'M', 'net_profit': 2.74}, {'period': ""Q2 '20"", 'revenue': 25.45, 'unit': 'M', 'net_profit': -5.88}]",0.0288,0.0288,1021998000,988499000,141658000,825633000,9782000,11624000,27734000,141658000,-328469000,-0.6865854952919592,-0.9873875202832276,-0.9872566371681416,"[0.14, 0.06]","['2021-11-05', '2011-11-09']",__nan__,0.8078616592204682
87,MRM,MEDIROM Healthcare Technologies Inc. American Depositary Share,"MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. It operates in two segments, Relaxation Salon and Digital Preventative Healthcare. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. As of December 31, 2021, this segment operated 312 relaxation salons under the Re.Ra.Ku and Ruam Ruam brand. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program, utilizing Lav, its internally developed on-demand health monitoring smartphone application; MOTHER Tracker for fitness applications; and preventative healthcare services utilizing its digital application and devices. MEDIROM Healthcare Technologies Inc. also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques located in the Odaiba area in Tokyo. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.",Mr. Kouji  Eguchi,Personal Products & Services,0.569,USD,2809921,https://images.financialmodelingprep.com/symbol/MRM.png,1317873,-3.56,0.0546,424082,310085000,115049000,"[{'period': '2023', 'revenue': 6830.0, 'unit': 'M', 'net_profit': 115.05}, {'period': '2022', 'revenue': 6950.0, 'unit': 'M', 'net_profit': 148.97}, {'period': '2021', 'revenue': 5410.0, 'unit': 'M', 'net_profit': -990.73}, {'period': '2020', 'revenue': 3340.0, 'unit': 'M', 'net_profit': -539.17}]","[{'period': ""Q2 '24"", 'revenue': 3480.0, 'unit': 'M', 'net_profit': -582.18}, {'period': ""Q4 '23"", 'revenue': 3590.0, 'unit': 'M', 'net_profit': 470.47}, {'period': ""Q2 '23"", 'revenue': 3240.0, 'unit': 'M', 'net_profit': -355.07}, {'period': ""Q4 '22"", 'revenue': 3810.0, 'unit': 'M', 'net_profit': 330.51}, {'period': ""Q2 '22"", 'revenue': 1570.0, 'unit': 'M', 'net_profit': -90.77}, {'period': ""Q4 '21"", 'revenue': 1640.0, 'unit': 'M', 'net_profit': -234.48}]",22.27,22.27,6849189000,1758704000,106847000,6633228000,621867000,81542000,3560593000,106347000,-767577000,0.10341502296965017,-0.22767764239922128,-0.27079240340537,__nan__,__nan__,__nan__,0.9684691136425057
88,MRNA,Moderna Inc. Common Stock,"Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.",Mr. Stephane  Bancel,Biotechnology,24.64,USD,9506506240,https://images.financialmodelingprep.com/symbol/MRNA.png,11769447,-2.66,-1,8934979,-3394000000,-3561000000,"[{'period': '2024', 'revenue': 3.24, 'unit': 'B', 'net_profit': -3.56}, {'period': '2023', 'revenue': 6.85, 'unit': 'B', 'net_profit': -4.71}, {'period': '2022', 'revenue': 19.26, 'unit': 'B', 'net_profit': 8.36}, {'period': '2021', 'revenue': 17.74, 'unit': 'B', 'net_profit': 12.2}]","[{'period': ""Q4 '24"", 'revenue': 0.966, 'unit': 'B', 'net_profit': -1.12}, {'period': ""Q3 '24"", 'revenue': 1850.0, 'unit': 'M', 'net_profit': 13.0}, {'period': ""Q2 '24"", 'revenue': 0.241, 'unit': 'B', 'net_profit': -1.28}, {'period': ""Q1 '24"", 'revenue': 0.167, 'unit': 'B', 'net_profit': -1.18}, {'period': ""Q4 '23"", 'revenue': 2810.0, 'unit': 'M', 'net_profit': 217.0}, {'period': ""Q3 '23"", 'revenue': 1.83, 'unit': 'B', 'net_profit': -3.63}]",-9.27,-9.27,14142000000,8099000000,1927000000,3241000000,358000000,2508000000,2206000000,1927000000,-4055000000,-0.03381053914102954,0.24459058124734834,0.2487844408427877,__nan__,__nan__,__nan__,0.22917550558619715
89,MRNS,Marinus Pharmaceuticals Inc. Common Stock,"Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult and pediatric patient populations in acute and chronic care, and in-patient and self-administered settings. The company's ZTALMY product candidate acts at synaptic and extrasynaptic GABAA receptors, a target for its anti-seizure, antidepressant, and anxiolytic potential. It is developing ganaxolone for treating genetic epilepsy disorders, such as PCDH19-related epilepsy, tuberous sclerosis complex, depressive disorders, and Lennox-Gestaut Syndrome. Marinus Pharmaceuticals, Inc. has license agreement with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc.; and collaboration agreement with Orion Corporation. The company was incorporated in 2003 and is headquartered in Radnor, Pennsylvania.",Dr. Scott N. Braunstein M.D.,Biotechnology,0.55,USD,30370175,https://images.financialmodelingprep.com/symbol/MRNS.png,1810773,-0.22267206477732793,0,1100953,-125497000,-141405000,"[{'period': '2023', 'revenue': 30.99, 'unit': 'M', 'net_profit': -141.41}, {'period': '2022', 'revenue': 25.48, 'unit': 'M', 'net_profit': -19.82}, {'period': '2021', 'revenue': 15.35, 'unit': 'M', 'net_profit': -101.66}, {'period': '2020', 'revenue': 1.72, 'unit': 'M', 'net_profit': -66.64}]","[{'period': ""Q3 '24"", 'revenue': 8.54, 'unit': 'M', 'net_profit': -24.23}, {'period': ""Q2 '24"", 'revenue': 8.06, 'unit': 'M', 'net_profit': -35.83}, {'period': ""Q1 '24"", 'revenue': 7.68, 'unit': 'M', 'net_profit': -38.67}, {'period': ""Q4 '23"", 'revenue': 7.19, 'unit': 'M', 'net_profit': -41.77}, {'period': ""Q3 '23"", 'revenue': 7.34, 'unit': 'M', 'net_profit': -32.97}, {'period': ""Q2 '23"", 'revenue': 6.08, 'unit': 'M', 'net_profit': -31.93}]",-2.63,-2.63,170908000,165246000,150288000,154143000,3799000,0,40624000,120572000,-118120000,-23.674990169091625,-6.135900282599919,-4.1568627450980395,__nan__,__nan__,__nan__,0.9019062887635453
90,MRSN,Mersana Therapeutics Inc. Common Stock,"Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also develops XMT-1660, a B7-H4-targeted Dolasynthen ADC candidate; and XMT-2056, an immunosynthen development candidate. It has a strategic research and development partnerships with Merck KGaA and Asana BioSciences, LLC for the development of ADC product candidates utilizing Fleximer. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts.",Dr. Martin H. Huber M.D.,Biotechnology,0.2926,USD,36467031,https://images.financialmodelingprep.com/symbol/MRSN.png,5874034,-0.52,-0.0127,1817609,-63272000,-69192000,"[{'period': '2024', 'revenue': 40.5, 'unit': 'M', 'net_profit': -69.19}, {'period': '2023', 'revenue': 36.85, 'unit': 'M', 'net_profit': -171.67}, {'period': '2022', 'revenue': 26.58, 'unit': 'M', 'net_profit': -207.54}, {'period': '2021', 'revenue': 0.043000000000000003, 'unit': 'M', 'net_profit': -169.21}]","[{'period': ""Q4 '24"", 'revenue': 16.36, 'unit': 'M', 'net_profit': -14.12}, {'period': ""Q3 '24"", 'revenue': 12.6, 'unit': 'M', 'net_profit': -11.5}, {'period': ""Q2 '24"", 'revenue': 2.29, 'unit': 'M', 'net_profit': -24.27}, {'period': ""Q1 '24"", 'revenue': 9.24, 'unit': 'M', 'net_profit': -19.31}, {'period': ""Q4 '23"", 'revenue': 10.7, 'unit': 'M', 'net_profit': -19.54}, {'period': ""Q3 '23"", 'revenue': 7.7, 'unit': 'M', 'net_profit': -41.66}]",-0.56,-0.56,144663000,136904000,134620000,154172000,0,0,62458000,107750000,-82472000,0.6190269749518305,0.5969476320848139,0.6216216216216216,__nan__,__nan__,__nan__,1.065732080767024
91,MRTN,Marten Transport Ltd. Common Stock,"Marten Transport, Ltd. operates as a temperature-sensitive truckload carrier for shippers in the United States, Canada, and Mexico. It operates through four segments: Truckload, Dedicated, Intermodal, and Brokerage. The Truckload segment transports food and other consumer packaged goods that require a temperature-controlled or insulated environment. The Dedicated segment offers customized transportation solutions for individual customers' requirements using temperature-controlled trailers, dry vans, and other specialized equipment. The Intermodal segment transports customers' freight utilizing its refrigerated containers and temperature-controlled trailers on railroad flatcars for portions of trips, as well as using tractors and contracted carriers. The Brokerage segment develops contractual relationships with and arranges for third-party carriers to transport freight for customers in temperature-controlled trailers and dry vans. As of December 31, 2021, the company operated a fleet of 3,204 tractors, including 3,111 company-owned tractors and 93 tractors supplied by independent contractors. Marten Transport, Ltd. was founded in 1946 and is headquartered in Mondovi, Wisconsin.",Mr. Timothy M. Kohl,Trucking,12.69,USD,1033784505,https://images.financialmodelingprep.com/symbol/MRTN.png,465832,38.45,-0.2,440596,33220000,26922000,"[{'period': '2024', 'revenue': 963.71, 'unit': 'M', 'net_profit': 26.92}, {'period': '2023', 'revenue': 1130.0, 'unit': 'M', 'net_profit': 70.37}, {'period': '2022', 'revenue': 1260.0, 'unit': 'M', 'net_profit': 110.35}, {'period': '2021', 'revenue': 973.64, 'unit': 'M', 'net_profit': 85.43}]","[{'period': ""Q4 '24"", 'revenue': 230.43, 'unit': 'M', 'net_profit': 5.63}, {'period': ""Q3 '24"", 'revenue': 237.37, 'unit': 'M', 'net_profit': 3.75}, {'period': ""Q2 '24"", 'revenue': 246.24, 'unit': 'M', 'net_profit': 7.89}, {'period': ""Q1 '24"", 'revenue': 249.67, 'unit': 'M', 'net_profit': 9.65}, {'period': ""Q4 '23"", 'revenue': 268.22, 'unit': 'M', 'net_profit': 12.4}, {'period': ""Q3 '23"", 'revenue': 279.54, 'unit': 'M', 'net_profit': 13.6}]",0.33,0.33,968757000,138511000,17267000,200835000,96940000,0,93519000,17267000,134814000,-0.8280716281958389,-0.617438506245293,-0.6206896551724138,"[0.06, 0.02]","['2025-03-14', '2010-08-26']",__nan__,0.20731205039034556
92,MRTX,Mirati Therapeutics Inc. Common Stock,"Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; and Sitravatinib, an investigational spectrum-selective kinase inhibitor that is in Phase 3 clinical trial for the treatment of NSCL cancer, as well as a KRAS G12D inhibitor program, which is in preclinical development. It has a collaboration and license agreement with BeiGene, Ltd. to develop, manufacture, and commercialize sitravatinib. Mirati Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California.","Dr. Charles M. Baum M.D., Ph.D.",Biotechnology,58.7,USD,4117669755,https://images.financialmodelingprep.com/symbol/MRTX.png,1778618,-4.819376026272578,-0.1,20956839,-756660000,-740867000,"[{'period': '2022', 'revenue': 12.44, 'unit': 'M', 'net_profit': -740.87}, {'period': '2021', 'revenue': 72.09, 'unit': 'M', 'net_profit': -581.78}, {'period': '2020', 'revenue': 13.4, 'unit': 'M', 'net_profit': -357.43}, {'period': '2019', 'revenue': 3.33, 'unit': 'M', 'net_profit': -212.6}]","[{'period': ""Q3 '23"", 'revenue': 16.4, 'unit': 'M', 'net_profit': -161.9}, {'period': ""Q2 '23"", 'revenue': 13.69, 'unit': 'M', 'net_profit': -176.91}, {'period': ""Q1 '23"", 'revenue': 7.17, 'unit': 'M', 'net_profit': -175.35}, {'period': ""Q4 '22"", 'revenue': 0.934, 'unit': 'M', 'net_profit': -202.47}, {'period': ""Q3 '22"", 'revenue': 5.43, 'unit': 'M', 'net_profit': -173.56}, {'period': ""Q2 '22"", 'revenue': 5.36, 'unit': 'M', 'net_profit': -176.59}]",-13.18,-13.18,1202647000,1108961000,1083837000,206131000,865000,3465000,159448000,235260000,-575421000,-0.324221211060553,-0.27343997084828736,-0.1757359500446029,__nan__,__nan__,__nan__,0.17139775844449784
93,MRUS,Merus N.V. Common Shares,"Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase 1/2 clinical trials for the treatment of solid tumors that harbor Neuregulin 1. The company is also developing MCLA-158, which is in a phase I clinical trial for the treatment of solid tumors; MCLA-145, which is in phase 1 clinical trials for the treatment of solid tumors; MCLA-129, which is in phase 1/2 clinical trials for the treatment of patients with advanced non-small cell lung cancer and other solid tumors; and ONO-4685 that is Phase 1 clinical trial to treat relapsed/refractory T cell lymphoma. In addition, it has collaboration agreement with Betta Pharmaceuticals Co. Ltd for the research and development of stage bispecific antibody candidates include MCLA-129; and collaboration with Incyte Corporation for the development of MCLA-145. The company was incorporated in 2003 and is headquartered in Utrecht, the Netherlands.",Dr. Sven Ante Lundberg M.D.,Biotechnology,34.89,USD,2410567545,https://images.financialmodelingprep.com/symbol/MRUS.png,722449,-10.41,-2.5,910768,-269596000,-215326000,"[{'period': '2024', 'revenue': 36.13, 'unit': 'M', 'net_profit': -215.33}, {'period': '2023', 'revenue': 43.95, 'unit': 'M', 'net_profit': -154.94}, {'period': '2022', 'revenue': 41.59, 'unit': 'M', 'net_profit': -131.19}, {'period': '2021', 'revenue': 49.11, 'unit': 'M', 'net_profit': -66.82}]","[{'period': ""Q4 '24"", 'revenue': 9.14, 'unit': 'M', 'net_profit': -30.92}, {'period': ""Q3 '24"", 'revenue': 11.77, 'unit': 'M', 'net_profit': -99.91}, {'period': ""Q2 '24"", 'revenue': 7.33, 'unit': 'M', 'net_profit': -50.04}, {'period': ""Q1 '24"", 'revenue': 7.89, 'unit': 'M', 'net_profit': -34.46}, {'period': ""Q4 '23"", 'revenue': 8.94, 'unit': 'M', 'net_profit': -60.15}, {'period': ""Q3 '23"", 'revenue': 11.03, 'unit': 'M', 'net_profit': -23.01}]",-3.35,-3.35,782693000,569072000,537027000,134766000,4710000,187008000,17909000,293294000,-187502000,-0.7505438064503561,-0.38974693266382254,-0.1166666666666667,__nan__,__nan__,__nan__,0.17218245212362956
94,MRVI,Maravai LifeSciences Holdings Inc. Class A Common Stock,"Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as plasmid DNA and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. Maravai LifeSciences Holdings, Inc. was incorporated in 2020 and is headquartered in San Diego, California.",Mr. William E. Martin III,Biotechnology,1.88,USD,270065760,https://images.financialmodelingprep.com/symbol/MRVI.png,3463647,-1.79,-0.11,4698165,-156917000,-144846000,"[{'period': '2024', 'revenue': 259.19, 'unit': 'M', 'net_profit': -144.85}, {'period': '2023', 'revenue': 288.94, 'unit': 'M', 'net_profit': -119.03}, {'period': '2022', 'revenue': 883.0, 'unit': 'M', 'net_profit': 490.66}, {'period': '2021', 'revenue': 799.24, 'unit': 'M', 'net_profit': 469.25}]","[{'period': ""Q4 '24"", 'revenue': 56.41, 'unit': 'M', 'net_profit': -26.14}, {'period': ""Q3 '24"", 'revenue': 65.2, 'unit': 'M', 'net_profit': -99.04}, {'period': ""Q2 '24"", 'revenue': 73.4, 'unit': 'M', 'net_profit': -7.58}, {'period': ""Q1 '24"", 'revenue': 64.18, 'unit': 'M', 'net_profit': -12.08}, {'period': ""Q4 '23"", 'revenue': 74.14, 'unit': 'M', 'net_profit': -105.96}, {'period': ""Q3 '23"", 'revenue': 66.86, 'unit': 'M', 'net_profit': -6.46}]",-1.05,-1.05,1008244000,429146000,322399000,431035000,38520000,0,56971000,322399000,-22193000,-1.2202625177391078,-0.21689672264742205,-0.16666666666666669,__nan__,__nan__,__nan__,0.42751060259222967
95,MRVL,Marvell Technology Inc. Common Stock,"Marvell Technology, Inc., together with its subsidiaries, designs, develops, and sells analog, mixed-signal, digital signal processing, and embedded and standalone integrated circuits. It offers a portfolio of Ethernet solutions, including controllers, network adapters, physical transceivers, and switches; single or multiple core processors; ASIC; and printer System-on-a-Chip products and application processors. The company also provides a range of storage products comprising storage controllers for hard disk drives (HDD) and solid-state drives that support various host system interfaces consisting of serial attached SCSI (SAS), serial advanced technology attachment (SATA), peripheral component interconnect express, non-volatile memory express (NVMe), and NVMe over fabrics; and fiber channel products, including host bus adapters, and controllers for server and storage system connectivity. It has operations in the United States, China, Malaysia, the Philippines, Thailand, Singapore, India, Israel, Japan, South Korea, Taiwan, and Vietnam. Marvell Technology, Inc. was incorporated in 1995 and is headquartered in Wilmington, Delaware.",Mr. Matthew J. Murphy,Semiconductors,50.03,USD,43329181920,https://images.financialmodelingprep.com/symbol/MRVL.png,17499439,-49.05,-0.97,31666280,-720300000,-885000000,"[{'period': '2025', 'revenue': 5770.0, 'unit': 'M', 'net_profit': -885.0}, {'period': '2024', 'revenue': 5510.0, 'unit': 'M', 'net_profit': -933.4}, {'period': '2023', 'revenue': 5920.0, 'unit': 'M', 'net_profit': -163.5}, {'period': '2022', 'revenue': 4460.0, 'unit': 'M', 'net_profit': -421.03}]","[{'period': ""Q4 '25"", 'revenue': 1820.0, 'unit': 'M', 'net_profit': 200.2}, {'period': ""Q3 '25"", 'revenue': 1520.0, 'unit': 'M', 'net_profit': -676.3}, {'period': ""Q2 '25"", 'revenue': 1270.0, 'unit': 'M', 'net_profit': -193.3}, {'period': ""Q1 '25"", 'revenue': 1160.0, 'unit': 'M', 'net_profit': -215.6}, {'period': ""Q4 '24"", 'revenue': 1430.0, 'unit': 'M', 'net_profit': -392.7}, {'period': ""Q3 '24"", 'revenue': 1420.0, 'unit': 'M', 'net_profit': -164.3}]",-1.02,-1.02,20204500000,3120300000,948300000,6777500000,1028400000,0,2026800000,948300000,1396600000,-1.8467144704361114,0.05185343904006857,0.0555555555555556,"[0.06, 0.06]","['2025-04-11', '2012-06-19']",__nan__,0.33544507411715213
96,MSAC,Medicus Sciences Acquisition Corp. Class A Ordinary Share,"Medicus Sciences Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on the healthcare industry primarily the medical technology sector in the United States and internationally. The company was incorporated in 2020 and is based in New York, New York.","Dr. Jacob Jay Gottlieb C.F.A., CFA, M.D.",Shell Companies,10.17,USD,0,https://images.financialmodelingprep.com/symbol/MSAC.png,51851,31.78125,0.005,1522,-3118642,1897877,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.9}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 939.78}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.31}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.71}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -385.1}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.26}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.54}]",0.18,0.18,93624429,1580004,1433753,8267336,0,92008585,32008,1433753,-798519,0,0.0,0.0,__nan__,__nan__,__nan__,0.08830319274897794
97,MSACW,Medicus Sciences Acquisition Corp. Warrant,"Medicus Sciences Acquisition Corp. operates as blank check company targeting the medical technology sector. The company was incorporated in 2020 and is based in New York, New York.","Dr. Jacob Jay Gottlieb C.F.A., CFA, M.D.",Shell Companies,0.0017,USD,0,https://images.financialmodelingprep.com/symbol/MSACW.png,0,0,0,3454,-3118642,1897877,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.9}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 939.78}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.31}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.71}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -385.1}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.26}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.54}]",0.18,0.18,93624429,1580004,1433753,8267336,0,92008585,32008,1433753,-798519,0,0.0,0.0,__nan__,__nan__,__nan__,0.08830319274897794
98,MSBI,Midland States Bancorp Inc. Common Stock,"Midland States Bancorp, Inc. operates as a financial holding company for Midland States Bank that provides various banking products and services to individuals, businesses, municipalities, and other entities. It operates through Banking, Wealth Management, and Other segments. The company accepts various deposits, such as checking, savings, money market, and sweep accounts, as well as certificates of deposits. It also offers term loans to purchase capital equipment; lines of credit for working capital and operational purposes; commercial real estate loans for owner occupied and non-owner occupied commercial property, as well as farmland loans; construction and land development loans developers of commercial real estate investment properties, residential developments, individual clients for construction of single family homes, as well as to construct owner-user properties; and residential real estate loans and home equity lines of credit.. In addition, the company provides consumer installment loans for the purchase of cars, boats, and other recreational vehicles, as well as for the purchase of major appliances and other home improvement projects; commercial equipment leasing; and trust and wealth management products and services, including financial and estate planning, trustee and custodial services, investment management, tax and insurance planning, business planning, corporate retirement plan consulting and administration, and retail brokerage services. As of December 31, 2021, it operated 52 full-service banking offices. The company was founded in 1881 and is headquartered in Effingham, Illinois.",Mr. Jeffrey G. Ludwig CPA,Banks - Regional,15.71,USD,336217565,https://images.financialmodelingprep.com/symbol/MSBI.png,122783,-14.96,-0.21,94435,0,-13430000,"[{'period': '2024', 'revenue': 77.74, 'unit': 'M', 'net_profit': -13.43}, {'period': '2023', 'revenue': 404.3, 'unit': 'M', 'net_profit': 75.46}, {'period': '2022', 'revenue': 322.3, 'unit': 'M', 'net_profit': 99.03}, {'period': '2021', 'revenue': 285.11, 'unit': 'M', 'net_profit': 81.32}]","[{'period': ""Q4 '24"", 'revenue': 56.03, 'unit': 'M', 'net_profit': -54.77}, {'period': ""Q3 '24"", 'revenue': 72.35, 'unit': 'M', 'net_profit': 18.48}, {'period': ""Q2 '24"", 'revenue': 120.85, 'unit': 'M', 'net_profit': 6.75}, {'period': ""Q1 '24"", 'revenue': 122.86, 'unit': 'M', 'net_profit': 13.88}, {'period': ""Q4 '23"", 'revenue': 118.55, 'unit': 'M', 'net_profit': 14.07}, {'period': ""Q3 '23"", 'revenue': 18.18, 'unit': 'M', 'net_profit': 18.04}]",-0.62,-0.62,7866868000,633345000,135061000,7075015000,498284000,963817000,3290070000,134212000,145907000,0,-1.1779750861383513,-1.2087542087542087,"[0.31, 0.18]","['2025-02-14', '2016-08-10']",__nan__,0.8993432964681751
99,MSDAU,MSD Acquisition Corp. Unit,"MSD Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the technology and media sectors. The company was incorporated in 2021 and is based in New York, New York.",Mr. Gregg Robert Lemkau,Shell Companies,10.22,USD,600271700,https://images.financialmodelingprep.com/symbol/MSDAU.png,26835,132.72727272727272,0,579562,-32271373,61870535,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 61.87}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.17}]","[{'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 29.36}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 14.8}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 18.75}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'T', 'net_profit': 8.7}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.35}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.26}]",1.08,1.08,583479441,144505,38125,22840416,0,583334936,5135,38125,-432566,-5.484397218840401,7.748763919000699,9.307692307692307,__nan__,__nan__,__nan__,0.03914519414917997
100,MSEX,Middlesex Water Company Common Stock,"Middlesex Water Company owns and operates regulated water utility and wastewater systems. It operates in two segments, Regulated and Non-Regulated. The Regulated segment collects, treats, and distributes water on a retail and wholesale basis to residential, commercial, industrial, and fire protection customers, as well as provides regulated wastewater systems in New Jersey and Delaware. The Non-Regulated segment provides non-regulated contract services for the operation and maintenance of municipal and private water and wastewater systems in New Jersey and Delaware. The company was incorporated in 1896 and is headquartered in Iselin, New Jersey.",Ms. Nadine M. Duchemin-Leslie,Regulated Water,60.87,USD,1088812125,https://images.financialmodelingprep.com/symbol/MSEX.png,166608,24.64,-0.75,164518,92063000,44351000,"[{'period': '2024', 'revenue': 191.88, 'unit': 'M', 'net_profit': 44.35}, {'period': '2023', 'revenue': 166.27, 'unit': 'M', 'net_profit': 31.52}, {'period': '2022', 'revenue': 162.43, 'unit': 'M', 'net_profit': 42.43}, {'period': '2021', 'revenue': 143.14, 'unit': 'M', 'net_profit': 36.54}]","[{'period': ""Q4 '24"", 'revenue': 47.11, 'unit': 'M', 'net_profit': 8.8}, {'period': ""Q3 '24"", 'revenue': 55.1, 'unit': 'M', 'net_profit': 14.32}, {'period': ""Q2 '24"", 'revenue': 49.15, 'unit': 'M', 'net_profit': 10.55}, {'period': ""Q1 '24"", 'revenue': 40.52, 'unit': 'M', 'net_profit': 10.68}, {'period': ""Q4 '23"", 'revenue': 38.6, 'unit': 'M', 'net_profit': 5.76}, {'period': ""Q3 '23"", 'revenue': 46.72, 'unit': 'M', 'net_profit': 9.99}]",2.48,2.48,1255174000,42973000,4226000,809911000,18842000,0,82888000,4226000,58730000,0.26604507886739004,0.40689633295267097,0.4011299435028248,"[0.34, 1.5008]","['2025-02-18', '1985-02-08']",__nan__,0.645257948300395
101,MSFT,Microsoft Corporation Common Stock,"Microsoft Corporation develops, licenses, and supports software, services, devices, and solutions worldwide. The company operates in three segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment offers Office, Exchange, SharePoint, Microsoft Teams, Office 365 Security and Compliance, Microsoft Viva, and Skype for Business; Skype, Outlook.com, OneDrive, and LinkedIn; and Dynamics 365, a set of cloud-based and on-premises business solutions for organizations and enterprise divisions. The Intelligent Cloud segment licenses SQL, Windows Servers, Visual Studio, System Center, and related Client Access Licenses; GitHub that provides a collaboration platform and code hosting service for developers; Nuance provides healthcare and enterprise AI solutions; and Azure, a cloud platform. It also offers enterprise support, Microsoft consulting, and nuance professional services to assist customers in developing, deploying, and managing Microsoft server and desktop solutions; and training and certification on Microsoft products. The More Personal Computing segment provides Windows original equipment manufacturer (OEM) licensing and other non-volume licensing of the Windows operating system; Windows Commercial, such as volume licensing of the Windows operating system, Windows cloud services, and other Windows commercial offerings; patent licensing; and Windows Internet of Things. It also offers Surface, PC accessories, PCs, tablets, gaming and entertainment consoles, and other devices; Gaming, including Xbox hardware, and Xbox content and services; video games and third-party video game royalties; and Search, including Bing and Microsoft advertising. The company sells its products through OEMs, distributors, and resellers; and directly through digital marketplaces, online stores, and retail stores. Microsoft Corporation was founded in 1975 and is headquartered in Redmond, Washington.",Mr. Satya  Nadella,Software - Infrastructure,354.56,USD,2635791948800,https://images.financialmodelingprep.com/symbol/MSFT.png,24604840,28.55,-3.3,34995691,133009000000,88136000000,"[{'period': '2024', 'revenue': 245.12, 'unit': 'B', 'net_profit': 88.14}, {'period': '2023', 'revenue': 211.91, 'unit': 'B', 'net_profit': 72.36}, {'period': '2022', 'revenue': 198.27, 'unit': 'B', 'net_profit': 72.74}, {'period': '2021', 'revenue': 168.09, 'unit': 'B', 'net_profit': 61.27}]","[{'period': ""Q2 '25"", 'revenue': 69.63, 'unit': 'B', 'net_profit': 24.11}, {'period': ""Q1 '25"", 'revenue': 65.58, 'unit': 'B', 'net_profit': 24.67}, {'period': ""Q4 '24"", 'revenue': 64.73, 'unit': 'B', 'net_profit': 22.04}, {'period': ""Q3 '24"", 'revenue': 61.86, 'unit': 'B', 'net_profit': 21.94}, {'period': ""Q2 '24"", 'revenue': 62.02, 'unit': 'B', 'net_profit': 21.87}, {'period': ""Q1 '24"", 'revenue': 56.52, 'unit': 'B', 'net_profit': 22.29}]",11.86,11.8,512163000000,159734000000,75531000000,243686000000,56924000000,14600000000,125286000000,18315000000,74071000000,0.2650656267833365,0.2180041735188845,0.2201646090534978,"[0.83, 0.08]","['2025-05-15', '2003-02-19']",__nan__,0.47579774407756903
102,MSGM,Motorsport Games Inc. Class A Common Stock,"Motorsport Games Inc. develops and publishes multi-platform racing video games in the United States. It operates through Gaming and Esports segments. The company offers video games for game consoles, personal computer, and mobile platforms through various retail and digital channels, including full-game and downloadable content. It also organizes and facilitates esports tournaments, competitions, and events for its licensed racing games, as well as on behalf of third-party racing game developers and publishers. The company sells its video game products through various retail and digital channels. Motorsport Games Inc. was founded in 2018 and is headquartered in Miami, Florida. Motorsport Games Inc. operates as a subsidiary of Motorsport Network LLC.",Mr. Stephen  Hood,Electronic Gaming & Multimedia,0.821,USD,2613703,https://images.financialmodelingprep.com/symbol/MSGM.png,27337,-0.87,-0.07,9060,-337877,-2752956,"[{'period': '2024', 'revenue': 8.69, 'unit': 'M', 'net_profit': -2.75}, {'period': '2023', 'revenue': 6.91, 'unit': 'M', 'net_profit': -13.05}, {'period': '2022', 'revenue': 10.32, 'unit': 'M', 'net_profit': -47.42}, {'period': '2021', 'revenue': 15.08, 'unit': 'M', 'net_profit': -34.99}]","[{'period': ""Q4 '24"", 'revenue': 1.97, 'unit': 'M', 'net_profit': -3.85}, {'period': ""Q3 '24"", 'revenue': 1800.0, 'unit': 'K', 'net_profit': 9.83}, {'period': ""Q2 '24"", 'revenue': 1.88, 'unit': 'M', 'net_profit': 2.38}, {'period': ""Q1 '24"", 'revenue': 3.03, 'unit': 'M', 'net_profit': -1.63}, {'period': ""Q4 '23"", 'revenue': 1.75, 'unit': 'M', 'net_profit': 3.71}, {'period': ""Q3 '23"", 'revenue': 1.69, 'unit': 'M', 'net_profit': -3.49}]",-0.94,-0.94,6268221,2796482,859271,5042219,1446990,0,5021782,859271,-2863161,0.9704517757907574,0.789063927677117,0.8142292490118577,__nan__,__nan__,__nan__,0.8044098955668602
103,MSON,MISONIX Inc. Common Stock (DE),"Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets minimally invasive surgical ultrasonic medical devices in the United States and internationally. The company's products include BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, general surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.",Mr. Stavros George Vizirgianakis,Medical - Devices,26.54,USD,0,https://images.financialmodelingprep.com/symbol/MSON.png,57194,0,0,157169,-6148968,-14473325,"[{'period': '2021', 'revenue': 74.02, 'unit': 'M', 'net_profit': -14.47}, {'period': '2020', 'revenue': 62.48, 'unit': 'M', 'net_profit': -17.42}, {'period': '2019', 'revenue': 38.85, 'unit': 'M', 'net_profit': -7.39}, {'period': '2018', 'revenue': 36.68, 'unit': 'M', 'net_profit': -7.61}]","[{'period': ""Q2 '21"", 'revenue': 19.69, 'unit': 'M', 'net_profit': -4.47}, {'period': ""Q1 '21"", 'revenue': 18.35, 'unit': 'M', 'net_profit': -3.76}, {'period': ""Q4 '20"", 'revenue': 18.26, 'unit': 'M', 'net_profit': -1.26}, {'period': ""Q3 '20"", 'revenue': 17.74, 'unit': 'M', 'net_profit': -4.98}, {'period': ""Q2 '20"", 'revenue': 13.71, 'unit': 'M', 'net_profit': -8.54}, {'period': ""Q1 '20"", 'revenue': 17.9, 'unit': 'M', 'net_profit': -5.59}]",-0.99,-0.99,198860218,59266558,31045935,63660589,11349976,0,22692107,31045935,-9280973,0.6100919557474578,0.16907714807363763,0.16806722689075626,__nan__,__nan__,__nan__,0.32012732179545333
104,MSTR,MicroStrategy Incorporated Common Stock Class A,"MicroStrategy Incorporated provides enterprise analytics software and services worldwide. It offers MicroStrategy, an enterprise platform, which provides a modern analytics experience by delivering insights across multiple devices to users via hyperintelligence products, visualization and reporting capabilities, mobility features, and custom applications developed on the platform; analysts and data scientists with seamless access to trusted, governed data directly within their tools; and APIs and gateways, multiple deployment options, enterprise semantic graph, scalability, and security. The company also provides MicroStrategy Support that helps customers to achieve their system availability and uptime goals, and to improve the overall experience through highly responsive troubleshooting and proactive technical product support. In addition, it offers MicroStrategy Consulting that provides customers with architecture and implementation services to help them quickly realize results, and helps to achieve returns on investment derived from understanding of data; and MicroStrategy Education that offers free and paid learning options. The company provides its services through enterprise sales force and channel partners. It serves companies from a range of industries, including retail, consulting, technology, manufacturing, finance, banking, insurance, healthcare, education, and telecommunications, as well as the public sector. The company was incorporated in 1989 and is headquartered in Tysons Corner, Virginia.",Mr. Phong Q. Le,Software - Application,237.95,USD,61975608708,https://images.financialmodelingprep.com/symbol/MSTR.png,18367521,-39.27,-30.19,22692908,-1854597000,-1166661000,"[{'period': '2024', 'revenue': 0.46346, 'unit': 'B', 'net_profit': -1.17}, {'period': '2023', 'revenue': 496.26, 'unit': 'M', 'net_profit': 429.12}, {'period': '2022', 'revenue': 0.49926, 'unit': 'B', 'net_profit': -1.47}, {'period': '2021', 'revenue': 510.76, 'unit': 'M', 'net_profit': -535.48}]","[{'period': ""Q4 '24"", 'revenue': 120.7, 'unit': 'M', 'net_profit': -670.81}, {'period': ""Q3 '24"", 'revenue': 116.07, 'unit': 'M', 'net_profit': -340.17}, {'period': ""Q2 '24"", 'revenue': 111.44, 'unit': 'M', 'net_profit': -102.56}, {'period': ""Q1 '24"", 'revenue': 115.25, 'unit': 'M', 'net_profit': -53.12}, {'period': ""Q4 '23"", 'revenue': 124.48, 'unit': 'M', 'net_profit': 89.13}, {'period': ""Q3 '23"", 'revenue': 129.46, 'unit': 'M', 'net_profit': -143.44}]",-6.06,-6.06,25843685000,252324000,38117000,7613701000,181203000,0,355384000,38117000,-53032000,-29.38430158262066,-3.718722691268896,-2.89375,__nan__,__nan__,__nan__,0.29460585825899055
105,MSVB,Mid-Southern Bancorp Inc. Common Stock,"Mid-Southern Bancorp, Inc. operates as the holding company for Mid-Southern Savings Bank, FSB that provides various banking products and services to individuals and business customers. It accepts various deposit products, including checking, savings, money market, and demand accounts, as well as certificates of deposit and term deposits. The company also offers loans secured by first mortgages on one- to four-family residences, including home equity loans and lines of credit; commercial and multifamily real estate loans; construction loans secured by single-family residences; commercial and multifamily real estate loans; land and lot loans; commercial business loans; consumer loans, including new and used manufactured homes, automobiles and truck, boats, and motorcycles and recreational vehicle loans; loans secured by savings deposits and other personal loans; and unsecured consumer loans. In addition, it holds and manages an investment securities portfolio. The company provides its products and services through its main office in Salem; and through its branch offices located in Mitchell and Orleans, Indiana, as well as through loan production offices located in New Albany, Indiana and Louisville, Kentucky. The company was founded in 1886 and is headquartered in Salem, Indiana.",Mr. Alexander G. Babey,Banks - Regional,15.77,USD,45497065,https://images.financialmodelingprep.com/symbol/MSVB.png,1772,26.28,0,500,1623000,1456000,"[{'period': '2023', 'revenue': 11.71, 'unit': 'M', 'net_profit': 1.46}, {'period': '2022', 'revenue': 0.093, 'unit': 'M', 'net_profit': 1.88}, {'period': '2021', 'revenue': 8.15, 'unit': 'M', 'net_profit': 1.61}, {'period': '2020', 'revenue': 7.38, 'unit': 'M', 'net_profit': 1.19}]","[{'period': ""Q3 '24"", 'revenue': 2860.0, 'unit': 'K', 'net_profit': 460.0}, {'period': ""Q2 '24"", 'revenue': 2860.0, 'unit': 'K', 'net_profit': 400.0}, {'period': ""Q1 '24"", 'revenue': 2880.0, 'unit': 'K', 'net_profit': -33.0}, {'period': ""Q4 '23"", 'revenue': 3100.0, 'unit': 'K', 'net_profit': 276.0}, {'period': ""Q3 '23"", 'revenue': 2970.0, 'unit': 'K', 'net_profit': 440.0}, {'period': ""Q2 '23"", 'revenue': 2230.0, 'unit': 'K', 'net_profit': 400.0}]",0.54,0.54,269154000,14954000,13676000,233166000,0,13350000,82203000,13676000,3093000,-0.24895881536325776,-0.22594364699627859,-0.08474576271186429,"[0.06, 0.09]","['2025-02-07', '2000-12-13']",__nan__,0.8662921598787311
106,MTAC,MedTech Acquisition Corporation Class A Common Stock,"MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States.. The company was incorporated in 2020 and is based in Greenwich, Connecticut.",Mr. Christopher C. Dewey,Shell Companies,11.34,USD,83856919,https://images.financialmodelingprep.com/symbol/MTAC.png,13969,226.8,1.7841,176266,-58298000,-59038000,"[{'period': '2023', 'revenue': 18.51, 'unit': 'M', 'net_profit': -59.04}, {'period': '2022', 'revenue': 12.4, 'unit': 'M', 'net_profit': -47.19}, {'period': '2021', 'revenue': 8.4, 'unit': 'M', 'net_profit': -28.84}, {'period': '2020', 'revenue': 5.43, 'unit': 'M', 'net_profit': -31.83}]","[{'period': ""Q3 '24"", 'revenue': 7.35, 'unit': 'M', 'net_profit': -2.4}, {'period': ""Q2 '24"", 'revenue': 7.36, 'unit': 'M', 'net_profit': -4.33}, {'period': ""Q1 '24"", 'revenue': 6.46, 'unit': 'M', 'net_profit': -13.22}, {'period': ""Q4 '23"", 'revenue': 5.72, 'unit': 'M', 'net_profit': -35.51}, {'period': ""Q3 '23"", 'revenue': 5.19, 'unit': 'M', 'net_profit': -1.29}, {'period': ""Q2 '23"", 'revenue': 4.61, 'unit': 'M', 'net_profit': -13.97}]",-6.73,-6.73,25725000,20862000,11777000,51663000,3554000,350000,14687000,11777000,-51166000,-0.24666937536086223,-0.2511496810562231,-3.2327044025157234,__nan__,__nan__,__nan__,2.008279883381924
107,MTACU,MedTech Acquisition Corporation Unit,"MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States.. The company was incorporated in 2020 and is based in Greenwich, Connecticut.",Mr. Christopher C. Dewey,Shell Companies,11.35,USD,84294010,https://images.financialmodelingprep.com/symbol/MTACU.png,94,44.509803921568626,1.3,1975,-58298000,-59038000,"[{'period': '2023', 'revenue': 18.51, 'unit': 'M', 'net_profit': -59.04}, {'period': '2022', 'revenue': 12.4, 'unit': 'M', 'net_profit': -47.19}, {'period': '2021', 'revenue': 8.4, 'unit': 'M', 'net_profit': -28.84}, {'period': '2020', 'revenue': 5.43, 'unit': 'M', 'net_profit': -31.83}]","[{'period': ""Q3 '24"", 'revenue': 7.35, 'unit': 'M', 'net_profit': -2.4}, {'period': ""Q2 '24"", 'revenue': 7.36, 'unit': 'M', 'net_profit': -4.33}, {'period': ""Q1 '24"", 'revenue': 6.46, 'unit': 'M', 'net_profit': -13.22}, {'period': ""Q4 '23"", 'revenue': 5.72, 'unit': 'M', 'net_profit': -35.51}, {'period': ""Q3 '23"", 'revenue': 5.19, 'unit': 'M', 'net_profit': -1.29}, {'period': ""Q2 '23"", 'revenue': 4.61, 'unit': 'M', 'net_profit': -13.97}]",-6.73,-6.73,25725000,20862000,11777000,51663000,3554000,350000,14687000,11777000,-51166000,-0.24666937536086223,-0.2511496810562231,-3.2327044025157234,__nan__,__nan__,__nan__,2.008279883381924
108,MTACW,MedTech Acquisition Corporation Warrant,,,Shell Companies,0.218,USD,0,https://images.financialmodelingprep.com/symbol/MTACW.png,17420,0,0.0211,193352,-58298000,-59038000,"[{'period': '2023', 'revenue': 18.51, 'unit': 'M', 'net_profit': -59.04}, {'period': '2022', 'revenue': 12.4, 'unit': 'M', 'net_profit': -47.19}, {'period': '2021', 'revenue': 8.4, 'unit': 'M', 'net_profit': -28.84}, {'period': '2020', 'revenue': 5.43, 'unit': 'M', 'net_profit': -31.83}]","[{'period': ""Q3 '24"", 'revenue': 7.35, 'unit': 'M', 'net_profit': -2.4}, {'period': ""Q2 '24"", 'revenue': 7.36, 'unit': 'M', 'net_profit': -4.33}, {'period': ""Q1 '24"", 'revenue': 6.46, 'unit': 'M', 'net_profit': -13.22}, {'period': ""Q4 '23"", 'revenue': 5.72, 'unit': 'M', 'net_profit': -35.51}, {'period': ""Q3 '23"", 'revenue': 5.19, 'unit': 'M', 'net_profit': -1.29}, {'period': ""Q2 '23"", 'revenue': 4.61, 'unit': 'M', 'net_profit': -13.97}]",-6.73,-6.73,25725000,20862000,11777000,51663000,3554000,350000,14687000,11777000,-51166000,-0.24666937536086223,-0.2511496810562231,-3.2327044025157234,__nan__,__nan__,__nan__,2.008279883381924
109,MTBC,CareCloud Inc. Common Stock,"CareCloud, Inc., a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Practice Management. The company's Software-as-a-Service platform includes revenue cycle management, practice management, electronic health record, business intelligence, telehealth, and patient experience management solutions, as well as complementary software tools and business services for medical groups and health systems. It serves physicians, nurses, nurse practitioners, physician assistants, and other clinicians that render bills for their services. The company was formerly known as MTBC, Inc. and changed its name to CareCloud, Inc. in March 2021. CareCloud, Inc. was founded in 1999 and is headquartered in Somerset, New Jersey.",Mr. A. Hadi Chaudhry,Medical - Healthcare Information Services,3.13,USD,0,https://images.financialmodelingprep.com/symbol/MTBC.png,43786,0,0.34,66971,25374000,7851000,"[{'period': '2024', 'revenue': 110.84, 'unit': 'M', 'net_profit': 7.85}, {'period': '2023', 'revenue': 117.06, 'unit': 'M', 'net_profit': -48.67}, {'period': '2022', 'revenue': 138.83, 'unit': 'M', 'net_profit': 5.43}, {'period': '2021', 'revenue': 139.6, 'unit': 'M', 'net_profit': 2.84}]","[{'period': ""Q4 '24"", 'revenue': 28.24, 'unit': 'M', 'net_profit': 3.3}, {'period': ""Q3 '24"", 'revenue': 28.55, 'unit': 'M', 'net_profit': 3.12}, {'period': ""Q2 '24"", 'revenue': 28.09, 'unit': 'M', 'net_profit': 1.67}, {'period': ""Q1 '24"", 'revenue': 25960.0, 'unit': 'K', 'net_profit': -241.0}, {'period': ""Q4 '23"", 'revenue': 28.42, 'unit': 'M', 'net_profit': -43.69}, {'period': ""Q3 '23"", 'revenue': 29.28, 'unit': 'M', 'net_profit': -2.75}]",0.49,0.49,71614000,24800000,5145000,21840000,17124000,0,19580000,5145000,18945000,1.8109300095877277,1.161297612688499,1.119221411192214,__nan__,__nan__,__nan__,0.3049683022872623
110,MTBCP,CareCloud Inc. 11% Series A Cumulative Redeemable Perpetual Preferred Stock,"CareCloud, Inc., a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Practice Management. The company's Software-as-a-Service platform includes revenue cycle management, practice management, electronic health record, business intelligence, telehealth, and patient experience management solutions, as well as complementary software tools and business services for medical groups and health systems. It serves physicians, nurses, nurse practitioners, physician assistants, and other clinicians that render bills for their services. The company was formerly known as MTBC, Inc. and changed its name to CareCloud, Inc. in March 2021. CareCloud, Inc. was founded in 1999 and is headquartered in Somerset, New Jersey.",Mr. A. Hadi Chaudhry,Medical - Healthcare Information Services,26.9137,USD,0,https://images.financialmodelingprep.com/symbol/MTBCP.png,6478,0,-0.0763,7740,25374000,7851000,"[{'period': '2024', 'revenue': 110.84, 'unit': 'M', 'net_profit': 7.85}, {'period': '2023', 'revenue': 117.06, 'unit': 'M', 'net_profit': -48.67}, {'period': '2022', 'revenue': 138.83, 'unit': 'M', 'net_profit': 5.43}, {'period': '2021', 'revenue': 139.6, 'unit': 'M', 'net_profit': 2.84}]","[{'period': ""Q4 '24"", 'revenue': 28.24, 'unit': 'M', 'net_profit': 3.3}, {'period': ""Q3 '24"", 'revenue': 28.55, 'unit': 'M', 'net_profit': 3.12}, {'period': ""Q2 '24"", 'revenue': 28.09, 'unit': 'M', 'net_profit': 1.67}, {'period': ""Q1 '24"", 'revenue': 25960.0, 'unit': 'K', 'net_profit': -241.0}, {'period': ""Q4 '23"", 'revenue': 28.42, 'unit': 'M', 'net_profit': -43.69}, {'period': ""Q3 '23"", 'revenue': 29.28, 'unit': 'M', 'net_profit': -2.75}]",0.49,0.49,71614000,24800000,5145000,21840000,17124000,0,19580000,5145000,18945000,1.8109300095877277,1.161297612688499,1.119221411192214,"[0.22917, 0.206]","['2023-02-27', '2015-11-25']",__nan__,0.3049683022872623
111,MTC,MMTec Inc. Common Shares,"MMTec, Inc., together with its subsidiaries, develops and deploys platforms that enable financial institutions to engage in securities market transactions and settlements worldwide. The company operates in two segments, Gujia, MM Future, MMBD Advisory and HC Securities; and MM Global. It offers Internet-based securities solutions comprising Securities Dealers Trading System, which supports securities registration and clearing, account management, risk management, trading and execution, and third party access middleware; Private Fund Investment Management System that supports multi-account management, fund valuation, risk management, quantitative trading access, liquidation, and requisition management; and Mobile Transaction Individual Client System and PC Client System for Apple IOS, Android, PC, and Web applications. The company enables its customers to white label its trading interface, as well as select modular functionalities. It serves hedge funds, mutual funds, registered investment advisors, proprietary trading groups, and brokerage firms. The company was founded in 2015 and is headquartered in Beijing, the People's Republic of China.",Mr. Xiangdong  Wen,Software - Application,0.8,USD,20149520,https://images.financialmodelingprep.com/symbol/MTC.png,126611,-0.91,-0.0001,146619,-4244555,48958083,"[{'period': '2023', 'revenue': 0.86993, 'unit': 'M', 'net_profit': 48.96}, {'period': '2022', 'revenue': 1.1, 'unit': 'M', 'net_profit': -5.45}, {'period': '2021', 'revenue': 0.65304, 'unit': 'M', 'net_profit': -8.22}, {'period': '2020', 'revenue': 0.74212, 'unit': 'M', 'net_profit': -3.19}]","[{'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.19}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.19}, {'period': ""Q2 '23"", 'revenue': 1.43, 'unit': 'M', 'net_profit': -14.38}, {'period': ""Q1 '23"", 'revenue': 1.43, 'unit': 'M', 'net_profit': -7.19}, {'period': ""Q4 '22"", 'revenue': 0.73381, 'unit': 'M', 'net_profit': 2.05}, {'period': ""Q3 '22"", 'revenue': 0.18287, 'unit': 'M', 'net_profit': -1.38}]",0.47,0.47,156987220,3023537,1759786,34622814,92040,0,1993948,1759786,-5152478,0.2738379761821258,9.98043871601112,1.3012820512820513,__nan__,__nan__,__nan__,0.2205454303859894
112,MTCH,Match Group Inc. Common Stock,"Match Group, Inc. provides dating products worldwide. The company's portfolio of brands includes Tinder, Match, Meetic, OkCupid, Hinge, Pairs, PlentyOfFish, and OurTime, as well as a various other brands. The company was incorporated in 1986 and is based in Dallas, Texas.",Mr. Spencer M. Rascoff,Internet Content & Information,27.03,USD,6769095870,https://images.financialmodelingprep.com/symbol/MTCH.png,5333791,13.38,-0.82,5621088,823312000,551276000,"[{'period': '2024', 'revenue': 3480.0, 'unit': 'M', 'net_profit': 551.28}, {'period': '2023', 'revenue': 3360.0, 'unit': 'M', 'net_profit': 651.54}, {'period': '2022', 'revenue': 3190.0, 'unit': 'M', 'net_profit': 361.95}, {'period': '2021', 'revenue': 2980.0, 'unit': 'M', 'net_profit': 277.72}]","[{'period': ""Q4 '24"", 'revenue': 860.18, 'unit': 'M', 'net_profit': 158.3}, {'period': ""Q3 '24"", 'revenue': 895.48, 'unit': 'M', 'net_profit': 136.47}, {'period': ""Q2 '24"", 'revenue': 864.07, 'unit': 'M', 'net_profit': 133.31}, {'period': ""Q1 '24"", 'revenue': 859.65, 'unit': 'M', 'net_profit': 123.2}, {'period': ""Q4 '23"", 'revenue': 866.23, 'unit': 'M', 'net_profit': 229.66}, {'period': ""Q3 '23"", 'revenue': 881.6, 'unit': 'M', 'net_profit': 163.73}]",2.12,2.02,4465771000,1397762000,970727000,4529428000,324963000,0,549461000,965993000,0,-0.21304982001632566,-0.1538864135531411,-0.12033195020746888,"[0.19, 0.12]","['2025-04-03', '2011-11-10']",__nan__,1.0142544254956198
113,MTCR,Metacrine Inc. Common Stock,"Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.",Mr. David M. Maggio,Biotechnology,0.5814,USD,0,https://images.financialmodelingprep.com/symbol/MTCR.png,52473,-0.5644660194174758,-0.0076,83889,-61079000,-61235000,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -61.23}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -36.37}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -29.28}, {'period': '2018', 'revenue': 1.45, 'unit': 'M', 'net_profit': -25.82}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.33}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.76}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.25}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.98}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -18.33}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.59}]",-1.45,-1.45,79989000,78740000,76427000,22634000,26000,0,7760000,76427000,-47168000,-0.6647315344780594,-0.6835289912847442,0.6253229974160206,"[0.58, 0.58]","['2023-06-21', '2023-06-21']",__nan__,0.2829639075372864
114,MTEM,Molecular Templates Inc. Common Stock,"Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT-5111, an ETB candidate that is in Phase I clinical trial for the treatment of HER2-positive cancers; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory myeloma patients; and MT-6402 in that is in Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients. Its pipeline of ETBs in development for other targets, including CTLA-4, TIGIT, TROP2, BCMA, SLAMF-7, and CD45. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.",Dr. Eric E. Poma Ph.D.,Biotechnology,0.0001,USD,658,https://images.financialmodelingprep.com/symbol/MTEM.png,27004,,-0.0001,26,1430000,-8124000,"[{'period': '2023', 'revenue': 57.31, 'unit': 'M', 'net_profit': -8.12}, {'period': '2022', 'revenue': 19.75, 'unit': 'M', 'net_profit': -92.72}, {'period': '2021', 'revenue': 38.7, 'unit': 'M', 'net_profit': -79.31}, {'period': '2020', 'revenue': 15.63, 'unit': 'M', 'net_profit': -104.92}]","[{'period': ""Q2 '24"", 'revenue': 0.5720000000000001, 'unit': 'M', 'net_profit': -8.1}, {'period': ""Q1 '24"", 'revenue': 11090.0, 'unit': 'K', 'net_profit': 572.0}, {'period': ""Q4 '23"", 'revenue': 7.02, 'unit': 'M', 'net_profit': -3.95}, {'period': ""Q3 '23"", 'revenue': 6.8, 'unit': 'M', 'net_profit': 4.15}, {'period': ""Q2 '23"", 'revenue': 6.63, 'unit': 'M', 'net_profit': -10.87}, {'period': ""Q1 '23"", 'revenue': 33.63, 'unit': 'M', 'net_profit': 10.85}]",-1.8,-1.8,35383000,16771999,11523000,31171000,250000,1315000,17321000,11523000,-42020000,1.01785647390832,0.9123794732414418,0.9270959902794653,__nan__,__nan__,__nan__,0.8809597829466128
115,MTEX,Mannatech Incorporated Common Stock,"Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.",Mr. Landen Granvel Fredrick,Household & Personal Products,8.37,USD,15910784,https://images.financialmodelingprep.com/symbol/MTEX.png,4609,6.34,0,663,5553000,2490000,"[{'period': '2024', 'revenue': 117.87, 'unit': 'M', 'net_profit': 2.49}, {'period': '2023', 'revenue': 131.96, 'unit': 'M', 'net_profit': -2.24}, {'period': '2022', 'revenue': 137.21, 'unit': 'M', 'net_profit': -4.49}, {'period': '2021', 'revenue': 159.76, 'unit': 'M', 'net_profit': 9.84}]","[{'period': ""Q4 '24"", 'revenue': 29.01, 'unit': 'M', 'net_profit': 2.26}, {'period': ""Q3 '24"", 'revenue': 31730.0, 'unit': 'K', 'net_profit': -328.0}, {'period': ""Q2 '24"", 'revenue': 27740.0, 'unit': 'K', 'net_profit': -624.0}, {'period': ""Q1 '24"", 'revenue': 29.39, 'unit': 'M', 'net_profit': 1.18}, {'period': ""Q4 '23"", 'revenue': 32.69, 'unit': 'M', 'net_profit': -1.76}, {'period': ""Q3 '23"", 'revenue': 32549.999999999996, 'unit': 'K', 'net_profit': 18.0}]",1.32,1.32,36056000,26121000,11396000,27442000,19000,0,20896000,11396000,2261000,6.910256410256411,2.112103617686467,2.1,"[0.2, 0.1]","['2023-06-14', '2004-02-18']",__nan__,0.7610938540048813
116,MTLS,Materialise NV American Depositary Shares,"Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company's Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. Its Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.",Ms. Brigitte  de Vet-Veithen,Software - Application,4.17,USD,246310166,https://images.financialmodelingprep.com/symbol/MTLS.png,311883,16.68,0.01,181970,31238000,13436000,"[{'period': '2024', 'revenue': 266.76, 'unit': 'M', 'net_profit': 13.44}, {'period': '2023', 'revenue': 256.13, 'unit': 'M', 'net_profit': 6.72}, {'period': '2022', 'revenue': 232.02, 'unit': 'M', 'net_profit': -2.15}, {'period': '2021', 'revenue': 205.45, 'unit': 'M', 'net_profit': 13.15}]","[{'period': ""Q4 '24"", 'revenue': 65.68, 'unit': 'M', 'net_profit': 2.92}, {'period': ""Q3 '24"", 'revenue': 68.65, 'unit': 'M', 'net_profit': 3.04}, {'period': ""Q2 '24"", 'revenue': 69.14, 'unit': 'M', 'net_profit': 4.16}, {'period': ""Q1 '24"", 'revenue': 64.01, 'unit': 'M', 'net_profit': 3.59}, {'period': ""Q4 '23"", 'revenue': 63620.0, 'unit': 'K', 'net_profit': -515.43}, {'period': ""Q3 '23"", 'revenue': 60.13, 'unit': 'M', 'net_profit': 4.02}]",0.23,0.23,396336000,190513000,102304000,147844000,53052000,3994000,102178000,102304000,6806999,0.03808321148478001,0.9988098780124963,1.090909090909091,__nan__,__nan__,__nan__,0.37302692664809656
117,MTP,Midatech Pharma PLC American Depositary Shs,"Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.",Mr. Stephen A. Stamp,Biotechnology,0.2851,USD,1976846,https://images.financialmodelingprep.com/symbol/MTP.png,1839469,-0.13839805825242718,-0.0647,164362,-7161000,-7079000,"[{'period': '2023', 'revenue': 0.381, 'unit': 'M', 'net_profit': -7.08}, {'period': '2022', 'revenue': 0.6990000000000001, 'unit': 'M', 'net_profit': -7.66}, {'period': '2021', 'revenue': 0.578, 'unit': 'M', 'net_profit': -5.46}, {'period': '2020', 'revenue': 0.343, 'unit': 'M', 'net_profit': -22.19}]","[{'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.31}, {'period': ""Q4 '23"", 'revenue': 0.083, 'unit': 'M', 'net_profit': -3.51}, {'period': ""Q2 '23"", 'revenue': 0.298, 'unit': 'M', 'net_profit': -3.57}, {'period': ""Q4 '22"", 'revenue': 0.231, 'unit': 'M', 'net_profit': -4.59}, {'period': ""Q2 '22"", 'revenue': 0.468, 'unit': 'M', 'net_profit': -3.06}, {'period': ""Q4 '21"", 'revenue': 0.177, 'unit': 'M', 'net_profit': -2.31}]",-224.13,-224.13,10542000,7030000,5971000,5864000,704000,0,5569000,5971000,-7089000,0.031643002028397565,0.0753657262277952,0.6383366681727232,__nan__,__nan__,__nan__,0.5562511857332575
118,MTRX,Matrix Service Company Common Stock,"Matrix Service Company provides engineering, fabrication, infrastructure, construction, and maintenance services primarily to the oil, gas, power, petrochemical, industrial, agricultural, mining, and minerals markets in the United States, Canada, South Korea, Australia, and internationally. It operates through three segments: Utility and Power Infrastructure, Process and Industrial Facilities, and Storage and Terminal Solutions. The Utility and Power Infrastructure segment offers power delivery services, including construction of new substations, upgrades of existing substations, transmission and distribution line installations, distribution upgrades, and maintenance; and emergency and storm restoration services. This segment also provides construction and maintenance services to combined cycle plants and other natural gas fired power stations. The Process and Industrial Facilities segment engages in the crude oil refining; processing, fractionating, and marketing of natural gas and natural gas liquids; and offers plant maintenance, turnarounds, engineering, industrial cleaning services, and capital construction service. The Storage and Terminal Solutions segment undertakes work related to aboveground storage tanks and terminals; engineering, fabrication and construction, and maintenance and repair, which include planned and emergency services; and liquefied natural gas, liquid nitrogen/liquid oxygen, liquid petroleum, hydrogen, and other specialty vessels, which comprise spheres, as well as marine structures, and truck and rail loading/offloading facilities. Its services include engineering, fabrication and construction, and maintenance and repair, including planned and emergency services, as well as geodesic domes, aluminum internal floating roofs, floating suction and skimmer systems, roof drain systems, and floating roof seals. Matrix Service Company was founded in 1984 and is headquartered in Tulsa, Oklahoma.",Mr. John R. Hewitt,Engineering & Construction,10.03,USD,276897207,https://images.financialmodelingprep.com/symbol/MTRX.png,234380,-8.22,-0.065,273425,-12859000,-24976000,"[{'period': '2024', 'revenue': 728.21, 'unit': 'M', 'net_profit': -24.98}, {'period': '2023', 'revenue': 795.02, 'unit': 'M', 'net_profit': -52.36}, {'period': '2022', 'revenue': 707.78, 'unit': 'M', 'net_profit': -63.9}, {'period': '2021', 'revenue': 673.4, 'unit': 'M', 'net_profit': -31.22}]","[{'period': ""Q2 '25"", 'revenue': 187.17, 'unit': 'M', 'net_profit': -5.53}, {'period': ""Q1 '25"", 'revenue': 165.58, 'unit': 'M', 'net_profit': -9.22}, {'period': ""Q4 '24"", 'revenue': 189.5, 'unit': 'M', 'net_profit': -4.38}, {'period': ""Q3 '24"", 'revenue': 166.01, 'unit': 'M', 'net_profit': -14.58}, {'period': ""Q2 '24"", 'revenue': 175.04, 'unit': 'M', 'net_profit': -2.85}, {'period': ""Q1 '24"", 'revenue': 197.66, 'unit': 'M', 'net_profit': -3.17}]",-0.91,-0.91,451351000,301591000,115615000,287169000,173060000,0,265115000,115615000,65577000,0.6528628890748589,0.5230037623422013,0.5309278350515463,__nan__,__nan__,__nan__,0.6362431898899082
119,MTSI,MACOM Technology Solutions Holdings Inc. Common Stock,"MACOM Technology Solutions Holdings, Inc., together with its subsidiaries, designs and manufactures analog semiconductor solutions for use in wireless and wireline applications across the radio frequency (RF), microwave, millimeter wave, and lightwave spectrum in the United States, China, the Asia Pacific, and internationally. The company offers a portfolio of standard and custom devices, including integrated circuits, multi-chip modules, diodes, amplifiers, switches and switch limiters, passive and active components, and subsystems. Its semiconductor products are electronic components that are incorporated in electronic systems, such as wireless basestations, high-capacity optical networks, radar, and medical systems and test and measurement. The company serves various markets comprising telecommunication that includes carrier infrastructure, which comprise long-haul/metro, 5G, and fiber-to-the-X/passive optical network; industrial and defense, including military and commercial radar, RF jammers, electronic countermeasures, and communication data links, as well as multi-market applications, such as industrial, medical, test and measurement, and scientific applications; and data centers. It sells its products through direct sales force, applications engineering staff, independent sales representatives, resellers, and distributors. The company was founded in 1950 and is headquartered in Lowell, Massachusetts.",Mr. Stephen G. Daly,Semiconductors,87.64,USD,6515140072,https://images.financialmodelingprep.com/symbol/MTSI.png,801724,-61.29,-2.18,1001172,163911000,76859000,"[{'period': '2024', 'revenue': 729.58, 'unit': 'M', 'net_profit': 76.86}, {'period': '2023', 'revenue': 648.41, 'unit': 'M', 'net_profit': 91.58}, {'period': '2022', 'revenue': 675.17, 'unit': 'M', 'net_profit': 439.95}, {'period': '2021', 'revenue': 606.92, 'unit': 'M', 'net_profit': 37.97}]","[{'period': ""Q1 '25"", 'revenue': 218.12, 'unit': 'M', 'net_profit': -167.53}, {'period': ""Q4 '24"", 'revenue': 200.71, 'unit': 'M', 'net_profit': 29.41}, {'period': ""Q3 '24"", 'revenue': 190.49, 'unit': 'M', 'net_profit': 19.94}, {'period': ""Q2 '24"", 'revenue': 181.23, 'unit': 'M', 'net_profit': 14.98}, {'period': ""Q1 '24"", 'revenue': 157.15, 'unit': 'M', 'net_profit': 12.53}, {'period': ""Q4 '23"", 'revenue': 150.38, 'unit': 'M', 'net_profit': 24.45}]",1.07,1.04,1755640000,903078000,581888000,629297000,105700000,0,108184000,146806000,140200000,-0.028116902752989868,-0.16071721065332997,-0.1705426356589147,__nan__,__nan__,__nan__,0.3584430748900686
120,MTSL,MER Telemanagement Solutions Ltd. Common Shares,"MER Telemanagement Solutions Ltd. engages in the provision of expense management and billing solutions and services. The firm is provider of solutions for online video advertising and telecommunications expense management (TEM) used by enterprises, and billing solutions used by information and telecommunication service providers. The firm operates through three segments: Enterprise, Service Providers and Video Advertising. Its Enterprise segment includes TEM solutions and services. Its Service Providers segment includes billing, mobile virtual network operator (MVNO) and machine-to-machine/Internet of Things (IoT/M2M) services and solutions. The online video advertising is provided through Vexigo Ltd. (Vexigo), a subsidiary of the Company, which has an in-house technology solution designed for content publishers. The Vexigo solution for online and mobile platforms supports multiple advertisement formats and interactive advertisement units.",Mr. Alon Mualem,Telecommunications Services,3.37,USD,91957190,https://images.financialmodelingprep.com/symbol/MTSL.png,1553585,-11.049180327868852,-0.03000021,728401,,,[],[],,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
121,MU,Micron Technology Inc. Common Stock,"Micron Technology, Inc. designs, manufactures, and sells memory and storage products worldwide. The company operates through four segments: Compute and Networking Business Unit, Mobile Business Unit, Storage Business Unit, and Embedded Business Unit. It provides memory and storage technologies comprises DRAM products, which are dynamic random access memory semiconductor devices with low latency that provide high-speed data retrieval; NAND products that are non-volatile and re-writeable semiconductor storage devices; and NOR memory products, which are non-volatile re-writable semiconductor memory devices that provide fast read speeds under the Micron and Crucial brands, as well as through private labels. The company offers memory products for the cloud server, enterprise, client, graphics, and networking markets, as well as for smartphone and other mobile-device markets; SSDs and component-level solutions for the enterprise and cloud, client, and consumer storage markets; other discrete storage products in component and wafers; and memory and storage products for the automotive, industrial, and consumer markets. It markets its products through its direct sales force, independent sales representatives, distributors, and retailers; and web-based customer direct sales channel, as well as through channel and distribution partners. Micron Technology, Inc. was founded in 1978 and is headquartered in Boise, Idaho.",Mr. Sanjay  Mehrotra,Semiconductors,65.54,USD,73245537800,https://images.financialmodelingprep.com/symbol/MU.png,23273657,15.68,-2.83,40128653,9582000000,778000000,"[{'period': '2024', 'revenue': 25110.0, 'unit': 'M', 'net_profit': 778.0}, {'period': '2023', 'revenue': 15.54, 'unit': 'B', 'net_profit': -5.83}, {'period': '2022', 'revenue': 30.76, 'unit': 'B', 'net_profit': 8.69}, {'period': '2021', 'revenue': 27.7, 'unit': 'B', 'net_profit': 5.86}]","[{'period': ""Q2 '25"", 'revenue': 8.05, 'unit': 'B', 'net_profit': 1.58}, {'period': ""Q1 '25"", 'revenue': 8.71, 'unit': 'B', 'net_profit': 1.87}, {'period': ""Q4 '24"", 'revenue': 7750.0, 'unit': 'M', 'net_profit': 887.0}, {'period': ""Q3 '24"", 'revenue': 6810.0, 'unit': 'M', 'net_profit': 332.0}, {'period': ""Q2 '24"", 'revenue': 5820.0, 'unit': 'M', 'net_profit': 793.0}, {'period': ""Q1 '24"", 'revenue': 4.73, 'unit': 'B', 'net_profit': -1.23}]",0.7,0.7,69416000000,24372000000,8106000000,24285000000,6615000000,1046000000,9248000000,7041000000,121000000,2.8543845534995977,1.1333790502314418,1.1310861423220975,"[0.115, 0.05]","['2025-03-31', '1991-11-22']",__nan__,0.3498472974530368
122,MUDS,Mudrick Capital Acquisition Corporation II Class A Common Stock,"Mudrick Capital Acquisition Corp II does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.",Mr. Jason Ben Mudrick,Shell Companies,10.17,USD,2036756151,https://images.financialmodelingprep.com/symbol/MUDS.png,0,3.39,0.010000229,38937,-4505597,-1969968,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.97}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -102.5}, {'period': '2019', 'revenue': 0.0, 'unit': 'B', 'net_profit': 2.61}, {'period': '2018', 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.68}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.15}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'T', 'net_profit': 18.51}, {'period': ""Q4 '21"", 'revenue': 28.61, 'unit': 'M', 'net_profit': -9.19}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 112.28}, {'period': ""Q2 '21"", 'revenue': 212.24, 'unit': 'M', 'net_profit': -115.9}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.27}]",-0.0498,-0.0498,321261318,221394,138686,39210561,0,321039924,5044473,138686,-2014.101,-42.959188253085514,-18.22013756768623,-18.153846153846153,__nan__,__nan__,__nan__,0.1220519209847729
123,MUDSU,Mudrick Capital Acquisition Corporation II Unit,"Mudrick Capital Acquisition Corp II does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.",None,Shell Companies,10.13,USD,2028745311,https://images.financialmodelingprep.com/symbol/MUDSU.png,0,-1125.5555555555557,-0.02,79,-4505597,-1969968,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.97}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -102.5}, {'period': '2019', 'revenue': 0.0, 'unit': 'B', 'net_profit': 2.61}, {'period': '2018', 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.68}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.15}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'T', 'net_profit': 18.51}, {'period': ""Q4 '21"", 'revenue': 28.61, 'unit': 'M', 'net_profit': -9.19}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 112.28}, {'period': ""Q2 '21"", 'revenue': 212.24, 'unit': 'M', 'net_profit': -115.9}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.27}]",-0.0498,-0.0498,321261318,221394,138686,39210561,0,321039924,5044473,138686,-2014.101,-42.959188253085514,-18.22013756768623,-18.153846153846153,__nan__,__nan__,__nan__,0.1220519209847729
124,MUDSW,Mudrick Capital Acquisition Corporation II Warrant,,None,Shell Companies,0.0035,USD,0,https://images.financialmodelingprep.com/symbol/MUDSW.png,83317,0,0.0002,128404,-4505597,-1969968,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.97}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -102.5}, {'period': '2019', 'revenue': 0.0, 'unit': 'B', 'net_profit': 2.61}, {'period': '2018', 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.68}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.15}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'T', 'net_profit': 18.51}, {'period': ""Q4 '21"", 'revenue': 28.61, 'unit': 'M', 'net_profit': -9.19}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 112.28}, {'period': ""Q2 '21"", 'revenue': 212.24, 'unit': 'M', 'net_profit': -115.9}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.27}]",-0.0498,-0.0498,321261318,221394,138686,39210561,0,321039924,5044473,138686,-2014.101,-42.959188253085514,-18.22013756768623,-18.153846153846153,__nan__,__nan__,__nan__,0.1220519209847729
125,MVBF,MVB Financial Corp. Common Stock,"MVB Financial Corp., through its subsidiaries, provides financial services to individuals and corporate clients in the Mid-Atlantic region and internationally. The company operates through three segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. It offers various demand deposit accounts, savings accounts, money market accounts, and certificates of deposit; and commercial, consumer, and real estate mortgage loans, as well as lines of credit. The company also provides debit cards; cashier's checks; safe deposit rental facilities; and non-deposit investment services, as well as financial technology (Fintech) banking services. In addition, it offers title insurance; and integrated regulatory compliance, state licensing, financial crimes prevention, and enterprise risk management services that include consulting, outsourcing, testing, and training solutions. Further, the company offers a customizable suite of fraud prevention services for merchants, credit agencies, Fintech companies, and other vendors; and consulting for the development of online and mobile banking platforms, and digital products for Fintech companies, as well as develops software. As of December 31, 2021, it operated six full-service branches in West Virginia and two full-service branches in Virginia. MVB Financial Corp. was founded in 1997 and is headquartered in Fairmont, West Virginia.",Mr. Larry F. Mazza CPA,Banks - Regional,16.35,USD,211712880,https://images.financialmodelingprep.com/symbol/MVBF.png,33080,10.69,0.22,29670,0,-154000,"[{'period': '2024', 'revenue': 150690.0, 'unit': 'K', 'net_profit': -154.0}, {'period': '2023', 'revenue': 146.48, 'unit': 'M', 'net_profit': 31.23}, {'period': '2022', 'revenue': 150.1, 'unit': 'M', 'net_profit': 15.05}, {'period': '2021', 'revenue': 139.75, 'unit': 'M', 'net_profit': 39.12}]","[{'period': ""Q4 '24"", 'revenue': 44.87, 'unit': 'M', 'net_profit': 9.44}, {'period': ""Q3 '24"", 'revenue': 32.28, 'unit': 'M', 'net_profit': 2.08}, {'period': ""Q2 '24"", 'revenue': 52.77, 'unit': 'M', 'net_profit': 4.09}, {'period': ""Q1 '24"", 'revenue': 59.04, 'unit': 'M', 'net_profit': 4.48}, {'period': ""Q4 '23"", 'revenue': 56.57, 'unit': 'M', 'net_profit': 7.91}, {'period': ""Q3 '23"", 'revenue': 36.41, 'unit': 'M', 'net_profit': 3.87}]",-0.0119,-0.0117,3128704000,2499984000,419516000,2822913000,2080468000,0,0,7876000,20059000,0,-1.0049308401639345,-1.0048373983739836,"[0.17, 0.07]","['2025-02-28', '2012-11-28']",__nan__,0.9022627260360839
126,MVIS,MicroVision Inc. Common Stock,"MicroVision, Inc. develops lidar sensors used in automotive safety and autonomous driving applications. Its laser beam scanning technology is based on micro-electrical mechanical systems, laser diodes, opto-mechanics, electronics, algorithms, and software. The company also develops micro-display concepts and designs for head-mounted augmented reality (AR) headsets, as well as 1440i MEMS module that can support AR headsets; Interactive Display modules used in smart speakers and other devices; and Consumer Lidar used in smart home systems. In addition, it provides PicoP, a scanning technology that creates full color, high-contrast, and uniform image over the entire field-of-view from a small and thin module. Further, the company develops 1st generation long range lidar. The company sells its products primarily to original equipment manufacturers and original design manufacturers. MicroVision, Inc. was founded in 1993 and is headquartered in Redmond, Washington.",Mr. Sumit  Sharma,"Hardware, Equipment & Parts",1.11,USD,271955550,https://images.financialmodelingprep.com/symbol/MVIS.png,6669337,-2.41,-0.07,4163211,-85031000,-96915000,"[{'period': '2024', 'revenue': 4.7, 'unit': 'M', 'net_profit': -96.92}, {'period': '2023', 'revenue': 7.26, 'unit': 'M', 'net_profit': -82.84}, {'period': '2022', 'revenue': 0.664, 'unit': 'M', 'net_profit': -52.29}, {'period': '2021', 'revenue': 2.5, 'unit': 'M', 'net_profit': -41.04}]","[{'period': ""Q4 '24"", 'revenue': 1.65, 'unit': 'M', 'net_profit': -31.16}, {'period': ""Q3 '24"", 'revenue': 0.19, 'unit': 'M', 'net_profit': -15.52}, {'period': ""Q2 '24"", 'revenue': 1.9, 'unit': 'M', 'net_profit': -23.93}, {'period': ""Q1 '24"", 'revenue': 0.9560000000000001, 'unit': 'M', 'net_profit': -26.31}, {'period': ""Q4 '23"", 'revenue': 5.1, 'unit': 'M', 'net_profit': -19.74}, {'period': ""Q3 '23"", 'revenue': 1.05, 'unit': 'M', 'net_profit': -23.47}]",-0.46,-0.46,121161000,82470000,74702000,72392000,926000,0,45951000,54486000,-68914000,-0.04918255290270837,-0.1698775983196929,-0.02222222222222224,__nan__,__nan__,__nan__,0.5974859897161628
127,MXIM,Maxim Integrated Products Inc. Common Stock,"Maxim Integrated Products, Inc. designs, develops, manufactures, and markets a range of linear and mixed-signal integrated circuits in the United States, China, rest of Asia, Europe, and internationally. The company also provides various high-frequency process technologies and capabilities used in custom designs. It serves automotive, communications and data center, consumer, and industrial markets. The company markets its products through a direct-sales and applications organization, as well as through its own and other unaffiliated distribution channels. Maxim Integrated Products, Inc. was founded in 1983 and is headquartered in San Jose, California.",Mr. Tunc Doluca,Semiconductors,103.14,USD,0,https://images.financialmodelingprep.com/symbol/MXIM.png,3254521,33.81639344262295,0,74,1061931000,827261000,"[{'period': '2021', 'revenue': 2630.0, 'unit': 'M', 'net_profit': 827.26}, {'period': '2020', 'revenue': 2190.0, 'unit': 'M', 'net_profit': 654.69}, {'period': '2019', 'revenue': 2310.0, 'unit': 'M', 'net_profit': 827.49}, {'period': '2018', 'revenue': 2480.0, 'unit': 'M', 'net_profit': 467.32}]","[{'period': ""Q2 '21"", 'revenue': 719.86, 'unit': 'M', 'net_profit': 253.74}, {'period': ""Q1 '21"", 'revenue': 665.03, 'unit': 'M', 'net_profit': 220.06}, {'period': ""Q4 '20"", 'revenue': 628.29, 'unit': 'M', 'net_profit': 183.94}, {'period': ""Q3 '20"", 'revenue': 619.36, 'unit': 'M', 'net_profit': 169.51}, {'period': ""Q2 '20"", 'revenue': 545.37, 'unit': 'M', 'net_profit': 207.3}, {'period': ""Q1 '20"", 'revenue': 561.92, 'unit': 'M', 'net_profit': 161.19}]",3.05,3.05,4523099000,3218285000,2291399000,2107159000,658829000,0,637312000,2291399000,859318000,0.2912176901022098,0.26358420880594596,0.26556016597510357,"[0.48, 0.02]","['2020-08-26', '2002-11-06']",__nan__,0.4658662125237586
128,MYFW,First Western Financial Inc. Common Stock,"First Western Financial, Inc., a financial holding company, provides wealth management, private banking, personal trust, investment management, mortgage lending, and institutional asset management services. The company operates through two segments: Wealth Management and Mortgage. The Wealth Management segment provides deposit, loan, insurance, and trust and investment management advisory products and services. The Mortgage segment engages in soliciting, originating, and selling mortgage loans into the secondary market. It serves entrepreneurs, professionals, high-net worth individuals or families, and philanthropic and business organizations. The company operates 18 profit centers, including 14 boutique private trust bank offices with 2 locations in Arizona, 9 locations in Colorado, and 3 location in Wyoming; 2 loan production offices with 1 location in Ft. Collins, Colorado, and 1 location in Greenwood Village, Colorado; and 2 trust offices with 1 location in Laramie, Wyoming, and 1 location in Century City, California. First Western Financial, Inc. was incorporated in 2002 and is headquartered in Denver, Colorado.",Mr. Scott C. Wylie,Banks - Regional,18.22,USD,176814532,https://images.financialmodelingprep.com/symbol/MYFW.png,22055,20.94,-0.16,19127,0,8473000,"[{'period': '2024', 'revenue': 152.65, 'unit': 'M', 'net_profit': 8.47}, {'period': '2023', 'revenue': 82.7, 'unit': 'M', 'net_profit': 5.22}, {'period': '2022', 'revenue': 1.45, 'unit': 'M', 'net_profit': 21.7}, {'period': '2021', 'revenue': 96.66, 'unit': 'M', 'net_profit': 20.61}]","[{'period': ""Q4 '24"", 'revenue': 38.11, 'unit': 'M', 'net_profit': 2.75}, {'period': ""Q3 '24"", 'revenue': 22.04, 'unit': 'M', 'net_profit': 2.13}, {'period': ""Q2 '24"", 'revenue': 45.03, 'unit': 'M', 'net_profit': 1.08}, {'period': ""Q1 '24"", 'revenue': 45.68, 'unit': 'M', 'net_profit': 2.52}, {'period': ""Q4 '23"", 'revenue': 44080.0, 'unit': 'K', 'net_profit': 255.0}, {'period': ""Q3 '23"", 'revenue': 22.86, 'unit': 'M', 'net_profit': 3.12}]",0.88,0.87,2919037000,30607000,9770000,2666715000,20837000,0,1995000,9770000,-544000,0,0.6216267942583732,0.5999999999999999,__nan__,__nan__,__nan__,0.9135598486761216
129,MYGN,Myriad Genetics Inc. Common Stock,"Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic Test, a DNA sequencing test to help determine the therapy for patients with metastatic breast, ovarian, metastatic pancreatic, or metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic Test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. The company also offers Prolaris Prostate Cancer Prognostic Test, a RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic Test, a RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor, a solution for precision oncology; and Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus. In addition, it provides Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; and GeneSight Psychotropic Mental Health Medication Test, a DNA genotyping test to aid psychotropic drug selection for patients suffering from depression, anxiety, ADHD, and other mental health conditions. Myriad Genetics, Inc. has a strategic collaboration with Illumina, Inc. and Intermountain Precision Genomics for an offering of germline and somatic tumor testing services. The company was founded in 1991 and is headquartered in Salt Lake City, Utah.",Mr. Paul J. Diaz J.D.,Medical - Diagnostics & Research,7.73,USD,705819343,https://images.financialmodelingprep.com/symbol/MYGN.png,1118827,-5.48,-0.34,1129358,-186100000,-263300000,"[{'period': '2023', 'revenue': 753.2, 'unit': 'M', 'net_profit': -263.3}, {'period': '2022', 'revenue': 678.4, 'unit': 'M', 'net_profit': -112.0}, {'period': '2021', 'revenue': 690.6, 'unit': 'M', 'net_profit': -27.2}, {'period': '2020', 'revenue': 557.0, 'unit': 'M', 'net_profit': -223.7}]","[{'period': ""Q3 '24"", 'revenue': 213.3, 'unit': 'M', 'net_profit': -22.1}, {'period': ""Q2 '24"", 'revenue': 211.5, 'unit': 'M', 'net_profit': -36.7}, {'period': ""Q1 '24"", 'revenue': 202.2, 'unit': 'M', 'net_profit': -26.0}, {'period': ""Q4 '23"", 'revenue': 196.6, 'unit': 'M', 'net_profit': -31.2}, {'period': ""Q3 '23"", 'revenue': 191.9, 'unit': 'M', 'net_profit': -61.3}, {'period': ""Q2 '23"", 'revenue': 183.5, 'unit': 'M', 'net_profit': -116.1}]",-3.18,-3.18,1146500000,313600000,140900000,363300000,114300000,0,155900000,132100000,-184200000,-1.7448377581120944,-1.3508928571428571,-1.287769784172662,"[1.75, 1.75]","['2009-07-01', '2009-06-15']",__nan__,0.31687745311818577
130,MYMD,MyMD Pharmaceuticals Inc. Common Stock,"MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines; and to delay aging and increase longevity, as well as treat autoimmune diseases and COVID-19-associated depression. It is also developing Supera-CBD, a synthetic derivative of cannabidiol for treating chronic pain, addiction, and epilepsy. The company was founded in 2014 and is headquartered in Baltimore, Maryland.",Mr. Ian  Rhodes CPA,Biotechnology,1.81,USD,4290460,https://images.financialmodelingprep.com/symbol/MYMD.png,61809,-0.19525350593311758,-0.01,22707,-17123050,-3999950,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.0}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.11}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -29.88}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.68}]","[{'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.8}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.36}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.04}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.17}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -433.14}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.68}]",-2.59,-2.59,17862270,5816342,4923116,5088627,0,1500000,4988089,2681010,-12980625,-201.44072717056667,0.7353114024177885,0.7782534246575342,__nan__,__nan__,__nan__,0.2848813168762985
131,MYRG,MYR Group Inc. Common Stock,"MYR Group Inc., through its subsidiaries, provides electrical construction services in the United States and Canada. It operates in two segments, Transmission and Distribution, and Commercial and Industrial. The Transmission and Distribution segment offers a range of services on electric transmission and distribution networks, and substation facilities, including design, engineering, procurement, construction, upgrade, maintenance, and repair services with primary focus on construction, maintenance, and repair to customers in the electric utility industry; and services, including construction and maintenance of high voltage transmission lines, substations, and lower voltage underground and overhead distribution systems, renewable power facilities, and limited gas construction services, as well as emergency restoration services in response to hurricane, ice, or other storm related damages. This segment serves as a prime contractor to customers, such as investor-owned utilities, cooperatives, private developers, government-funded utilities, independent power producers, independent transmission companies, industrial facility owners, and other contractors. The Commercial and Industrial segment provides a range of services, including design, installation, maintenance, and repair of commercial and industrial wiring; and installation of traffic networks, bridge, roadway, and tunnel lighting for airports, hospitals, data centers, hotels, stadiums, convention centers, renewable energy projects, manufacturing plants, processing facilities, waste-water treatment facilities, mining facilities, and transportation control and management systems. This segment serves general contractors, commercial and industrial facility owners, governmental agencies, and developers. The company was founded in 1891 and is headquartered in Henderson, Colorado.",Mr. Richard S. Swartz Jr.,Engineering & Construction,101.85,USD,1643706225,https://images.financialmodelingprep.com/symbol/MYRG.png,243904,55.35,-3.62,202818,54082000,30263000,"[{'period': '2024', 'revenue': 3360.0, 'unit': 'M', 'net_profit': 30.26}, {'period': '2023', 'revenue': 3640.0, 'unit': 'M', 'net_profit': 90.99}, {'period': '2022', 'revenue': 3010.0, 'unit': 'M', 'net_profit': 83.38}, {'period': '2021', 'revenue': 2500.0, 'unit': 'M', 'net_profit': 85.01}]","[{'period': ""Q4 '24"", 'revenue': 829.79, 'unit': 'M', 'net_profit': 15.95}, {'period': ""Q3 '24"", 'revenue': 888.04, 'unit': 'M', 'net_profit': 10.65}, {'period': ""Q2 '24"", 'revenue': 828.89, 'unit': 'M', 'net_profit': -15.28}, {'period': ""Q1 '24"", 'revenue': 815.56, 'unit': 'M', 'net_profit': 18.94}, {'period': ""Q4 '23"", 'revenue': 1000.0, 'unit': 'M', 'net_profit': 24.04}, {'period': ""Q3 '23"", 'revenue': 939.48, 'unit': 'M', 'net_profit': 21.51}]",1.84,1.83,1574059000,1014662000,3464000,973699000,662150000,3730000,748900000,3464000,11177000,-0.7139744342371788,-0.6674030113199253,-0.6623853211009175,__nan__,__nan__,__nan__,0.6185911709789785
132,MYSZ,My Size Inc. Common Stock,"My Size, Inc. develops and commercializes mobile device measurement solutions for e-commerce fashion/apparel, shipping/parcel, and do it yourself industries in Israel. It offers MySizeID, an application that enables consumers to create an online profile of their personal measurements to get the right fit; BoxSize, a parcel measurement application that allows customers to measure the size of their parcel with their smartphone, calculate shipping costs, and arrange for a convenient pick-up time for the package; SizeUp app, which allows users to utilize their smartphone as a tape measure; and SizeIT, a smart measuring tape SDK that provides users with the ability to instantly and accurately measure objects with a quick movement of their mobile device. The company was formerly known as Knowledgetree Ventures, Inc. and changed its name to My Size, Inc. in January 2014. My Size, Inc. was incorporated in 1999 and is headquartered in Airport City, Israel.",Mr. Yoav  Venkert,Software - Application,1.17,USD,2469574,https://images.financialmodelingprep.com/symbol/MYSZ.png,1278283,-0.27,0.04,349392,-3603000,-3995000,"[{'period': '2024', 'revenue': 8.26, 'unit': 'M', 'net_profit': -4.0}, {'period': '2023', 'revenue': 7.0, 'unit': 'M', 'net_profit': -6.38}, {'period': '2022', 'revenue': 4.46, 'unit': 'M', 'net_profit': -8.31}, {'period': '2021', 'revenue': 0.131, 'unit': 'M', 'net_profit': -10.81}]","[{'period': ""Q4 '24"", 'revenue': 1460.0, 'unit': 'K', 'net_profit': -715.0}, {'period': ""Q3 '24"", 'revenue': 1.84, 'unit': 'M', 'net_profit': -1.3}, {'period': ""Q2 '24"", 'revenue': 1980.0, 'unit': 'K', 'net_profit': -964.0}, {'period': ""Q1 '24"", 'revenue': 2.98, 'unit': 'M', 'net_profit': -1.02}, {'period': ""Q4 '23"", 'revenue': 2.98, 'unit': 'M', 'net_profit': -1.37}, {'period': ""Q3 '23"", 'revenue': 2.16, 'unit': 'M', 'net_profit': -1.13}]",-0.44,-0.44,10059000,9072000,4880000,3150000,1064000,7000,2996000,4880000,-3099000,0.42324315671522333,0.3738244514106583,0.9780109945027485,__nan__,__nan__,__nan__,0.31315240083507306
133,MYT,Urban Tea Inc. Ordinary Shares,"Urban Tea, Inc. engages in the supply and distribution of tea beverages and related products. The company is headquartered in Zhenjiang, Jiangsu and currently employs 65 full-time employees. The firm is a chemical manufacturer, which is engaged in manufacturing and selling of organic compounds, including para-chlorotoluene (PCT), ortho-chlorotoluene (OCT), PCT/OCT downstream products, unsaturated polyester resin (UPR), maleic acid (MA) and other by-product chemicals, and distributing fine and specialty chemicals to end application markets, including automotive, pharmaceutical, agrochemical, dye and pigments, aerospace, ceramics, coating-printing, clean energy and food additives. The firm's products are PCT/OCT and UPR. The PCT/OCT products together with its downstream products can be used in pharmaceuticals, pesticides, dyes and consumables manufacturing industries. UPR is used as renovation material for bathroom and kitchen; manufacturing materials for trains, cars, aircrafts and vessels, and infrastructure materials, such as anti-collusion pipes and oil and gas pipelines.",Anatoly Danilitskiy,Restaurants,2.16,USD,22405896,https://images.financialmodelingprep.com/symbol/MYT.png,903519,-8,-0.13999987,333674,,,[],[],,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
134,NAAC,North Atlantic Acquisition Corporation Class A Ordinary Share,"North Atlantic Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on the consumer, industrials, and telecommunications industries in Europe and North America. The company was incorporated in 2020 and is based in New York, New York.",Mr. Gary  Quin,Shell Companies,10.15,USD,481490584,https://images.financialmodelingprep.com/symbol/NAAC.png,80451,0,-0.01,901,6668643,16006491,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 16.01}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.62}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 9.14}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 18.92}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.57}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 13.29}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.62}]",0.34,0.34,1.999838999999998,-379621811.411971,1.39333,32.214132,0,0,1960403,1.39333,-2320236,0,0,0,__nan__,__nan__,__nan__,16.108362723199235
135,NAACU,North Atlantic Acquisition Corporation Unit,"North Atlantic Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on the consumer, industrials, and telecommunications industries in Europe and North America. The company was incorporated in 2020 and is based in New York, New York.",Mr. Gary  Quin,Shell Companies,10.17,USD,0,https://images.financialmodelingprep.com/symbol/NAACU.png,526,0,0,3,6668643,16006491,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 16.01}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.62}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 9.14}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 18.92}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.57}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 13.29}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.62}]",0.34,0.34,1.999838999999998,-379621811.411971,1.39333,32.214132,0,0,1960403,1.39333,-2320236,0,0,0,__nan__,__nan__,__nan__,16.108362723199235
136,NAACW,North Atlantic Acquisition Corporation Warrant,"North Atlantic Acquisition Corporation does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. North Atlantic Acquisition Corporation was founded in 2020 and is based in New York, New York.",Mr. Gary  Quin,Shell Companies,0.0014,USD,0,https://images.financialmodelingprep.com/symbol/NAACW.png,0,0,0,198500,6668643,16006491,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 16.01}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.62}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 9.14}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 18.92}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.57}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 13.29}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.62}]",0.34,0.34,1.999838999999998,-379621811.411971,1.39333,32.214132,0,0,1960403,1.39333,-2320236,0,0,0,__nan__,__nan__,__nan__,16.108362723199235
137,NAII,Natural Alternatives International Inc. Common Stock,"Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Asia, and internationally. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical studies, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, packaging and delivery system design, and regulatory review. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.",Mr. Mark A. LeDoux J.D.,Packaged Foods,2.99,USD,18534352,https://images.financialmodelingprep.com/symbol/NAII.png,7119,-2.32,-0.13,6462,-4456000,-7217000,"[{'period': '2023', 'revenue': 113.8, 'unit': 'M', 'net_profit': -7.22}, {'period': '2022', 'revenue': 154.01, 'unit': 'M', 'net_profit': 2.52}, {'period': '2021', 'revenue': 170.97, 'unit': 'M', 'net_profit': 10.71}, {'period': '2020', 'revenue': 178.52, 'unit': 'M', 'net_profit': 10.77}]","[{'period': ""Q2 '24"", 'revenue': 34.08, 'unit': 'M', 'net_profit': -2.19}, {'period': ""Q1 '24"", 'revenue': 33.15, 'unit': 'M', 'net_profit': -1.98}, {'period': ""Q4 '23"", 'revenue': 29.49, 'unit': 'M', 'net_profit': -1.87}, {'period': ""Q3 '23"", 'revenue': 25.1, 'unit': 'M', 'net_profit': -1.58}, {'period': ""Q2 '23"", 'revenue': 25.2, 'unit': 'M', 'net_profit': -3.07}, {'period': ""Q1 '23"", 'revenue': 33970.0, 'unit': 'K', 'net_profit': -695.0}]",-1.23,-1.23,162342000,61610000,11981000,79747000,16891000,0,23465000,11981000,-4514000,-1.4019121493641202,-3.8616177636796194,-3.8604651162790695,__nan__,__nan__,__nan__,0.49122839437730226
138,NAKD,Naked Brand Group Limited Ordinary Shares,"Cenntro Automotive Group, Inc. manufactures electric light and medium-duty commercial vehicles (ECV). The company was founded in 2013 and is based in Freehold, New Jersey.",Ms. Anna Johnson,Auto - Manufacturers,2.61,USD,682013880,https://images.financialmodelingprep.com/symbol/NAKD.png,7532157,-0.9620346479911537,-0.46,14904169,-31841270,-44866813,"[{'period': '2024', 'revenue': 31.3, 'unit': 'M', 'net_profit': -44.87}, {'period': '2023', 'revenue': 22.08, 'unit': 'M', 'net_profit': -54.2}, {'period': '2022', 'revenue': 8.94, 'unit': 'M', 'net_profit': -110.09}, {'period': '2021', 'revenue': 8.58, 'unit': 'M', 'net_profit': -18.6}]","[{'period': ""Q4 '24"", 'revenue': 2.85, 'unit': 'M', 'net_profit': -17.48}, {'period': ""Q3 '24"", 'revenue': 16.73, 'unit': 'M', 'net_profit': -8.97}, {'period': ""Q2 '24"", 'revenue': 8.32, 'unit': 'M', 'net_profit': -9.18}, {'period': ""Q1 '24"", 'revenue': 3.39, 'unit': 'M', 'net_profit': -9.23}, {'period': ""Q4 '23"", 'revenue': 8.61, 'unit': 'M', 'net_profit': -13.06}, {'period': ""Q3 '23"", 'revenue': 5.76, 'unit': 'M', 'net_profit': -16.1}]",-1.45,-1.45,132566314,65916446,12547168,54606812,7542834,3710663,29114024,12547168,-21362312,0.3391945792209141,0.1721887126823074,0.18539325842696633,__nan__,__nan__,__nan__,0.41192072369154054
139,NAOV,NanoVibronix Inc. Common Stock,"NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.",Mr. Brian M. Murphy,Medical - Devices,7.2,USD,5466938,https://images.financialmodelingprep.com/symbol/NAOV.png,2472195,-0.05,4.26,91543833,-3550000,-3705000,"[{'period': '2024', 'revenue': 2.56, 'unit': 'M', 'net_profit': -3.71}, {'period': '2023', 'revenue': 2.28, 'unit': 'M', 'net_profit': -3.71}, {'period': '2022', 'revenue': 0.752, 'unit': 'M', 'net_profit': -5.45}, {'period': '2021', 'revenue': 1.7, 'unit': 'M', 'net_profit': -14.28}]","[{'period': ""Q4 '24"", 'revenue': 0.444, 'unit': 'M', 'net_profit': -1.43}, {'period': ""Q3 '24"", 'revenue': 376.0, 'unit': 'K', 'net_profit': -998.0}, {'period': ""Q2 '24"", 'revenue': 817.0, 'unit': 'K', 'net_profit': -688.0}, {'period': ""Q1 '24"", 'revenue': 921.0, 'unit': 'K', 'net_profit': -588.0}, {'period': ""Q4 '23"", 'revenue': 1180.0, 'unit': 'K', 'net_profit': -813.0}, {'period': ""Q3 '23"", 'revenue': 458.0, 'unit': 'K', 'net_profit': -727.0}]",-1.37,-1.37,3629000,3331000,752000,3002000,268000,0,2722000,752000,-2519000,-0.033478893740902474,0.0016168148746968471,0.35377358490566035,__nan__,__nan__,__nan__,0.8272251308900523
140,NARI,Inari Medical Inc. Common Stock,"Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.",Mr. Kevin  Strange,Medical - Devices,79.97,USD,4683331092,https://images.financialmodelingprep.com/symbol/NARI.png,2438930,-59.237037037037034,0,2356692,15187000,-1636000,"[{'period': '2023', 'revenue': 493.63, 'unit': 'M', 'net_profit': -1.64}, {'period': '2022', 'revenue': 383.47, 'unit': 'M', 'net_profit': -29.27}, {'period': '2021', 'revenue': 276.98, 'unit': 'M', 'net_profit': 9.84}, {'period': '2020', 'revenue': 139.67, 'unit': 'M', 'net_profit': 13.79}]","[{'period': ""Q3 '24"", 'revenue': 153.39, 'unit': 'M', 'net_profit': -18.37}, {'period': ""Q2 '24"", 'revenue': 145.82, 'unit': 'M', 'net_profit': -31.35}, {'period': ""Q1 '24"", 'revenue': 143.19, 'unit': 'M', 'net_profit': -24.2}, {'period': ""Q4 '23"", 'revenue': 132.09, 'unit': 'M', 'net_profit': -4.67}, {'period': ""Q3 '23"", 'revenue': 126.37, 'unit': 'M', 'net_profit': 3.16}, {'period': ""Q2 '23"", 'revenue': 119.0, 'unit': 'M', 'net_profit': 2.08}]",-0.0288,-0.0288,674235000,235563000,115452000,209325000,70119000,1500000,76339000,38597000,29726000,1.8319820313355977,0.9441008644548468,0.9476363636363635,__nan__,__nan__,__nan__,0.3104629691428063
141,NATH,Nathan's Famous Inc. Common Stock,"Nathan's Famous, Inc., together with its subsidiaries, operates in the foodservice industry. The company owns and franchises restaurants under the Nathan's Famous brand name, as well as sells products bearing the Nathan's Famous trademarks through various channels of distribution. It also has license agreements for the manufacture, distribution, marketing, and sale of Nathan's Famous branded hot dogs, sausages, and corned beef products in refrigerated consumer packages to be resold through retail channels, such as supermarkets, groceries, mass merchandisers, and club stores; and other Nathan's Famous branded refrigerated meat products in consumer packages to be resold through retail channels. In addition, the company has license agreements to manufacture Nathan's Famous branded hot dog and sausage products in bulk for use in the food service industry; for supplying Nathan's Famous natural casing and skinless hot dogs in bulk for use in the Nathan's Famous restaurant system; to manufacture proprietary spices; to produce and distribute sauerkraut and pickles; to produce and sell French fries and onion rings for retail sale; and to produce and sell miniature bagel dogs, franks-in-a-blanket, mozzarella sticks, and other hors d'oeuvres through club stores, supermarkets, and other retail food stores. Further, the company sells Nathan's products directly to foodservice operators or to various foodservice distributors, as well as provides Arthur Treacher's brand fish fillets. As of March 27, 2022, its restaurant system consisted of four company-owned units in the New York City metropolitan area; and 239 franchised units in 18 states and 12 foreign countries. Nathan's Famous, Inc. was founded in 1916 and is based in Jericho, New York.",Mr. Eric  Gatoff J.D.,Restaurants,91.4,USD,373781123,https://images.financialmodelingprep.com/symbol/NATH.png,12286,15.76,0.79,13476,33941000,19616000,"[{'period': '2023', 'revenue': 138.61, 'unit': 'M', 'net_profit': 19.62}, {'period': '2022', 'revenue': 130.78, 'unit': 'M', 'net_profit': 19.62}, {'period': '2021', 'revenue': 114.88, 'unit': 'M', 'net_profit': 13.6}, {'period': '2020', 'revenue': 75.84, 'unit': 'M', 'net_profit': 11.07}]","[{'period': ""Q3 '24"", 'revenue': 31.52, 'unit': 'M', 'net_profit': 4.48}, {'period': ""Q2 '24"", 'revenue': 41.11, 'unit': 'M', 'net_profit': 6.03}, {'period': ""Q1 '24"", 'revenue': 44.77, 'unit': 'M', 'net_profit': 9.28}, {'period': ""Q4 '23"", 'revenue': 28.99, 'unit': 'M', 'net_profit': 3.91}, {'period': ""Q3 '23"", 'revenue': 28.89, 'unit': 'M', 'net_profit': 2.61}, {'period': ""Q2 '23"", 'revenue': 38.74, 'unit': 'M', 'net_profit': 5.71}]",4.81,4.8,48858000,38776000,21027000,81781000,14731000,0,15573000,21027000,19689000,-0.04876544939883972,-0.0003567242521530857,0.002083333333333289,"[0.5, 25]","['2025-02-18', '2015-03-30']",__nan__,1.6738507511564125
142,NATI,National Instruments Corporation Common Stock,"National Instruments Corporation provides a software-centric platform and systems to engineers and scientists worldwide. Its programming environments software includes NI LabVIEW, a graphical software platform to visualize hardware configuration, measurement data, and debugging of application; NI LabWindows/CVI, an ANSI C integrated development environment and engineering toolbox; and NI Measurement Studio, a suite of .NET tools for building engineering applications in Microsoft Visual Studio. The company's application software comprises NI TestStand that is used for automated test and measurement applications in manufacturing environment; NI VeriStand, a software environment for configuring real-time testing applications; Flexlogger for sensor configuration and data logging of mixed signals; and NI InsightCM Enterprise, a software for monitoring ancillary rotating equipment. Its operations management and analytic enterprise software include NI DIAdem, which is configuration-based technical data management, analysis, and report generation tools to mine and analyze engineering and measurement data; NI SystemLink, a systems management and data collection software that enables the mass coordination of connected devices, software deployments, and data communications throughout a distributed system; and NI Optimal Plus. The company also offers PXI hardware form factor; and NI semiconductor test systems, as well as software and hardware maintenance, and training and certification services. It serves semiconductor, transportation, aerospace, and defense industries; and government agencies. National Instruments Corporation has strategic agreements with Konrad Technologies, Inc. to develop test systems and solutions for autonomous driving software and hardware validation; and Foretellix Ltd. to enhance the safety of advanced driver-assistance systems and autonomous vehicles. The company was incorporated in 1976 and is headquartered in Austin, Texas.",Mr. Eric Howard Starkloff,Software - Application,59.99,USD,7966492030,https://images.financialmodelingprep.com/symbol/NATI.png,1382385,44.43703703703704,0.01,3858765,215504000,139644000,"[{'period': '2022', 'revenue': 1660.0, 'unit': 'M', 'net_profit': 139.64}, {'period': '2021', 'revenue': 1470.0, 'unit': 'M', 'net_profit': 89.31}, {'period': '2020', 'revenue': 1290.0, 'unit': 'M', 'net_profit': 143.66}, {'period': '2019', 'revenue': 1350.0, 'unit': 'M', 'net_profit': 162.15}]","[{'period': ""Q2 '23"", 'revenue': 416.8, 'unit': 'M', 'net_profit': 30.49}, {'period': ""Q1 '23"", 'revenue': 436.82, 'unit': 'M', 'net_profit': 46.93}, {'period': ""Q4 '22"", 'revenue': 448.28, 'unit': 'M', 'net_profit': 40.07}, {'period': ""Q3 '22"", 'revenue': 427.93, 'unit': 'M', 'net_profit': 61.91}, {'period': ""Q2 '22"", 'revenue': 395.51, 'unit': 'M', 'net_profit': 12.43}, {'period': ""Q1 '22"", 'revenue': 385.26, 'unit': 'M', 'net_profit': 25.24}]",1.05,1.04,2358538000,1088919000,139799000,1202414000,445279000,0,522875000,139799000,-9175000,-0.009482136537250593,0.563499972009181,0.5441176470588235,"[0.28, 0.05]","['2023-08-07', '2003-07-31']",__nan__,0.5098132826352596
143,NATR,Nature's Sunshine Products Inc. Common Stock,"Nature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. The company was founded in 1972 and is headquartered in Lehi, Utah.",Mr. Terrence O. Moorehead,Packaged Foods,12.01,USD,221986835,https://images.financialmodelingprep.com/symbol/NATR.png,36219,30.03,0.54,80576,4500,1800,"[{'period': '2024', 'revenue': 100.0, 'unit': 'K', 'net_profit': 1.8}, {'period': '2023', 'revenue': 445.32, 'unit': 'M', 'net_profit': 15.08}, {'period': '2022', 'revenue': 421910.0, 'unit': 'K', 'net_profit': 550.0}, {'period': '2021', 'revenue': 444.08, 'unit': 'M', 'net_profit': 28.85}]","[{'period': ""Q4 '24"", 'revenue': 118200.0, 'unit': 'K', 'net_profit': -321.0}, {'period': ""Q3 '24"", 'revenue': 114.61, 'unit': 'M', 'net_profit': 4.35}, {'period': ""Q2 '24"", 'revenue': 110.55, 'unit': 'M', 'net_profit': 1.35}, {'period': ""Q1 '24"", 'revenue': 110.99, 'unit': 'M', 'net_profit': 2.32}, {'period': ""Q4 '23"", 'revenue': 108.94, 'unit': 'M', 'net_profit': 8.96}, {'period': ""Q3 '23"", 'revenue': 111.2, 'unit': 'M', 'net_profit': 2.83}]",0.0001,0.0001,240855000,160579000,84700000,79864000,9477000,915000,65692000,84700000,14327000,-0.9998597562875932,-0.999880604934996,-0.999873417721519,"[1, 0.05]","['2021-03-26', '2012-05-16']",__nan__,0.3315853937016047
144,NAVI,Navient Corporation Common Stock,"Navient Corporation provides education loan management and business processing solutions for education, healthcare, and government clients at the federal, state, and local levels in the United States. It operates through three segments: Federal Education Loans, Consumer Lending, and Business Processing. The company owns Federal Family Education Loan Program (FFELP) loans that are insured or guaranteed by state or not-for-profit agencies; and performs servicing and asset recovery services on its own loan portfolio, as well as asset recovery services on FFELP loans owned by other institutions. It also owns, originates, acquires, and services refinance and in-school private education loans; and offers healthcare services that include revenue cycle outsourcing, accounts receivable management, extended business office support, consulting engagement, and public health programs, as well as business processing services to state governments, agencies, court systems, municipalities, and parking and tolling authorities. In addition, the company provides customizable solutions for its clients that include hospitals, hospital systems, medical centers, large physician groups, other healthcare providers, and public health departments; and corporate liquidity portfolio services. Navient Corporation was founded in 1973 and is headquartered in Wilmington, Delaware.",Mr. David L. Yowan,Financial - Credit Services,10.76,USD,1100489760,https://images.financialmodelingprep.com/symbol/NAVI.png,816432,9.12,-0.28,1034441,2813000000,131000000,"[{'period': '2024', 'revenue': 3810.0, 'unit': 'M', 'net_profit': 131.0}, {'period': '2023', 'revenue': 1280.0, 'unit': 'M', 'net_profit': 228.0}, {'period': '2022', 'revenue': 1740.0, 'unit': 'M', 'net_profit': 645.0}, {'period': '2021', 'revenue': 2210.0, 'unit': 'M', 'net_profit': 717.0}]","[{'period': ""Q4 '24"", 'revenue': 595.0, 'unit': 'M', 'net_profit': 24.0}, {'period': ""Q3 '24"", 'revenue': 948.0, 'unit': 'M', 'net_profit': -2.0}, {'period': ""Q2 '24"", 'revenue': 1100.0, 'unit': 'M', 'net_profit': 36.0}, {'period': ""Q1 '24"", 'revenue': 1170.0, 'unit': 'M', 'net_profit': 73.0}, {'period': ""Q4 '23"", 'revenue': 1270.0, 'unit': 'M', 'net_profit': 79.0}, {'period': ""Q3 '23"", 'revenue': 422.0, 'unit': 'M', 'net_profit': 79.0}]",1.2,1.2,51789000000,2103000000,2103000000,49148000000,1902000000,0,5134000000,2103000000,459000000,-0.2880283472538598,-0.42543859649122806,-0.358288770053476,"[0.16, 0.15]","['2025-03-07', '2014-06-04']",__nan__,0.9490046148796076
145,NBEV,NewAge Inc. Common Stock,"NewAge, Inc. develops, markets, sells, and distributes healthy products in the United States, Japan, China, and internationally. The company operates in two segments, Direct / Social Selling and Direct Store. It provides health and wellness, energy drink, essential oil and anti-aging skincare, cosmetic, beverage, snacks, water and air filtration, and personal care products, as well as weight management, nutritional supplement, nutraceutical, and slenderiize products; diagnostic products, such as DNA testing and diagnostic kits and products; and CBD products. The company offers its products under the Tahitian Noni, LIMU, Zennoa, LIMU Blue Frog, Hiro Natural, TeMana, Lucim, Reviive, Puritii, and MaVie brands. It sells its products directly to customers, as well as through distributors, e-commerce sites, and direct-store-delivery systems. The company was formerly known as New Age Beverages Corporation and changed its name to NewAge, Inc. in July 2020. NewAge, Inc. was incorporated in 2010 and is headquartered in Denver, Colorado. On August 30, 2022, NewAge, Inc. along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.",Mr. Brent David Willis,Beverages - Non-Alcoholic,0.0935,USD,0,https://images.financialmodelingprep.com/symbol/NBEV.png,0,-0.3475836431226766,-0.0315,46006506,-29928000,-39344000,"[{'period': '2020', 'revenue': 279.47, 'unit': 'M', 'net_profit': -39.34}, {'period': '2019', 'revenue': 253.71, 'unit': 'M', 'net_profit': -89.83}, {'period': '2018', 'revenue': 52.16, 'unit': 'M', 'net_profit': -12.13}, {'period': '2017', 'revenue': 52.19, 'unit': 'M', 'net_profit': -3.54}]","[{'period': ""Q3 '21"", 'revenue': 99.55, 'unit': 'M', 'net_profit': -2.7}, {'period': ""Q2 '21"", 'revenue': 124.04, 'unit': 'M', 'net_profit': 17.37}, {'period': ""Q1 '21"", 'revenue': 125.52, 'unit': 'M', 'net_profit': -17.77}, {'period': ""Q4 '20"", 'revenue': 90420.0, 'unit': 'K', 'net_profit': -4.04}, {'period': ""Q3 '20"", 'revenue': 62.72, 'unit': 'M', 'net_profit': -14.13}, {'period': ""Q2 '20"", 'revenue': 62.64, 'unit': 'M', 'net_profit': -9.55}]",-0.41,-0.41,379815000,127135000,43711000,298928000,12341000,-24603000,122547000,43711000,-36722000,0.5360287734094009,0.5620415205654812,0.646551724137931,__nan__,__nan__,__nan__,0.7870357937416901
146,NBIX,Neurocrine Biosciences Inc. Common Stock,"Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company's commercial products include ONGENTYS, a catechol-O-methyltransferase inhibitor used as an adjunct therapy to levodopa/DOPA decarboxylase inhibitors for patients with Parkinson's disease; ORILISSA for the management of moderate to severe endometriosis pain in women; and ORIAHNN, a non-surgical oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. Its product candidates in clinical development include NBI-921352 for treating pediatric patients, as well as adult focal epilepsy indications; and NBI-827104 to treat rare pediatric epilepsy and essential tremor. The company's products in clinical development also comprise NBI-1065845 for the treatment of major depressive disorder; NBI-1065846 for treating anhedonia in major depressive disorder; and NBI-118568 for the treatment of schizophrenia. It has license and collaboration agreements with Heptares Therapeutics Limited; Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. Neurocrine Biosciences, Inc. was incorporated in 1992 and is headquartered in San Diego, California.",Mr. Kyle W. Gano Ph.D.,Drug Manufacturers - Specialty & Generic,87.54,USD,8728044390,https://images.financialmodelingprep.com/symbol/NBIX.png,1401890,26.61,-5.71,2004910,610100000,341300000,"[{'period': '2024', 'revenue': 2360.0, 'unit': 'M', 'net_profit': 341.3}, {'period': '2023', 'revenue': 1890.0, 'unit': 'M', 'net_profit': 249.7}, {'period': '2022', 'revenue': 1490.0, 'unit': 'M', 'net_profit': 154.5}, {'period': '2021', 'revenue': 1130.0, 'unit': 'M', 'net_profit': 89.6}]","[{'period': ""Q4 '24"", 'revenue': 627.7, 'unit': 'M', 'net_profit': 103.1}, {'period': ""Q3 '24"", 'revenue': 622.1, 'unit': 'M', 'net_profit': 129.8}, {'period': ""Q2 '24"", 'revenue': 590.2, 'unit': 'M', 'net_profit': 65.0}, {'period': ""Q1 '24"", 'revenue': 515.3, 'unit': 'M', 'net_profit': 43.4}, {'period': ""Q4 '23"", 'revenue': 515.2, 'unit': 'M', 'net_profit': 147.7}, {'period': ""Q3 '23"", 'revenue': 498.8, 'unit': 'M', 'net_profit': 83.1}]",3.4,3.29,3718700000,1724700000,1076100000,1129000000,479100000,124800000,507700000,233000000,557200000,0.7041899441340782,0.3668402082498999,0.32812499999999994,__nan__,__nan__,__nan__,0.30360072068195876
147,NBN,Northeast Bank Common Stock,"Northeast Bank provides banking services to individual and corporate customers in Maine. The company's deposit products include demand deposit, NOW, money market, savings, certificate of deposit, and individual retirement accounts, as well as checking accounts. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, such as term loans, lines of credit and equipment, and receivables financing; consumer loans comprising mobile home and overdraft, and deposit-secured loans; and small business administration loans. In addition, the company offers telephone banking, online banking and bill payment, mobile banking, cash management, and remote deposit capture services, as well as debit and credit card, ATM, electronic transfer, and check services. It operates a network of nine branches in Western, Central, and Southern Maine. Northeast Bank was founded in 1872 and is headquartered in Portland, Maine.",Mr. Richard N. Wayne,Banks - Regional,83.71,USD,667812430,https://images.financialmodelingprep.com/symbol/NBN.png,47644,9.77,-0.76,44819,91179000,58231000,"[{'period': '2023', 'revenue': 263.77, 'unit': 'M', 'net_profit': 58.23}, {'period': '2022', 'revenue': 121.54, 'unit': 'M', 'net_profit': 44.19}, {'period': '2021', 'revenue': 104.67, 'unit': 'M', 'net_profit': 42.16}, {'period': '2020', 'revenue': 135.85, 'unit': 'M', 'net_profit': 71.5}]","[{'period': ""Q2 '24"", 'revenue': 52.38, 'unit': 'M', 'net_profit': 22.44}, {'period': ""Q1 '24"", 'revenue': 41.83, 'unit': 'M', 'net_profit': 17.11}, {'period': ""Q4 '23"", 'revenue': 68.68, 'unit': 'M', 'net_profit': 15.14}, {'period': ""Q3 '23"", 'revenue': 66.09, 'unit': 'M', 'net_profit': 13.87}, {'period': ""Q2 '23"", 'revenue': 37.53, 'unit': 'M', 'net_profit': 14.05}, {'period': ""Q1 '23"", 'revenue': 37.71, 'unit': 'M', 'net_profit': 15.17}]",7.69,7.58,3132203000,242158000,242158000,2762341000,0,55991000,0,242158000,111000,0.332500328817572,0.3178310362776382,0.2774086378737543,"[0.01, 0.2403]","['2025-02-18', '1988-06-23']",__nan__,0.8819163381172932
148,NBRV,Nabriva Therapeutics plc Ordinary Shares Ireland,"Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company's product includes SIVEXTRO, an oxazolidinone-class antibacterial for the treatment of acute bacterial skin and skin structure infection (ABSSSI); and XENLETA, a semi-synthetic pleuromutilin antibiotic for the treatment of community-acquired bacterial pneumonia. It also develops XENLETA that is in Phase I clinical trial for the treatment of pediatric infections, as well as sexually transmitted infections, cystic fibrosis, ABSSSI, ventilator-associated bacterial pneumonia, hospital-acquired bacterial pneumonia, osteomyelitis, and prosthetic joint infections. In addition, the company develops CONTEPO, an epoxide antibiotic for use in treating complicated urinary tract infections, as well as is in Phase I clinical trial for peri-operative prophylaxis. The company was formerly known as Nabriva Therapeutics Forschungs GmbH and changed its name to Nabriva Therapeutics plc in 2007. Nabriva Therapeutics plc was incorporated in 2005 and is headquartered in Dublin, Ireland.",Dr. Colin  Broom M.D.,Biotechnology,1.42,USD,4546072,https://images.financialmodelingprep.com/symbol/NBRV.png,13843,-0.07219115404168785,0.01,706536,-54702000,-57185000,"[{'period': '2022', 'revenue': 35.67, 'unit': 'M', 'net_profit': -57.19}, {'period': '2021', 'revenue': 27.22, 'unit': 'M', 'net_profit': -49.45}, {'period': '2020', 'revenue': 2.86, 'unit': 'M', 'net_profit': -69.48}, {'period': '2019', 'revenue': 7.75, 'unit': 'M', 'net_profit': -82.76}]","[{'period': ""Q1 '23"", 'revenue': 7.59, 'unit': 'M', 'net_profit': -9.12}, {'period': ""Q4 '22"", 'revenue': 10.44, 'unit': 'M', 'net_profit': -22.78}, {'period': ""Q3 '22"", 'revenue': 8.78, 'unit': 'M', 'net_profit': -11.51}, {'period': ""Q2 '22"", 'revenue': 8.78, 'unit': 'M', 'net_profit': -11.07}, {'period': ""Q1 '22"", 'revenue': 7.67, 'unit': 'M', 'net_profit': -11.82}, {'period': ""Q4 '21"", 'revenue': 8.91, 'unit': 'M', 'net_profit': -13.06}]",-21.32,-21.32,31765000,31104000,12414000,28472000,6742000,0,27605000,12414000,-36922000,-0.12722551928783382,-0.1564206268958544,0.25245441795231416,__nan__,__nan__,__nan__,0.8963324413662836
149,NBSE,NeuBase Therapeutics Inc.  Common Stock,"NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its lead programs include NT0100, a PATrOL enabled anti-gene for Huntington's disease; NT0200, a PATrOL enabled anti-gene for myotonic dystrophy type 1; NT0300, a PATrOL-enabled therapeutic treatment to target the mutated KRAS gene. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania.",Mr. Todd P. Branning,Biotechnology,0.378,USD,1418101,https://images.financialmodelingprep.com/symbol/NBSE.png,128236,-0.02032258064516129,-0.006,89703,-32489891,-34234561,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -34.23}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -25.67}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -17.26}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -27.09}]","[{'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.82}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.45}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.02}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.02}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.54}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.62}]",-21.08,-21.08,32693429,24648665,23152663,9501549,127715,0,4166385,23152663,-29483677,-0.2532707912207797,-0.3337756452677766,-0.12127659574468072,__nan__,__nan__,__nan__,0.2906256483527623
150,NBST,Newbury Street Acquisition Corporation Common Stock,"Newbury Street Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Boston, Massachusetts.",Mr. Kenneth  King,Shell Companies,11.1,USD,48769737,https://images.financialmodelingprep.com/symbol/NBST.png,43,-277.5,0,15,2660764,97368,"[{'period': '2023', 'revenue': 0.0, 'unit': 'K', 'net_profit': 97.37}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.29}, {'period': '2021', 'revenue': 0.0, 'unit': 'K', 'net_profit': -594.3}]","[{'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -186.07}, {'period': ""Q4 '23"", 'revenue': 2800.0, 'unit': 'K', 'net_profit': -119.38}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -100.74}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -77.32}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 394.81}, {'period': ""Q4 '22"", 'revenue': 1660.0, 'unit': 'K', 'net_profit': -815.58}]",0.01,0.01,22542028,960653,956202,6275881,4451,0,6275881,956202,-1311888,1.5550112722545677,1.0756151183641265,1.129366106080207,__nan__,__nan__,__nan__,0.27840800304213975
151,NBSTU,Newbury Street Acquisition Corporation Units,"Newbury Street Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Boston, Massachusetts.",Mr. Kenneth  King,Shell Companies,10.52,USD,52094977,https://images.financialmodelingprep.com/symbol/NBSTU.png,6,-219.17,0,100,2660764,97368,"[{'period': '2023', 'revenue': 0.0, 'unit': 'K', 'net_profit': 97.37}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.29}, {'period': '2021', 'revenue': 0.0, 'unit': 'K', 'net_profit': -594.3}]","[{'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -186.07}, {'period': ""Q4 '23"", 'revenue': 2800.0, 'unit': 'K', 'net_profit': -119.38}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -100.74}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -77.32}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 394.81}, {'period': ""Q4 '22"", 'revenue': 1660.0, 'unit': 'K', 'net_profit': -815.58}]",0.01,0.01,22542028,960653,956202,6275881,4451,0,6275881,956202,-1311888,1.5550112722545677,1.0756151183641265,1.129366106080207,__nan__,__nan__,__nan__,0.27840800304213975
152,NBSTW,Newbury Street Acquisition Corporation Warrants,"Newbury Street Acquisition Corporation focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Boston, Massachusetts.",Mr. Kenneth  King,Shell Companies,0.08,USD,396160,https://images.financialmodelingprep.com/symbol/NBSTW.png,0,0,0.08,0,2660764,97368,"[{'period': '2023', 'revenue': 0.0, 'unit': 'K', 'net_profit': 97.37}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.29}, {'period': '2021', 'revenue': 0.0, 'unit': 'K', 'net_profit': -594.3}]","[{'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -186.07}, {'period': ""Q4 '23"", 'revenue': 2800.0, 'unit': 'K', 'net_profit': -119.38}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -100.74}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -77.32}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 394.81}, {'period': ""Q4 '22"", 'revenue': 1660.0, 'unit': 'K', 'net_profit': -815.58}]",0.01,0.01,22542028,960653,956202,6275881,4451,0,6275881,956202,-1311888,1.5550112722545677,1.0756151183641265,1.129366106080207,__nan__,__nan__,__nan__,0.27840800304213975
153,NBTB,NBT Bancorp Inc. Common Stock,"NBT Bancorp Inc., a financial holding company, provides commercial banking, retail banking, and wealth management services. Its deposit products include demand deposit, savings, negotiable order of withdrawal, money market deposit, and certificate of deposit accounts. The company's loan portfolio comprises commercial and industrial, commercial real estate, agricultural, and commercial construction loans; indirect and direct consumer, home equity, mortgages, business banking loans, and commercial loans; and residential real estate loans. It also provides trust and investment services; financial planning and life insurance services; and retirement plan consulting and recordkeeping services. In addition, the company offers insurance products comprising personal property and casualty, business liability, and commercial insurance, as well as other products and services through 24-hour online, mobile, and telephone channels that enable customers to check balances, make deposits, transfer funds, pay bills, access statements, apply for loans, and access various other products and services. As of December 31, 2021, it had 140 branches and 164 ATMs in New York, Pennsylvania, Vermont, Massachusetts, New Hampshire, Connecticut, and Maine. NBT Bancorp Inc. was founded in 1856 and is headquartered in Norwich, New York.",Mr. Scott A. Kingsley CPA,Banks - Regional,38.64,USD,1825886832,https://images.financialmodelingprep.com/symbol/NBTB.png,229437,13.01,-0.33,235129,0,140641000,"[{'period': '2024', 'revenue': 611.67, 'unit': 'M', 'net_profit': 140.64}, {'period': '2023', 'revenue': 490.37, 'unit': 'M', 'net_profit': 118.78}, {'period': '2022', 'revenue': 515.12, 'unit': 'M', 'net_profit': 152.0}, {'period': '2021', 'revenue': 475.97, 'unit': 'M', 'net_profit': 154.88}]","[{'period': ""Q4 '24"", 'revenue': 147.85, 'unit': 'M', 'net_profit': 36.01}, {'period': ""Q3 '24"", 'revenue': 156.23, 'unit': 'M', 'net_profit': 38.1}, {'period': ""Q2 '24"", 'revenue': 194.0, 'unit': 'M', 'net_profit': 32.72}, {'period': ""Q1 '24"", 'revenue': 192.4, 'unit': 'M', 'net_profit': 33.82}, {'period': ""Q4 '23"", 'revenue': 189.4, 'unit': 'M', 'net_profit': 30.45}, {'period': ""Q3 '23"", 'revenue': 134.56, 'unit': 'M', 'net_profit': 24.61}]",2.95,2.96,13786666000,1779747000,1779747000,12260525000,0,0,162942000,205083000,188567000,-1,0.18402619925577948,0.10486891385767799,"[0.34, 0.10666]","['2025-03-03', '1992-05-26']",__nan__,0.8893031136026651
154,NBTX,Nanobiotix S.A. American Depositary Shares,"Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has a partnership with LianBio to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. The company was incorporated in 2003 and is headquartered in Paris, France.",Mr. Laurent  Levy Ph.D.,Biotechnology,3.02,USD,142275770,https://images.financialmodelingprep.com/symbol/NBTX.png,11757,-3.73,-0.21,15566,-23686000,-39700000,"[{'period': '2023', 'revenue': 36.21, 'unit': 'M', 'net_profit': -39.7}, {'period': '2022', 'revenue': 4.78, 'unit': 'M', 'net_profit': -57.04}, {'period': '2021', 'revenue': 0.01, 'unit': 'M', 'net_profit': -47.0}, {'period': '2020', 'revenue': 0.05, 'unit': 'M', 'net_profit': -33.62}]","[{'period': ""Q2 '24"", 'revenue': 9.29, 'unit': 'M', 'net_profit': -21.87}, {'period': ""Q4 '23"", 'revenue': 32.91, 'unit': 'M', 'net_profit': -11.6}, {'period': ""Q2 '23"", 'revenue': 3.29, 'unit': 'M', 'net_profit': -28.1}, {'period': ""Q4 '22"", 'revenue': 1.72, 'unit': 'M', 'net_profit': -30.68}, {'period': ""Q2 '22"", 'revenue': 0.6645, 'unit': 'M', 'net_profit': -26.36}, {'period': ""Q4 '21"", 'revenue': 0.664, 'unit': 'M', 'net_profit': -16.58}]",-1.08,-1.08,93897000,87339000,75283000,95741000,2967000,0,49873000,75283000,-12813000,0.47540475294013423,0.30403379906386413,0.34146341463414626,__nan__,__nan__,__nan__,1.0196385401024526
155,NCBS,Nicolet Bankshares Inc. Common Stock,"Nicolet Bankshares, Inc. operates as the bank holding company for Nicolet National Bank that provides banking products and services for businesses and individuals. The company accepts checking, savings, and money market accounts; various certificates of deposit; and individual retirement accounts. It also offers commercial loans, including commercial, industrial, and business loans and lines of credit; commercial real estate loans; agricultural (AG) production and AG real estate loans; commercial real estate investment real estate loans; construction and land development loans; residential real estate loans, such as residential first lien and junior lien mortgages, home equity loans, lines of credit, and residential construction loans; and consumer loans. In addition, the company provides cash management, international banking, personal brokerage, safe deposit boxes, and trust and fiduciary services, as well as wealth management and retirement plan services. Further, it offers mortgage refinancing; online services, such as commercial, retail, and trust online banking; automated bill payment, mobile banking deposits and account access, and remote deposit capture services; and other services consisting of wire transfers, debit cards, credit cards, pre-paid gift cards, direct deposits, and official bank checks, as well as facilitates crop insurance products. As of December 31, 2021, it operated 52 branches throughout Wisconsin and Michigan. The company was formerly known as Green Bay Financial Corporation and changed its name to Nicolet Bankshares, Inc. in March 2002. Nicolet Bankshares, Inc. was incorporated in 2000 and is headquartered in Green Bay, Wisconsin.",Mr. Robert Atwell,Banks - Regional,75.35,USD,1101722490,https://images.financialmodelingprep.com/symbol/NCBS.png,47436,12.655357742693987,0.26000214,54282,0,124059000,"[{'period': '2024', 'revenue': 438.37, 'unit': 'M', 'net_profit': 124.06}, {'period': '2023', 'revenue': 272.5, 'unit': 'M', 'net_profit': 61.52}, {'period': '2022', 'revenue': 297.88, 'unit': 'M', 'net_profit': 94.26}, {'period': '2021', 'revenue': 225.32, 'unit': 'M', 'net_profit': 60.65}]","[{'period': ""Q4 '24"", 'revenue': 91.19, 'unit': 'M', 'net_profit': 34.48}, {'period': ""Q3 '24"", 'revenue': 89.99, 'unit': 'M', 'net_profit': 32.52}, {'period': ""Q2 '24"", 'revenue': 128.49, 'unit': 'M', 'net_profit': 29.27}, {'period': ""Q1 '24"", 'revenue': 123.45, 'unit': 'M', 'net_profit': 27.79}, {'period': ""Q4 '23"", 'revenue': 126.0, 'unit': 'M', 'net_profit': 30.66}, {'period': ""Q3 '23"", 'revenue': 116.42, 'unit': 'M', 'net_profit': 17.16}]",8.24,8.05,8796795000,922358000,922358000,7623897000,0,0,0,115943000,133749000,-1,1.0166948436179206,0.9760191846522782,__nan__,__nan__,__nan__,0.8666675760887914
156,NCMI,National CineMedia Inc. Common Stock,"National CineMedia, Inc., through its subsidiary, National CineMedia, LLC, operates cinema advertising network in North America. It engages in the sale of advertising to national, regional, and local businesses in Noovie, a cinema advertising and entertainment pre-show seen on movie screens; and sells advertising on its Lobby Entertainment Network, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theatre lobbies. The company is also engaged in the sale of online and mobile advertising through its Noovie Audience Accelerator product, as well as a suite of Noovie digital properties, such as Noovie Shuffle, Noovie Trivia, Name That Movie, and Noovie Arcade to reach entertainment audiences beyond the theater. It offers its services to third-party theater circuits under long-term network affiliate agreements. The company was incorporated in 2006 and is headquartered in Centennial, Colorado.",Mr. Thomas F. Lesinski,Advertising Agencies,5.67,USD,539739774,https://images.financialmodelingprep.com/symbol/NCMI.png,649118,-24.65,-0.08,1007370,-1300000,-22300000,"[{'period': '2024', 'revenue': 240.8, 'unit': 'M', 'net_profit': -22.3}, {'period': '2023', 'revenue': 165.2, 'unit': 'M', 'net_profit': 705.2}, {'period': '2022', 'revenue': 249.2, 'unit': 'M', 'net_profit': -28.6}, {'period': '2021', 'revenue': 114.6, 'unit': 'M', 'net_profit': -113.5}]","[{'period': ""Q4 '24"", 'revenue': 86.3, 'unit': 'M', 'net_profit': 24.7}, {'period': ""Q3 '24"", 'revenue': 62.4, 'unit': 'M', 'net_profit': -3.6}, {'period': ""Q2 '24"", 'revenue': 54.7, 'unit': 'M', 'net_profit': -8.7}, {'period': ""Q1 '24"", 'revenue': 37.4, 'unit': 'M', 'net_profit': -34.7}, {'period': ""Q4 '23"", 'revenue': 90.9, 'unit': 'M', 'net_profit': 23.7}, {'period': ""Q3 '23"", 'revenue': 24.7, 'unit': 'M', 'net_profit': 181.8}]",-0.23,-0.23,568600000,177900000,75200000,157400000,85300000,3800000,73500000,75100000,54500000,-1.001733102253033,-1.0316222348269994,-1.0156143923964698,"[0.03, 0.15]","['2025-03-24', '2007-08-21']",__nan__,0.2768202602884277
157,NCNA,NuCana plc American Depositary Share,"NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients with recurrent ovarian cancer; Phase Ib clinical trials for the treatment of patients with biliary tract cancer; Phase II clinical trial for the treatment of patients with platinum-resistant ovarian cancer; and Phase III clinical trial for the treatment of patients with pancreatic cancer. The company is also developing NUC-3373, a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil, which is in Phase I clinical trial for the treatment of patients with advanced solid tumors and in a Phase 1b/2 clinical trial for patients with advanced colorectal cancer; and NUC-7738, a nucleoside analog that is in Phase 1/2 clinical trial for the treatment of patients with advanced solid tumors and hematological tumors. It has a research, collaboration, and license agreement with Cardiff University and University College Cardiff Consultants Ltd. for the design, synthesis, characterization, and evaluation of ProTides; and an assignment, license, and collaboration agreement with Cardiff ProTides Ltd. The company was formerly known as NuCana BioMed Limited and changed its name to NuCana plc in August 2017. NuCana plc was incorporated in 1997 and is headquartered in Edinburgh, the United Kingdom.",Mr. Hugh Stephen Griffith,Biotechnology,0.725,USD,4104578,https://images.financialmodelingprep.com/symbol/NCNA.png,85388,-0.09,-0.025,69409,-28891000,-27632000,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -27.63}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -32.02}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -40.53}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -30.68}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -653.0}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.51}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.0}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.84}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.66}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.7}]",-13.12,-13.12,14774000,12265000,6749000,8820000,4639000,0,8666000,6749000,-19411000,0.44604440694865205,0.1370663002404672,0.15190691661279906,__nan__,__nan__,__nan__,0.5969947204548531
158,NCNO,nCino Inc. Common Stock,"nCino, Inc., a software-as-a-service company, provides cloud-based software applications to financial institutions in the United States and internationally. Its nCino Bank Operating System, a tenant cloud platform, which digitizes, automates, and streamlines complex processes and workflow; and utilizes data analytics and artificial intelligence and machine learning (AI/ML) to enable banks and credit unions to onboard new clients, make loans and manage the entire loan life cycle, open deposit and other accounts, and manage regulatory compliance. The company's nCino IQ, an application suite that utilizes data analytics and AI/ML to provide its customers with automation and insights into their operations, such as tools for analyzing, measuring, and managing credit risk, as well as to enhance their ability to comply with regulatory requirements. It also offers SimpleNexus, a suite of products that enables loan officers, borrowers, real estate agents, settlement agents, and others to engage in the homeownership process from internet-enabled device. The company serves financial institution customers, including global financial institutions, enterprise banks, regional banks, community banks, credit unions, new market entrants, and independent mortgage banks through sales team comprising business development representatives, account executives, field sales engineers, and customer success managers. nCino, Inc. was founded in 2011 and is headquartered in Wilmington, North Carolina.",Mr. Sean  Desmond,Software - Application,22.05,USD,2567722500,https://images.financialmodelingprep.com/symbol/NCNO.png,1787770,-66.82,0.33,4148501,9548000,-37878000,"[{'period': '2025', 'revenue': 540.66, 'unit': 'M', 'net_profit': -37.88}, {'period': '2024', 'revenue': 476.54, 'unit': 'M', 'net_profit': -42.35}, {'period': '2023', 'revenue': 273.87, 'unit': 'M', 'net_profit': -50.12}, {'period': '2022', 'revenue': 204.29, 'unit': 'M', 'net_profit': -41.27}]","[{'period': ""Q4 '25"", 'revenue': 141.37, 'unit': 'M', 'net_profit': -18.61}, {'period': ""Q3 '25"", 'revenue': 138.8, 'unit': 'M', 'net_profit': -5.25}, {'period': ""Q2 '25"", 'revenue': 132.4, 'unit': 'M', 'net_profit': -11.04}, {'period': ""Q1 '25"", 'revenue': 128.09, 'unit': 'M', 'net_profit': -2.98}, {'period': ""Q4 '24"", 'revenue': 123.69, 'unit': 'M', 'net_profit': 1.16}, {'period': ""Q3 '24"", 'revenue': 121.94, 'unit': 'M', 'net_profit': -16.38}]",-0.33,-0.33,1610381000,302249000,120928000,512783000,146787000,9294000,251512000,120928000,53383000,0.27937826611282324,0.10551173664572805,0.13157894736842102,__nan__,__nan__,__nan__,0.31842340415094317
159,NCSM,NCS Multistage Holdings Inc. Common Stock,"NCS Multistage Holdings, Inc. provides engineered products and support services for oil and natural gas well completions and field development strategies in the United States, Canada, and internationally. It offers fracturing systems, which include casing-installed sliding sleeves, downhole frac isolation assemblies, sand jet perforating products, accelus sliding sleeves, injection control devices, repeat precision products, chemical and radioactive tracer diagnostics, and well construction products. The company also provides tracer diagnostics services for well completion and reservoir characterization that utilize downhole chemical and radioactive tracers. It offers its products and services primarily to exploration and production companies for use in onshore wells through technically-trained direct sales force, and operating partners or sales representatives. The company was formerly known as Pioneer Super Holdings, Inc. and changed its name to NCS Multistage Holdings, Inc. in December 2016. NCS Multistage Holdings, Inc. was founded in 2006 and is headquartered in Houston, Texas.",Mr. Ryan  Hummer,Oil & Gas Equipment & Services,26.06,USD,66214551,https://images.financialmodelingprep.com/symbol/NCSM.png,11245,10.22,-2.1,10801,13984000,6593000,"[{'period': '2024', 'revenue': 162.56, 'unit': 'M', 'net_profit': 6.59}, {'period': '2023', 'revenue': 142.47, 'unit': 'M', 'net_profit': -3.15}, {'period': '2022', 'revenue': 155630.0, 'unit': 'K', 'net_profit': -952.0}, {'period': '2021', 'revenue': 118.5, 'unit': 'M', 'net_profit': -3.78}]","[{'period': ""Q4 '24"", 'revenue': 45.0, 'unit': 'M', 'net_profit': 3.47}, {'period': ""Q3 '24"", 'revenue': 44.01, 'unit': 'M', 'net_profit': 4.15}, {'period': ""Q2 '24"", 'revenue': 29.89, 'unit': 'M', 'net_profit': -3.1}, {'period': ""Q1 '24"", 'revenue': 44.18, 'unit': 'M', 'net_profit': 2.07}, {'period': ""Q4 '23"", 'revenue': 35.25, 'unit': 'M', 'net_profit': 39.64}, {'period': ""Q3 '23"", 'revenue': 38.28, 'unit': 'M', 'net_profit': 4.41}]",2.6,2.55,152812000,105570000,25880000,36703000,36656000,0,25419000,25880000,11416000,6.522327876453941,3.0910244211861717,3.047244094488189,__nan__,__nan__,__nan__,0.2401840169620187
160,NCTY,The9 Limited American Depository Shares,"The9 Limited, together with its subsidiaries, operates as an Internet company in the People's Republic of China. It engages in the operation of cryptocurrency mining; and NFTSTAR, a NFT trading and community platform that provides users with purchase, trade, and interactive activities. The company was formerly known as GameNow.net Limited and changed its name to The9 Limited in February 2004. The9 Limited was incorporated in 1999 and is headquartered in Shanghai, the People's Republic of China.",Mr. Jun  Zhu,Electronic Gaming & Multimedia,10.45,USD,323710,https://images.financialmodelingprep.com/symbol/NCTY.png,82939,1.54,-0.72,93452,-26031753,20003614,"[{'period': '2023', 'revenue': 179.05, 'unit': 'M', 'net_profit': 20.0}, {'period': '2022', 'revenue': 0.11889000000000001, 'unit': 'B', 'net_profit': -1.38}, {'period': '2021', 'revenue': 135.88, 'unit': 'M', 'net_profit': -485.82}, {'period': '2020', 'revenue': 0.62549, 'unit': 'M', 'net_profit': 397.88}]","[{'period': ""Q2 '24"", 'revenue': 92080.0, 'unit': 'K', 'net_profit': 226.0}, {'period': ""Q4 '23"", 'revenue': 82.0, 'unit': 'M', 'net_profit': 289.81}, {'period': ""Q2 '23"", 'revenue': 97.05, 'unit': 'M', 'net_profit': -268.4}, {'period': ""Q4 '22"", 'revenue': 68.14, 'unit': 'M', 'net_profit': -395.19}, {'period': ""Q2 '22"", 'revenue': 50.75, 'unit': 'M', 'net_profit': -579.67}, {'period': ""Q4 '21"", 'revenue': 10.1, 'unit': 'M', 'net_profit': -285.46}]",42.5,42.5,363725025,222795882,45221538,182387956,56067,35291289,162853793,45221538,-48431556,0.9550159329039684,1.014516244414381,1.7404181184668992,"[1.11, 1.11]","['2009-01-29', '2009-01-29']",__nan__,0.5014446174001913
161,NDAC,NightDragon Acquisition Corp. Class A Common stock,"NightDragon Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to identify business opportunities in the field of cybersecurity, safety, security, and privacy sectors. The company was incorporated in 2020 and is based in San Francisco, California.",Mr. Morgan  Kyauk,Shell Companies,10.0754,USD,0,https://images.financialmodelingprep.com/symbol/NDAC.png,216279,91.59454545454545,0.0604,59135,2275306,6041852,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.04}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.87}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.65}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.19}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.46}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.87}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 595.94}]",0.14,0.14,35648,1737.606,1102.919,18761,0,345030,491.165,1102.919,-1745543,0,0,0,__nan__,__nan__,__nan__,0.5262847845601436
162,NDACU,NightDragon Acquisition Corp. SCALE Units,"NightDragon Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to identify business opportunities in the field of cybersecurity, safety, security, and privacy sectors. The company was incorporated in 2020 and is based in San Francisco, California.",Mr. Morgan  Kyauk,Shell Companies,10.06,USD,0,https://images.financialmodelingprep.com/symbol/NDACU.png,8730,74.51851851851852,0.06,11868,2275306,6041852,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.04}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.87}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.65}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.19}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.46}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.87}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 595.94}]",0.14,0.14,35648,1737.606,1102.919,18761,0,345030,491.165,1102.919,-1745543,0,0,0,__nan__,__nan__,__nan__,0.5262847845601436
163,NDACW,NightDragon Acquisition Corp. Warrants to purchase Class A common stock,"NightDragon Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in San Francisco, California.",Mr. Morgan  Kyauk,Shell Companies,0.009,USD,0,https://images.financialmodelingprep.com/symbol/NDACW.png,0,0,0.0059,42850,2275306,6041852,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.04}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.87}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.65}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.19}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.46}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.87}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 595.94}]",0.14,0.14,35648,1737.606,1102.919,18761,0,345030,491.165,1102.919,-1745543,0,0,0,__nan__,__nan__,__nan__,0.5262847845601436
164,NDAQ,Nasdaq Inc. Common Stock,"Nasdaq, Inc. operates as a technology company that serves capital markets and other industries worldwide. The Market Technology segment includes anti financial crime technology business, which offers Nasdaq Trade Surveillance, a SaaS solution for brokers and other market participants to assist them in complying with market rules, regulations, and internal market surveillance policies; Nasdaq Automated Investigator, a cloud-deployed anti-money laundering tool; and Verafin, a SaaS technology provider of anti-financial crime management solutions. This segment also handles assets, such as cash equities, equity derivatives, currencies, interest-bearing securities, commodities, energy products, and digital currencies. The Investment Intelligence segment sells and distributes historical and real-time market data; develops and licenses Nasdaq-branded indexes and financial products; and provides investment insights and workflow solutions. The Corporate Platforms segment operates listing platforms; and offers investor relations intelligence and governance solutions. As of December 31, 2021, it had 4,178 companies listed securities on The Nasdaq Stock Market, including 1,632 listings on The Nasdaq Global Select Market; 1,169 on The Nasdaq Global Market; and 1,377 on The Nasdaq Capital Market. The Market Services segment includes equity derivative trading and clearing, cash equity trading, fixed income and commodities trading and clearing, and trade management service businesses. This segment operates various exchanges and other marketplace facilities across various asset classes, which include derivatives, commodities, cash equity, debt, structured products, and exchange traded products; and provides broker, clearing, settlement, and central depository services. The company was formerly known as The NASDAQ OMX Group, Inc. and changed its name to Nasdaq, Inc. in September 2015. Nasdaq, Inc. was founded in 1971 and is headquartered in New York, New York.",Ms. Adena T. Friedman,Financial - Data & Stock Exchanges,66.4,USD,38189628000,https://images.financialmodelingprep.com/symbol/NDAQ.png,3031116,34.4,-1.34,6749894,2460000000,1117000000,"[{'period': '2024', 'revenue': 7.4, 'unit': 'B', 'net_profit': 1.12}, {'period': '2023', 'revenue': 6.06, 'unit': 'B', 'net_profit': 1.06}, {'period': '2022', 'revenue': 6.23, 'unit': 'B', 'net_profit': 1.12}, {'period': '2021', 'revenue': 5.89, 'unit': 'B', 'net_profit': 1.19}]","[{'period': ""Q4 '24"", 'revenue': 2029.9999999999998, 'unit': 'M', 'net_profit': 355.0}, {'period': ""Q3 '24"", 'revenue': 1900.0, 'unit': 'M', 'net_profit': 306.0}, {'period': ""Q2 '24"", 'revenue': 1790.0, 'unit': 'M', 'net_profit': 222.0}, {'period': ""Q1 '24"", 'revenue': 1670.0, 'unit': 'M', 'net_profit': 234.0}, {'period': ""Q4 '23"", 'revenue': 1650.0, 'unit': 'M', 'net_profit': 197.0}, {'period': ""Q3 '23"", 'revenue': 1450.0, 'unit': 'M', 'net_profit': 294.0}]",1.94,1.93,30395000000,7786000000,776000000,19195000000,1022000000,0,7902000000,592000000,1732000000,0.23246492985971945,0.05476864966949953,-0.06730769230769236,"[0.24, 0.13]","['2025-03-14', '2012-09-12']",__nan__,0.6315183418325383
165,NDLS,Noodles & Company Class A Common Stock,"Noodles & Company, a restaurant concept company, develops and operates fast-casual restaurants. It offers cooked-to-order dishes, including noodles and pasta, soups, salads, and appetizers. As of December 28, 2021, the company operated 448 restaurants in 29 states, which included 372 company locations and 76 franchise locations. Noodles & Company was founded in 1995 and is based in Broomfield, Colorado.",Mr. Andrew H. Madsen,Restaurants,0.926,USD,42507104,https://images.financialmodelingprep.com/symbol/NDLS.png,206155,-1.16,-0.084,117683,1288000,-36213000,"[{'period': '2024', 'revenue': 493.27, 'unit': 'M', 'net_profit': -36.21}, {'period': '2023', 'revenue': 503.4, 'unit': 'M', 'net_profit': -9.86}, {'period': '2022', 'revenue': 509.48, 'unit': 'M', 'net_profit': -3.31}, {'period': '2021', 'revenue': 475.15, 'unit': 'M', 'net_profit': 3.67}]","[{'period': ""Q4 '24"", 'revenue': 121.77, 'unit': 'M', 'net_profit': -9.69}, {'period': ""Q3 '24"", 'revenue': 122.75, 'unit': 'M', 'net_profit': -6.75}, {'period': ""Q2 '24"", 'revenue': 127.35, 'unit': 'M', 'net_profit': -13.62}, {'period': ""Q1 '24"", 'revenue': 121.39, 'unit': 'M', 'net_profit': -6.14}, {'period': ""Q4 '23"", 'revenue': 124.32, 'unit': 'M', 'net_profit': -6.14}, {'period': ""Q3 '23"", 'revenue': 127850.0, 'unit': 'K', 'net_profit': 700.0}]",-0.8,-0.8,324648000,20192000,1149000,330227000,4058000,0,65717000,1149000,-21206000,-0.9408169829527179,-2.674208603896104,-2.80952380952381,__nan__,__nan__,__nan__,1.0171847662699294
166,NDRA,ENDRA Life Sciences Inc. Common Stock,"ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.",Mr. Alexander Y. Tokman,Medical - Diagnostics & Research,3.99,USD,2243230,https://images.financialmodelingprep.com/symbol/NDRA.png,21706,-0.07,-0.39,149066,0,-11507947,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.51}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.06}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.2}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.19}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.15}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.35}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.23}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.78}, {'period': ""Q4 '23"", 'revenue': 0.42841, 'unit': 'M', 'net_profit': -1.46}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.1}]",-56.94,-56.94,4452362,3433665,3229480,1891996,0,0,605230,3229480,-7416547,1,-0.1439026863149524,-50.29729729729729,__nan__,__nan__,__nan__,0.42494208691925767
167,NDRAW,ENDRA Life Sciences Inc. Warrants,,None,,0.03,USD,0,https://images.financialmodelingprep.com/symbol/NDRAW.png,0,0,0.018,113761,-11006835,-11352321,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.35}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.73}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -17.53}, {'period': '2018', 'revenue': 0.00617, 'unit': 'M', 'net_profit': -9.8}]","[{'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.86}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.23}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.66}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.2}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.27}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -11.73}]",-0.82,-0.82,12874644,12094115,9461534,2090398,0,0,1543767,9461534,-11167384,0.033957088515239035,0.03182635863491035,0.03529411764705886,__nan__,__nan__,__nan__,0.16236549919360876
168,NDSN,Nordson Corporation Common Stock,"Nordson Corporation engineers, manufactures, and markets products and systems to dispense, apply, and control adhesives, coatings, polymers, sealants, biomaterials, and other fluids worldwide. It operates through two segments, Industrial Precision Solutions (IPS) and Advanced Technology Solutions (ATS). The IPS segment provides dispensing, coating, and laminating systems for adhesives, lotions, liquids, and fibers to disposable products and roll goods; automated adhesive dispensing systems used in packaged goods industries; components and systems used in the thermoplastic melt stream; and product assembly systems for use in paper and paperboard converting applications, and manufacturing roll goods, as well as for the assembly of plastic, metal, and wood products. It also offers automated and manual dispensing products and systems to apply adhesive and sealant materials; dispensing and curing systems to coat and cure containers; systems to apply liquid paints and coatings to consumer and industrial products; and systems to apply powder paints and coatings to metal, plastic, and wood products, as well as ultraviolet equipment for use in curing and drying operations for specialty coatings, semiconductor materials, and paints. The ATS segment provides automated dispensing systems for the attachment, protection, and coating of fluids, as well as related gas plasma treatment systems for cleaning and conditioning surfaces; precision manual and semi-automated dispensers, minimally invasive interventional delivery devices, plastic molded syringes, cartridges, tips, fluid connection components, tubing, balloons, and catheters; and bond testing and automated optical, acoustic microscopy, and x-ray inspection systems for use in semiconductor and printed circuit board industries. The company markets its products through direct sales force, as well as distributors and sales representatives. Nordson Corporation was founded in 1935 and is headquartered in Westlake, Ohio.",Mr. Sundaram  Nagarajan,Industrial - Machinery,167.51,USD,9533278867,https://images.financialmodelingprep.com/symbol/NDSN.png,370216,21.31,-3.29,693857,674001000,467284000,"[{'period': '2024', 'revenue': 2690.0, 'unit': 'M', 'net_profit': 467.28}, {'period': '2023', 'revenue': 2630.0, 'unit': 'M', 'net_profit': 487.49}, {'period': '2022', 'revenue': 2590.0, 'unit': 'M', 'net_profit': 513.1}, {'period': '2021', 'revenue': 2360.0, 'unit': 'M', 'net_profit': 454.37}]","[{'period': ""Q1 '25"", 'revenue': 615.42, 'unit': 'M', 'net_profit': 94.65}, {'period': ""Q4 '24"", 'revenue': 744.48, 'unit': 'M', 'net_profit': 122.17}, {'period': ""Q3 '24"", 'revenue': 661.6, 'unit': 'M', 'net_profit': 117.33}, {'period': ""Q2 '24"", 'revenue': 650.64, 'unit': 'M', 'net_profit': 118.22}, {'period': ""Q1 '24"", 'revenue': 633.19, 'unit': 'M', 'net_profit': 109.57}, {'period': ""Q4 '23"", 'revenue': 719.31, 'unit': 'M', 'net_profit': 127.78}]",8.17,8.11,6000966000,1275032000,115952000,3068774000,594663000,0,528477000,115952000,491783000,-0.14330110760579706,-0.04145495422498374,-0.043325526932084225,"[0.78, 0.18]","['2025-03-20', '1986-11-21']",__nan__,0.5113800011531476
169,NEBC,Nebula Caravel Acquisition Corp. Class A Common Stock,,,,,,,,,,,,-114648,-114648,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -114.65}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.46}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -114.65}, {'period': ""Q2 '20"", 'revenue': 5.38, 'unit': 'M', 'net_profit': -18.08}]",-0.0042,-0.0042,276772221,1772221,1280345,9795629,0,0,170629,1005345,,0,0,0,__nan__,__nan__,__nan__,0.03539238498938808
170,NEBCU,Nebula Caravel Acquisition Corp. Unit,,,Personal Products & Services,11,USD,0,https://images.financialmodelingprep.com/symbol/NEBCU.png,7747,0,0.63,2992,-5211000,-21381000,"[{'period': '2022', 'revenue': 174.01, 'unit': 'M', 'net_profit': -21.38}, {'period': '2021', 'revenue': 109.84, 'unit': 'M', 'net_profit': -64.05}, {'period': '2020', 'revenue': 48.8, 'unit': 'M', 'net_profit': -57.48}, {'period': '2019', 'revenue': 95.05, 'unit': 'M', 'net_profit': -51.71}]","[{'period': ""Q3 '23"", 'revenue': 66.2, 'unit': 'M', 'net_profit': 10.5}, {'period': ""Q2 '23"", 'revenue': 58530.0, 'unit': 'K', 'net_profit': -253.0}, {'period': ""Q1 '23"", 'revenue': 41.12, 'unit': 'M', 'net_profit': -4.34}, {'period': ""Q4 '22"", 'revenue': 51.95, 'unit': 'M', 'net_profit': 5.27}, {'period': ""Q3 '22"", 'revenue': 50.86, 'unit': 'M', 'net_profit': -15.15}, {'period': ""Q2 '22"", 'revenue': 43.37, 'unit': 'M', 'net_profit': -3.63}]",-0.12,-0.12,418261000,312042000,250222000,109987000,53181000,22463000,87065000,58875000,-6525000,0.9123435607589826,0.6661774578838077,0.8333333333333334,__nan__,__nan__,__nan__,0.26296259990771315
171,NEBCW,Nebula Caravel Acquisition Corp. Warrant,,,,,,,,,,,,-114648,-114648,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -114.65}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.46}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -114.65}, {'period': ""Q2 '20"", 'revenue': 5.38, 'unit': 'K', 'net_profit': -18.08}]",-0.0042,-0.0042,2047221,1772221,276005345,9795629,0,0,170629,1005345,,0,0,0,__nan__,__nan__,__nan__,4.784841988236736
172,NEGG,Newegg Commerce Inc. Common Shares,"Newegg Commerce, Inc. operates as an electronics-focused e-retailer in North America. The company offers desktops, laptops, gaming laptops, peripherals, and accessories; CPU/processors, graphic cards, motherboards, storage devices, and computer accessories; home video, home audio, headphones, pro audio/video, cellphones, wearables, and digital cameras; Xbox, Playstation, legacy gaming, and gaming titles; and home networking, commercial networking, server and components, and smart home products. It also provides display and printing, office technology furniture, office supplies, and mailing and inventory supplies; software, digital downloads, warranty and services, 3rd party gift cards, and entertainment products; car electronics, marine and aviation, motorcycles and ATV, performance parts, tools and equipment, and wheels and tires; home improvement tools, home appliances, kitchen utensils, outdoor and garden furniture, pet supplies, and generators; and fitness, sports, and health and beauty supplies. The company operates B2C platforms, including Newegg.com, Newegg.ca, and Newegg Global, as well as mobile apps; and B2B platforms comprising NeweggBusiness.com. The company was founded in 2001 and is headquartered in City of Industry, California. Newegg Commerce, Inc. is a subsidiary of Hangzhou Liaison Interactive Information Technology Co., Ltd.",Mr. Anthony K.  Chow,Specialty Retail,4.03,USD,78167492,https://images.financialmodelingprep.com/symbol/NEGG.png,43729,-1.37,-1.1,118720,-45694000,-58990000,"[{'period': '2023', 'revenue': 1500.0, 'unit': 'M', 'net_profit': -58.99}, {'period': '2022', 'revenue': 1720.0, 'unit': 'M', 'net_profit': -57.43}, {'period': '2021', 'revenue': 2380.0, 'unit': 'M', 'net_profit': 36.26}, {'period': '2020', 'revenue': 2110.0, 'unit': 'M', 'net_profit': 30.43}]","[{'period': ""Q2 '24"", 'revenue': 309.06, 'unit': 'M', 'net_profit': -12.48}, {'period': ""Q1 '24"", 'revenue': 309.06, 'unit': 'M', 'net_profit': -12.48}, {'period': ""Q4 '23"", 'revenue': 456.14, 'unit': 'M', 'net_profit': -14.98}, {'period': ""Q3 '23"", 'revenue': 317.57, 'unit': 'M', 'net_profit': -14.68}, {'period': ""Q2 '23"", 'revenue': 361.62, 'unit': 'M', 'net_profit': -14.67}, {'period': ""Q1 '23"", 'revenue': 361.62, 'unit': 'M', 'net_profit': -14.67}]",-0.16,-0.16,499047000,344451000,106474000,369655000,83609000,2250000,296544000,102512000,-34104000,-0.4450066409461767,-0.027181389193612984,-0.06666666666666674,__nan__,__nan__,__nan__,0.7407218157808784
173,NEO,NeoGenomics Inc. Common Stock,"NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. The company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited. The company was founded in 2001 and is headquartered in Fort Myers, Florida.",Mr. Jeffrey S. Sherman M.B.A.,Medical - Diagnostics & Research,8.2,USD,1053380200,https://images.financialmodelingprep.com/symbol/NEO.png,1422332,-13.23,-0.63,1976745,-1511000,-78726000,"[{'period': '2024', 'revenue': 660.57, 'unit': 'M', 'net_profit': -78.73}, {'period': '2023', 'revenue': 591.64, 'unit': 'M', 'net_profit': -87.97}, {'period': '2022', 'revenue': 509.73, 'unit': 'M', 'net_profit': -144.25}, {'period': '2021', 'revenue': 484.33, 'unit': 'M', 'net_profit': -8.35}]","[{'period': ""Q4 '24"", 'revenue': 172.0, 'unit': 'M', 'net_profit': -15.32}, {'period': ""Q3 '24"", 'revenue': 167.82, 'unit': 'M', 'net_profit': -17.7}, {'period': ""Q2 '24"", 'revenue': 164.5, 'unit': 'M', 'net_profit': -18.64}, {'period': ""Q1 '24"", 'revenue': 156.24, 'unit': 'M', 'net_profit': -27.06}, {'period': ""Q4 '23"", 'revenue': 155.55, 'unit': 'M', 'net_profit': -14.33}, {'period': ""Q3 '23"", 'revenue': 151.95, 'unit': 'M', 'net_profit': -18.52}]",-0.62,-0.62,1638038000,596019000,386844000,735699000,150540000,0,301241000,367012000,-34038000,0.9141818594877038,0.10506093124772645,0.11428571428571424,"[0.4, 0.4]","['2020-12-17', '2020-12-17']",__nan__,0.44913426916835875
174,NEOG,Neogen Corporation Common Stock,"Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.",Mr. John Edward Adent,Medical - Diagnostics & Research,7.04,USD,1527285760,https://images.financialmodelingprep.com/symbol/NEOG.png,3610683,-3.21,-0.81,6502081,182597000,-9421000,"[{'period': '2024', 'revenue': 924.22, 'unit': 'M', 'net_profit': -9.42}, {'period': '2023', 'revenue': 822.45, 'unit': 'M', 'net_profit': -22.87}, {'period': '2022', 'revenue': 527.16, 'unit': 'M', 'net_profit': 48.31}, {'period': '2021', 'revenue': 468.46, 'unit': 'M', 'net_profit': 60.88}]","[{'period': ""Q2 '25"", 'revenue': 231.26, 'unit': 'M', 'net_profit': -456.28}, {'period': ""Q1 '25"", 'revenue': 216.96, 'unit': 'M', 'net_profit': -12.61}, {'period': ""Q4 '24"", 'revenue': 236.79, 'unit': 'M', 'net_profit': -5.42}, {'period': ""Q3 '24"", 'revenue': 228.81, 'unit': 'M', 'net_profit': -2.02}, {'period': ""Q2 '24"", 'revenue': 229.63, 'unit': 'M', 'net_profit': -3.49}, {'period': ""Q1 '24"", 'revenue': 228.99, 'unit': 'M', 'net_profit': 1.5}]",-0.0435,-0.0435,4548833000,589233000,170936000,1404691000,173005000,229000,154323000,170611000,-76157000,0.4930741806763917,0.5880629645824224,0.6375000000000001,__nan__,__nan__,__nan__,0.30880249945425564
175,NEON,Neonode Inc. Common Stock,"Neonode Inc., together with its subsidiaries, develops optical sensing solutions for contactless touch, touch, and gesture sensing in the United States, Japan, South Korea, China, and internationally. It also offers software solutions for scene analysis using advanced machine learning algorithms to detect and track persons and objects in video streams for cameras and other types of imagers. In addition, the company licenses its technology to original equipment manufacturers (OEMs) and Tier 1 suppliers. Further, it provides embedded sensors modules to OEMs, original design manufacturers, and systems integrators; and engineering consulting services. Additionally, the company sells Neonode branded sensor products, such as AirBar products through distributors. It serves office equipment, automotive, industrial automation, medical, military, and avionics markets. Neonode Inc. was incorporated in 1997 and is headquartered in Stockholm, Sweden.",Mr. Thomas  Eriksson,"Hardware, Equipment & Parts",7.2,USD,120836880,https://images.financialmodelingprep.com/symbol/NEON.png,85309,-19.46,-0.48,122870,-6410000,-6466000,"[{'period': '2024', 'revenue': 3.11, 'unit': 'M', 'net_profit': -6.47}, {'period': '2023', 'revenue': 4.45, 'unit': 'M', 'net_profit': -10.12}, {'period': '2022', 'revenue': 5.67, 'unit': 'M', 'net_profit': -5.28}, {'period': '2021', 'revenue': 5.84, 'unit': 'M', 'net_profit': -7.27}]","[{'period': ""Q4 '24"", 'revenue': 0.655, 'unit': 'M', 'net_profit': -1.6}, {'period': ""Q3 '24"", 'revenue': 0.838, 'unit': 'M', 'net_profit': -1.09}, {'period': ""Q2 '24"", 'revenue': 1.42, 'unit': 'M', 'net_profit': -1.7}, {'period': ""Q1 '24"", 'revenue': 1.01, 'unit': 'M', 'net_profit': -2.08}, {'period': ""Q4 '23"", 'revenue': 0.993, 'unit': 'M', 'net_profit': -5.92}, {'period': ""Q3 '23"", 'revenue': 1.0, 'unit': 'M', 'net_profit': -1.27}]",-0.41,-0.41,18381000,17685000,16427000,1939000,732000,0,1620000,16427000,-5629000,0.39436885865457294,0.3612565445026178,0.37878787878787884,__nan__,__nan__,__nan__,0.10548936401719167
176,NEPH,Nephros Inc. Common Stock,"Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells real-time water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it offers water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and AETHER brands for the food service, hospitality, convenience store, and health care markets. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.",Mr. Robert  Banks,Medical - Instruments & Supplies,1.81,USD,19186724,https://images.financialmodelingprep.com/symbol/NEPH.png,15326,181,-0.04,10509,227000,74000,"[{'period': '2024', 'revenue': 14160.0, 'unit': 'K', 'net_profit': 74.0}, {'period': '2023', 'revenue': 14.24, 'unit': 'M', 'net_profit': -1.57}, {'period': '2022', 'revenue': 9.97, 'unit': 'M', 'net_profit': -7.32}, {'period': '2021', 'revenue': 10.4, 'unit': 'M', 'net_profit': -4.17}]","[{'period': ""Q4 '24"", 'revenue': 3870.0, 'unit': 'K', 'net_profit': 349.0}, {'period': ""Q3 '24"", 'revenue': 3520.0, 'unit': 'K', 'net_profit': 183.0}, {'period': ""Q2 '24"", 'revenue': 3250.0, 'unit': 'K', 'net_profit': -289.0}, {'period': ""Q1 '24"", 'revenue': 3520.0, 'unit': 'K', 'net_profit': -169.0}, {'period': ""Q4 '23"", 'revenue': 3250.0, 'unit': 'K', 'net_profit': -654.0}, {'period': ""Q3 '23"", 'revenue': 3740.0, 'unit': 'K', 'net_profit': -182.0}]",0.007,0.007,11210000,8298000,3760000,2625000,1781000,0,1562000,3760000,-547000,1.1670345842531273,1.046984126984127,1.0466666666666666,__nan__,__nan__,__nan__,0.23416592328278324
177,NEPT,Neptune Wellness Solutions Inc. Ordinary Shares,"Neptune Wellness Solutions Inc. operates as an integrated health and wellness company in Canada, the United States, and internationally. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, MaxSimil, and NurturMe brands. The company also offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, including nutraceuticals, beauty and personal care products, and organic foods and beverages. In addition, it is involved in the extraction, purification, formulation, and manufacturing of health and wellness products. Further, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.",Ms. Lisa H. Gainsborg CPA,Drug Manufacturers - Specialty & Generic,0.2,USD,857046,https://images.financialmodelingprep.com/symbol/NEPT.png,0,-0.000999000999000999,0,2226075,-63054910,-81712447,"[{'period': '2023', 'revenue': 52.62, 'unit': 'M', 'net_profit': -81.71}, {'period': '2022', 'revenue': 61.01, 'unit': 'M', 'net_profit': -93.73}, {'period': '2021', 'revenue': 44.49, 'unit': 'M', 'net_profit': -154.8}, {'period': '2020', 'revenue': 29.58, 'unit': 'M', 'net_profit': -60.86}]","[{'period': ""Q3 '24"", 'revenue': 7.6, 'unit': 'M', 'net_profit': -17.75}, {'period': ""Q2 '24"", 'revenue': 8740.0, 'unit': 'K', 'net_profit': -890.19}, {'period': ""Q1 '24"", 'revenue': 14.08, 'unit': 'M', 'net_profit': -6.51}, {'period': ""Q4 '23"", 'revenue': 16.42, 'unit': 'M', 'net_profit': -35.9}, {'period': ""Q3 '23"", 'revenue': 16530.0, 'unit': 'K', 'net_profit': 889.6}, {'period': ""Q2 '23"", 'revenue': 16.56, 'unit': 'M', 'net_profit': -42.67}]",-276.7,-276.7,30928258,23550173,2010797,58488927,7507333,0,41034144,2693926,-39865563,0.21069948786209172,0.12821853736393493,0.6439554783503828,"[0.0002, 0.0002]","['2008-07-24', '2008-07-24']",__nan__,1.8911161113568051
178,NERV,Minerva Neurosciences Inc Common Stock,"Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. The company was formerly known as Cyrenaic Pharmaceuticals, Inc. and changed its name to Minerva Neurosciences, Inc. in 2013. Minerva Neurosciences, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.",Dr. Remy  Luthringer Ph.D.,Biotechnology,1.39,USD,9720840,https://images.financialmodelingprep.com/symbol/NERV.png,37660,7.32,0.03,5481,-21848386000,1438865,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.44}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -30.01}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -38.99}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -49.91}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.27}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 22.51}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.23}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.57}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.02}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.82}]",0.19,0.19,37143744000,22268903000,21362008000,62836844000,0,0,2836844,21362008,-19550567000,-1006.2358994882264,1.0479536101441633,1.0412147505422995,__nan__,__nan__,__nan__,1.6917207915281776
179,NESR,National Energy Services Reunited Corp. Ordinary Shares,"National Energy Services Reunited Corp. provides oilfield services to oil and gas companies in the Middle East, North Africa, and the Asia Pacific regions. It operates through two segments, Production Services; and Drilling and Evaluation Services. The Production Services segment offers hydraulic fracturing services; coiled tubing services, including nitrogen lifting, fishing, milling, clean-out, scale removal, and other well applications; stimulation and pumping services; primary and remedial cementing services; nitrogen services; filtration services, as well as frac tanks and pumping units; and pipeline services, such as water filling and hydro testing, nitrogen purging, and de-gassing and pressure testing, as well as cutting/welding and cooling down piping/vessels systems. It also provides production assurance chemicals; laboratory services; artificial lift services; and surface and subsurface safety systems, high-pressure packer systems, flow controls, service tools, expandable liner technology, vacuum insulated tubing technology, and engineering capabilities with manufacturing capacity and testing facilities, as well as sources, treats, and disposes water for oil and gas, municipal, and industrial use. The Drilling and Evaluation Services segment offers drilling and workover rigs; rig services; fishing and remedial solutions; directional and turbines drilling services; drilling fluid systems and related technologies; wireline logging services; slickline services for removal of scale, wax and sand build-up, setting plugs, changing out gas lift valves, and fishing and other well applications; and well testing services to measure solids, gas, and oil and water produced from a well, as well as rents drilling tools. It also provides oilfield solutions for thru-tubing intervention; tubular running services; and a range of wellhead products, flow control equipment, and frac equipment. The company was incorporated in 2017 and is headquartered in Houston, Texas.",Mr. Sherif  Foda,Oil & Gas Equipment & Services,5.49,USD,527292013,https://images.financialmodelingprep.com/symbol/NESR.png,248367,6.86,-0.42,371548,278163000,76310000,"[{'period': '2024', 'revenue': 1300.0, 'unit': 'M', 'net_profit': 76.31}, {'period': '2023', 'revenue': 1150.0, 'unit': 'M', 'net_profit': 12.58}, {'period': '2022', 'revenue': 909.52, 'unit': 'M', 'net_profit': -36.42}, {'period': '2021', 'revenue': 876.73, 'unit': 'M', 'net_profit': -64.57}]","[{'period': ""Q4 '24"", 'revenue': 343.68, 'unit': 'M', 'net_profit': 26.84}, {'period': ""Q3 '24"", 'revenue': 336.2, 'unit': 'M', 'net_profit': 20.62}, {'period': ""Q2 '24"", 'revenue': 324.97, 'unit': 'M', 'net_profit': 18.87}, {'period': ""Q4 '23"", 'revenue': 307.52, 'unit': 'M', 'net_profit': 2.26}, {'period': ""Q3 '23"", 'revenue': 300.08, 'unit': 'M', 'net_profit': 14.73}, {'period': ""Q2 '23"", 'revenue': 280.31, 'unit': 'M', 'net_profit': 1.95}]",0,0,1773678000,540516000,107956000,865446000,318547000,0,503512000,107956000,124224000,0.2765509265633175,5.0659777424483305,-1,__nan__,__nan__,__nan__,0.4879386224557107
180,NESRW,National Energy Services Reunited Corp. Warrant,,Mr. Sherif  Foda,,0.2,USD,567631293,https://images.financialmodelingprep.com/symbol/NESRW.png,31073.78571,,-0.0033,83104,278163000,76310000,"[{'period': '2024', 'revenue': 1300.0, 'unit': 'M', 'net_profit': 76.31}, {'period': '2023', 'revenue': 1150.0, 'unit': 'M', 'net_profit': 12.58}, {'period': '2022', 'revenue': 909.52, 'unit': 'M', 'net_profit': -36.42}, {'period': '2021', 'revenue': 876.73, 'unit': 'M', 'net_profit': -64.57}]","[{'period': ""Q4 '24"", 'revenue': 343.68, 'unit': 'M', 'net_profit': 26.84}, {'period': ""Q3 '24"", 'revenue': 336.2, 'unit': 'M', 'net_profit': 20.62}, {'period': ""Q2 '24"", 'revenue': 324.97, 'unit': 'M', 'net_profit': 18.87}, {'period': ""Q4 '23"", 'revenue': 307.52, 'unit': 'M', 'net_profit': 2.26}, {'period': ""Q3 '23"", 'revenue': 300.08, 'unit': 'M', 'net_profit': 14.73}, {'period': ""Q2 '23"", 'revenue': 280.31, 'unit': 'M', 'net_profit': 1.95}]",0,0,1773678000,540516000,107956000,865446000,318547000,0,503512000,107956000,124224000,0.2765509265633175,5.0659777424483305,-1,__nan__,__nan__,__nan__,0.4879386224557107
181,NETE,Net Element Inc. Common Stock,"Net Element, Inc. provides mobile payments and other transactional services. The company is headquartered in North Miami Beach, Florida and currently employs 88 full-time employees. The firm is a global transaction processing technology and value-added solutions company. The company operates through segments, including North America Transaction Solutions, Mobile Solutions, Online Solutions and Corporate Expenses & Eliminations. Through TOT Group Russia and Net Element Russia, it provides transactional services, mobile payment transactions, online payment transactions and other payment technologies in countries in the Russian Federation, Commonwealth of Independent States, Europe and Asia. The North America Transaction Solutions segment provides technology and services that businesses require in accepting cashless transaction. The Russian mobile and online payment processing segment consists of Digital Provider. The Online Solutions segment consists of PayOnline, which includes a protected payment processing system to accept bank card payments for goods and services.",Mr. Oleg Firer,Software - Infrastructure,13.09,USD,27819785360,https://images.financialmodelingprep.com/symbol/NETE.png,582471,0,1.04,4070566,-1494049,-5976488,"[{'period': '2020', 'revenue': 65.71, 'unit': 'M', 'net_profit': -5.98}, {'period': '2019', 'revenue': 65.0, 'unit': 'M', 'net_profit': -6.46}, {'period': '2018', 'revenue': 65.79, 'unit': 'M', 'net_profit': -4.94}, {'period': '2017', 'revenue': 60.06, 'unit': 'M', 'net_profit': -9.91}]","[{'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -44.24}, {'period': ""Q2 '21"", 'revenue': 33.29, 'unit': 'M', 'net_profit': 1.26}, {'period': ""Q1 '21"", 'revenue': 23790.0, 'unit': 'K', 'net_profit': 304.56}, {'period': ""Q4 '20"", 'revenue': 19410.0, 'unit': 'K', 'net_profit': -1.96}, {'period': ""Q3 '20"", 'revenue': 16.73, 'unit': 'M', 'net_profit': -2.33}, {'period': ""Q2 '20"", 'revenue': 13720.0, 'unit': 'K', 'net_profit': -324.69}]",-1,-1,25244670,13968158,4541013,24344658,7109173,0,15070450,4541013,1041269,0.3287019480484469,0.07461528289902951,0.37500000000000006,__nan__,__nan__,__nan__,0.9643484347388973
182,NEWA,Newater Technology Inc. Ordinary Shares,"Newater Technology, Inc. engages in the wastewater purification treatment solutions. The company is headquartered in Yantai, Shandong and currently employs 203 full-time employees. The firm is focused on the development, manufacture and sale of disk tube reverse osmosis (DTRO) and disk tube nanofiltration (DTNF) membrane filtration products that are used in the treatment, recycling and discharge of wastewater. The DTRO membrane and DTNF membrane is used to treat and recycle wastewater. The firm also supplies hardware and engineered systems necessary to implement integrated solutions with DTRO and DTNF products. The firm provides engineering support and installation, technical advice and service, and other project-related solutions to filter wastewater into clean water. The firm provides services to chemical and energy industries. The firm also offers traditional wastewater treatment solutions, such as activated carbon and resins.",Mr. Yuebiao Li,Industrial - Pollution & Treatment Controls,4.17,USD,0,https://images.financialmodelingprep.com/symbol/NEWA.png,352688,8.176470588235293,0,76369,10465125,5562761,"[{'period': '2020', 'revenue': 51.16, 'unit': 'M', 'net_profit': 5.56}, {'period': '2019', 'revenue': 37.57, 'unit': 'M', 'net_profit': 4.31}, {'period': '2018', 'revenue': 47.04, 'unit': 'M', 'net_profit': 7.21}, {'period': '2017', 'revenue': 25.34, 'unit': 'M', 'net_profit': 2.59}]","[{'period': ""Q2 '20"", 'revenue': 5100.0, 'unit': 'K', 'net_profit': 325.29}, {'period': ""Q4 '19"", 'revenue': 28.85, 'unit': 'M', 'net_profit': 5.29}, {'period': ""Q2 '19"", 'revenue': 8730.0, 'unit': 'K', 'net_profit': -979.99}, {'period': ""Q4 '18"", 'revenue': 20560.0, 'unit': 'K', 'net_profit': -26.11}, {'period': ""Q2 '18"", 'revenue': 26.48, 'unit': 'M', 'net_profit': 7.24}, {'period': ""Q4 '17"", 'revenue': 25.34, 'unit': 'M', 'net_profit': 2.59}]",0.51,0.51,93235861,61026897,4462530,54384369,26741865,1074142,54271561,4462530,-29993339,0.24412436149482877,0.2902007098612169,0.27499999999999997,__nan__,__nan__,__nan__,0.5832988339111278
183,NEWT,Newtek Business Services Corp. Common Stock (Maryland),"Newtek Business Services Corp. is a business development company specializing in providing financial and business services to the small-and medium-sized business market in the United States. The firm also seeks to invest in early stage businesses. The firm seeks to makes both debt and equity investments. Under debt investments, it focuses on first lien loans, which have terms of 1 to 25 years; second lien loans, which have terms of 5 to 25 years, and unsecured loans, which are provided to meet short-term funding needs and are repaid within 6 to 12 months. It operates through Electronic Payment Processing, Managed Technology Solutions, Small Business Finance, and Capcos segments. The company originates small business administration loans for the purpose of acquiring commercial real estate, machinery, equipment, and inventory, as well as to refinance debt and fund franchises, working capital, and business acquisitions; and offers small business loan servicing and consulting services to the Federal Deposit Insurance Corporation and various other financial institutions, as well as provides management services. Its electronic payment processing services include credit and debit card processing, check approval, ancillary processing equipment and software to merchants, eCommerce, electronic solutions to accept non-cash payments, check conversion, remote deposit capture, ACH processing, and electronic gift and loyalty card programs. The company also provides Website hosting, dedicated server, and cloud hosting services; Web design and development; Internet marketing; data storage and backup and other related services; and ecommerce services, such as payment processing, online shopping cart tools, Website design and Web related services; Accounts Receivable Financing, and The Secure Gateway. In addition, it offers Newtek Advantage, a mobile, real-time operating platform enabling a business to access data on a smartphone, tablet, laptop, or PC for eCommerce, credit/debit transactions, Website statistics, payroll, insurance, and business loans. Further, the company sells personal, commercial, and health/benefits lines of insurance products; and payroll management processing and employee tax filing services. It has strategic alliances with American International Group, CTAA, Navy Federal Credit Union, Credit Union National Association, Pershing, and others to provide agent services to small business clients. The firm seeks to invest in New York and Louisiana area. The firm seeks to invest $0.3 million to $3 million in businesses. It provides small business terms loans ranging from $0.05 million to $10 million. The firm also provides account receivable financing ranging from $0.05 million to $1.5 million. It also provides $0.05 million to $10 million financing to owner occupied real estate businesses whose average net income over the last 2 years must not exceed $2.5 million. Newtek Business Services Corp.,was founded in 1998 and converted to a BDC company in 2014 and is headquartered in Boca Raton, Florida with additional offices in Lake Success, New York, Garden City, New York; Miami, Florida; Milwaukee, Wisconsin; New Orleans, Louisiana; and New York, New York.",Mr. Barry Scott Sloane,Asset Management,9.82,USD,258174674,https://images.financialmodelingprep.com/symbol/NEWT.png,206611,5.01,-0.05,415058,0,50853000,"[{'period': '2024', 'revenue': 237.74, 'unit': 'M', 'net_profit': 50.85}, {'period': '2023', 'revenue': 253.14, 'unit': 'M', 'net_profit': 47.33}, {'period': '2022', 'revenue': 105.17, 'unit': 'M', 'net_profit': 32.31}, {'period': '2021', 'revenue': 147.76, 'unit': 'M', 'net_profit': 84.14}]","[{'period': ""Q4 '24"", 'revenue': 70.47, 'unit': 'M', 'net_profit': 18.32}, {'period': ""Q3 '24"", 'revenue': 31.27, 'unit': 'M', 'net_profit': 11.93}, {'period': ""Q2 '24"", 'revenue': 84.27, 'unit': 'M', 'net_profit': 10.95}, {'period': ""Q1 '24"", 'revenue': 73.64, 'unit': 'M', 'net_profit': 9.65}, {'period': ""Q4 '23"", 'revenue': 70.18, 'unit': 'M', 'net_profit': 13.36}, {'period': ""Q3 '23"", 'revenue': 46.16, 'unit': 'M', 'net_profit': 9.97}]",1.97,1.96,2059912000,30857000,30857000,1763630000,0,0,26765000,6941000,-153453000,-1,0.07445752075894271,0.04232804232804237,"[0.19, 0.02]","['2025-04-15', '2009-11-23']",__nan__,0.856167642112867
184,NEWTL,Newtek Business Services Corp. 5.75% Notes due 2024,"NewtekOne, Inc. is a financial holding company, which engages in the provision of business and financial solutions. Its brands include Newtek Bank, Newtek Lending, Newtek Payments, Newtek Insurance, Newtek Payroll, and Newtek Technology. The company was founded by Barry Sloane in 1998 and is headquartered in Boca Raton, FL.",None,Asset Management,24.9897,USD,316497349,https://images.financialmodelingprep.com/symbol/NEWTL.png,5842,13.243084260731319,-0.0003,258,0,50853000,"[{'period': '2024', 'revenue': 237.74, 'unit': 'M', 'net_profit': 50.85}, {'period': '2023', 'revenue': 253.14, 'unit': 'M', 'net_profit': 47.33}, {'period': '2022', 'revenue': 105.17, 'unit': 'M', 'net_profit': 32.31}, {'period': '2021', 'revenue': 147.76, 'unit': 'M', 'net_profit': 84.14}]","[{'period': ""Q4 '24"", 'revenue': 70.47, 'unit': 'M', 'net_profit': 18.32}, {'period': ""Q3 '24"", 'revenue': 31.27, 'unit': 'M', 'net_profit': 11.93}, {'period': ""Q2 '24"", 'revenue': 84.27, 'unit': 'M', 'net_profit': 10.95}, {'period': ""Q1 '24"", 'revenue': 73.64, 'unit': 'M', 'net_profit': 9.65}, {'period': ""Q4 '23"", 'revenue': 70.18, 'unit': 'M', 'net_profit': 13.36}, {'period': ""Q3 '23"", 'revenue': 46.16, 'unit': 'M', 'net_profit': 9.97}]",1.97,1.96,2059912000,30857000,30857000,1763630000,0,0,26765000,6941000,-153453000,-1,0.07445752075894271,0.04232804232804237,"[0.35938, 0.367]","['2024-07-15', '2019-10-11']",__nan__,0.856167642112867
185,NEWTZ,Newtek Business Services Corp. 5.50% Notes Due 2026,"NewtekOne, Inc. is a financial holding company, which engages in the provision of business and financial solutions. Its brands include Newtek Bank, Newtek Lending, Newtek Payments, Newtek Insurance, Newtek Payroll, and Newtek Technology. The company was founded by Barry Sloane in 1998 and is headquartered in Boca Raton, FL.",Barry Sloane,Asset Management,24.71,USD,259593944,https://images.financialmodelingprep.com/symbol/NEWTZ.png,7114,,-0.09,1271,0,50853000,"[{'period': '2024', 'revenue': 237.74, 'unit': 'M', 'net_profit': 50.85}, {'period': '2023', 'revenue': 253.14, 'unit': 'M', 'net_profit': 47.33}, {'period': '2022', 'revenue': 105.17, 'unit': 'M', 'net_profit': 32.31}, {'period': '2021', 'revenue': 147.76, 'unit': 'M', 'net_profit': 84.14}]","[{'period': ""Q4 '24"", 'revenue': 70.47, 'unit': 'M', 'net_profit': 18.32}, {'period': ""Q3 '24"", 'revenue': 31.27, 'unit': 'M', 'net_profit': 11.93}, {'period': ""Q2 '24"", 'revenue': 84.27, 'unit': 'M', 'net_profit': 10.95}, {'period': ""Q1 '24"", 'revenue': 73.64, 'unit': 'M', 'net_profit': 9.65}, {'period': ""Q4 '23"", 'revenue': 70.18, 'unit': 'M', 'net_profit': 13.36}, {'period': ""Q3 '23"", 'revenue': 46.16, 'unit': 'M', 'net_profit': 9.97}]",1.97,1.96,2059912000,30857000,30857000,1763630000,0,0,26765000,6941000,-153453000,-1,0.07445752075894271,0.04232804232804237,"[0.34375, 0.344]","['2025-04-15', '2021-07-14']",__nan__,0.856167642112867
186,NEXI,NexImmune Inc. Common Stock,"NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a candidate targeted against HPV-associated malignancies, which is in preclinical stage. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.",Mr. John  Trainer M.B.A.,Biotechnology,0.0001,USD,139,https://images.financialmodelingprep.com/symbol/NEXI.png,2447,,0,6,-28167510,-32344392,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -32.34}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 514.18}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -51.75}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -31.64}]","[{'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.33}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.08}, {'period': ""Q4 '23"", 'revenue': 2.12, 'unit': 'M', 'net_profit': -5.36}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.85}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.57}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.57}]",-30.82,-30.82,8593949,5400959,4646495,5084232,0,0,5084232,3202452,-31479116,0.542642716367629,-1.062904338754149,-1.0576840292724925,__nan__,__nan__,__nan__,0.5916060241921379
187,NEXT,NextDecade Corporation Common Stock,"NextDecade Corporation engages in the development activities related to the liquefaction and sale of liquefied natural gas (LNG); and capture and storage of CO2 emissions. The company focuses on the development activities on the Rio Grande LNG terminal facility located in the  Port of Brownsville in southern Texas. It also focuses on a carbon capture and storage project (CCS project) at the terminal, as well as on other CCS projects with third-party industrial source facilities. The company was founded in 2010 is based in Houston, Texas.",Mr. Matthew K. Schatzman,Oil & Gas Exploration & Production,6.49,USD,1690275064,https://images.financialmodelingprep.com/symbol/NEXT.png,1986945,-27.04,0.51,5095086,0,-61751000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -61.75}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -162.26}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -65.67}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -24.57}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 65.68}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -123.2}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -32.58}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 28.35}, {'period': ""Q4 '23"", 'revenue': 0.91, 'unit': 'M', 'net_profit': -129.26}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 114.64}]",-0.24,-0.24,6404059000,412572000,148137000,4659673000,0,0,595084000,148137000,-95585000,1,0.61943412156957,0.7446808510638298,__nan__,__nan__,__nan__,0.7276124407973131
188,NFBK,Northfield Bancorp Inc. Common Stock (Delaware),"Northfield Bancorp, Inc. (Staten Island, NY) operates as the bank holding company for Northfield Bank that provides various banking services primarily to individuals and corporate customers. It accepts various deposits products, including certificates of deposit, passbook, statement, and money market savings accounts; transaction deposit accounts comprising negotiable orders of withdrawal accounts, and interest and non-interest-bearing checking accounts; individual retirement accounts; and brokered deposits. The company also offers various loans comprising multifamily and other commercial real estate loans, construction and land loans, commercial and industrial loans, one-to-four family residential real estate loans, and home equity loans and lines of credit. In addition, it purchases various investment securities, such as mortgage-backed securities and corporate bonds; and deposits funds in other financial institutions, as well as holds mortgage loans, mortgage-backed securities, and other investments. As of December 31, 2021, the company operated 38 full-service banking offices in Staten Island and Brooklyn, New York; and Hunterdon, Middlesex, Mercer, and Union counties, New Jersey. Northfield Bancorp, Inc. (Staten Island, NY) was founded in 1887 and is headquartered in Woodbridge, New Jersey.",Mr. Steven M. Klein CPA,Banks - Regional,9.85,USD,424696540,https://images.financialmodelingprep.com/symbol/NFBK.png,180747,13.68,0.02,221310,0,29945000,"[{'period': '2024', 'revenue': 237.91, 'unit': 'M', 'net_profit': 29.95}, {'period': '2023', 'revenue': 136.56, 'unit': 'M', 'net_profit': 37.67}, {'period': '2022', 'revenue': 166.29, 'unit': 'M', 'net_profit': 61.12}, {'period': '2021', 'revenue': 170.1, 'unit': 'M', 'net_profit': 70.65}]","[{'period': ""Q4 '24"", 'revenue': 59.72, 'unit': 'M', 'net_profit': 11.25}, {'period': ""Q3 '24"", 'revenue': 29.27, 'unit': 'M', 'net_profit': 6.52}, {'period': ""Q2 '24"", 'revenue': 63.08, 'unit': 'M', 'net_profit': 5.96}, {'period': ""Q1 '24"", 'revenue': 62.03, 'unit': 'M', 'net_profit': 6.21}, {'period': ""Q4 '23"", 'revenue': 58.09, 'unit': 'M', 'net_profit': 8.22}, {'period': ""Q3 '23"", 'revenue': 31.81, 'unit': 'M', 'net_profit': 8.18}]",0.72,0.72,5666378000,1132938000,1113860000,4961682000,19078000,0,0,167744000,31105000,0,-0.2050492447370517,-0.16279069767441862,"[0.13, 0.04]","['2025-02-05', '2008-11-07']",__nan__,0.8756355470813983
189,NFE,New Fortress Energy Inc. Class A Common Stock,"New Fortress Energy Inc. operates as an integrated gas-to-power infrastructure company that provides energy and development services to end-users worldwide. The company operates in two segments, Terminals and Infrastructure, and Ships. The Terminals and Infrastructure segment engages in the natural gas procurement and liquefaction; and shipping, logistics, facilities and conversion, or development of natural gas-fired power generation. The Ships segment offers floating storage and regasification units, and liquefied natural gas (LNG) carriers which are leased to customers under long-term or spot arrangements. The company operates LNG storage and regasification facility at the Port of Montego Bay, Jamaica; marine LNG storage and regasification facility in Old Harbour, Jamaica; landed micro-fuel handling facility in San Juan, Puerto Rico; marine LNG storage and regasification facility in Sergipe, Brazil; and LNG receiving facility in La Paz, Mexico, as well as Miami facility. New Fortress Energy Inc. was founded in 1998 and is based in New York, New York.",Mr. Wesley Robert Edens,Regulated Gas,5.42,USD,1483844240,https://images.financialmodelingprep.com/symbol/NFE.png,6128119,-4.34,-0.32,11516337,317513000,-249039000,"[{'period': '2024', 'revenue': 2360.0, 'unit': 'M', 'net_profit': -249.04}, {'period': '2023', 'revenue': 2410.0, 'unit': 'M', 'net_profit': 547.88}, {'period': '2022', 'revenue': 2370.0, 'unit': 'M', 'net_profit': 194.48}, {'period': '2021', 'revenue': 1320.0, 'unit': 'M', 'net_profit': 97.1}]","[{'period': ""Q4 '24"", 'revenue': 679.0, 'unit': 'M', 'net_profit': -223.56}, {'period': ""Q3 '24"", 'revenue': 567.53, 'unit': 'M', 'net_profit': 9.3}, {'period': ""Q2 '24"", 'revenue': 428.01, 'unit': 'M', 'net_profit': -88.85}, {'period': ""Q1 '24"", 'revenue': 690.32, 'unit': 'M', 'net_profit': 54.08}, {'period': ""Q4 '23"", 'revenue': 758.36, 'unit': 'M', 'net_profit': 217.21}, {'period': ""Q3 '23"", 'revenue': 514.46, 'unit': 'M', 'net_profit': 61.22}]",-1.04,-1.03,12867496000,1610110000,492881000,10868408000,335813000,0,1707418000,492881000,-2034492000,-0.714206119609068,-1.4545486071818383,-1.3909774436090225,"[0.1, 0.1]","['2024-09-13', '2020-09-03']",__nan__,0.8446404801680141
190,NFLX,Netflix Inc. Common Stock,"Netflix, Inc. provides entertainment services. It offers TV series, documentaries, feature films, and mobile games across various genres and languages. The company provides members the ability to receive streaming content through a host of internet-connected devices, including TVs, digital video players, television set-top boxes, and mobile devices. It also provides DVDs-by-mail membership services in the United States. The company has approximately 222 million paid members in 190 countries. Netflix, Inc. was incorporated in 1997 and is headquartered in Los Gatos, California.",Mr. Theodore A. Sarandos,Entertainment,870.4,USD,372319692800,https://images.financialmodelingprep.com/symbol/NFLX.png,4812772,43.8,2.57,5525767,24877355000,8711631000,"[{'period': '2024', 'revenue': 39.0, 'unit': 'B', 'net_profit': 8.71}, {'period': '2023', 'revenue': 33.72, 'unit': 'B', 'net_profit': 5.41}, {'period': '2022', 'revenue': 31.62, 'unit': 'B', 'net_profit': 4.49}, {'period': '2021', 'revenue': 29.7, 'unit': 'B', 'net_profit': 5.12}]","[{'period': ""Q4 '24"", 'revenue': 10.25, 'unit': 'B', 'net_profit': 1.87}, {'period': ""Q3 '24"", 'revenue': 9.82, 'unit': 'B', 'net_profit': 2.36}, {'period': ""Q2 '24"", 'revenue': 9.53, 'unit': 'B', 'net_profit': 2.15}, {'period': ""Q1 '24"", 'revenue': 9.38, 'unit': 'B', 'net_profit': 2.33}, {'period': ""Q4 '23"", 'revenue': 8830.0, 'unit': 'M', 'net_profit': 937.84}, {'period': ""Q3 '23"", 'revenue': 8.54, 'unit': 'B', 'net_profit': 1.68}]",20.28,19.83,53630374000,13100379000,9583739000,28886807000,1988304000,0,10755400000,7804733000,6921826000,0.15663508379312685,0.6108814920145932,0.6555102040816327,__nan__,__nan__,__nan__,0.5386277373340712
191,NGAC,NextGen Acquisition Corporation Class A Ordinary Shares,"NextGen Acquisition Corporation intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded in 2020 and is based in Boca Raton, Florida.",Mr. Patrick T. Ford,Shell Companies,8.83,USD,1483740220,https://images.financialmodelingprep.com/symbol/NGAC.png,223291,0,-0.3699999,104426,,,[],[],,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
192,NGACU,NextGen Acquisition Corporation Units,,,Shell Companies,9.26,USD,0,https://images.financialmodelingprep.com/symbol/NGACU.png,2200,0,-0.28999996,1781,,,[],[],,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
193,NGACW,NextGen Acquisition Corporation Warrants,,,,,,,,,,,,,,[],[],,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
194,NGCA,NextGen Acquisition Corp. II Class A Ordinary Shares,"As of December 29, 2021, NextGen Acquisition Corp. II was acquired by Vieco USA, Inc., in a reverse merger transaction. NextGen Acquisition Corp. II focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was incorporated in 2020 and is based in Boca Raton, Florida.",Mr. Patrick T. Ford,Shell Companies,9.25,USD,0,https://images.financialmodelingprep.com/symbol/NGCA.png,687836,0,-0.3199997,539800,,,[],"[{'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 11.25}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -34.71}]",,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
195,NGCAU,NextGen Acquisition Corp. II Units,"As of December 29, 2021, NextGen Acquisition Corp. II was acquired by Vieco USA, Inc., in a reverse merger transaction. NextGen Acquisition Corp. II focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was incorporated in 2020 and is based in Boca Raton, Florida.",,Shell Companies,9.46,USD,0,https://images.financialmodelingprep.com/symbol/NGCAU.png,12034,0,0.06000042,2087,,,[],"[{'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 11.25}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -34.71}]",,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
196,NGCAW,NextGen Acquisition Corp. II Warrant,"NextGen Acquisition Corp. II focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was incorporated in 2020 and is based in Boca Raton, Florida.",Mr. Patrick T. Ford,Shell Companies,1.655,USD,0,https://images.financialmodelingprep.com/symbol/NGCAW.png,0,0,0.05499995,61998,,,[],"[{'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 11.25}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -34.71}]",,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
197,NGM,NGM Biopharmaceuticals Inc. Common Stock,"NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trials for the treatment of non-alcoholic steatohepatitis (NASH); and MK-3655, an agonistic antibody that activates fibroblast growth factor receptor 1c-beta-klotho, which is in Phase IIb clinical trials for use in the treatment of type 2 diabetes and NASH. Its products under development also comprise NGM120, an antagonist antibody that binds GFRAL that is in Phase I/II clinical trials; NGM621, an immunoglobulin 1 monoclonal antibody in Phase II clinical trials for the treatment of geographic atrophy; NGM707, an immunoglobulin-like transcript 2/ immunoglobulin-like transcript 4 dual antagonist monoclonal antibody that is in Phase I/II clinical trials for the treatment of patients with advanced solid tumors; and NGM831 and NGM438 for the treatment of advanced solid tumors. The company has research collaboration, product development, and license agreements with Merck Sharp & Dohme Corp.; and a collaboration agreement with Merck & Co., Inc. to focus primarily on the development of novel medicines for unmet patient needs in retinal and CVM diseases, including heart failure. NGM Biopharmaceuticals, Inc. was incorporated in 2007 and is headquartered in South San Francisco, California.",Dr. David J. Woodhouse Ph.D.,Biotechnology,1.54,USD,128532096,https://images.financialmodelingprep.com/symbol/NGM.png,1070739,-0.8901734104046243,-0.02,2205569,-144326000,-142375000,"[{'period': '2023', 'revenue': 4.42, 'unit': 'M', 'net_profit': -142.38}, {'period': '2022', 'revenue': 55.33, 'unit': 'M', 'net_profit': -159.09}, {'period': '2021', 'revenue': 77.88, 'unit': 'M', 'net_profit': -113.83}, {'period': '2020', 'revenue': 87.37, 'unit': 'M', 'net_profit': -93.99}]","[{'period': ""Q4 '23"", 'revenue': 0.165, 'unit': 'M', 'net_profit': -27.67}, {'period': ""Q3 '23"", 'revenue': 0.582, 'unit': 'M', 'net_profit': -28.8}, {'period': ""Q2 '23"", 'revenue': 1.42, 'unit': 'M', 'net_profit': -38.26}, {'period': ""Q1 '23"", 'revenue': 2.25, 'unit': 'M', 'net_profit': -45.1}, {'period': ""Q4 '22"", 'revenue': 18.18, 'unit': 'M', 'net_profit': -34.58}, {'period': ""Q3 '22"", 'revenue': 7.91, 'unit': 'M', 'net_profit': -46.22}]",-1.73,-1.73,168868000,156444000,147184000,20230000,58000,2455000,20081000,58815000,-133454000,0.13186846236669092,0.10503818713266493,0.1306532663316583,__nan__,__nan__,__nan__,0.1197977118222517
198,NGMS,NeoGames S.A. Ordinary Shares,"NeoGames S.A. provides iLottery solutions worldwide. The company offers various technology platforms, a range of value-added services, and a game studio that provides a portfolio of draw based games and instant tickets through personal computers, smartphones, and handheld devices. It also develops and operates online lotteries and games that allows lottery operators to distribute lottery products through online sales channels using the company's technology. In addition, the company offers software development and platforms sub-licensing services; and regulation and compliance, payment processing, risk management, player relationship management, and player value optimization services. The company was incorporated in 2014 and is headquartered in Tel Aviv, Israel.",Mr. Mordechay  Malool,"Gambling, Resorts & Casinos",29.45,USD,998207750,https://images.financialmodelingprep.com/symbol/NGMS.png,149370,-81.80555555555556,0.02,211866,35742000,-18277000,"[{'period': '2023', 'revenue': 191.54, 'unit': 'M', 'net_profit': -18.28}, {'period': '2022', 'revenue': 165.7, 'unit': 'M', 'net_profit': -18.96}, {'period': '2021', 'revenue': 50.46, 'unit': 'M', 'net_profit': 4.65}, {'period': '2020', 'revenue': 49.2, 'unit': 'M', 'net_profit': 5.12}]","[{'period': ""Q4 '23"", 'revenue': 47.76, 'unit': 'M', 'net_profit': -6.08}, {'period': ""Q3 '23"", 'revenue': 46.34, 'unit': 'M', 'net_profit': -3.56}, {'period': ""Q2 '23"", 'revenue': 47.91, 'unit': 'M', 'net_profit': -7.76}, {'period': ""Q1 '23"", 'revenue': 49530.0, 'unit': 'K', 'net_profit': -878.0}, {'period': ""Q4 '22"", 'revenue': 69220.0, 'unit': 'K', 'net_profit': -793.0}, {'period': ""Q3 '22"", 'revenue': 62.17, 'unit': 'M', 'net_profit': -4.37}]",-0.54,-0.54,459380000,85899000,29495000,323908000,49591000,15919000,76234000,29495000,58088000,-0.08454780626488743,0.03627735301871869,0.15624999999999997,__nan__,__nan__,__nan__,0.7050981758021682
199,NH,NantHealth Inc. Common Stock,"NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers Quadris, a data solution that includes multi-data analysis, reporting, and professional services. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Morrisville, North Carolina. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.","Dr. Patrick  Soon-Shiong F.A.C.S., FACS, FRCS (C), M.Sc.",Medical - Healthcare Information Services,1.35,USD,0,https://images.financialmodelingprep.com/symbol/NH.png,197968,-0.11842105263157894,0,197968,-37985000,-67779000,"[{'period': '2022', 'revenue': 67.0, 'unit': 'M', 'net_profit': -67.78}, {'period': '2021', 'revenue': 62.65, 'unit': 'M', 'net_profit': -58.57}, {'period': '2020', 'revenue': 73.17, 'unit': 'M', 'net_profit': -88.44}, {'period': '2019', 'revenue': 95.96, 'unit': 'M', 'net_profit': -62.64}]","[{'period': ""Q3 '23"", 'revenue': 12.47, 'unit': 'M', 'net_profit': -14.99}, {'period': ""Q2 '23"", 'revenue': 17.25, 'unit': 'M', 'net_profit': -17.48}, {'period': ""Q1 '23"", 'revenue': 17.05, 'unit': 'M', 'net_profit': -12.24}, {'period': ""Q4 '22"", 'revenue': 17.5, 'unit': 'M', 'net_profit': -25.66}, {'period': ""Q3 '22"", 'revenue': 16.63, 'unit': 'M', 'net_profit': -13.66}, {'period': ""Q2 '22"", 'revenue': 16.5, 'unit': 'M', 'net_profit': -12.51}]",-8.8,-8.8,159551000,12585000,1759000,384944000,6885000,0,35631000,1759000,-38735000,0.07124868578693856,-0.15730970187480792,-0.14285714285714293,__nan__,__nan__,__nan__,2.4126705567498794
200,NHIC,NewHold Investment Corp. Class A Common Stock,"NewHold Investment Corp. II does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on the industrial technology business. NewHold Investment Corp. II was incorporated in 2021 and is based in Houston, Texas.",Mr. Kevin M. Charlton,Shell Companies,10.26,USD,0,https://images.financialmodelingprep.com/symbol/NHIC.png,0,513,0.04,268366,-1719000,392000,"[{'period': '2022', 'revenue': 0.0, 'unit': 'K', 'net_profit': 392.0}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.25}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -951.0}]","[{'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 538.0}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 389.0}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -75.0}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 67.54}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 15.47}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",0.0201,0.0201,199770000,1402000,986000,6966000,102000,198368,144000,986000,-2069000,-3.162227602905569,1.3123505976095617,1.312111801242236,__nan__,__nan__,__nan__,0.03487010061570806
201,NHICU,NewHold Investment Corp. Unit,"NewHold Investment Corp. II does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on the industrial technology business. NewHold Investment Corp. II was incorporated in 2021 and is based in Houston, Texas.",Mr. Kevin M. Charlton,Shell Companies,10.22,USD,0,https://images.financialmodelingprep.com/symbol/NHICU.png,699,0,0,0,-1719000,392000,"[{'period': '2022', 'revenue': 0.0, 'unit': 'K', 'net_profit': 392.0}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.25}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -951.0}]","[{'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 538.0}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 389.0}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -75.0}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 67.54}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 15.47}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",0.0201,0.0201,199770000,1402000,986000,6966000,102000,198368,144000,986000,-2069000,-3.162227602905569,1.3123505976095617,1.312111801242236,__nan__,__nan__,__nan__,0.03487010061570806
202,NHICW,NewHold Investment Corp. Warrant,"NewHold Investment Corp. II is a blank check company. It intends to complete a business combination with an industrial technology business. The company was incorporated in 2021 and is based in Houston, Texas.",Mr. Kevin M. Charlton,Shell Companies,0.013,USD,0,https://images.financialmodelingprep.com/symbol/NHICW.png,0,0,0,428447,-1719000,392000,"[{'period': '2022', 'revenue': 0.0, 'unit': 'K', 'net_profit': 392.0}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.25}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -951.0}]","[{'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 538.0}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 389.0}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -75.0}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 67.54}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 15.47}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",0.0201,0.0201,199770000,1402000,986000,6966000,102000,198368,144000,986000,-2069000,-3.162227602905569,1.3123505976095617,1.312111801242236,__nan__,__nan__,__nan__,0.03487010061570806
203,NHTC,Natural Health Trends Corp. Common Stock,"Natural Health Trends Corp., a direct-selling and e-commerce company, provides personal care, wellness, and lifestyle products under the NHT Global brand. The company offers wellness products, including liquid, encapsulated, tableted, and powder dietary and nutritional supplements, as well as vitamins and minerals; and herbal products comprising herbal supplements. It also provides beauty products, such as age-defying and hydrating cleansers, creams, lotions, serums, and toners; and lifestyle products, which include weight management and energy enhancing supplements. In addition, the company offers home appliances; daily products, such as oral care, hair care, and body care; and home appliances products. It sells its products directly to consumers, as well as through an e-commerce retail platform in the United States, Canada, Cayman Islands, Mexico, Peru, Hong Kong, Taiwan, China, Singapore, Malaysia, Thailand, Vietnam, South Korea, Japan, India, Russia, Kazakhstan, and Europe. The company was formerly known as Florida Institute of Massage Therapy, Inc. and changed its name to Natural Health Trends Corp. in June 1993. Natural Health Trends Corp. was incorporated in 1988 and is headquartered in Tsim Sha Tsui, Hong Kong.",Mr. Chris T.  Sharng,Specialty Retail,4.8,USD,55262880,https://images.financialmodelingprep.com/symbol/NHTC.png,18634,96,0,13640,-1299000,572000,"[{'period': '2024', 'revenue': 42960.0, 'unit': 'K', 'net_profit': 572.0}, {'period': '2023', 'revenue': 43920.0, 'unit': 'K', 'net_profit': 568.0}, {'period': '2022', 'revenue': 49130.0, 'unit': 'K', 'net_profit': 313.0}, {'period': '2021', 'revenue': 60.01, 'unit': 'M', 'net_profit': 1.08}]","[{'period': ""Q4 '24"", 'revenue': 10850.0, 'unit': 'K', 'net_profit': 176.0}, {'period': ""Q3 '24"", 'revenue': 10690.0, 'unit': 'K', 'net_profit': 35.0}, {'period': ""Q2 '24"", 'revenue': 10470.0, 'unit': 'K', 'net_profit': 173.0}, {'period': ""Q1 '24"", 'revenue': 10950.0, 'unit': 'K', 'net_profit': 188.0}, {'period': ""Q4 '23"", 'revenue': 10940.0, 'unit': 'K', 'net_profit': 358.0}, {'period': ""Q3 '23"", 'revenue': 10620.0, 'unit': 'K', 'net_profit': 172.0}]",0.0499,0.0498,55359000,50983000,43940000,22487000,0,0,20799000,13533000,-3424000,0.13802256138022562,0.007042253521126761,0.004024144869215267,"[0.2, 0.005]","['2025-02-18', '2014-03-26']",__nan__,0.40620314673314184
204,NICE,NICE Ltd American Depositary Shares,"NICE Ltd., together with its subsidiaries, provides cloud platforms for AI-driven digital business solutions worldwide. It offers CXone, a cloud native open platform that supports contact centers ranging from small single sites to distributed remote agents and enterprises; Enlighten, an AI engine for CX that discovers automation opportunities for self-service; digital-entry points solutions that enable organizations to address consumers' needs; and journey orchestration solutions that empower organizations to connect and route customers to deal with the customer's request, and connecting them using real time AI-based routing. The company also provides smart self service solutions that empower organizations to build intelligent automated conversations based on data; and prepared agent solutions and tools enable contact center agents to guide and alert them in real time so they can provide resolutions; complete performance solutions that help organizations to record structured and unstructured customer interaction and transaction data; and NICE Evidencentral, an digital evidence management platform for public safety emergency communications, law enforcement, and criminal justice helps agencies. In addition, it offers X-Sight, is an open and flexible AI-cloud platform for financial crime and compliance; Xceed, a cloud platform for comprehensive AML and fraud prevention for small and mid-sized organizations; data intelligence solutions that enable organizations to turn raw data into comprehensive actionable intelligence to prevent and detect financial crimes; AI and analytics technologies to detect and prevent financial crimes in real-time; money laundering and fraud prevention solutions that help organizations adhere to capital markets compliance and anti-money laundering compliance regulations; intelligent investigations solutions; and self-service solutions that provide organizations with customization and self-development capabilities. The company was formerly known as NICE-Systems Ltd. and changed its name to NICE Ltd. in June 2016. NICE Ltd. was founded in 1986 and is based in Ra'anana, Israel.",Mr. Craig B. Costigan,Software - Application,142.24,USD,8996651552,https://images.financialmodelingprep.com/symbol/NICE.png,681562,21.07,-4.86,470611,754141000,442588000,"[{'period': '2024', 'revenue': 2740.0, 'unit': 'M', 'net_profit': 442.59}, {'period': '2023', 'revenue': 2380.0, 'unit': 'M', 'net_profit': 338.3}, {'period': '2022', 'revenue': 2180.0, 'unit': 'M', 'net_profit': 265.94}, {'period': '2021', 'revenue': 1920.0, 'unit': 'M', 'net_profit': 199.22}]","[{'period': ""Q4 '24"", 'revenue': 721.6, 'unit': 'M', 'net_profit': 99.51}, {'period': ""Q3 '24"", 'revenue': 689.96, 'unit': 'M', 'net_profit': 120.92}, {'period': ""Q2 '24"", 'revenue': 664.4, 'unit': 'M', 'net_profit': 115.78}, {'period': ""Q1 '24"", 'revenue': 659.31, 'unit': 'M', 'net_profit': 106.37}, {'period': ""Q4 '23"", 'revenue': 623.19, 'unit': 'M', 'net_profit': 81.65}, {'period': ""Q3 '23"", 'revenue': 601.34, 'unit': 'M', 'net_profit': 92.35}]",6.76,6.76,5295906000,2504773000,1621708000,1692743000,643985000,0,1474424000,481712000,797679000,0.1909376169593183,0.3082668984129518,0.2706766917293232,"[0.16, 0.16]","['2017-02-23', '2013-05-21']",__nan__,0.3196323726289704
205,NICK,Nicholas Financial Inc. Common Stock,"Nicholas Financial, Inc. operates as a consumer finance company in the United States. The company engages in acquiring and servicing automobile finance installment contracts for the purchase of new and used automobiles and light trucks. It also originates direct consumer loans and sells consumer-finance related products. As of March 31, 2022, the company operated 47 branch offices located in Alabama, Florida, Georgia, Idaho, Illinois, Indiana, Kentucky, Michigan, Missouri, Nevada, North Carolina, Nevada, Ohio, Pennsylvania, South Carolina, Tennessee, Texas, Utah, and Wisconsin. Nicholas Financial, Inc. was founded in 1985 and is headquartered in Clearwater, Florida.",Mr. Michael  Rost,Financial - Credit Services,6.19,USD,45187000,https://images.financialmodelingprep.com/symbol/NICK.png,9976,-1.7942028985507246,-0.01,4554,0,-20801000,"[{'period': '2024', 'revenue': 22.24, 'unit': 'M', 'net_profit': -20.8}, {'period': '2023', 'revenue': 40.41, 'unit': 'M', 'net_profit': -34.12}, {'period': '2022', 'revenue': 44.35, 'unit': 'M', 'net_profit': 3.0}, {'period': '2021', 'revenue': 50.04, 'unit': 'M', 'net_profit': 8.35}]","[{'period': ""Q1 '25"", 'revenue': 0.489, 'unit': 'M', 'net_profit': -3.28}, {'period': ""Q4 '24"", 'revenue': 3870.0, 'unit': 'K', 'net_profit': -211.0}, {'period': ""Q3 '24"", 'revenue': 4.95, 'unit': 'M', 'net_profit': -11.66}, {'period': ""Q2 '24"", 'revenue': 6.33, 'unit': 'M', 'net_profit': -10.48}, {'period': ""Q1 '24"", 'revenue': 6.58, 'unit': 'M', 'net_profit': 1.56}, {'period': ""Q4 '23"", 'revenue': 7.54, 'unit': 'M', 'net_profit': -15.8}]",-2.85,-2.85,37000,18982000,18982000,35267000,902000,0,26000,18982000,1814000,0,0.3903396934259504,0.3949044585987261,"[0.12, 0.05]","['2013-09-18', '2003-09-04']",__nan__,953.1621621621622
206,NISN,NiSun International Enterprise Development Group Co. Ltd. Class A Common Shares,"Nisun International Enterprise Development Group Co., Ltd, an investment holding company, provides technology-driven integrated supply chain solutions for enterprises and financial institutions in the People's Republic of China and internationally. It offers professional solutions for technology supply chain management, technology asset routing, and digital transformation of tech and finance institutions. The company also provides a range of technology-driven customized financing solutions to small- and mid-sized enterprises (SMEs) to enhance SMEs' access to capital through its closed-loop ecosystem built on fintech platforms; and direct banking solutions to small- and medium-sized commercial banks and other financial institutions in their distribution and management of direct banking and other financial products. Nisun International Enterprise Development Group Co., Ltd has a strategic collaboration with Henan Wanbang International Agricultural Products Logistics Co., Ltd. for cooperation on businesses related to the agricultural field. The company was formerly known as Hebron Technology Co., Ltd. and changed its name to Nisun International Enterprise Development Group Co., Ltd in September 2020. Nisun International Enterprise Development Group Co., Ltd was founded in 2005 and is headquartered in Shanghai, the People's Republic of China.",Mr. Xin  Liu,Financial - Credit Services,5.27,USD,21172752,https://images.financialmodelingprep.com/symbol/NISN.png,46322,1.25,-0.39,17158,25549940,17577738,"[{'period': '2023', 'revenue': 386.67, 'unit': 'M', 'net_profit': 17.58}, {'period': '2022', 'revenue': 234.17, 'unit': 'M', 'net_profit': 17.62}, {'period': '2021', 'revenue': 160.2, 'unit': 'M', 'net_profit': 30.38}, {'period': '2020', 'revenue': 42.19, 'unit': 'M', 'net_profit': 9.92}]","[{'period': ""Q2 '24"", 'revenue': 192.25, 'unit': 'M', 'net_profit': 10.3}, {'period': ""Q1 '24"", 'revenue': 96.27, 'unit': 'M', 'net_profit': 5.15}, {'period': ""Q4 '23"", 'revenue': 259.43, 'unit': 'M', 'net_profit': 6.26}, {'period': ""Q3 '23"", 'revenue': 129.86, 'unit': 'M', 'net_profit': 3.13}, {'period': ""Q2 '23"", 'revenue': 126.71, 'unit': 'M', 'net_profit': 11.32}, {'period': ""Q1 '23"", 'revenue': 63.47, 'unit': 'M', 'net_profit': 5.66}]",4.46,4.46,315898834,293303058,127243473,112844313,21120795,368528,111086587,114454844,34951794,0.0730909362914705,-0.0024444957474150453,0.009049773755656116,__nan__,__nan__,__nan__,0.35721661764664825
207,NIU,Niu Technologies American Depositary Shares,"Niu Technologies designs, manufactures, and sells smart electric scooters in the People's Republic of China. The company offers NQi, MQi, UQi, and Gova series electric scooters and motorcycles; KQi series electric kick-scooters; NIU Aero and BQi series e-bikes; RQi and TQi series high-performance motorcycles; and YQi series hybrid motorcycles. It also provides accessories and spare parts under the NIU brand name comprising scooter accessories, such as raincoats, gloves, knee pads, storage baskets and tail boxes, smart phone holders, backrests, and locks; lifestyle accessories, which includes T-shirts, coats, sweaters and hoodies, jeans, hats, bags, jewelry, notebook, badges, key chain, and mugs; and performance upgrade components that comprises of upgraded wheels, shock absorbers, brake calipers, and carbon fiber body panels. In addition, the company, through its NIU app, offers online repair request, DIY repairs, service station locator, theft reporting, and smart services, as well as NIU cover, which provides insurance services; NIU Care that offers maintenance and reserve services in offline service stations; and NIU Wash, which provides free wash coupon on a monthly basis. Niu Technologies sells and services its products through city partners and franchised stores, distributors, and third-party e-commerce platforms and the company's online store. As of December 31, 2021, it operated through 338 city partners and 3,108 franchised stores in approximately 239 cities in the People's Republic of China; and 42 distributors in 50 countries internationally. Niu Technologies was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China.",Dr. Yan  Li Ph.D.,Auto - Manufacturers,2.93,USD,113681800,https://images.financialmodelingprep.com/symbol/NIU.png,1223944,-8.62,-0.08,1246891,-102567369,-193200639,"[{'period': '2024', 'revenue': 3290.0, 'unit': 'M', 'net_profit': -193.2}, {'period': '2023', 'revenue': 2650.0, 'unit': 'M', 'net_profit': -271.84}, {'period': '2022', 'revenue': 3170.0, 'unit': 'M', 'net_profit': -49.46}, {'period': '2021', 'revenue': 3700.0, 'unit': 'M', 'net_profit': 225.82}]","[{'period': ""Q4 '24"", 'revenue': 819.18, 'unit': 'M', 'net_profit': -72.54}, {'period': ""Q3 '24"", 'revenue': 1020.0, 'unit': 'M', 'net_profit': -40.95}, {'period': ""Q2 '24"", 'revenue': 940.49, 'unit': 'M', 'net_profit': -24.92}, {'period': ""Q1 '24"", 'revenue': 504.73, 'unit': 'M', 'net_profit': -54.8}, {'period': ""Q4 '23"", 'revenue': 478.69, 'unit': 'M', 'net_profit': -130.17}, {'period': ""Q3 '23"", 'revenue': 927.02, 'unit': 'M', 'net_profit': -79.42}]",-1.22,-1.22,2613158167,2169806471,904373198,1681875947,131921418,0,1651931793,630021303,0,0.22614133556764443,0.28927496066359604,0.29682997118155624,__nan__,__nan__,__nan__,0.6436181201120537
208,NKLA,Nikola Corporation Common Stock,"Nikola Corporation operates as a technology innovator and integrator that works to develop energy and transportation solutions. It operates through two business units, Truck and Energy. The Truck business unit develops and commercializes battery hydrogen-electric and battery-electric semi-trucks to the trucking sector. The Energy business unit develops and constructs a network of hydrogen fueling stations; and offers BEV charging solutions for its FCEV and BEV customers, as well as other third-party customers. The company also assembles, integrates, and commissions its vehicles in collaboration with its business partners and suppliers. Nikola Corporation is headquartered in Phoenix, Arizona.",Mr. Stephen J. Girsky,Agricultural - Machinery,0.183,USD,15457589,https://images.financialmodelingprep.com/symbol/NKLA.png,21114406,-0.014829821717990275,0,36268083,-736278000,-966282000,"[{'period': '2023', 'revenue': 35.84, 'unit': 'M', 'net_profit': -966.28}, {'period': '2022', 'revenue': 50.83, 'unit': 'M', 'net_profit': -763.57}, {'period': '2021', 'revenue': 0.095, 'unit': 'M', 'net_profit': -686.86}, {'period': '2020', 'revenue': 0.095, 'unit': 'M', 'net_profit': -383.68}]","[{'period': ""Q3 '24"", 'revenue': 25.18, 'unit': 'M', 'net_profit': -199.78}, {'period': ""Q2 '24"", 'revenue': 31.32, 'unit': 'M', 'net_profit': -133.67}, {'period': ""Q1 '24"", 'revenue': 7.5, 'unit': 'M', 'net_profit': -147.72}, {'period': ""Q4 '23"", 'revenue': 11.53, 'unit': 'M', 'net_profit': -153.6}, {'period': ""Q3 '23"", 'revenue': -1.73, 'unit': 'M', 'net_profit': -425.76}, {'period': ""Q2 '23"", 'revenue': 15.36, 'unit': 'M', 'net_profit': -217.83}]",-36.31,-36.23,1274857000,572412000,466358000,555683000,27199000,57062000,260105000,464715000,-616694000,-0.08757588738386092,-0.2654742899500113,0.3017307692307692,__nan__,__nan__,__nan__,0.4358786907080559
209,NKSH,National Bankshares Inc. Common Stock,"National Bankshares, Inc. operates as the bank holding company for the National Bank of Blacksburg that provides retail and commercial banking products and services to individuals, businesses, non-profits, and local governments. The company accepts interest-bearing and non-interest bearing demand deposit accounts, money market deposit accounts, savings accounts, certificates of deposit, health savings accounts, and individual retirement accounts. Its loan products include commercial and agricultural, commercial real estate, residential real estate, home equity, and various consumer loan products, as well as loans for the construction of commercial and residential properties. The company also provides business and consumer debit and credit cards; letters of credit, night depository services, safe deposit boxes, utility payment services, and automatic funds transfer; wealth management, trust, and estate services; non-deposit investment and insurance products; and telephone, mobile, and Internet banking services. It operates 23 branch offices, a loan production office, and 22 automated teller machines in Southwest Virginia. National Bankshares, Inc. was founded in 1891 and is headquartered in Blacksburg, Virginia.",Mr. F. Brad Denardo,Banks - Regional,24.73,USD,157243479,https://images.financialmodelingprep.com/symbol/NKSH.png,9855,19.94,-2.14,23567,0,7623000,"[{'period': '2024', 'revenue': 44.13, 'unit': 'M', 'net_profit': 7.62}, {'period': '2023', 'revenue': 47.9, 'unit': 'M', 'net_profit': 15.69}, {'period': '2022', 'revenue': 59.43, 'unit': 'M', 'net_profit': 25.93}, {'period': '2021', 'revenue': 50.31, 'unit': 'M', 'net_profit': 20.38}]","[{'period': ""Q4 '24"", 'revenue': 12.31, 'unit': 'M', 'net_profit': 3.08}, {'period': ""Q3 '24"", 'revenue': 11.72, 'unit': 'M', 'net_profit': 2.68}, {'period': ""Q2 '24"", 'revenue': 19360.0, 'unit': 'K', 'net_profit': -306.0}, {'period': ""Q1 '24"", 'revenue': 18.22, 'unit': 'M', 'net_profit': 2.17}, {'period': ""Q4 '23"", 'revenue': 17.77, 'unit': 'M', 'net_profit': 4.18}, {'period': ""Q3 '23"", 'revenue': 10.76, 'unit': 'M', 'net_profit': 3.07}]",1.24,1.24,1811636000,13863000,13863000,1655227000,6469000,0,1462000,13863000,6182000,-1,-0.5141801032438977,-0.5338345864661654,"[0.78, 0.42]","['2024-11-25', '2000-05-18']",__nan__,0.9136642239390252
210,NKTR,Nektar Therapeutics  Common Stock,"Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, squamous cell carcinoma of the head and neck, and adjuvant melanoma; phase 2 clinical trial for the treatment of renal cell carcinoma, non-small cell lung cancer, and urothelial cancer; phase 1/2A clinical trial to treat squamous cell carcinoma of the head and neck; phase 1/2 clinical trial for the treatment of solid tumors; and phase 1B clinical trial to treat COVID-19. It is also developing NKTR-358, a cytokine Treg stimulant that is in phase 2 clinical trial for the treatment of systemic lupus erythematosus and ulcerative colitis, as well as phase 1B clinical trial to treat atopic dermatitis and psoriasis; NKTR-255, an IL-15 receptor agonist, which is in phase 1/2 clinical trial for the treatment of non-Hodgkin's lymphoma and multiple myeloma, and head and neck cancer and colorectal cancer; and NKTR-262, a toll-like receptor agonist that is in phase 1/2 clinical trial to treat solid tumors, as well as various other drug candidates. The company has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma S.A.; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; Amgen Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Baxalta Incorporated; Eli Lilly and Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. Nektar Therapeutics was incorporated in 1990 and is headquartered in San Francisco, California.",Mr. Howard W. Robin,Biotechnology,0.4923,USD,91618999,https://images.financialmodelingprep.com/symbol/NKTR.png,2218954,-0.85,0.0019,3129998,-86697000,-118961000,"[{'period': '2024', 'revenue': 98.43, 'unit': 'M', 'net_profit': -118.96}, {'period': '2023', 'revenue': 90.12, 'unit': 'M', 'net_profit': -276.06}, {'period': '2022', 'revenue': 92.06, 'unit': 'M', 'net_profit': -368.2}, {'period': '2021', 'revenue': 101.91, 'unit': 'M', 'net_profit': -523.84}]","[{'period': ""Q4 '24"", 'revenue': 29.18, 'unit': 'M', 'net_profit': 7.26}, {'period': ""Q3 '24"", 'revenue': 24.12, 'unit': 'M', 'net_profit': -37.06}, {'period': ""Q2 '24"", 'revenue': 23.49, 'unit': 'M', 'net_profit': -52.36}, {'period': ""Q1 '24"", 'revenue': 21.64, 'unit': 'M', 'net_profit': -36.8}, {'period': ""Q4 '23"", 'revenue': 23.89, 'unit': 'M', 'net_profit': -42.08}, {'period': ""Q3 '23"", 'revenue': 24.14, 'unit': 'M', 'net_profit': -45.84}]",-0.58,-0.58,303850000,261292000,255226000,243113000,0,13869000,61400000,44252000,-177177000,0.6433792527570165,0.5690693192685542,0.6,__nan__,__nan__,__nan__,0.8001086062201744
211,NKTX,Nkarta Inc. Common Stock,"Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the surface of tumor cells. Its two co-lead product candidates are NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes; and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells. The company has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.",Mr. Paul J. Hastings,Biotechnology,1.51,USD,107145976,https://images.financialmodelingprep.com/symbol/NKTX.png,1499855,-0.94,-0.05,1061223,-128194000,-108790000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -108.79}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -117.5}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -119.42}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -83.95}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -25.93}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -28.34}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -24.99}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -29.52}, {'period': ""Q4 '23"", 'revenue': 10.54, 'unit': 'M', 'net_profit': -27.75}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -25.64}]",-1.6,-1.6,501203000,273338000,267354000,93227000,0,110392000,18917000,27873000,-104105000,-0.06401839294162565,0.0741355392720062,0.33333333333333326,__nan__,__nan__,__nan__,0.18600646843694071
212,NLOK,NortonLifeLock Inc. Common Stock,"NortonLifeLock Inc. provides cyber safety solutions for consumers in the United States, Canada, Latin America, Europe, the Middle East, Africa, the Asia Pacific, and Japan. It offers Norton 360, an integrated platform provides extensive cyber safety coverage and a subscription service providing protection for PCs, Macs, and mobile devices against malware, viruses, adware, ransomware, and other online threats on various platforms; and Norton and LifeLock identity theft protection solution that offers monitoring, alerts, and restoration services to its customers. The company also provides Norton Secure VPN solution, which enhances security and online privacy by providing an encrypted data tunnel; Privacy Monitor Assistant, an on-demand, white glove service where agents help members delete personal information from data brokers online; Home Title Protect product that detects fraud and notifies members; and Avira Security, a consumer-focused portfolio of cybersecurity and privacy solutions. It offers Dark Web Monitoring product, which looks for personal information of its Norton 360 members on the Dark Web; and Social Media Monitoring solution that helps to keep customers' social media accounts safer by monitoring them for account takeovers, risky activity, and inappropriate content. The company also provides AntiTrack product, which helps to keep personal information and browsing activity private by blocking trackers and disguising digital fingerprints online; and Online Reputation Management solution that manages online search results, personal branding, and digital privacy. It markets and sells its products and related services through retailers, telecom service providers, hardware original equipment manufacturers, and employee benefit providers, as well as e-commerce platform. The company was formerly known as Symantec Corporation and changed its name to NortonLifeLock Inc. in November 2019. NortonLifeLock Inc. was founded in 1982 and is based in Tempe, Arizona.",Mr. Vincent Pilette,Software - Infrastructure,21.66,USD,14319556003,https://images.financialmodelingprep.com/symbol/NLOK.png,5588600,15.146853146853147,-0.5,7732320,1122000000,616000000,"[{'period': '2024', 'revenue': 3810.0, 'unit': 'M', 'net_profit': 616.0}, {'period': '2023', 'revenue': 3.34, 'unit': 'B', 'net_profit': 1.35}, {'period': '2022', 'revenue': 2800.0, 'unit': 'M', 'net_profit': 836.0}, {'period': '2021', 'revenue': 2550.0, 'unit': 'M', 'net_profit': 554.0}]","[{'period': ""Q3 '25"", 'revenue': 986.0, 'unit': 'M', 'net_profit': 159.0}, {'period': ""Q2 '25"", 'revenue': 974.0, 'unit': 'M', 'net_profit': 161.0}, {'period': ""Q1 '25"", 'revenue': 965.0, 'unit': 'M', 'net_profit': 181.0}, {'period': ""Q3 '24"", 'revenue': 951.0, 'unit': 'M', 'net_profit': 144.0}, {'period': ""Q2 '24"", 'revenue': 948.0, 'unit': 'M', 'net_profit': 149.0}, {'period': ""Q1 '24"", 'revenue': 946.0, 'unit': 'M', 'net_profit': 189.0}]",0.97,0.96,15772000000,1358000000,846000000,13575000000,163000000,0,2648000000,846000000,2044000000,-0.08557457212713937,-0.5433654558932542,-0.5509259259259259,"[0.125, 0.15]","['2022-11-18', '2013-06-17']",__nan__,0.8607025107785949
213,NLSP,NLS Pharmaceutics Ltd. Ordinary Shares,"NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy; and Nolazol for the treatment of ADHD. The company was incorporated in 2015 and is based in Zurich, Switzerland.",Mr. Alexander  Zwyer M.B.A.,Biotechnology,1.36,USD,3362518,https://images.financialmodelingprep.com/symbol/NLSP.png,2061593,-0.2,-0.04,14907,-11795655,-12172029,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.17}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -16.5}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.95}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.86}]","[{'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.04}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -4.56}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.61}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.85}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.64}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.34}]",-0.32,-0.32,1846641,1823062,897680,10680204,10664,0,7919550,897680,-9684466,0.23756133751527703,0.26210807920619217,0.6190476190476191,__nan__,__nan__,__nan__,5.783584356677881
214,NLSPW,NLS Pharmaceutics Ltd. Warrant,"NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy; and Nolazol for the treatment of ADHD. The company also developing NLS-4, a selective dopamine reuptake inhibitor to prevent rare sleep disorders; NLS-3, a repurposed reverse ester of methylphenidate for treatment of ADHD; NLS-8, a melatonin ML1A receptor agonist, improved scopolamine-induced amnesia; NLS-11, a norepinephrine and dopamine reuptake inhibitor and muscarinic M1, M2, M3 receptor antagonist; and NLS-12, a norepinephrine and dopamine reuptake inhibitor and muscarinic M4 receptor antagonist. NLS Pharmaceutics AG was incorporated in 2015 and is based in Zurich, Switzerland.",Mr. Alexander  Zwyer M.B.A.,Biotechnology,0.0049,USD,3510862,https://images.financialmodelingprep.com/symbol/NLSPW.png,44985,,0.0039,800,-11795655,-12172029,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.17}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -16.5}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.95}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.86}]","[{'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.04}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -4.56}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.61}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.85}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.64}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.34}]",-0.32,-0.32,1846641,1823062,897680,10680204,10664,0,7919550,897680,-9684466,0.23756133751527703,0.26210807920619217,0.6190476190476191,__nan__,__nan__,__nan__,5.783584356677881
215,NLTX,Neoleukin Therapeutics Inc. Common Stock,"Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington.",Ms. Donna M. Cochener-Metcalfe J.D.,Drug Manufacturers - Specialty & Generic,3.49,USD,8199685,https://images.financialmodelingprep.com/symbol/NLTX.png,5520,-0.28420195439739415,0.05,109095,-56485000,-56017000,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -56.02}, {'period': '2021', 'revenue': 0.006, 'unit': 'M', 'net_profit': -58.41}, {'period': '2020', 'revenue': 0.451, 'unit': 'M', 'net_profit': -24.96}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -69.44}]","[{'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.53}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.08}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -20.11}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.64}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.54}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.31}]",-1.01,-1.01,115948000,99134000,96384000,21617000,0,0,11062000,37887000,-46717000,0.0694092062341428,0.04105109988872721,0.047169811320754755,__nan__,__nan__,__nan__,0.18643702349329008
216,NMFC,New Mountain Finance Corporation Common Stock,"New Mountain Finance Corporation (Nasdaq: NMFC), a business development company is a private equity / buyouts and loan fund specializes in directly investing and lending to middle market companies in defensive growth industries. The fund prefers investing in buyout and middle market companies. It also makes investments in debt securities at all levels of the capital structure including first and second lien debt, unsecured notes and mezzanine securities. In some cases, its investments may also include equity interests. It targets energy, specialty chemicals and materials, trading companies and distributors, commercial printing, diversified support services, education services, environmental and facilities services, office services and supplies, media, distributors, health care services, health care facilities, application software, business services, systems software, federal services, distribution and logistics, interactive home entertainment, telecommunication services, hydroelectric power generation, electric power generation by fossil fuels, electric power generation by nuclear fuels, health care technology, and security and alarm services. The fund seeks to invest in United States of America. It seeks to invest between $10 million and $50 million per transaction. The firm invests through both primary originations and open-market secondary purchases. It invests in companies with EBITDA between $10 million and $200 million and target investments up to a $125 million hold size. The fund seeks a majority stake in its portfolio companies.",Mr. John R. Kline,Asset Management,9.11,USD,982522610,https://images.financialmodelingprep.com/symbol/NMFC.png,501040,8.84,-0.22,1304922,0,113443000,"[{'period': '2024', 'revenue': 123.78, 'unit': 'M', 'net_profit': 113.44}, {'period': '2023', 'revenue': 374.84, 'unit': 'M', 'net_profit': 135.34}, {'period': '2022', 'revenue': 89.09, 'unit': 'M', 'net_profit': 74.73}, {'period': '2021', 'revenue': 203.65, 'unit': 'M', 'net_profit': 201.4}]","[{'period': ""Q4 '24"", 'revenue': 29.72, 'unit': 'M', 'net_profit': 27.68}, {'period': ""Q3 '24"", 'revenue': 95.33, 'unit': 'M', 'net_profit': 23.89}, {'period': ""Q2 '24"", 'revenue': 63.42, 'unit': 'M', 'net_profit': 34.47}, {'period': ""Q1 '24"", 'revenue': 78.73, 'unit': 'M', 'net_profit': 27.41}, {'period': ""Q4 '23"", 'revenue': 52.28, 'unit': 'M', 'net_profit': 27.24}, {'period': ""Q3 '23"", 'revenue': 94.35, 'unit': 'M', 'net_profit': 40.67}]",0.0009,0.0008,3246701000,122699000,80320000,1887410000,42379000,3091024000,299522000,80320000,41999000,0,-0.1618111021626534,-0.9994073488739629,"[0.32, 0.27]","['2025-03-17', '2011-08-18']",__nan__,0.581331634788667
217,NMIH,NMI Holdings Inc. Class A Common Stock,"NMI Holdings, Inc. provides private mortgage guaranty insurance services in the United States. The company offers mortgage insurance services; and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, internet-sourced lenders, and other non-bank lenders. NMI Holdings, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.",Mr. Adam S. Pollitzer,Insurance - Specialty,32.84,USD,2569358908,https://images.financialmodelingprep.com/symbol/NMIH.png,541101,7.41,0.05,719838,512243000,360106000,"[{'period': '2024', 'revenue': 650.97, 'unit': 'M', 'net_profit': 360.11}, {'period': '2023', 'revenue': 579.0, 'unit': 'M', 'net_profit': 322.11}, {'period': '2022', 'revenue': 524.46, 'unit': 'M', 'net_profit': 292.9}, {'period': '2021', 'revenue': 485.64, 'unit': 'M', 'net_profit': 231.13}]","[{'period': ""Q4 '24"", 'revenue': 166.5, 'unit': 'M', 'net_profit': 86.17}, {'period': ""Q3 '24"", 'revenue': 166.09, 'unit': 'M', 'net_profit': 92.81}, {'period': ""Q2 '24"", 'revenue': 162.12, 'unit': 'M', 'net_profit': 92.08}, {'period': ""Q1 '24"", 'revenue': 156.25, 'unit': 'M', 'net_profit': 89.05}, {'period': ""Q4 '23"", 'revenue': 151.38, 'unit': 'M', 'net_profit': 83.41}, {'period': ""Q3 '23"", 'revenue': 148.16, 'unit': 'M', 'net_profit': 83.95}]",4.51,4.43,3349973000,54218000,54218000,1132541000,0,0,15600000,54218000,393604000,0.12221769458611564,0.11795970320697899,0.15345268542199478,__nan__,__nan__,__nan__,0.3380746650793902
218,NMMC,North Mountain Merger Corp. Class A Common Stock,"North Mountain Merger Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on businesses in the financial technology segment of the financial services industry. The company was incorporated in 2020 and is based in New York, New York.",,Shell Companies,10.01,USD,0,https://images.financialmodelingprep.com/symbol/NMMC.png,0,16.966101694915253,-0.01,41845,4998849,11161607,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 11.16}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -234.54}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -167.76}, {'period': ""Q1 '22"", 'revenue': 40.83, 'unit': 'M', 'net_profit': 3.53}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.89}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.2}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.37}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.46}]",3.72,3.72,132692941,431115,303615,13503164,0,0,428439,303615,-667854,22.313690377211273,48.58996235135608,48.63124199743918,__nan__,__nan__,__nan__,0.10176248938517385
219,NMMCU,North Mountain Merger Corp. Unit,"North Mountain Merger Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on businesses in the financial technology segment of the financial services industry. The company was incorporated in 2020 and is based in New York, New York.",,Shell Companies,10,USD,0,https://images.financialmodelingprep.com/symbol/NMMCU.png,0,21.691973969631235,-0.01,,4998849,11161607,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 11.16}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -234.54}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -167.76}, {'period': ""Q1 '22"", 'revenue': 40.83, 'unit': 'M', 'net_profit': 3.53}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.89}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.2}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.37}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.46}]",3.72,3.72,132692941,431115,303615,13503164,0,0,428439,303615,-667854,22.313690377211273,48.58996235135608,48.63124199743918,__nan__,__nan__,__nan__,0.10176248938517385
220,NMMCW,North Mountain Merger Corp. Warrant,,,Shell Companies,0.0001,USD,0,https://images.financialmodelingprep.com/symbol/NMMCW.png,0,0,0,1063754,4998849,11161607,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 11.16}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -234.54}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -167.76}, {'period': ""Q1 '22"", 'revenue': 40.83, 'unit': 'M', 'net_profit': 3.53}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.89}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.2}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.37}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.46}]",3.72,3.72,132692941,431115,303615,13503164,0,0,428439,303615,-667854,22.313690377211273,48.58996235135608,48.63124199743918,__nan__,__nan__,__nan__,0.10176248938517385
221,NMRD,Nemaura Medical Inc. Common Stock,"Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.",Dr. Dewan Fazlul Hoque Chowdhury Ph.D.,Medical - Devices,0.0002,USD,8070,https://images.financialmodelingprep.com/symbol/NMRD.png,2414,,5.00000000712604e-12,1010,-7287057,-14143735,"[{'period': '2023', 'revenue': 0.07704000000000001, 'unit': 'M', 'net_profit': -14.14}, {'period': '2022', 'revenue': 0.5039100000000001, 'unit': 'M', 'net_profit': -13.89}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.26}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.16}]","[{'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.16}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.2}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.6}, {'period': ""Q4 '23"", 'revenue': -1550.0, 'unit': 'K', 'net_profit': -328.48}, {'period': ""Q3 '23"", 'revenue': 0.00302, 'unit': 'M', 'net_profit': -1.72}, {'period': ""Q2 '23"", 'revenue': 0.07403, 'unit': 'M', 'net_profit': -3.86}]",-0.57,-0.57,14563233,13537235,10105135,26377431,409648,0,22267969,10105135,-8990998,0.007296930327829213,-0.01850173600046951,0.0338983050847458,__nan__,__nan__,__nan__,1.8112345658412525
222,NMRK,Newmark Group Inc. Class A Common Stock,"Newmark Group, Inc. provides commercial real estate services in the United States and internationally. The company's investor/owner services and products include capital markets, such as investment, debt and structured finance, and loan sales; agency leasing, property management, and valuation and advisory; and commercial real estate due diligence consulting and advisory services, as well as government sponsored enterprise lending, loan servicing, mortgage broking, and equity-raising services. Its occupier services and products comprise tenant representation; real estate management technology systems; workplace and occupancy strategy; global corporate consulting; project management; account and transaction management; and lease administration and facilities management services. The company provides its services to commercial real estate tenants, investors, owners, occupiers, and developers, as well as lenders and multi-national corporations. As of December 31, 2021, it operated approximately 160 offices on four continents. The company was formerly known as Newmark Knight Frank and changed its name to Newmark Group, Inc. in October 2017. Newmark Group, Inc. was founded in 1929 and is based in New York, New York.",Mr. Barry M. Gosin,Real Estate - Services,10.24,USD,1847933737,https://images.financialmodelingprep.com/symbol/NMRK.png,1039859,30.12,-0.35,996413,337341000,24257000,"[{'period': '2024', 'revenue': 2740.0, 'unit': 'M', 'net_profit': 24.26}, {'period': '2023', 'revenue': 2470.0, 'unit': 'M', 'net_profit': 42.58}, {'period': '2022', 'revenue': 2710.0, 'unit': 'M', 'net_profit': 83.28}, {'period': '2021', 'revenue': 2910.0, 'unit': 'M', 'net_profit': 750.73}]","[{'period': ""Q4 '24"", 'revenue': 872.72, 'unit': 'M', 'net_profit': 18.64}, {'period': ""Q3 '24"", 'revenue': 685.91, 'unit': 'M', 'net_profit': 17.79}, {'period': ""Q2 '24"", 'revenue': 633.38, 'unit': 'M', 'net_profit': 14.28}, {'period': ""Q1 '24"", 'revenue': 546.5, 'unit': 'M', 'net_profit': -16.25}, {'period': ""Q4 '23"", 'revenue': 747.44, 'unit': 'M', 'net_profit': 36.55}, {'period': ""Q3 '23"", 'revenue': 616.28, 'unit': 'M', 'net_profit': 9.95}]",0.14,0.14,4710120000,1772673000,197691000,3185951000,607900000,5213000,1780431000,197691000,-43055000,0.1570208533406503,-0.43025249559600703,-0.43999999999999995,"[0.03, 0.09]","['2025-03-03', '2018-05-18']",__nan__,0.6764054843613326
223,NMTR,9 Meters Biopharma Inc. Common Stock,"9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as well as in Phase IIa clinical trial for treatment of multi-system inflammatory syndrome; and Vurolenatide, a long-acting injectable glucagon-like-peptide-1 that is in Phase 2 clinical trial to treat short bowel syndrome. It also develops NM-102, a small molecule peptide; NM-003, a proprietary long-acting glucagon-like peptide-2 receptor agonist for prevention of acute graft versus host disease; NM-136, a humanized monoclonal antibody for targeted obesity disorders; and NM-004, a double-cleaved mesalamine with an immunomodulator for rare and/or orphan indications. The company is based in Raleigh, North Carolina.","Ms. Bethany  Sensenig C.M.A., M.B.A.",Biotechnology,0.0722,USD,1043990,https://images.financialmodelingprep.com/symbol/NMTR.png,446108,-0.04272189349112426,-0.0544,4594310,-41507300,-45515779,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -45.52}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -36.83}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -65.54}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -28.87}]","[{'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.7}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.04}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.99}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.06}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.34}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.55}]",-3.51,-3.51,33147844,33017849,12646282,30747301,0,0,30695905,12646282,-37246059,-0.31236403217085074,-0.23594884760977586,-0.15841584158415842,__nan__,__nan__,__nan__,0.9275807198803036
224,NNBR,NN Inc. Common Stock,"NN, Inc., a diversified industrial company, designs, manufactures, and sells high-precision components and assemblies. It operates through two segments, Mobile Solutions and Power Solutions. The Mobile Solutions segment manufactures and sells system critical components for general industrial and automotive end markets. This segments products are used in power steering, braking, transmissions, gasoline fuel system, diesel injection, and diesel emissions treatment applications, as well as use in heating, ventilation, and air conditioning. The Power Solutions segment designs, manufactures, and sells a range of high-precision metal and plastic components, assemblies, and finished devices used in various applications, such as power control, flight control, and military devices. Its products include electrical contacts, connectors, contact assemblies, and precision stampings for the electrical, general industrial, automotive, aerospace, defense, and medical end markets. This segment also produces various tools and instruments for the orthopaedics and medical/surgical end markets. NN, Inc. was founded in 1980 and is headquartered in Charlotte, North Carolina.",Mr. Harold C. Bevis,Conglomerates,1.99,USD,99240305,https://images.financialmodelingprep.com/symbol/NNBR.png,642736,-1.79,-0.01,212887,21963000,-43024000,"[{'period': '2024', 'revenue': 464.29, 'unit': 'M', 'net_profit': -43.02}, {'period': '2023', 'revenue': 489.27, 'unit': 'M', 'net_profit': -50.15}, {'period': '2022', 'revenue': 498.74, 'unit': 'M', 'net_profit': -32.69}, {'period': '2021', 'revenue': 477.58, 'unit': 'M', 'net_profit': -20.69}]","[{'period': ""Q4 '24"", 'revenue': 106.51, 'unit': 'M', 'net_profit': -20.98}, {'period': ""Q3 '24"", 'revenue': 113.59, 'unit': 'M', 'net_profit': -2.56}, {'period': ""Q2 '24"", 'revenue': 122.99, 'unit': 'M', 'net_profit': -2.2}, {'period': ""Q1 '24"", 'revenue': 121.2, 'unit': 'M', 'net_profit': -12.54}, {'period': ""Q4 '23"", 'revenue': 112.53, 'unit': 'M', 'net_profit': -20.54}, {'period': ""Q3 '23"", 'revenue': 124.44, 'unit': 'M', 'net_profit': -5.06}]",-0.88,-0.88,456893000,167562000,18128000,382371000,61549000,34971000,83912000,18128000,11070000,0.42607622881631063,0.14209371884346958,0.3481481481481482,"[0.07, 0.08]","['2019-09-06', '1994-08-01']",__nan__,0.8368939773645033
225,NNDM,Nano Dimension Ltd. American Depositary Shares,"Nano Dimension Ltd., together with its subsidiaries, provides additive electronics in Israel and internationally. The company's flagship product is DragonFly IV system that serves cross-industry High-Performance-Electronic-Devices' fabrication needs by depositing proprietary conductive and dielectric substances, as well as integrates in-situ capacitors, antennas, coils, transformers, and electromechanical components. It also provides nanotechnology based conductive and dielectric inks; and FLIGHT software platform that enables the 3D design of electrical and mechanical features. The company markets and sells products and services to companies that develop products with electronic components, including companies in the defense, automotive, consumer electronics, semiconductor, aerospace, and medical industries, as well as research institutes. Nano Dimension Ltd. was founded in 2012 and is headquartered in Ness Ziona, Israel.",Mr. Julien D. Lederman,Computer Hardware,1.38,USD,302548164,https://images.financialmodelingprep.com/symbol/NNDM.png,2300149,-3.37,-0.04,2735635,-48207456,-54550000,"[{'period': '2023', 'revenue': 56.31, 'unit': 'M', 'net_profit': -54.55}, {'period': '2022', 'revenue': 43.63, 'unit': 'M', 'net_profit': -228.29}, {'period': '2021', 'revenue': 10.49, 'unit': 'M', 'net_profit': -200.82}, {'period': '2020', 'revenue': 3.4, 'unit': 'M', 'net_profit': -46.45}]","[{'period': ""Q3 '24"", 'revenue': 14.86, 'unit': 'M', 'net_profit': -8.35}, {'period': ""Q2 '24"", 'revenue': 14.93, 'unit': 'M', 'net_profit': -43.97}, {'period': ""Q1 '24"", 'revenue': 13.51, 'unit': 'M', 'net_profit': -35.16}, {'period': ""Q4 '23"", 'revenue': 14.45, 'unit': 'M', 'net_profit': -1.05}, {'period': ""Q3 '23"", 'revenue': 12.16, 'unit': 'M', 'net_profit': -66.6}, {'period': ""Q2 '23"", 'revenue': 14.74, 'unit': 'M', 'net_profit': -9.12}]",-0.22,-0.22,1064338000,893988000,851538000,48552001,22223131,138446000,34472000,309571000,-115691000,0.7804336300734407,0.7610547756192646,0.752808988764045,__nan__,__nan__,__nan__,0.04561708874436504
226,NNOX,NANO-X IMAGING LTD Ordinary Shares,"Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company develops a prototype of the Nanox.ARC, a medical imaging system incorporating its digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that would allow for the delivery of medical screening as a service. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was founded in 2011 and is headquartered in Neve Ilan, Israel.",Mr. Erez I. Meltzer,Medical - Devices,4.1,USD,239850000,https://images.financialmodelingprep.com/symbol/NNOX.png,2275442,-4.51,-0.31,980045,-47693000,-60776000,"[{'period': '2023', 'revenue': 9.9, 'unit': 'M', 'net_profit': -60.78}, {'period': '2022', 'revenue': 8.58, 'unit': 'M', 'net_profit': -105.24}, {'period': '2021', 'revenue': 1.3, 'unit': 'M', 'net_profit': -61.8}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -43.5}]","[{'period': ""Q3 '24"", 'revenue': 3.03, 'unit': 'M', 'net_profit': -13.64}, {'period': ""Q2 '24"", 'revenue': 2.7, 'unit': 'M', 'net_profit': -13.57}, {'period': ""Q1 '24"", 'revenue': 2.55, 'unit': 'M', 'net_profit': -12.24}, {'period': ""Q4 '23"", 'revenue': 2.4, 'unit': 'M', 'net_profit': -10.25}, {'period': ""Q3 '23"", 'revenue': 2.48, 'unit': 'M', 'net_profit': -21.4}, {'period': ""Q2 '23"", 'revenue': 2.58, 'unit': 'M', 'net_profit': -17.36}]",-1.08,-1.08,218648000,88635000,82383000,23134000,1484000,327000,15524000,56377000,-48080000,0.3699402874656521,0.4225174120844142,0.462686567164179,__nan__,__nan__,__nan__,0.10580476382130181
227,NOAC,Natural Order Acquisition Corp. Common Stock,"Natural Order Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to focus on companies that use plant-based, cell-based, or precision fermentation technologies for developing food products that eliminate animals from the food supply chain. The company was incorporated in 2020 and is based in Weston, Massachusetts.",,Shell Companies,10.06,USD,0,https://images.financialmodelingprep.com/symbol/NOAC.png,87668,91.45454545454545,0,100641,1167625,4163322,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.16}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -103.23}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 970.65}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 607.02}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.54}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 13.13}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.23}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 487.5}]",0.14,0.14,230497912,405607,152487,11561716,0,230092305,655716,152487,-1248678,12.311126826054947,41.33132483434727,39.88888888888889,__nan__,__nan__,__nan__,0.05015974287871206
228,NOACU,Natural Order Acquisition Corp. Unit,"Natural Order Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to focus on companies that use plant-based, cell-based, or precision fermentation technologies for developing food products that eliminate animals from the food supply chain. The company was incorporated in 2020 and is based in Weston, Massachusetts.",,Shell Companies,10.04,USD,0,https://images.financialmodelingprep.com/symbol/NOACU.png,13802,97.47572815533981,-0.01,1020,1167625,4163322,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.16}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -103.23}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 970.65}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 607.02}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.54}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 13.13}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.23}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 487.5}]",0.14,0.14,230497912,405607,152487,11561716,0,230092305,655716,152487,-1248678,12.311126826054947,41.33132483434727,39.88888888888889,__nan__,__nan__,__nan__,0.05015974287871206
229,NOACW,Natural Order Acquisition Corp. Warrant,,,Shell Companies,0.0004,USD,0,https://images.financialmodelingprep.com/symbol/NOACW.png,123710,0,0,1392797,1167625,4163322,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.16}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -103.23}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 970.65}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 607.02}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.54}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 13.13}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.23}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 487.5}]",0.14,0.14,230497912,405607,152487,11561716,0,230092305,655716,152487,-1248678,12.311126826054947,41.33132483434727,39.88888888888889,__nan__,__nan__,__nan__,0.05015974287871206
230,NODK,NI Holdings Inc. Common Stock,"NI Holdings, Inc. underwrites property and casualty insurance products in the United States. The company's products include private passenger auto, non-standard automobile, homeowners, farm owners, crop hail and multi-peril crop, and liability insurance policies. The company was founded in 1946 and is headquartered in Fargo, North Dakota. NI Holdings, Inc. is a subsidiary of Nodak Mutual Group, Inc.",Mr. Seth Christopher Daggett C.P.A.,Insurance - Property & Casualty,13.52,USD,279613880,https://images.financialmodelingprep.com/symbol/NODK.png,16472,43.61,0.36,37559,0,-1512000,"[{'period': '2024', 'revenue': 32.6, 'unit': 'M', 'net_profit': -1.51}, {'period': '2023', 'revenue': 365.69, 'unit': 'M', 'net_profit': -5.48}, {'period': '2022', 'revenue': 324.44, 'unit': 'M', 'net_profit': -53.77}, {'period': '2021', 'revenue': 323.97, 'unit': 'M', 'net_profit': 8.42}]","[{'period': ""Q4 '24"", 'revenue': 73.91, 'unit': 'M', 'net_profit': 9.85}, {'period': ""Q3 '24"", 'revenue': 88.98, 'unit': 'M', 'net_profit': -2.71}, {'period': ""Q2 '24"", 'revenue': 87.81, 'unit': 'M', 'net_profit': -8.47}, {'period': ""Q1 '24"", 'revenue': 91.35, 'unit': 'M', 'net_profit': 6.42}, {'period': ""Q4 '23"", 'revenue': 94.41, 'unit': 'M', 'net_profit': 6.62}, {'period': ""Q3 '23"", 'revenue': 92750.0, 'unit': 'K', 'net_profit': 231.0}]",-0.29,-0.29,526545000,3345000,3345000,281914000,0,332352000,7126000,3345000,-5906000,0,0.7238860482103725,-0.11538461538461527,__nan__,__nan__,__nan__,0.5354034318054487
231,NOTV,Inotiv Inc. Common Stock,"Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers' data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It has an agreement with BioVaxys to conduct preclinical toxicity studies for its Covid-T Immunodiagnostic program. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.",Mr. Robert W. Leasure Jr.,Medical - Diagnostics & Research,2.42,USD,81963706,https://images.financialmodelingprep.com/symbol/NOTV.png,644981,-0.52,0.06,1068829,-26758000,-108445000,"[{'period': '2024', 'revenue': 490.74, 'unit': 'M', 'net_profit': -108.44}, {'period': '2023', 'revenue': 572.42, 'unit': 'M', 'net_profit': -105.14}, {'period': '2022', 'revenue': 547.66, 'unit': 'M', 'net_profit': -337.26}, {'period': '2021', 'revenue': 89.61, 'unit': 'M', 'net_profit': 10.89}]","[{'period': ""Q1 '25"", 'revenue': 119.88, 'unit': 'M', 'net_profit': -27.63}, {'period': ""Q4 '24"", 'revenue': 130.42, 'unit': 'M', 'net_profit': -18.89}, {'period': ""Q3 '24"", 'revenue': 105.79, 'unit': 'M', 'net_profit': -26.09}, {'period': ""Q2 '24"", 'revenue': 119.03, 'unit': 'M', 'net_profit': -48.08}, {'period': ""Q1 '24"", 'revenue': 135.5, 'unit': 'M', 'net_profit': -15.39}, {'period': ""Q4 '23"", 'revenue': 140.74, 'unit': 'M', 'net_profit': -9.66}]",-4.19,-4.19,781361000,163413000,21432000,610857000,73560000,0,119042000,21432000,-29115000,-0.00950728137025579,-0.031434278105383295,-0.021951219512195305,__nan__,__nan__,__nan__,0.781785883861621
232,NOVN,Novan Inc. Common Stock,"Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases. The company also develops SB207, an anti-viral product candidate for the treatment of external genital warts; WH602, a nitric oxide-containing intravaginal gel to treat high-risk human papilloma virus (HPV); WH504, a non-gel formulation product candidate to treat high-risk HPV; and SB019 for the treatment of SARS-CoV-2. Novan, Inc. has a license agreement with Sato Pharmaceutical Co., Ltd.; and a strategic alliance with Orion Corporation. Novan, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.",Ms. Paula Brown Stafford M.P.H.,Biotechnology,0.0941,USD,2636249,https://images.financialmodelingprep.com/symbol/NOVN.png,1036545,-0.11202380952380953,-0.0311,6929105,-33759000,-19561000,"[{'period': '2022', 'revenue': 23.61, 'unit': 'M', 'net_profit': -19.56}, {'period': '2021', 'revenue': 2.82, 'unit': 'M', 'net_profit': -28.84}, {'period': '2020', 'revenue': 4.21, 'unit': 'M', 'net_profit': -30.16}, {'period': '2019', 'revenue': 4.48, 'unit': 'M', 'net_profit': -30.78}]","[{'period': ""Q1 '23"", 'revenue': 3.0, 'unit': 'M', 'net_profit': -14.12}, {'period': ""Q4 '22"", 'revenue': 10.47, 'unit': 'M', 'net_profit': 26.58}, {'period': ""Q3 '22"", 'revenue': 5.1, 'unit': 'M', 'net_profit': -2.44}, {'period': ""Q2 '22"", 'revenue': 6.15, 'unit': 'M', 'net_profit': -9.02}, {'period': ""Q1 '22"", 'revenue': 1.89, 'unit': 'M', 'net_profit': -13.53}, {'period': ""Q4 '21"", 'revenue': 0.648, 'unit': 'M', 'net_profit': -8.23}]",-0.89,-0.89,90330000,42368000,12316000,85725000,22002000,0,46398000,12316000,-35156000,-0.11419518795999868,0.321670076637653,0.47337278106508873,__nan__,__nan__,__nan__,0.9490202590501494
233,NOVT,Novanta Inc. Common Stock,"Novanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. It's Vision segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless technologies, video recorders, and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. In addition, its Precision Motion segment offers optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles. The company sells its products through its direct sales force, resellers, distributors, and system integrators under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was founded in 1968 and is headquartered in Bedford, Massachusetts.",Mr. Matthijs  Glastra,"Hardware, Equipment & Parts",102.65,USD,3691355590,https://images.financialmodelingprep.com/symbol/NOVT.png,274459,57.99,-2.35,552068,179856000,64087000,"[{'period': '2024', 'revenue': 949.25, 'unit': 'M', 'net_profit': 64.09}, {'period': '2023', 'revenue': 881.66, 'unit': 'M', 'net_profit': 72.88}, {'period': '2022', 'revenue': 860.9, 'unit': 'M', 'net_profit': 74.05}, {'period': '2021', 'revenue': 706.79, 'unit': 'M', 'net_profit': 50.33}]","[{'period': ""Q4 '24"", 'revenue': 238.06, 'unit': 'M', 'net_profit': 16.46}, {'period': ""Q3 '24"", 'revenue': 244.41, 'unit': 'M', 'net_profit': 19.19}, {'period': ""Q2 '24"", 'revenue': 235.86, 'unit': 'M', 'net_profit': 13.76}, {'period': ""Q1 '24"", 'revenue': 230.92, 'unit': 'M', 'net_profit': 14.68}, {'period': ""Q4 '23"", 'revenue': 211.57, 'unit': 'M', 'net_profit': 12.51}, {'period': ""Q3 '23"", 'revenue': 221.5, 'unit': 'M', 'net_profit': 21.22}]",1.78,1.77,1388511000,433648000,113989000,642813000,151026000,0,167791000,113989000,141350000,0.05846211791292475,-0.12062625209253822,-0.12315270935960582,__nan__,__nan__,__nan__,0.46295131979508986
234,NPCE,Neuropace Inc. Common Stock,"NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.",Mr. Joel D. Becker,Medical - Devices,11.1,USD,361417110,https://images.financialmodelingprep.com/symbol/NPCE.png,249904,-11.94,-1.2,211048,-16574000,-27141000,"[{'period': '2024', 'revenue': 79.91, 'unit': 'M', 'net_profit': -27.14}, {'period': '2023', 'revenue': 65.42, 'unit': 'M', 'net_profit': -32.96}, {'period': '2022', 'revenue': 45.52, 'unit': 'M', 'net_profit': -53.37}, {'period': '2021', 'revenue': 45.18, 'unit': 'M', 'net_profit': -38.11}]","[{'period': ""Q4 '24"", 'revenue': 21.47, 'unit': 'M', 'net_profit': -5.25}, {'period': ""Q3 '24"", 'revenue': 21.06, 'unit': 'M', 'net_profit': -5.45}, {'period': ""Q2 '24"", 'revenue': 19.26, 'unit': 'M', 'net_profit': -7.51}, {'period': ""Q1 '24"", 'revenue': 18.12, 'unit': 'M', 'net_profit': -8.93}, {'period': ""Q4 '23"", 'revenue': 18.01, 'unit': 'M', 'net_profit': -6.2}, {'period': ""Q3 '23"", 'revenue': 16.43, 'unit': 'M', 'net_profit': -7.26}]",-0.93,-0.93,94647000,81339000,52755000,86634000,12851000,0,15156000,13430000,-17949000,0.27415257948673033,0.17644738439130964,0.26771653543307083,__nan__,__nan__,__nan__,0.9153380455798916
235,NRAC,Noble Rock Acquisition Corporation Class A Ordinary Share,"Noble Rock Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the software and tech-enabled services sectors. The company was incorporated in 2020 and is based in Wilmington, Delaware.",Mr. Aemish  Shah,Shell Companies,11,USD,87425140,https://images.financialmodelingprep.com/symbol/NRAC.png,14749,220,-0.01,1900,-1508654,18258476,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 18.26}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 9.42}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': -183.25}]","[{'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 556.31}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 120.65}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -323.17}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.36}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.07}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.76}]",0.6,0.6,245094305,84588,42071,10838361,0,245009717,83063,42071,-755627,-0.14143496678941106,0.93742959518985,0.9354838709677419,__nan__,__nan__,__nan__,0.04422118661631081
236,NRACU,Noble Rock Acquisition Corporation Unit,"Noble Rock Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the software and tech-enabled services sectors. The company was incorporated in 2020 and is based in Wilmington, Delaware.",Mr. Aemish  Shah,Shell Companies,10.93,USD,87504607,https://images.financialmodelingprep.com/symbol/NRACU.png,191,29.78201634877384,-0.02,892,-1508654,18258476,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 18.26}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 9.42}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': -183.25}]","[{'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 556.31}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 120.65}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -323.17}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.36}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.07}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.76}]",0.6,0.6,245094305,84588,42071,10838361,0,245009717,83063,42071,-755627,-0.14143496678941106,0.93742959518985,0.9354838709677419,__nan__,__nan__,__nan__,0.04422118661631081
237,NRBO,NeuroBo Pharmaceuticals Inc. Common Stock,"NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of tau protein; and Gemcabene, an acute indication for COVID-19. NeuroBo Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts.",Mr. Hyung-Heon  Kim,Biotechnology,2.36,USD,20333784,https://images.financialmodelingprep.com/symbol/NRBO.png,0,-0.5501165501165501,,0,-15880000,-12470000,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.47}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.12}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.22}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -29.59}]","[{'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.65}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.05}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.71}, {'period': ""Q4 '23"", 'revenue': 0.004, 'unit': 'M', 'net_profit': -5.31}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.82}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -734.0}]",-2.46,-2.46,22781000,22512000,22435000,6096000,0,0,5960000,22435000,-10849000,-0.3932268819091069,-1.0392477514309075,0.8705944239873751,__nan__,__nan__,__nan__,0.2675914138975462
238,NRC,National Research Corporation Common Stock,"National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.",Mr. Michael D. Hays,Medical - Healthcare Information Services,11.96,USD,274428180,https://images.financialmodelingprep.com/symbol/NRC.png,89239,11.5,-0.12,136969,41307000,24783000,"[{'period': '2024', 'revenue': 143.06, 'unit': 'M', 'net_profit': 24.78}, {'period': '2023', 'revenue': 148.58, 'unit': 'M', 'net_profit': 30.97}, {'period': '2022', 'revenue': 151.57, 'unit': 'M', 'net_profit': 31.8}, {'period': '2021', 'revenue': 147.95, 'unit': 'M', 'net_profit': 37.47}]","[{'period': ""Q4 '24"", 'revenue': 36.91, 'unit': 'M', 'net_profit': 6.56}, {'period': ""Q3 '24"", 'revenue': 35.82, 'unit': 'M', 'net_profit': 5.69}, {'period': ""Q2 '24"", 'revenue': 35.02, 'unit': 'M', 'net_profit': 6.17}, {'period': ""Q1 '24"", 'revenue': 35.31, 'unit': 'M', 'net_profit': 6.36}, {'period': ""Q4 '23"", 'revenue': 38.0, 'unit': 'M', 'net_profit': 8.86}, {'period': ""Q3 '23"", 'revenue': 37.95, 'unit': 'M', 'net_profit': 7.88}]",1.05,1.04,132539000,19600000,4233000,101255000,11195000,0,35858000,4233000,19177000,-0.10172882461672285,-0.1997998127280359,-0.16666666666666663,"[0.12, 0.06]","['2025-03-28', '2014-12-29']",__nan__,0.7639638144244336
239,NRIM,Northrim BanCorp Inc Common Stock,"Northrim BanCorp, Inc. operates as the bank holding company for Northrim Bank that provides commercial banking products and services to businesses and professional individuals. It operates in two segments, Community Banking and Home Mortgage Lending. The company offers noninterest-bearing checking accounts and interest-bearing time deposits, checking and savings accounts, individual retirement and money market deposit accounts, certificates of deposit, and business sweep accounts. It also provides short and medium-term commercial loans, commercial credit lines, construction and real estate loans, and consumer loans, as well as short-term working capital. In addition, the company offers other services comprising consumer and business online banking, mobile app, and mobile deposits; and debit and credit cards. Further, it provides mobile web and text banking, consumer online account opening, personal finance, online documents, consumer debit cards, business debit cards, my rewards for consumer debit cards, retail lockbox, card control, business employee purchase cards, home equity advantage access cards, telebanking, and automated teller services. Additionally, the company offers personalized checks at account opening, overdraft protection from a savings account, commercial drive-up banking, automatic transfer and payment, People Pay, external transfer, Bill Pay, wire transfer, direct payroll deposit, electronic tax payment, Automated Clearing House origination and receipt, remote deposit capture, account reconciliation and positive pay, merchant, cash management, annuity, and long term investment portfolio products and services. It also provides investment advisory, trust, wealth management, factoring, and mortgage brokerage services. As of January 28, 2022, the company operated 17 branches in Anchorage, the Matanuska Valley, Soldotna, Juneau, Fairbanks, Ketchikan, and Sitka. Northrim BanCorp, Inc. was founded in 1990 and is headquartered in Anchorage, Alaska.",Mr. Michael G. Huston,Banks - Regional,68.88,USD,380278214,https://images.financialmodelingprep.com/symbol/NRIM.png,40775,10.4,0.22,29009,0,36971000,"[{'period': '2024', 'revenue': 155.22, 'unit': 'M', 'net_profit': 36.97}, {'period': '2023', 'revenue': 125.79, 'unit': 'M', 'net_profit': 25.39}, {'period': '2022', 'revenue': 129.19, 'unit': 'M', 'net_profit': 30.74}, {'period': '2021', 'revenue': 133.09, 'unit': 'M', 'net_profit': 37.52}]","[{'period': ""Q4 '24"", 'revenue': 41.79, 'unit': 'M', 'net_profit': 10.93}, {'period': ""Q3 '24"", 'revenue': 39.42, 'unit': 'M', 'net_profit': 8.82}, {'period': ""Q2 '24"", 'revenue': 46.19, 'unit': 'M', 'net_profit': 9.02}, {'period': ""Q1 '24"", 'revenue': 43.22, 'unit': 'M', 'net_profit': 8.2}, {'period': ""Q4 '23"", 'revenue': 35.93, 'unit': 'M', 'net_profit': 6.61}, {'period': ""Q3 '23"", 'revenue': 34.35, 'unit': 'M', 'net_profit': 8.37}]",6.72,6.61,3041869000,594796000,520718000,2774753000,74078000,0,7487000,42101000,-8727000,0,0.45589509332913286,0.4834437086092714,"[0.64, 0.05]","['2025-03-06', '1995-04-13']",__nan__,0.9121868824725851
240,NRIX,Nurix Therapeutics Inc. Common stock,"Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies; NX-5948, an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and autoimmune diseases; and NX-1607, an orally available Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor for immuno-oncology indications. It also develops NX-0255, a CBL-B inhibitor for ex vivo use to enhance adoptive T-cell therapy; and DeTIL-0255 that is in the Phase 1 clinical trial for the treatment of gynecologic cancers, including ovarian, endometrial, and cervical cancer. The company has a strategic collaboration agreement with Gilead Sciences, Inc. for cancer and other challenging diseases patients; and Sanofi S.A. The company was formerly known as Nurix Inc. and changed its name to Nurix Therapeutics, Inc. in October 2018. The company was incorporated in 2009 and is headquartered in San Francisco, California.","Dr. Arthur T. Sands M.D., Ph.D.",Biotechnology,9.26,USD,705941656,https://images.financialmodelingprep.com/symbol/NRIX.png,869257,-3.22,-0.46,1048534,-213027000,-193569000,"[{'period': '2024', 'revenue': 54.55, 'unit': 'M', 'net_profit': -193.57}, {'period': '2023', 'revenue': 76.99, 'unit': 'M', 'net_profit': -143.95}, {'period': '2022', 'revenue': 38.63, 'unit': 'M', 'net_profit': -166.04}, {'period': '2021', 'revenue': 29.75, 'unit': 'M', 'net_profit': -117.19}]","[{'period': ""Q1 '25"", 'revenue': 18.45, 'unit': 'M', 'net_profit': -56.35}, {'period': ""Q4 '24"", 'revenue': 13.28, 'unit': 'M', 'net_profit': -58.55}, {'period': ""Q3 '24"", 'revenue': 12.59, 'unit': 'M', 'net_profit': -48.96}, {'period': ""Q2 '24"", 'revenue': 12.09, 'unit': 'M', 'net_profit': -44.55}, {'period': ""Q1 '24"", 'revenue': 16.59, 'unit': 'M', 'net_profit': -41.52}, {'period': ""Q4 '23"", 'revenue': 15.16, 'unit': 'M', 'net_profit': -41.96}]",-2.88,-2.88,669343000,619387000,609583000,142350000,0,0,95854000,109997000,-181857000,-0.5064599848665926,-0.34471475810709423,-0.08679245283018867,__nan__,__nan__,__nan__,0.21267123134177843
241,NSEC,National Security Group Inc. Common Stock,"The National Security Group, Inc., an insurance holding company, provides insurance products and services in the United States. It operates in two segments, Property and Casualty (P&C) Insurance, and Life Insurance. The P&C Insurance segment primarily underwrites home insurance coverage with primary lines of business consisting of dwelling fire and extended coverage, mobile homeowners, and other liability insurance in Alabama, Arkansas, Florida, Georgia, Kentucky, Mississippi, Oklahoma, South Carolina, Tennessee, and West Virginia, as well as operates on a surplus lines basis in the state of Louisiana. The Life Insurance segment offers ordinary life, accident and health, supplemental hospital, and cancer insurance products in the states of Alabama, Florida, Georgia, Mississippi, South Carolina, Tennessee, and Texas. It distributes its products through independent agents and brokers, and home service agents. The National Security Group, Inc. was founded in 1947 and is based in Elba, Alabama.",Mr. William Brunson,Insurance - Property & Casualty,16.36,USD,0,https://images.financialmodelingprep.com/symbol/NSEC.png,0,51.125,0.025001526,1539,1565000,582000,"[{'period': '2021', 'revenue': 66210.0, 'unit': 'K', 'net_profit': 582.0}, {'period': '2020', 'revenue': 66.65, 'unit': 'M', 'net_profit': -8.62}, {'period': '2019', 'revenue': 67.4, 'unit': 'M', 'net_profit': 4.07}, {'period': '2018', 'revenue': 64860.0, 'unit': 'K', 'net_profit': 779.0}]","[{'period': ""Q1 '22"", 'revenue': 16230.0, 'unit': 'K', 'net_profit': 963.0}, {'period': ""Q4 '21"", 'revenue': -15.93, 'unit': 'M', 'net_profit': 1.71}, {'period': ""Q3 '21"", 'revenue': 16670.0, 'unit': 'K', 'net_profit': -644.0}, {'period': ""Q2 '21"", 'revenue': 16.24, 'unit': 'M', 'net_profit': -1.04}, {'period': ""Q1 '21"", 'revenue': 16309.999999999998, 'unit': 'K', 'net_profit': 722.0}, {'period': ""Q4 '20"", 'revenue': 16.99, 'unit': 'M', 'net_profit': -2.25}]",0.23,0.23,151683000,27084000,12705000,107881000,14379000,109148000,500000,10034000,5120000,1.1581926614778126,1.0675252349460493,1.067448680351906,"[0.06, 0.34]","['2022-05-06', '1987-05-11']",__nan__,0.711226703058352
242,NSIT,Insight Enterprises Inc. Common Stock,"IInsight Enterprises, Inc., together with its subsidiaries, provides information technology (IT) hardware, software, and services solutions in the United States, Canada, Europe, the Middle East, Africa, and the Asia-Pacific. The company's solution portfolio includes cloud enablement, data and AI, DevOps, digital strategy, intelligent applications and edge, and IoT solutions, as well as transformation services. It also offers cloud and data center transformation; connected workplace; and supply chain optimization solutions. In addition, the company provides software maintenance solutions that offers clients to obtain software upgrades, bug fixes, help desk, and other support services; vendor direct support services; and offers Software-as-a-Service subscription products. Further, it designs, procures, deploys, implements, and manages solutions that combine hardware, software, and services to help businesses. Additionally, the company sources, procures, stages, configures, integrates, tests, refurbishes, and redeploys IT products spanning endpoints to infrastructure; and offers software life cycle, and hardware warranty services. It serves construction technology, enterprise business, financial services, health care and life sciences, manufacturing technology, retails and restaurants, service providers, small to medium business, and travel and tourism industries. The company was founded in 1988 and is headquartered in Tempe, Arizona.",Ms. Joyce A. Mullen,Technology Distributors,128.11,USD,4088028533,https://images.financialmodelingprep.com/symbol/NSIT.png,422919,19.56,-3.4,368787,388584000,249691000,"[{'period': '2024', 'revenue': 8700.0, 'unit': 'M', 'net_profit': 249.69}, {'period': '2023', 'revenue': 9180.0, 'unit': 'M', 'net_profit': 281.31}, {'period': '2022', 'revenue': 10430.0, 'unit': 'M', 'net_profit': 280.61}, {'period': '2021', 'revenue': 9440.0, 'unit': 'M', 'net_profit': 219.34}]","[{'period': ""Q4 '24"", 'revenue': 2070.0, 'unit': 'M', 'net_profit': 37.01}, {'period': ""Q3 '24"", 'revenue': 2090.0, 'unit': 'M', 'net_profit': 58.21}, {'period': ""Q2 '24"", 'revenue': 2160.0, 'unit': 'M', 'net_profit': 87.44}, {'period': ""Q1 '24"", 'revenue': 2380.0, 'unit': 'M', 'net_profit': 67.03}, {'period': ""Q4 '23"", 'revenue': 2240.0, 'unit': 'M', 'net_profit': 90.61}, {'period': ""Q3 '23"", 'revenue': 2270.0, 'unit': 'M', 'net_profit': 60.25}]",7.73,6.55,6380309000,4844622000,259234000,4609698000,4259057000,0,4122202000,259234000,586063000,-0.19289485599870393,-0.1123959773771902,-0.09378663540445474,__nan__,__nan__,__nan__,0.722488205508542
243,NSPR,InspireMD Inc. Common Stock,"InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery. It is also developing PVGuard, a MicroNet mesh sleeve and self-expandable stent for use in peripheral vascular applications. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.",Mr. Marvin L. Slosman,Medical - Devices,2.67,USD,79272033,https://images.financialmodelingprep.com/symbol/NSPR.png,56581,-3.51,0.08,17409,-33503000,1557000,"[{'period': '2024', 'revenue': 7.01, 'unit': 'M', 'net_profit': 1.56}, {'period': '2023', 'revenue': 6.21, 'unit': 'M', 'net_profit': -19.92}, {'period': '2022', 'revenue': 5.17, 'unit': 'M', 'net_profit': -18.49}, {'period': '2021', 'revenue': 4.5, 'unit': 'M', 'net_profit': -14.92}]","[{'period': ""Q4 '24"", 'revenue': 1.95, 'unit': 'M', 'net_profit': -9.17}, {'period': ""Q3 '24"", 'revenue': 1.81, 'unit': 'M', 'net_profit': -7.89}, {'period': ""Q2 '24"", 'revenue': 1.74, 'unit': 'M', 'net_profit': -7.91}, {'period': ""Q1 '24"", 'revenue': 1.51, 'unit': 'M', 'net_profit': -7.03}, {'period': ""Q4 '23"", 'revenue': 1.76, 'unit': 'M', 'net_profit': -5.41}, {'period': ""Q3 '23"", 'revenue': 1.56, 'unit': 'M', 'net_profit': -5.18}]",-0.76,-0.76,46807000,40521000,34637000,10721000,2254000,0,7678000,18916000,-23270000,-0.602171106116398,1.0781783490660775,0.07317073170731701,__nan__,__nan__,__nan__,0.2290469374238896
244,NSSC,NAPCO Security Technologies Inc. Common Stock,"Napco Security Technologies, Inc. develops, manufactures, and sells electronic security products in the United States and internationally. The company offers access control systems, door-locking products, intrusion and fire alarm systems, and video surveillance systems for commercial, residential, institutional, industrial, and governmental applications. Its access control systems include various types of identification readers, control panels, PC-based computers, and electronically activated door-locking devices; and door locking devices comprise microprocessor-based electronic door locks with push button, card readers and bio-metric operation, door alarms, mechanical door locks, and simple dead bolt locks. The company's alarm systems include automatic communicators, cellular communication devices, control panels, combination control panels/digital communicators and digital keypad systems, fire alarm control panels, and area detectors; and video surveillance systems comprise video cameras, control panels, video monitors, or PCs. It also buys and resells various identification readers, video cameras, PC-based computers, and peripheral equipment for access control and video surveillance systems; offers school security products; and markets peripheral and related equipment manufactured by other companies. The company markets and sells its products primarily to independent distributors, dealers, and installers of security equipment. Napco Security Technologies, Inc. was founded in 1969 and is headquartered in Amityville, New York.",Mr. Richard L. Soloway,Security & Protection Services,19.82,USD,721475748,https://images.financialmodelingprep.com/symbol/NSSC.png,592281,15.13,-0.44,716464,55981000,49818000,"[{'period': '2024', 'revenue': 188.82, 'unit': 'M', 'net_profit': 49.82}, {'period': '2023', 'revenue': 170.0, 'unit': 'M', 'net_profit': 27.13}, {'period': '2022', 'revenue': 143.59, 'unit': 'M', 'net_profit': 19.6}, {'period': '2021', 'revenue': 114.03, 'unit': 'M', 'net_profit': 15.41}]","[{'period': ""Q2 '25"", 'revenue': 42.93, 'unit': 'M', 'net_profit': 10.47}, {'period': ""Q1 '25"", 'revenue': 44.0, 'unit': 'M', 'net_profit': 11.19}, {'period': ""Q4 '24"", 'revenue': 50.33, 'unit': 'M', 'net_profit': 13.53}, {'period': ""Q3 '24"", 'revenue': 49.27, 'unit': 'M', 'net_profit': 13.2}, {'period': ""Q2 '24"", 'revenue': 47.55, 'unit': 'M', 'net_profit': 12.61}, {'period': ""Q1 '24"", 'revenue': 41.68, 'unit': 'M', 'net_profit': 10.48}]",1.35,1.34,207752000,168763000,97719000,28863000,31971000,0,22229000,65340999,43774000,0.7355758797085723,0.8364728867917572,0.8243243243243245,"[0.125, 0.0625]","['2025-03-12', '2023-05-19']",__nan__,0.13893007046863567
245,NSTG,NanoString Technologies Inc. Common Stock,"NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.",Mr. R. Bradley Gray,Medical - Instruments & Supplies,0.1053,USD,5066857,https://images.financialmodelingprep.com/symbol/NSTG.png,17905172,-0.0298300283286119,-0.063,21428464,-143575000,-159543000,"[{'period': '2022', 'revenue': 127.26, 'unit': 'M', 'net_profit': -159.54}, {'period': '2021', 'revenue': 145.09, 'unit': 'M', 'net_profit': -115.25}, {'period': '2020', 'revenue': 117.32, 'unit': 'M', 'net_profit': -110.08}, {'period': '2019', 'revenue': 125.57, 'unit': 'M', 'net_profit': -40.7}]","[{'period': ""Q3 '23"", 'revenue': 48.09, 'unit': 'M', 'net_profit': -37.41}, {'period': ""Q2 '23"", 'revenue': 44.16, 'unit': 'M', 'net_profit': -43.67}, {'period': ""Q1 '23"", 'revenue': 35.8, 'unit': 'M', 'net_profit': -41.24}, {'period': ""Q4 '22"", 'revenue': 34.42, 'unit': 'M', 'net_profit': -44.11}, {'period': ""Q3 '22"", 'revenue': 29.54, 'unit': 'M', 'net_profit': -36.69}, {'period': ""Q2 '22"", 'revenue': 32.22, 'unit': 'M', 'net_profit': -39.24}]",-3.44,-3.44,353412000,286774000,196532000,307598000,31506000,0,58860000,112250000,-151672000,-0.4113894186343708,-0.38427299703264095,-0.3543307086614173,__nan__,__nan__,__nan__,0.8703665976254343
246,NSYS,Nortech Systems Incorporated Common Stock,"Nortech Systems Incorporated provides design and manufacturing solutions for electromedical devices, electromechanical systems, assemblies, and components in the United States, Mexico, and China. It offers a range of technical and manufacturing, and support services, including project management, designing, testing, prototyping, manufacturing, supply chain management, and post-market services. The company also provides manufacturing and engineering services for medical devices, printed circuit board assemblies, wire and cable assemblies, and higher-level electromechanical assemblies. In addition, it offers engineering and repair services. The company serves original equipment manufacturers in the aerospace and defense, medical, and industrial markets through business development teams and independent manufacturers' representatives. Nortech Systems Incorporated was founded in 1990 and is headquartered in Maple Grove, Minnesota.",Mr. Jay Dean Miller,"Hardware, Equipment & Parts",8.6,USD,23744514,https://images.financialmodelingprep.com/symbol/NSYS.png,5354,-18.3,0.29,4532,-195000,0,"[{'period': '2024', 'revenue': 128130000.0, 'unit': '', 'net_profit': 0.0}, {'period': '2023', 'revenue': 139.33, 'unit': 'M', 'net_profit': 6.87}, {'period': '2022', 'revenue': 134.12, 'unit': 'M', 'net_profit': 2.01}, {'period': '2021', 'revenue': 115.17, 'unit': 'M', 'net_profit': 7.15}]","[{'period': ""Q4 '24"", 'revenue': 28.62, 'unit': 'M', 'net_profit': -1.48}, {'period': ""Q3 '24"", 'revenue': 31410.0, 'unit': 'K', 'net_profit': -739.0}, {'period': ""Q2 '24"", 'revenue': 33890.0, 'unit': 'K', 'net_profit': 157.0}, {'period': ""Q1 '24"", 'revenue': 34220.0, 'unit': 'K', 'net_profit': 765.0}, {'period': ""Q4 '23"", 'revenue': 36.05, 'unit': 'M', 'net_profit': 4.35}, {'period': ""Q3 '23"", 'revenue': 33.37, 'unit': 'M', 'net_profit': 1.21}]",0,0,72435000,55315000,916000,38430000,28667000,0,21428000,916000,-3520000,-1.0243658628014494,-1,-1,__nan__,__nan__,__nan__,0.530544626216608
247,NTAP,NetApp Inc. Common Stock,"NetApp, Inc. provides cloud-led and data-centric services to manage and share data on-premises, and private and public clouds worldwide. It operates in two segments, Hybrid Cloud and Public Could. The company offers intelligent data management software, such as NetApp ONTAP, NetApp Snapshot, NetApp SnapCenter Backup Management, NetApp SnapMirror Data Replication, NetApp SnapLock Data Compliance, NetApp ElementOS software, and NetApp SANtricity software; and storage infrastructure solutions, including NetApp All-Flash FAS series, NetApp Fabric Attached Storage, NetApp FlexPod, NetApp E/EF series, NetApp StorageGRID, and NetApp SolidFire. It also provides cloud storage and data services comprising NetApp Cloud Volumes ONTAP, Azure NetApp Files, Amazon FSx for NetApp ONTAP, NetApp Cloud Volumes Service for Google Cloud, NetApp Cloud Sync, NetApp Cloud Tiering, NetApp Cloud Backup, NetApp Cloud Data Sense, and NetApp Cloud Volumes Edge Cache; and cloud operations services, such as NetApp Cloud Insights, Spot Ocean Kubernetes Suite, Spot Security, Spot Eco, and Spot CloudCheckr. In addition, the company offers application-aware data management service under the NetApp Astra name; and professional and support services, such as strategic consulting, professional, managed, and support services. Further, it provides assessment, design, implementation, and migration services. The company serves the energy, financial service, government, technology, internet, life science, healthcare service, manufacturing, media, entertainment, animation, video postproduction, and telecommunication markets through a direct sales force and an ecosystem of partners. NetApp, Inc. was incorporated in 1992 and is headquartered in San Jose, California.",Mr. George  Kurian,Computer Hardware,76.14,USD,15487789680,https://images.financialmodelingprep.com/symbol/NTAP.png,2189811,14.1,-0.93,2805224,1582000000,986000000,"[{'period': '2024', 'revenue': 6270.0, 'unit': 'M', 'net_profit': 986.0}, {'period': '2023', 'revenue': 6.36, 'unit': 'B', 'net_profit': 1.27}, {'period': '2022', 'revenue': 6320.0, 'unit': 'M', 'net_profit': 937.0}, {'period': '2021', 'revenue': 5740.0, 'unit': 'M', 'net_profit': 730.0}]","[{'period': ""Q3 '25"", 'revenue': 1640.0, 'unit': 'M', 'net_profit': 299.0}, {'period': ""Q2 '25"", 'revenue': 1660.0, 'unit': 'M', 'net_profit': 299.0}, {'period': ""Q1 '25"", 'revenue': 1540.0, 'unit': 'M', 'net_profit': 248.0}, {'period': ""Q4 '24"", 'revenue': 1670.0, 'unit': 'M', 'net_profit': 291.0}, {'period': ""Q3 '24"", 'revenue': 1610.0, 'unit': 'M', 'net_profit': 313.0}, {'period': ""Q2 '24"", 'revenue': 1560.0, 'unit': 'M', 'net_profit': 233.0}]",4.74,4.63,9887000000,4897000000,3258000000,8741000000,1007000000,117000000,4106000000,1903000000,1530000000,0.10320781032078104,-0.2260596546310832,-0.19250425894378193,"[0.52, 0.15]","['2025-04-04', '2013-07-09']",__nan__,0.8840902194801254
248,NTCT,NetScout Systems Inc. Common Stock,"NetScout Systems, Inc. provides service assurance and cybersecurity solutions for protect digital business services against disruptions in the United States, Europe, Asia, and internationally. The company offers nGeniusONE management software that enables customers to predict, preempt, and resolve network and service delivery problems, as well as facilitate the optimization and capacity planning of their network infrastructures; and specialized platforms and analytic modules that enable its customers to analyze and troubleshoot traffic in radio access and Wi-Fi networks. It also provides nGeniusPULSE, an active testing tool that enables enterprises to identify infrastructure performance issues and determine application availability, reliability, and performance; and nGenius Business Analytics solution, which enables service providers to analyze their network traffic. In addition, the company offers ISNG, an advanced passive network probe; packet flow systems that deliver targeted network traffic access to various monitoring and security tools and systems; and a suite of test access points that enable non-disruptive access to network traffic. Further, it provides cybersecurity solutions to protect their networks against distributed denial of service attacks under the Arbor brand, such as Arbor Sightline, Arbor Threat Mitigation System, Arbor Insight, Arbor Edge Defense, and Arbor Cloud. Additionally, it offers advanced threat detection solutions, such as Omnis Cyber Investigator. It serves enterprise customers in various industries, including financial services, technology, manufacturing, healthcare, utilities, education, transportation, and retail; mobile operators, wireline operators, cable operators, Internet service providers, and cloud providers; and governmental agencies through a direct sales force, and indirect reseller and distribution channels. NetScout Systems, Inc. was incorporated in 1984 and is headquartered in Westford, Massachusetts.",Mr. Anil K. Singhal,Software - Infrastructure,19.23,USD,1379842881,https://images.financialmodelingprep.com/symbol/NTCT.png,476578,-3.29,-0.07,474765,-51427000,-147734000,"[{'period': '2024', 'revenue': 829.46, 'unit': 'M', 'net_profit': -147.73}, {'period': '2023', 'revenue': 914.53, 'unit': 'M', 'net_profit': 59.65}, {'period': '2022', 'revenue': 855.58, 'unit': 'M', 'net_profit': 35.87}, {'period': '2021', 'revenue': 831.28, 'unit': 'M', 'net_profit': 19.35}]","[{'period': ""Q3 '25"", 'revenue': 252.02, 'unit': 'M', 'net_profit': 48.81}, {'period': ""Q2 '25"", 'revenue': 191.11, 'unit': 'M', 'net_profit': 9.03}, {'period': ""Q1 '25"", 'revenue': 174.56, 'unit': 'M', 'net_profit': -443.38}, {'period': ""Q4 '24"", 'revenue': 203.44, 'unit': 'M', 'net_profit': -32.42}, {'period': ""Q3 '24"", 'revenue': 218.07, 'unit': 'M', 'net_profit': -132.58}, {'period': ""Q2 '24"", 'revenue': 196.8, 'unit': 'M', 'net_profit': 21.46}]",-2.07,-2.07,2595302000,672494000,423133000,703237000,192096000,994000,395082000,389674000,52474000,-1.2955353910340033,-3.476763680257511,-3.4939759036144578,__nan__,__nan__,__nan__,0.2709653828340594
249,NTEC,Intec Pharma Ltd. Ordinary Shares,"Intec Pharma Ltd, a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Its Accordion Pill is an oral drug delivery system that is designed to enhance the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release mechanism. The company's lead product candidate is Accordion Pill Carbidopa/Levodopa, which is in a Phase III clinical trial for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients. It is also developing Accordion Pill Zaleplon that is in a Phase III clinical trial as a treatment for the induction and maintenance of sleep in patients suffering from insomnia; a product candidate, which has completed a Phase I clinical trial for the prevention and treatment of gastroduodenal and small bowel Nonsteroidal Anti-Inflammatory Drug induced ulcers; and AP-CBD/THC, AP-THC, and AP-CBD product candidates with Cannabidiol and 9-Tetrahydrocannabinol for the treatment of various pain indications. Intec Pharma Ltd. has a research collaboration agreement with Merck to explore using the Accordion Pill platform for development program. The company was formerly known as Intec Pharmaceuticals (2000) Ltd. and changed its name to Intec Pharma Ltd in March 2004. Intec Pharma Ltd was founded in 2000 and is based in Jerusalem, Israel.",Mr. Jeffrey Meckler,Biotechnology,9.63,USD,0,https://images.financialmodelingprep.com/symbol/NTEC.png,1050876,0,-1.3699999,988303,-12801000,-14128000,"[{'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.13}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -47.6}, {'period': '2018', 'revenue': 0.0, 'unit': 'M', 'net_profit': -43.54}, {'period': '2017', 'revenue': 0.0, 'unit': 'M', 'net_profit': -29.09}]","[{'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.23}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.57}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.74}, {'period': ""Q2 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.95}, {'period': ""Q1 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.87}, {'period': ""Q4 '19"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.56}]",-14.3,-14.3,20896000,14968000,14671000,6363000,85000,0,5334000,14671000,-11533000,0.7222728456131216,0.7031870417445745,0.8731594819939684,__nan__,__nan__,__nan__,0.30450803981623276
250,NTES,NetEase Inc. American Depositary Shares,"NetEase, Inc. engages in online games, music streaming, online intelligent learning services, and internet content services businesses in China and internationally. The company operates through Games and Related Value-Added Services; Youdao; Cloud Music; and Innovative Businesses and Others segments. It develops and operates PC and mobile games, as well as offers games licensed from other game developers. The company's products and services include Youdao Dictionary, an online knowledge tool; Youdao Translation, a tool specifically designed to support translation needs of business and leisure travelers; U-Dictionary, an online dictionary and translation app; Youdao Kids' Dictionary, a smart and fun tool; smart devices, such as Youdao Dictionary Pen, Youdao Smart Learning Pad, and Youdao Listening Pod; online courses; interactive learning apps; and education digitalization solutions, such as Youdao Smart Learning Terminal, a device that automates paper-based homework processing; Youdao Smart Cloud, a cloud-based platform that allows third-party app developers, smart device brands, and manufacturers to the company's OCR capabilities; and Youdao Sports, a sports-centric educational system. Its products and services include NetEase Cloud Music, a music streaming platform; Yanxuan, an e-commerce platform, which sells private label products; www.163.com portal and related mobile app, Wangyi Xinwen, which deliver information such as news, sports events, technology, fashion trends, and online entertainment; NetEase Mail, an email service; NetEase CC Live streaming, a live streaming platform with a focus on game broadcasting; and NetEase Pay, a payment platform. The company was formerly known as NetEase.com, Inc. and changed its name to NetEase, Inc. in March 2012. NetEase, Inc. was founded in 1997 and is headquartered in Hangzhou, the People's Republic of China.",Mr. Lei  Ding,Electronic Gaming & Multimedia,91.37,USD,58887418242,https://images.financialmodelingprep.com/symbol/NTES.png,1485765,14.48,-0.98,2962216,32001884000,29697609000,"[{'period': '2024', 'revenue': 105.3, 'unit': 'B', 'net_profit': 29.7}, {'period': '2023', 'revenue': 103.47, 'unit': 'B', 'net_profit': 29.42}, {'period': '2022', 'revenue': 96.5, 'unit': 'B', 'net_profit': 20.34}, {'period': '2021', 'revenue': 87.61, 'unit': 'B', 'net_profit': 16.86}]","[{'period': ""Q4 '24"", 'revenue': 26.75, 'unit': 'B', 'net_profit': 8.77}, {'period': ""Q3 '24"", 'revenue': 26.21, 'unit': 'B', 'net_profit': 6.54}, {'period': ""Q2 '24"", 'revenue': 25.49, 'unit': 'B', 'net_profit': 6.76}, {'period': ""Q1 '24"", 'revenue': 26.85, 'unit': 'B', 'net_profit': 7.63}, {'period': ""Q4 '23"", 'revenue': 27.14, 'unit': 'B', 'net_profit': 6.58}, {'period': ""Q3 '23"", 'revenue': 27.27, 'unit': 'B', 'net_profit': 7.84}]",9.19,9.19,195991550000,153324656000,137580808000,53497412000,5669027000,3025000000,49667657000,51383310000,38401413000,0.0402244100031972,0.00955438285221191,0.015469613259668374,"[1.21775, 1]","['2025-03-06', '2013-01-11']",__nan__,0.27295774741309
251,NTGR,NETGEAR Inc. Common Stock,"NETGEAR, Inc. designs, develops, and markets networking and Internet connected products for consumers, businesses, and service providers. The company operates in two segments, Connected Home, and Small and Medium Business. It offers smart home/connected home/broadband access products, such as Wi-Fi routers and home Wi-Fi systems, broadband modems, Wi-Fi gateways, Wi-Fi hotspots, Wi-Fi range extenders, Powerline adapters and bridges, Wi-Fi network adapters, and digital canvasses; and value-added service offerings, including technical support, parental controls, and cybersecurity protection. The company also provides Ethernet switches, Wi-Fi mesh systems and access points, local and remote unified storage products, and Internet security appliances for small and medium-sized businesses, as well as education, hospitality and health markets. It markets and sells its products through traditional retailers, online retailers, wholesale distributors, direct market resellers, value-added resellers, and broadband service providers, as well as through its direct online store at www.netgear.com. in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 1996 and is headquartered in San Jose, California.",Mr. Charles J. Prober,Communication Equipment,20.21,USD,583440469,https://images.financialmodelingprep.com/symbol/NTGR.png,383486,48.12,-0.34,424414,-65803000,12363000,"[{'period': '2024', 'revenue': 673.76, 'unit': 'M', 'net_profit': 12.36}, {'period': '2023', 'revenue': 740.84, 'unit': 'M', 'net_profit': -104.77}, {'period': '2022', 'revenue': 932.47, 'unit': 'M', 'net_profit': -68.99}, {'period': '2021', 'revenue': 1170.0, 'unit': 'M', 'net_profit': 49.39}]","[{'period': ""Q4 '24"", 'revenue': 182.42, 'unit': 'M', 'net_profit': -8.89}, {'period': ""Q3 '24"", 'revenue': 182.85, 'unit': 'M', 'net_profit': 85.07}, {'period': ""Q2 '24"", 'revenue': 144.03, 'unit': 'M', 'net_profit': -45.17}, {'period': ""Q1 '24"", 'revenue': 164.66, 'unit': 'M', 'net_profit': -18.65}, {'period': ""Q4 '23"", 'revenue': 188.67, 'unit': 'M', 'net_profit': -1.67}, {'period': ""Q3 '23"", 'revenue': 197.84, 'unit': 'M', 'net_profit': -84.8}]",0.43,0.42,850230000,758029000,408690000,309164000,156210000,0,270083000,286444000,155803000,-1.6276005270933993,1.118004715225214,1.1204481792717087,__nan__,__nan__,__nan__,0.3636239605753737
252,NTIC,Northern Technologies International Corporation Common Stock,"Northern Technologies International Corporation develops and markets rust and corrosion inhibiting products and services in North America, South America, Europe, Asia, the Middle East and internationally. It offers rust and corrosion inhibiting products, such as plastic and paper packaging, liquids, coatings, rust removers, cleaners, diffusers, and engineered solutions designed for the oil and gas industry under the ZERUST brand. The company also provides a portfolio of bio-based and certified compostable polymer resin compounds and finished products under the Natur-Tec brand. In addition, it offers on-site and technical consulting for rust and corrosion prevention issues. The company sells its products and services to automotive, electronics, electrical, mechanical, military, retail consumer, and oil and gas markets through direct sales force, network of independent distributors and agents, manufacturer's sales representatives, strategic partners, and joint venture. Northern Technologies International Corporation was founded in 1970 and is headquartered in Circle Pines, Minnesota.",Mr. G. Patrick Lynch,Chemicals - Specialty,9.25,USD,87602218,https://images.financialmodelingprep.com/symbol/NTIC.png,19813,17.79,-0.38,38164,9740374,5409082000,"[{'period': '2024', 'revenue': 0.08506000000000001, 'unit': 'B', 'net_profit': 5.41}, {'period': '2023', 'revenue': 79.9, 'unit': 'M', 'net_profit': 2.91}, {'period': '2022', 'revenue': 74.16, 'unit': 'M', 'net_profit': 6.32}, {'period': '2021', 'revenue': 56.49, 'unit': 'M', 'net_profit': 6.28}]","[{'period': ""Q1 '25"", 'revenue': 21340.0, 'unit': 'K', 'net_profit': 561.09}, {'period': ""Q4 '24"", 'revenue': 23.35, 'unit': 'M', 'net_profit': 1.84}, {'period': ""Q3 '24"", 'revenue': 20690.0, 'unit': 'K', 'net_profit': 976.6}, {'period': ""Q2 '24"", 'revenue': 20.84, 'unit': 'M', 'net_profit': 1.7}, {'period': ""Q1 '24"", 'revenue': 20180.0, 'unit': 'K', 'net_profit': 895.52}, {'period': ""Q4 '23"", 'revenue': 20710.0, 'unit': 'K', 'net_profit': 938.95}]",0.57,0.55,94676502,41579219,4952184,19501181,20422095,25397287,17896943,4952184,2464965,7.124520596620529,1856.3383841366683,0.8387096774193546,"[0.07, 0.05]","['2025-01-29', '1992-11-23']",__nan__,0.20597699099613967
253,NTLA,Intellia Therapeutics Inc. Common Stock,"Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemophilia A and hemophilia B, hyperoxaluria Type 1, and alpha-1 antitrypsin deficiency. Its ex vivo pipeline includes NTLA-5001 for the treatment of acute myeloid leukemia; and proprietary programs focused on developing engineered cell therapies to treat various oncological and autoimmune disorders. In addition, it offers tools comprising of Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. Intellia Therapeutics, Inc. has license and collaboration agreements with Novartis Institutes for BioMedical Research, Inc. to engineer hematopoietic stem cells for the treatment of sickle cell disease; Regeneron Pharmaceuticals, Inc. to co-develop potential products for the treatment of hemophilia A and hemophilia B; Ospedale San Raffaele; and a strategic collaboration with SparingVision SAS to develop novel genomic medicines utilizing CRISPR/Cas9 technology for the treatment of ocular diseases. The company was formerly known as AZRN, Inc. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.",Dr. John M. Leonard M.D.,Biotechnology,6.28,USD,650086760,https://images.financialmodelingprep.com/symbol/NTLA.png,3517027,-1.2,-0.26,3690325,-523978000,-519021000,"[{'period': '2024', 'revenue': 57.88, 'unit': 'M', 'net_profit': -519.02}, {'period': '2023', 'revenue': 36.27, 'unit': 'M', 'net_profit': -481.19}, {'period': '2022', 'revenue': 52.12, 'unit': 'M', 'net_profit': -490.21}, {'period': '2021', 'revenue': 33.05, 'unit': 'M', 'net_profit': -259.72}]","[{'period': ""Q4 '24"", 'revenue': 12.87, 'unit': 'M', 'net_profit': -128.9}, {'period': ""Q3 '24"", 'revenue': 9.11, 'unit': 'M', 'net_profit': -135.71}, {'period': ""Q2 '24"", 'revenue': 6.96, 'unit': 'M', 'net_profit': -146.97}, {'period': ""Q1 '24"", 'revenue': 28.93, 'unit': 'M', 'net_profit': -107.44}, {'period': ""Q4 '23"", 'revenue': -1.92, 'unit': 'M', 'net_profit': -132.16}, {'period': ""Q3 '23"", 'revenue': 11.99, 'unit': 'M', 'net_profit': -122.22}]",-5.25,-5.25,1191015000,639863000,601515000,319059000,8517000,44264000,110851000,189182000,-408071000,-0.03488539743045337,-0.07861518894744718,0.031365313653136516,__nan__,__nan__,__nan__,0.26788831374919714
254,NTNX,Nutanix Inc. Class A Common Stock,"Nutanix, Inc. provides an enterprise cloud platform in North America, Europe, the Asia Pacific, the Middle East, Latin America, and Africa. The company offers Acropolis converges virtualization, enterprise storage services, and networking visualization and security services; Acropolis Hypervisor, an enterprise-grade virtualization solution; Nutanix Karbon for automated deployment and management of Kubernetes clusters to simplify the provisioning, operations, and lifecycle management of cloud-native environments; and Nutanix Clusters solution. It also offers Prism Pro; Nutanix Beam, a cloud governance; and Nutanix Calm, an application marketplace, which provides automation services that streamline application lifecycle management and deliver powerful hybrid cloud orchestration. In addition, the company provides Nutanix Files, an enterprise-grade NFS and SMB files services; Nutanix Objects, a S3-compatible object services; Nutanix Era, a database automation and database-as-a-service solution; and Nutanix Frame, a desktop-as-a-service product to deliver virtual apps or desktops to users from multiple public cloud environments and/or an enterprises private cloud datacenter. Further, it offers products support, and consulting and implementation services. It serves customers in a range of industries, including automotive, consumer goods, education, energy, financial services, healthcare, manufacturing, media, public sector, retail, technology, and telecommunications, as well as service providers. The company was incorporated in 2009 and is headquartered in San Jose, California.",Dr. Rajiv  Ramaswami Ph.D.,Software - Infrastructure,58.17,USD,15511728482,https://images.financialmodelingprep.com/symbol/NTNX.png,2528485,-223.73,-0.45,2972479,172723000,-124775000,"[{'period': '2024', 'revenue': 2150.0, 'unit': 'M', 'net_profit': -124.78}, {'period': '2023', 'revenue': 1860.0, 'unit': 'M', 'net_profit': -254.56}, {'period': '2022', 'revenue': 1580.0, 'unit': 'M', 'net_profit': -797.54}, {'period': '2021', 'revenue': 1.39, 'unit': 'B', 'net_profit': -1.03}]","[{'period': ""Q2 '25"", 'revenue': 654.72, 'unit': 'M', 'net_profit': 56.43}, {'period': ""Q1 '25"", 'revenue': 590.96, 'unit': 'M', 'net_profit': 29.93}, {'period': ""Q4 '24"", 'revenue': 547.95, 'unit': 'M', 'net_profit': -126.1}, {'period': ""Q3 '24"", 'revenue': 524.58, 'unit': 'M', 'net_profit': -15.62}, {'period': ""Q2 '24"", 'revenue': 565.23, 'unit': 'M', 'net_profit': 32.8}, {'period': ""Q1 '24"", 'revenue': 511.05, 'unit': 'M', 'net_profit': -15.85}]",-0.51,-0.51,2143918000,1481294000,994342000,2872066000,229796000,0,1244341000,655270000,597679000,3.9920661042493113,0.5098405091137649,0.5321100917431193,__nan__,__nan__,__nan__,1.3396342583998082
255,NTRA,Natera Inc. Common Stock,"Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora miscarriage test products to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by gestation using a blood draw from the pregnant mother and alleged father. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests; Signatera, a circulating tumor DNA technology that screen for a generic set of mutations independent of an individual's tumor; and Prospera used to assess organ transplant rejection. The company offers products through its direct sales force, as well as through a network of approximately 100 laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is based in Austin, Texas.",Mr. Steven Leonard Chapman,Medical - Diagnostics & Research,132.23,USD,17875644780,https://images.financialmodelingprep.com/symbol/NTRA.png,1792486,-85.86,-6.03,1814726,-148078000,-190426000,"[{'period': '2024', 'revenue': 1700.0, 'unit': 'M', 'net_profit': -190.43}, {'period': '2023', 'revenue': 1080.0, 'unit': 'M', 'net_profit': -434.8}, {'period': '2022', 'revenue': 820.22, 'unit': 'M', 'net_profit': -547.8}, {'period': '2021', 'revenue': 625.49, 'unit': 'M', 'net_profit': -471.72}]","[{'period': ""Q4 '24"", 'revenue': 476.06, 'unit': 'M', 'net_profit': -53.77}, {'period': ""Q3 '24"", 'revenue': 439.76, 'unit': 'M', 'net_profit': -31.59}, {'period': ""Q2 '24"", 'revenue': 413.35, 'unit': 'M', 'net_profit': -37.46}, {'period': ""Q1 '24"", 'revenue': 367.74, 'unit': 'M', 'net_profit': -67.6}, {'period': ""Q4 '23"", 'revenue': 311.11, 'unit': 'M', 'net_profit': -78.03}, {'period': ""Q3 '23"", 'revenue': 268.31, 'unit': 'M', 'net_profit': -109.03}]",-1.53,-1.53,1660735000,1375820000,968276000,465315000,314165000,0,344045000,945587000,69241000,0.6136517809620221,0.5620387257619003,0.5952380952380952,__nan__,__nan__,__nan__,0.28018618262395867
256,NTRS,Northern Trust Corporation Common Stock,"Northern Trust Corporation, a financial holding company, provides wealth management, asset servicing, asset management, and banking solutions for corporations, institutions, families, and individuals worldwide. It operates in two segments, Asset Servicing and Wealth Management. The Asset Servicing segment offers asset servicing and related services, including custody, fund administration, investment operations outsourcing, investment management, investment risk and analytical services, employee benefit services, securities lending, foreign exchange, treasury management, brokerage services, transition management services, banking, and cash management services. This segment serves corporate and public retirement funds, foundations, endowments, fund managers, insurance companies, sovereign wealth funds, and other institutional investors. The Wealth Management segment offers trust, investment management, custody, and philanthropic; financial consulting; guardianship and estate administration; family business consulting; family financial education; brokerage services; and private and business banking services. This segment serves high-net-worth individuals and families, business owners, executives, professionals, retirees, and established privately held businesses. The company also provides asset management services, such as active and passive equity; active and passive fixed income; cash management; alternative asset classes comprising private equity and hedge funds of funds; and multi-manager advisory services and products through separately managed accounts, bank common and collective funds, registered investment companies, exchange traded funds, non-U.S. collective investment funds, and unregistered private investment funds. In addition, it offers overlay and other risk management services. Northern Trust Corporation was founded in 1889 and is headquartered in Chicago, Illinois.",Mr. Michael Gerard O'Grady,Asset Management,84.45,USD,16465385400,https://images.financialmodelingprep.com/symbol/NTRS.png,1355752,8.64,-1.05,1348044,0,2031100000,"[{'period': '2024', 'revenue': 8.29, 'unit': 'B', 'net_profit': 2.03}, {'period': '2023', 'revenue': 6.77, 'unit': 'B', 'net_profit': 1.11}, {'period': '2022', 'revenue': 6.75, 'unit': 'B', 'net_profit': 1.34}, {'period': '2021', 'revenue': 6.55, 'unit': 'B', 'net_profit': 1.55}]","[{'period': ""Q4 '24"", 'revenue': 1960.0, 'unit': 'M', 'net_profit': 455.4}, {'period': ""Q3 '24"", 'revenue': 1410.0, 'unit': 'M', 'net_profit': 464.9}, {'period': ""Q2 '24"", 'revenue': 4610.0, 'unit': 'M', 'net_profit': 896.1}, {'period': ""Q1 '24"", 'revenue': 3560.0, 'unit': 'M', 'net_profit': 214.7}, {'period': ""Q4 '23"", 'revenue': 3260.0, 'unit': 'M', 'net_profit': 113.1}, {'period': ""Q3 '23"", 'revenue': 1710.0, 'unit': 'M', 'net_profit': 327.8}]",10.45,10.42,155508400000,4677200000,4677200000,142720000000,41100000,51298200000,0,45397300000,-1231500000,-1,0.8342815858394292,1.0530451866404715,"[0.75, 0.23]","['2025-03-14', '1986-12-04']",__nan__,0.91776392786499
257,NTRSO,Northern Trust Corporation Depositary Shares Each Representing a 1/1000th Interest in a Share of Series E Non-Cumulative Perpetual Preferred Stock,"Northern Trust Corporation, a financial holding company, provides wealth management, asset servicing, asset management, and banking solutions for corporations, institutions, families, and individuals worldwide. It operates in two segments, Corporate & Institutional Services (C&IS) and Wealth Management. The C&IS segment offers asset servicing and related services, including custody, fund administration, investment operations outsourcing, investment management, investment risk and analytical services, employee benefit services, securities lending, foreign exchange, treasury management, brokerage services, transition management services, banking, and cash management services. This segment serves corporate and public retirement funds, foundations, endowments, fund managers, insurance companies, sovereign wealth funds, and other institutional investors. The Wealth Management segment offers trust, investment management, custody, and philanthropic; financial consulting; guardianship and estate administration; family business consulting; family financial education; brokerage services; and private and business banking services. This segment serves high-net-worth individuals and families, business owners, executives, professionals, retirees, and established privately held businesses. The company also provides asset management services, such as active and passive equity; active and passive fixed income; cash management; alternative asset classes comprising private equity and hedge funds of funds; and multi-manager advisory services and products through separately managed accounts, bank common and collective funds, registered investment companies, exchange traded funds, non-U.S. collective investment funds, and unregistered private investment funds. In addition, it offers overlay and other risk management services. The company was founded in 1889 and is headquartered in Chicago, Illinois.",Mr. Michael Gerard O'Grady,Asset Management,19.49,USD,3800004280,https://images.financialmodelingprep.com/symbol/NTRSO.png,34947,2.7,-0.02,28718,0,2031100000,"[{'period': '2024', 'revenue': 8.29, 'unit': 'B', 'net_profit': 2.03}, {'period': '2023', 'revenue': 6.77, 'unit': 'B', 'net_profit': 1.11}, {'period': '2022', 'revenue': 6.75, 'unit': 'B', 'net_profit': 1.34}, {'period': '2021', 'revenue': 6.55, 'unit': 'B', 'net_profit': 1.55}]","[{'period': ""Q4 '24"", 'revenue': 1960.0, 'unit': 'M', 'net_profit': 455.4}, {'period': ""Q3 '24"", 'revenue': 1410.0, 'unit': 'M', 'net_profit': 464.9}, {'period': ""Q2 '24"", 'revenue': 4610.0, 'unit': 'M', 'net_profit': 896.1}, {'period': ""Q1 '24"", 'revenue': 3560.0, 'unit': 'M', 'net_profit': 214.7}, {'period': ""Q4 '23"", 'revenue': 3260.0, 'unit': 'M', 'net_profit': 113.1}, {'period': ""Q3 '23"", 'revenue': 1710.0, 'unit': 'M', 'net_profit': 327.8}]",10.45,10.42,155508400000,4677200000,4677200000,142720000000,41100000,51298200000,0,45397300000,-1231500000,-1,0.8342815858394292,1.0530451866404715,"[0.29375, 0.477]","['2025-03-14', '2020-03-12']",__nan__,0.91776392786499
258,NTUS,Natus Medical Incorporated Common Stock,"Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers essential products used in the everyday operation of neonatal intensive care unit (NICU); balance assessment systems to evaluate patients with balance disorders; and NICVIEW, a live streaming video for families with babies in the NICU. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others. The company was formerly known as ALGOTEK Instruments, Inc. and changed its name to Natus Medical Incorporated in September 1988. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Middleton, Wisconsin.",Mr. Jonathan Kennedy,Medical - Devices,32.96,USD,0,https://images.financialmodelingprep.com/symbol/NTUS.png,339685,86.73684210526316,0,132698,49318000,13177000,"[{'period': '2021', 'revenue': 473.44, 'unit': 'M', 'net_profit': 13.18}, {'period': '2020', 'revenue': 415.68, 'unit': 'M', 'net_profit': -16.61}, {'period': '2019', 'revenue': 495.18, 'unit': 'M', 'net_profit': -15.67}, {'period': '2018', 'revenue': 530.89, 'unit': 'M', 'net_profit': -22.93}]","[{'period': ""Q1 '22"", 'revenue': 119.79, 'unit': 'M', 'net_profit': 1.9}, {'period': ""Q4 '21"", 'revenue': 128.66, 'unit': 'M', 'net_profit': 1.75}, {'period': ""Q3 '21"", 'revenue': 113.88, 'unit': 'M', 'net_profit': 5.57}, {'period': ""Q2 '21"", 'revenue': 115.98, 'unit': 'M', 'net_profit': 3.46}, {'period': ""Q1 '21"", 'revenue': 114.93, 'unit': 'M', 'net_profit': 2.4}, {'period': ""Q4 '20"", 'revenue': 118.72, 'unit': 'M', 'net_profit': 5.2}]",0.39,0.39,564288000,277291000,75595000,139538000,111760000,0,114601000,75595000,60375000,4.081186894704307,1.7931740203455127,1.7959183673469388,__nan__,__nan__,__nan__,0.24728152999886582
259,NTWK,NetSol Technologies Inc. Common  Stock,"NetSol Technologies, Inc. designs, develops, markets, and exports software products to the automobile financing and leasing, banking, and financial services industries worldwide. The company offers NFS Ascent, a suite of financial applications for businesses in the finance and leasing industry. Its NFS Ascent constituent applications include Omni Point of Sale, a web-based application; Contract Management System (CMS), an application for managing and maintaining credit contracts; Wholesale Finance System (WFS), a system for automating and managing the lifecycle of wholesale finance; Dealer Auditor Access System, a web-based solution that could be used in conjunction with WFS or any third-party wholesale finance system; NFS Ascent On The Cloud, a cloud-version of NFS Ascent; and NFS Digital solutions covering Self Point of Sale, Mobile Account, Mobile Point of Sale, Mobile Dealer, Mobile Auditor, Mobile Collector, and Mobile Field Investigator. The company also provides Otoz Digital Auto-Retail, a white-labelled SaaS platform; Otoz Ecosystem, an API-based architecture; and Otoz Platform, a white label platform, which includes Dealer Tool and Customer App portals. In addition, it offers system integration, consulting, and IT products and services. It serves blue chip organizations, Dow-Jones 30 Industrials, Fortune 500 manufacturers and financial institutions, vehicle manufacturers, and enterprise technology providers. The company was incorporated in 1997 and is headquartered in Calabasas, California.",Mr. Najeeb Ullah Ghauri,Software - Application,2.17,USD,25323900,https://images.financialmodelingprep.com/symbol/NTWK.png,20547,-31,-0.02,22063,6087413,683873,"[{'period': '2024', 'revenue': 61390.0, 'unit': 'K', 'net_profit': 683.87}, {'period': '2023', 'revenue': 52.39, 'unit': 'M', 'net_profit': -5.24}, {'period': '2022', 'revenue': 57.25, 'unit': 'M', 'net_profit': 1.1}, {'period': '2021', 'revenue': 54.92, 'unit': 'M', 'net_profit': 1.78}]","[{'period': ""Q2 '25"", 'revenue': 15.54, 'unit': 'M', 'net_profit': -1.15}, {'period': ""Q1 '25"", 'revenue': 14600.0, 'unit': 'K', 'net_profit': 70.8}, {'period': ""Q4 '24"", 'revenue': 16450.0, 'unit': 'K', 'net_profit': -82.88}, {'period': ""Q3 '24"", 'revenue': 15460.0, 'unit': 'K', 'net_profit': 327.55}, {'period': ""Q2 '24"", 'revenue': 15240.0, 'unit': 'K', 'net_profit': 408.32}, {'period': ""Q1 '24"", 'revenue': 14240.0, 'unit': 'K', 'net_profit': 30.89}]",0.0601,0.06,64186442,47462083,19127165,24653342,25993012,0,23868822,19127165,2393984,6.689457681799062,1.1304168316250132,1.1306521739130435,__nan__,__nan__,__nan__,0.3840895558597873
260,NUAN,Nuance Communications Inc. Common Stock,"Nuance Communications, Inc. provides conversational and cognitive artificial intelligence (AI) innovations that bring intelligence to everyday work and life. The company delivers solutions that understand, analyze, and respond to people - amplifying human intelligence to increase productivity and security. Its Healthcare segment provides clinical speech and clinical language understanding solutions that improve the clinical documentation process, from capturing the complete patient record to improving clinical documentation and quality measures for reimbursement. Its solutions include Dragon Medical One, cloud-based speech solution; computer-assisted physician documentation; diagnostic imaging solutions; Nuance Dragon Ambient eXperience, a voice-enabled solution; and clinical documentation improvement and coding. The company's Enterprise segment primarily engages in using speech, natural language understanding, and artificial intelligence to provide automated customer solutions and services for voice, mobile, web, and messaging channels. Its solutions include intelligent engagement solutions; Conversational AI; Engagement AI; and Security AI. Its Other segment provides voicemail transcription services. It serves organizations across healthcare, financial services, telecommunications, government, and retail. The company markets and sells its solutions and technologies directly through sales force, as well as through a network of resellers, including system integrators, independent software vendors, value-added resellers, distributors, hardware vendors, telecommunications carriers, and e-commerce Websites worldwide. The company was formerly known as ScanSoft, Inc. and changed its name to Nuance Communications, Inc. in October 2005. Nuance Communications, Inc. was incorporated in 1992 and is headquartered in Burlington, Massachusetts. As of March 4, 2022, Nuance Communications, Inc. operates as a subsidiary of Microsoft Corporation.",Mr. Mark Benjamin,Software - Application,55.99,USD,0,https://images.financialmodelingprep.com/symbol/NUAN.png,5693606,-171.22324159021406,0,0,82719000,-26726000,"[{'period': '2021', 'revenue': 1360.0, 'unit': 'M', 'net_profit': -26.73}, {'period': '2020', 'revenue': 1480.0, 'unit': 'M', 'net_profit': 21.4}, {'period': '2019', 'revenue': 1820.0, 'unit': 'M', 'net_profit': 213.81}, {'period': '2018', 'revenue': 2050.0, 'unit': 'M', 'net_profit': -159.93}]","[{'period': ""Q1 '22"", 'revenue': 321.44, 'unit': 'M', 'net_profit': -57.56}, {'period': ""Q4 '21"", 'revenue': 333.07, 'unit': 'M', 'net_profit': -11.72}, {'period': ""Q3 '21"", 'revenue': 336.58, 'unit': 'M', 'net_profit': -26.27}, {'period': ""Q2 '21"", 'revenue': 346.98, 'unit': 'M', 'net_profit': -3.63}, {'period': ""Q1 '21"", 'revenue': 345750.0, 'unit': 'K', 'net_profit': 14.89}, {'period': ""Q4 '20"", 'revenue': 352.93, 'unit': 'M', 'net_profit': -23.95}]",-0.0907,-0.0907,3386653000,603545000,209475000,1751719000,162292000,0,928349000,187307000,191125000,-0.611813732161377,-2.249111983548327,-2.198150594451783,__nan__,__nan__,__nan__,0.517241949499993
261,NURO,NeuroMetrix Inc. Common Stock,"NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.","Dr. Shai N. Gozani M.D., Ph.D.",Medical - Devices,4.401,USD,9064691,https://images.financialmodelingprep.com/symbol/NURO.png,11647,-1.11,0.021,7606,-8782037,-7806055,"[{'period': '2024', 'revenue': 3.03, 'unit': 'M', 'net_profit': -7.81}, {'period': '2023', 'revenue': 5.9, 'unit': 'M', 'net_profit': -6.53}, {'period': '2022', 'revenue': 8.26, 'unit': 'M', 'net_profit': -4.37}, {'period': '2021', 'revenue': 8.25, 'unit': 'M', 'net_profit': -2.21}]","[{'period': ""Q4 '24"", 'revenue': 0.5828200000000001, 'unit': 'M', 'net_profit': -1.78}, {'period': ""Q3 '24"", 'revenue': 0.58731, 'unit': 'M', 'net_profit': -1.51}, {'period': ""Q2 '24"", 'revenue': 0.76915, 'unit': 'M', 'net_profit': -1.49}, {'period': ""Q1 '24"", 'revenue': 1.09, 'unit': 'M', 'net_profit': -3.03}, {'period': ""Q4 '23"", 'revenue': 1.32, 'unit': 'M', 'net_profit': -1.65}, {'period': ""Q3 '23"", 'revenue': 1.2, 'unit': 'M', 'net_profit': -1.77}]",-3.96,-3.96,15324127,15013511,13095034,1012476,192916,0,1012476,1427784,-7128353,-0.23763717428132577,-0.19550816166721827,0.3684210526315789,"[0.15, 0.15]","['2007-03-28', '2007-03-28']",__nan__,0.0660707131962558
262,NUVA,NuVasive Inc. Common Stock,"NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary implant device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.",Mr. J. Christopher Barry,Medical - Devices,39.75,USD,2084855700,https://images.financialmodelingprep.com/symbol/NUVA.png,1414938,75,-0.91,30593998,211802000,40407000,"[{'period': '2022', 'revenue': 1200.0, 'unit': 'M', 'net_profit': 40.41}, {'period': '2021', 'revenue': 1140.0, 'unit': 'M', 'net_profit': -64.09}, {'period': '2020', 'revenue': 1050.0, 'unit': 'M', 'net_profit': -37.15}, {'period': '2019', 'revenue': 1170.0, 'unit': 'M', 'net_profit': 65.23}]","[{'period': ""Q2 '23"", 'revenue': 317.79, 'unit': 'M', 'net_profit': 7.36}, {'period': ""Q1 '23"", 'revenue': 307.71, 'unit': 'M', 'net_profit': -1.01}, {'period': ""Q4 '22"", 'revenue': 305.45, 'unit': 'M', 'net_profit': 24.08}, {'period': ""Q3 '22"", 'revenue': 295.28, 'unit': 'M', 'net_profit': -1.98}, {'period': ""Q2 '22"", 'revenue': 310450.0, 'unit': 'K', 'net_profit': -893.0}, {'period': ""Q1 '22"", 'revenue': 290.76, 'unit': 'M', 'net_profit': 19.2}]",0.78,0.76,2224505000,865212000,248663000,1355615000,249373000,0,716048000,248663000,29691000,0.17072658430754775,1.6305121243329277,1.6290322580645162,__nan__,__nan__,__nan__,0.6094007430866643
263,NUWE,Nuwellis Inc. Common Stock,"Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.",Mr. John L. Erb,Medical - Devices,0.7679,USD,3358787,https://images.financialmodelingprep.com/symbol/NUWE.png,442929,-0.09,0.0108,49669,-5243000,-10624000,"[{'period': '2024', 'revenue': 8.74, 'unit': 'M', 'net_profit': -10.62}, {'period': '2023', 'revenue': 8.86, 'unit': 'M', 'net_profit': -20.21}, {'period': '2022', 'revenue': 8.54, 'unit': 'M', 'net_profit': -14.53}, {'period': '2021', 'revenue': 7.92, 'unit': 'M', 'net_profit': -19.58}]","[{'period': ""Q4 '24"", 'revenue': 2.32, 'unit': 'M', 'net_profit': -1.47}, {'period': ""Q3 '24"", 'revenue': 2.37, 'unit': 'M', 'net_profit': 2.36}, {'period': ""Q2 '24"", 'revenue': 2.19, 'unit': 'M', 'net_profit': -7.72}, {'period': ""Q1 '24"", 'revenue': 1.86, 'unit': 'M', 'net_profit': -3.79}, {'period': ""Q4 '23"", 'revenue': 2.55, 'unit': 'M', 'net_profit': -5.51}, {'period': ""Q3 '23"", 'revenue': 2.41, 'unit': 'M', 'net_profit': -3.37}]",-8.41,-8.41,9864000,8855000,5095000,3334000,1727000,0,2559000,5095000,-9651000,0.6794448520420641,0.47429363155029935,0.9766427817585958,__nan__,__nan__,__nan__,0.3379967558799676
264,NUZE,NuZee Inc. Common Stock,"NuZee, Inc., a specialty coffee company, engages in the manufacture, packing, and sale of single serve coffee and tea bag-style coffee for coffee roasters and suppliers in North America and South Korea. The company provides its products under Coffee Blenders, Twin Peaks, and Pine Ranch brands. It serves retail and grocery customers, office, and hospitality sectors. NuZee, Inc. was incorporated in 2011 and is headquartered in Plano, Texas.",Ms. Jianshuang  Wang,Packaged Foods,0.7482,USD,6916914,https://images.financialmodelingprep.com/symbol/NUZE.png,6142091,-0.1032,-0.0397,574350,-8528814,-8749467,"[{'period': '2023', 'revenue': 3.35, 'unit': 'M', 'net_profit': -8.75}, {'period': '2022', 'revenue': 3.11, 'unit': 'M', 'net_profit': -11.8}, {'period': '2021', 'revenue': 1.93, 'unit': 'M', 'net_profit': -18.55}, {'period': '2020', 'revenue': 1.4, 'unit': 'M', 'net_profit': -9.48}]","[{'period': ""Q3 '24"", 'revenue': 0.36689, 'unit': 'M', 'net_profit': -1.29}, {'period': ""Q2 '24"", 'revenue': 0.60576, 'unit': 'M', 'net_profit': -1.65}, {'period': ""Q1 '24"", 'revenue': 1.35, 'unit': 'M', 'net_profit': -2.15}, {'period': ""Q4 '23"", 'revenue': 0.78271, 'unit': 'M', 'net_profit': -2.57}, {'period': ""Q3 '23"", 'revenue': 0.64861, 'unit': 'M', 'net_profit': -2.03}, {'period': ""Q2 '23"", 'revenue': 0.7811699999999999, 'unit': 'M', 'net_profit': -1.97}]",-11.95,-11.95,4440998,3376249,1373101,2766641,586878,162259,2556403,1373101,-6942520,0.22627415802749223,0.2583759461156536,0.43949343339587243,__nan__,__nan__,__nan__,0.6229773127571776
265,NVAX,Novavax Inc. Common Stock,"Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.",Mr. John Charles Jacobs M.B.A.,Biotechnology,6.31,USD,1014925640,https://images.financialmodelingprep.com/symbol/NVAX.png,4334304,-5.13,-0.23,5475746,-108044000,-187499000,"[{'period': '2024', 'revenue': 682.16, 'unit': 'M', 'net_profit': -187.5}, {'period': '2023', 'revenue': 556.38, 'unit': 'M', 'net_profit': -545.06}, {'period': '2022', 'revenue': 1600.0, 'unit': 'M', 'net_profit': -657.94}, {'period': '2021', 'revenue': 1.15, 'unit': 'B', 'net_profit': -1.74}]","[{'period': ""Q4 '24"", 'revenue': 88.31, 'unit': 'M', 'net_profit': -81.03}, {'period': ""Q3 '24"", 'revenue': 84.51, 'unit': 'M', 'net_profit': -121.3}, {'period': ""Q2 '24"", 'revenue': 415.48, 'unit': 'M', 'net_profit': 162.38}, {'period': ""Q1 '24"", 'revenue': 93.86, 'unit': 'M', 'net_profit': -147.55}, {'period': ""Q4 '23"", 'revenue': 291.34, 'unit': 'M', 'net_profit': -178.39}, {'period': ""Q3 '23"", 'revenue': 22.06, 'unit': 'M', 'net_profit': -130.78}]",-1.23,-1.23,1560418000,1128942000,923118000,2184259000,108285000,0,1154416000,530230000,-100320000,0.7783212622335296,0.6560042710737494,0.7726432532347504,__nan__,__nan__,__nan__,1.3997909534496527
266,NVCN,Neovasc Inc. Common Shares,"Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.",Mr. Fredericus A. Colen,Medical - Devices,30.03,USD,82859377,https://images.financialmodelingprep.com/symbol/NVCN.png,25784,-1.9927007299270072,0,1,-37068322,-41204418,"[{'period': '2022', 'revenue': 3.81, 'unit': 'M', 'net_profit': -41.2}, {'period': '2021', 'revenue': 2.55, 'unit': 'M', 'net_profit': -24.89}, {'period': '2020', 'revenue': 1.96, 'unit': 'M', 'net_profit': -28.7}, {'period': '2019', 'revenue': 2.09, 'unit': 'M', 'net_profit': -35.13}]","[{'period': ""Q4 '22"", 'revenue': 1.45, 'unit': 'M', 'net_profit': -13.84}, {'period': ""Q3 '22"", 'revenue': 0.92331, 'unit': 'M', 'net_profit': -8.51}, {'period': ""Q2 '22"", 'revenue': 0.81806, 'unit': 'M', 'net_profit': -8.41}, {'period': ""Q1 '22"", 'revenue': 0.61075, 'unit': 'M', 'net_profit': -13.88}, {'period': ""Q4 '21"", 'revenue': 0.75912, 'unit': 'M', 'net_profit': -6.15}, {'period': ""Q3 '21"", 'revenue': 0.7034199999999999, 'unit': 'M', 'net_profit': -7.54}]",-15.07,-15.07,38729112,29784841,25791598,22890087,2503956,0,10069599,25791598,-24983484,0.06455229596310934,-0.6555226714185252,-0.5253036437246963,__nan__,__nan__,__nan__,0.5910305147197797
267,NVCR,NovoCure Limited Ordinary Shares,"NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.",Ms. Ashley  Cordova,Medical - Instruments & Supplies,15.37,USD,1689393550,https://images.financialmodelingprep.com/symbol/NVCR.png,903757,-9.85,-1.24,779104,-109584000,-168627000,"[{'period': '2024', 'revenue': 605.22, 'unit': 'M', 'net_profit': -168.63}, {'period': '2023', 'revenue': 509.34, 'unit': 'M', 'net_profit': -207.04}, {'period': '2022', 'revenue': 537.84, 'unit': 'M', 'net_profit': -92.53}, {'period': '2021', 'revenue': 535.03, 'unit': 'M', 'net_profit': -58.35}]","[{'period': ""Q4 '24"", 'revenue': 161.27, 'unit': 'M', 'net_profit': -65.92}, {'period': ""Q3 '24"", 'revenue': 155.09, 'unit': 'M', 'net_profit': -30.57}, {'period': ""Q2 '24"", 'revenue': 150.36, 'unit': 'M', 'net_profit': -33.38}, {'period': ""Q1 '24"", 'revenue': 138.5, 'unit': 'M', 'net_profit': -38.76}, {'period': ""Q4 '23"", 'revenue': 133.78, 'unit': 'M', 'net_profit': -47.08}, {'period': ""Q3 '23"", 'revenue': 127.32, 'unit': 'M', 'net_profit': -49.48}]",-1.56,-1.56,1240784000,1106575000,959873000,880605000,102072000,0,756376000,163767000,-69224000,0.37688567935632444,0.18554599769130084,0.19999999999999996,__nan__,__nan__,__nan__,0.7097165985376988
268,NVDA,NVIDIA Corporation Common Stock,"NVIDIA Corporation provides graphics, and compute and networking solutions in the United States, Taiwan, China, and internationally. The company's Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building 3D designs and virtual worlds. Its Compute & Networking segment provides Data Center platforms and systems for AI, HPC, and accelerated computing; Mellanox networking and interconnect solutions; automotive AI Cockpit, autonomous driving development agreements, and autonomous vehicle solutions; cryptocurrency mining processors; Jetson for robotics and other embedded platforms; and NVIDIA AI Enterprise and other software. The company's products are used in gaming, professional visualization, datacenter, and automotive markets. NVIDIA Corporation sells its products to original equipment manufacturers, original device manufacturers, system builders, add-in board manufacturers, retailers/distributors, independent software vendors, Internet and cloud service providers, automotive manufacturers and tier-1 automotive suppliers, mapping companies, start-ups, and other ecosystem participants. It has a strategic collaboration with Kroger Co. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.",Mr. Jen-Hsun  Huang,Semiconductors,96.3,USD,2349720000000,https://images.financialmodelingprep.com/symbol/NVDA.png,295242447,32.76,-1.34,468737984,86137000000,72880000000,"[{'period': '2025', 'revenue': 130.5, 'unit': 'B', 'net_profit': 72.88}, {'period': '2024', 'revenue': 60.92, 'unit': 'B', 'net_profit': 29.76}, {'period': '2023', 'revenue': 26.97, 'unit': 'B', 'net_profit': 4.37}, {'period': '2022', 'revenue': 26.91, 'unit': 'B', 'net_profit': 9.75}]","[{'period': ""Q4 '25"", 'revenue': 39.33, 'unit': 'B', 'net_profit': 22.09}, {'period': ""Q3 '25"", 'revenue': 35.08, 'unit': 'B', 'net_profit': 19.31}, {'period': ""Q2 '25"", 'revenue': 30.04, 'unit': 'B', 'net_profit': 16.6}, {'period': ""Q1 '25"", 'revenue': 26.04, 'unit': 'B', 'net_profit': 14.88}, {'period': ""Q4 '24"", 'revenue': 22.1, 'unit': 'B', 'net_profit': 12.29}, {'period': ""Q3 '24"", 'revenue': 18.12, 'unit': 'B', 'net_profit': 9.24}]",2.97,2.94,111601000000,80126000000,43210000000,32274000000,23065000000,3387000000,18047000000,8589000000,60853000000,1.4207346204648288,1.4489247311827957,1.4545454545454548,"[0.01, 0.075]","['2025-03-12', '2012-11-20']",__nan__,0.28919095707027714
269,NVEC,NVE Corporation Common Stock,"NVE Corporation develops and sells devices that use spintronics, a nanotechnology that relies on electron spin to acquire, store, and transmit information in the United States and internationally. The company manufactures spintronic products, including sensors and couplers for use in acquiring and transmitting data. Its products comprise standard sensors to detect the presence of a magnetic or metallic material to determine position or speed primarily for the factory automation market; and custom and medical sensors for medical devices to replace electromechanical magnetic switches. The company also offers spintronic couplers for industrial Internet of Things market. In addition, it undertakes contracts for research and development, and licensing of spintronic magnetoresistive random access memory technology. NVE Corporation was founded in 1989 and is headquartered in Eden Prairie, Minnesota.",Dr. Daniel A. Baker Ph.D.,Semiconductors,54.12,USD,261787640,https://images.financialmodelingprep.com/symbol/NVEC.png,24901,17.46,-1.98,43611,18827012,17124699,"[{'period': '2024', 'revenue': 29.8, 'unit': 'M', 'net_profit': 17.12}, {'period': '2023', 'revenue': 38.25, 'unit': 'M', 'net_profit': 22.69}, {'period': '2022', 'revenue': 26.99, 'unit': 'M', 'net_profit': 14.51}, {'period': '2021', 'revenue': 21.37, 'unit': 'M', 'net_profit': 11.69}]","[{'period': ""Q3 '25"", 'revenue': 5.06, 'unit': 'M', 'net_profit': 3.05}, {'period': ""Q2 '25"", 'revenue': 6.76, 'unit': 'M', 'net_profit': 4.03}, {'period': ""Q1 '25"", 'revenue': 6.78, 'unit': 'M', 'net_profit': 4.1}, {'period': ""Q4 '24"", 'revenue': 7.08, 'unit': 'M', 'net_profit': 3.81}, {'period': ""Q3 '24"", 'revenue': 6.76, 'unit': 'M', 'net_profit': 4.18}, {'period': ""Q2 '24"", 'revenue': 7.13, 'unit': 'M', 'net_profit': 4.72}]",3.54,3.54,66780033,33194096,22201329,1211516,3144833,30788301,1035741,10283550,18230680,-0.26583690600854415,-0.24542375059144395,-0.2468085106382979,"[1, 2.06]","['2025-02-03', '2015-01-29']",__nan__,0.018141889807092488
270,NVEE,NV5 Global Inc. Common Stock,"NV5 Global offers professional and technical engineering and consulting solutions to public and private sector clients in the infrastructure, utility services, construction, real estate, and environmental markets in the United States and internationally. It operates through three segments: Infrastructure; Building, Technology & Sciences; and Geospatial Solutions. The company provides site selection and planning, design, water resources, transportation, structural engineering, land development, surveying, power delivery, building code compliance, and other services; and construction materials testing and engineering, geotechnical engineering and consulting, and forensic consulting services. It also provides governmental outsourcing and consulting, and technical outsourcing services; and geospatial data analytic and mapping services. In addition, it offers mechanical, electrical, and plumbing design; commissioning; energy performance, management, and optimization; climate change and reducing CO2 emissions; building program management; acoustical design consulting; and audiovisualsecurity and surveillanceinformation technologydata center services. Further, the company provides various services, such as investigating and analyzing environmental conditions, and recommending corrective measures and procedures; occupational health and safety services; radiation exposure and protection, and nuclear safety and industrial hygiene analyses services; hydrogeological modeling and environmental programs; water resource planning, monitoring, and environmental management of wastewater facilities; solid waste landfill investigations; permitting and compliance; storm water pollution; environmental impact statement support; agricultural waste management and permitting; and wetland evaluations. The company was formerly known as NV5 Holdings, Inc. and changed its name to NV5 Global, Inc. in December 2015. NV5 Global, Inc. was founded in 1949 and is headquartered in Hollywood, Florida.",Mr. Alexander A. Hockman P.E.,Engineering & Construction,15.42,USD,1005811134,https://images.financialmodelingprep.com/symbol/NVEE.png,529186,35.05,-1.46,774305,110045000,27979000,"[{'period': '2024', 'revenue': 483.23, 'unit': 'M', 'net_profit': 27.98}, {'period': '2023', 'revenue': 861.74, 'unit': 'M', 'net_profit': 44.61}, {'period': '2022', 'revenue': 786.78, 'unit': 'M', 'net_profit': 49.97}, {'period': '2021', 'revenue': 706.71, 'unit': 'M', 'net_profit': 47.15}]","[{'period': ""Q4 '24"", 'revenue': 122.19, 'unit': 'M', 'net_profit': 5.43}, {'period': ""Q3 '24"", 'revenue': 273.34, 'unit': 'M', 'net_profit': 14.23}, {'period': ""Q2 '24"", 'revenue': 236.33, 'unit': 'M', 'net_profit': 7.91}, {'period': ""Q1 '24"", 'revenue': 226050.0, 'unit': 'K', 'net_profit': 408.0}, {'period': ""Q4 '23"", 'revenue': 231.23, 'unit': 'M', 'net_profit': 9.94}, {'period': ""Q3 '23"", 'revenue': 239.29, 'unit': 'M', 'net_profit': 13.32}]",0.0454,0.0445,1315356000,411011000,50361000,482342000,340495000,0,210254000,50361000,40399000,-0.07680369127516778,-0.37285096272386975,-0.9386486486486486,__nan__,__nan__,__nan__,0.36670072588713626
271,NVFY,Nova Lifestyle Inc. Common Stock,"Nova LifeStyle, Inc., through its subsidiaries, designs, manufactures, markets, and sells residential and commercial furniture for middle and upper middle-income consumers worldwide. The company offers upholstered, wood, and metal-based furniture pieces for the living, dining, and bedrooms, as well as home offices. Its products include sofas, chairs, dining and coffee tables, beds, entertainment consoles, cabinets, and cupboards. The company also provides physiotherapeutic jade mats for use in therapy clinic, hospitality, and real estate projects. It distributes its products under the Diamond Sofa brand directly, as well as through internet sales and online marketing campaigns, and participation in exhibitions and trade shows primarily to furniture distributors and retailers. The company was formerly known as Stevens Resources, Inc. Nova LifeStyle, Inc. was founded in 2003 and is headquartered in Commerce, California.",Ms. Thanh H. Lam,"Furnishings, Fixtures & Appliances",0.6,USD,7924380,https://images.financialmodelingprep.com/symbol/NVFY.png,560736,-0.41,-0.009,141118,-5017645,-5561705,"[{'period': '2024', 'revenue': 9.69, 'unit': 'M', 'net_profit': -5.56}, {'period': '2023', 'revenue': 11.09, 'unit': 'M', 'net_profit': -7.72}, {'period': '2022', 'revenue': 12.74, 'unit': 'M', 'net_profit': -17.08}, {'period': '2021', 'revenue': 12.81, 'unit': 'M', 'net_profit': -19.96}]","[{'period': ""Q4 '24"", 'revenue': 2.01, 'unit': 'M', 'net_profit': -1.07}, {'period': ""Q3 '24"", 'revenue': 2.62, 'unit': 'M', 'net_profit': -2.47}, {'period': ""Q2 '24"", 'revenue': 2690.0, 'unit': 'K', 'net_profit': -563.49}, {'period': ""Q1 '24"", 'revenue': 2.38, 'unit': 'M', 'net_profit': -1.46}, {'period': ""Q4 '23"", 'revenue': 2.27, 'unit': 'M', 'net_profit': -4.67}, {'period': ""Q3 '23"", 'revenue': 2.48, 'unit': 'M', 'net_profit': -1.29}]",-1.61,-1.61,9917403,36738,161902,6793889,53786,0,5825319,161902,-1405900,0.1063470589471532,0.27987570528858485,0.6754032258064515,__nan__,__nan__,__nan__,0.6850471842275644
272,NVIV,InVivo Therapeutics Holdings Corp Common Stock,"InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.",Dr. Richard M. Toselli M.D.,Biotechnology,0.3207,USD,995918,https://images.financialmodelingprep.com/symbol/NVIV.png,3769288,-0.09777439024390244,-0.1673,1609868,-10205000,-10179000,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.18}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.89}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.05}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.24}]","[{'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.7}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.94}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.18}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.17}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.67}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.7}]",-6.62,-6.62,18822000,17601000,16351000,3076000,0,150000,2468000,16351000,-10642000,-0.07105373635600336,-0.029013344116457743,0.11378848728246314,__nan__,__nan__,__nan__,0.16342577834449049
273,NVMI,Nova Measuring Instruments Ltd. Ordinary Shares,"Nova Ltd. designs, develops, produces, and sells process control systems used in the manufacture of semiconductors in Israel, Taiwan, the United States, China, Korea, and internationally. Its product portfolio includes a set of metrology platforms for dimensional, films, and materials and chemical metrology measurements for process control for various semiconductor manufacturing process steps, including lithography, etch, chemical mechanical planarization, deposition, electrochemical plating, and advanced packaging. The company serves various sectors of the integrated circuit manufacturing industry, including logic, foundries, and memory manufacturers, as well as process equipment manufacturers. Nova Ltd. was formerly known as Nova Measuring Instruments Ltd. and changed its name to Nova Ltd. in July 2021. The company was incorporated in 1993 and is headquartered in Rehovot, Israel.",Mr. Gabriel  Waisman,Semiconductors,166.72,USD,4881294848,https://images.financialmodelingprep.com/symbol/NVMI.png,294552,28.99,-3.89,415934,233666000,183762000,"[{'period': '2024', 'revenue': 672.4, 'unit': 'M', 'net_profit': 183.76}, {'period': '2023', 'revenue': 517.92, 'unit': 'M', 'net_profit': 136.31}, {'period': '2022', 'revenue': 570.73, 'unit': 'M', 'net_profit': 140.21}, {'period': '2021', 'revenue': 416.11, 'unit': 'M', 'net_profit': 93.1}]","[{'period': ""Q4 '24"", 'revenue': 194.77, 'unit': 'M', 'net_profit': 50.48}, {'period': ""Q3 '24"", 'revenue': 178.97, 'unit': 'M', 'net_profit': 51.28}, {'period': ""Q2 '24"", 'revenue': 156.86, 'unit': 'M', 'net_profit': 45.14}, {'period': ""Q1 '24"", 'revenue': 141.8, 'unit': 'M', 'net_profit': 36.86}, {'period': ""Q4 '23"", 'revenue': 134.22, 'unit': 'M', 'net_profit': 38.07}, {'period': ""Q3 '23"", 'revenue': 128.81, 'unit': 'M', 'net_profit': 33.69}]",12.62,11.44,1390422000,901949000,586566000,462627000,140100000,233665000,388230000,157779000,218051000,0.3552926164375616,0.3481182598488739,1.6457023060796647,__nan__,__nan__,__nan__,0.3327241657568709
274,NVOS,Novo Integrated Sciences Inc. Common Stock,"Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. It operates through two segments, Healthcare Services, and Product Manufacturing and Development. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services. It also engages in the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across various demographics, including pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services, such as long-term care homes, retirement homes, community based home care physiotherapy, community based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement home and community, and long-term care sectors. Further, it offers medical technology services, such as telemedicine and remote patient monitoring; and develops and distributes personalized health and wellness product solutions. The company operates 16 owned clinics. The company was incorporated in 2000 and is based in Bellevue, Washington. Novo Integrated Sciences, Inc. operates as a subsidiary of ALMC-ASAP Holdings, Inc.",Mr. Christopher Mehlin David,Medical - Care Facilities,0.001,USD,19730,https://images.financialmodelingprep.com/symbol/NVOS.png,43206,,0.0007,1000,-10076298,-16128570,"[{'period': '2024', 'revenue': 13.29, 'unit': 'M', 'net_profit': -16.13}, {'period': '2023', 'revenue': 12.57, 'unit': 'M', 'net_profit': -13.21}, {'period': '2022', 'revenue': 11.74, 'unit': 'M', 'net_profit': -32.85}, {'period': '2021', 'revenue': 9.31, 'unit': 'M', 'net_profit': -4.46}]","[{'period': ""Q3 '24"", 'revenue': 3.15, 'unit': 'M', 'net_profit': -13.74}, {'period': ""Q2 '24"", 'revenue': 3.17, 'unit': 'M', 'net_profit': -2.75}, {'period': ""Q1 '24"", 'revenue': 3.89, 'unit': 'M', 'net_profit': -4.68}, {'period': ""Q4 '23"", 'revenue': 3.3, 'unit': 'M', 'net_profit': -3.16}, {'period': ""Q3 '23"", 'revenue': 3.29, 'unit': 'M', 'net_profit': -1.5}, {'period': ""Q2 '23"", 'revenue': 2.56, 'unit': 'M', 'net_profit': -4.62}]",-0.89,-0.89,32141276,5414850,844584,17527351,3152242,0,14579412,844584,-2292539,-0.7227382932572588,-0.22051583738896333,0.3153846153846154,__nan__,__nan__,__nan__,0.545322189448857
275,NVSA,New Vista Acquisition Corp Class A Ordinary Shares,"New Vista Acquisition Corp does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company focuses on identifying and acquiring a technology business operating in space, defence, communications, advanced air mobility, and logistics areas. The company was incorporated in 2020 and is based in Chicago, Illinois.",Mr. Dennis A. Muilenburg,Shell Companies,10.17,USD,350864990,https://images.financialmodelingprep.com/symbol/NVSA.png,97395,44.21739130434783,0,15484,-11324980,3976780,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.98}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.01}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.79}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 10.4}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.1}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.53}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.39}]",0.59,0.13,277561984,1435796,927861,23257517,0,0,2349017,927861,-1622327,0,0,0,__nan__,__nan__,__nan__,0.08379215577303266
276,NVSAU,New Vista Acquisition Corp Unit,"New Vista Acquisition Corp does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company focuses on identifying and acquiring a technology business operating in space, defence, communications, advanced air mobility, and logistics areas. The company was incorporated in 2020 and is based in Chicago, Illinois.",Mr. Dennis A. Muilenburg,Shell Companies,10.15,USD,0,https://images.financialmodelingprep.com/symbol/NVSAU.png,6535,33.609271523178805,-0.01,2361,-11324980,3976780,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.98}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.01}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.79}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 10.4}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.1}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.53}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.39}]",0.59,0.13,277561984,1435796,927861,23257517,0,0,2349017,927861,-1622327,0,0,0,__nan__,__nan__,__nan__,0.08379215577303266
277,NVSAW,New Vista Acquisition Corp. Warrant ,"New Vista Acquisition Corp focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in Chicago, Illinois.",Mr. Dennis A. Muilenburg,Shell Companies,0.0012,USD,0,https://images.financialmodelingprep.com/symbol/NVSAW.png,0,0,0.0001,102993,-11324980,3976780,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.98}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.01}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.79}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 10.4}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.1}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.53}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.39}]",0.59,0.13,277561984,1435796,927861,23257517,0,0,2349017,927861,-1622327,0,0,0,__nan__,__nan__,__nan__,0.08379215577303266
278,NVVE,Nuvve Holding Corp. Common Stock,"Nuvve Holding Corp., a green energy technology company, develops and commercializes vehicle-to-grid (V2G) technology in North America, Europe, and Japan. The company offers fleet and electric bus charging solutions, and V1G and V2G charging stations based on Grid Integrated Vehicle, a V2G technology platform that enables electric vehicle (EV) batteries to store and resell unused energy back to the local electric grid and provide other grid services. Its V2G technology also links EV batteries into a virtual power plant that sells excess power to utility companies or utilizes saved power to reduce building energy peak consumption. The company was founded in 2010 and is headquartered in San Diego, California.",Dr. Gregory  Poilasne Ph.D.,Specialty Retail,0.8949,USD,2745598,https://images.financialmodelingprep.com/symbol/NVVE.png,1420873,-0.03,0.0148,88616,-20460431000000,-17397603,"[{'period': '2024', 'revenue': 5290000.0, 'unit': 'M', 'net_profit': -17.4}, {'period': '2023', 'revenue': 8.33, 'unit': 'M', 'net_profit': -31.28}, {'period': '2022', 'revenue': 4.91, 'unit': 'M', 'net_profit': -24.56}, {'period': '2021', 'revenue': 2.92, 'unit': 'M', 'net_profit': -27.16}]","[{'period': ""Q4 '24"", 'revenue': 1.7, 'unit': 'M', 'net_profit': -5.07}, {'period': ""Q3 '24"", 'revenue': 1.81, 'unit': 'M', 'net_profit': -1.65}, {'period': ""Q2 '24"", 'revenue': 0.80218, 'unit': 'M', 'net_profit': -3.94}, {'period': ""Q1 '24"", 'revenue': 0.77976, 'unit': 'M', 'net_profit': -6.95}, {'period': ""Q4 '23"", 'revenue': 1.64, 'unit': 'M', 'net_profit': -7.28}, {'period': ""Q3 '23"", 'revenue': 2.64, 'unit': 'M', 'net_profit': -8.34}]",-26.92,-26.92,16797812000000,9275117000000,371497,18087459000000,2148198000000,670951000000,11351158000000,371497,-15779729000000,-645253.9452341152,0.4438876445847603,0.33300297324083244,__nan__,__nan__,__nan__,1.0767747013718216
279,NVVEW,Nuvve Holding Corp. Warrant,"Nuvve Holding Corp., a green energy technology company, develops and commercializes vehicle-to-grid (V2G) technology in the United States, the United Kingdom, and Denmark. The company offers fleet and electric bus charging solutions, and V1G and V2G charging stations based on Grid Integrated Vehicle, a V2G technology platform that enables electric vehicle (EV) batteries to store and resell unused energy back to the local electric grid and provide other grid services. Its V2G technology also links EV batteries into a virtual power plant that sells excess power to utility companies or utilizes saved power to reduce building energy peak consumption. The company was founded in 2010 and is headquartered in San Diego, California.",Dr. Gregory  Poilasne Ph.D.,Specialty Retail,0.0173,USD,2700190,https://images.financialmodelingprep.com/symbol/NVVEW.png,65174.37712,,0.0023,5100,-20460431000000,-17397603,"[{'period': '2024', 'revenue': 5290000.0, 'unit': 'M', 'net_profit': -17.4}, {'period': '2023', 'revenue': 8.33, 'unit': 'M', 'net_profit': -31.28}, {'period': '2022', 'revenue': 4.91, 'unit': 'M', 'net_profit': -24.56}, {'period': '2021', 'revenue': 2.92, 'unit': 'M', 'net_profit': -27.16}]","[{'period': ""Q4 '24"", 'revenue': 1.7, 'unit': 'M', 'net_profit': -5.07}, {'period': ""Q3 '24"", 'revenue': 1.81, 'unit': 'M', 'net_profit': -1.65}, {'period': ""Q2 '24"", 'revenue': 0.80218, 'unit': 'M', 'net_profit': -3.94}, {'period': ""Q1 '24"", 'revenue': 0.77976, 'unit': 'M', 'net_profit': -6.95}, {'period': ""Q4 '23"", 'revenue': 1.64, 'unit': 'M', 'net_profit': -7.28}, {'period': ""Q3 '23"", 'revenue': 2.64, 'unit': 'M', 'net_profit': -8.34}]",-26.92,-26.92,16797812000000,9275117000000,371497,18087459000000,2148198000000,670951000000,11351158000000,371497,-15779729000000,-645253.9452341152,0.4438876445847603,0.33300297324083244,__nan__,__nan__,__nan__,1.0767747013718216
280,NWBI,Northwest Bancshares Inc. Common Stock,"Northwest Bancshares, Inc. operates as the holding company for Northwest Bank, a state-chartered savings bank that provides personal and business banking solutions. The company accepts various deposits, including checking, savings, money market deposit, term certificate, and individual retirement accounts. It also offers loan products comprising one-to-four-family residential real estate loans and loans collateralized by multi-family residential and commercial real estate; commercial business loans; and consumer loans, including automobile loans, sales finance loans, unsecured personal loans, credit card loans, and loans secured by deposit accounts. The company also offers investment management and trust services. As of December 31, 2021, it operated 170 community-banking locations in Pennsylvania, Western New York, Eastern Ohio, and Indiana. Northwest Bancshares, Inc. was founded in 1896 and is headquartered in Columbus, Ohio.",Mr. Louis J. Torchio,Banks - Regional,11.08,USD,1412866200,https://images.financialmodelingprep.com/symbol/NWBI.png,733775,14.03,-0.02,1141342,0,100278000,"[{'period': '2024', 'revenue': 520.47, 'unit': 'M', 'net_profit': 100.28}, {'period': '2023', 'revenue': 526.63, 'unit': 'M', 'net_profit': 134.96}, {'period': '2022', 'revenue': 529.72, 'unit': 'M', 'net_profit': 133.67}, {'period': '2021', 'revenue': 506.89, 'unit': 'M', 'net_profit': 154.32}]","[{'period': ""Q4 '24"", 'revenue': 170.72, 'unit': 'M', 'net_profit': 32.75}, {'period': ""Q3 '24"", 'revenue': 138.66, 'unit': 'M', 'net_profit': 33.62}, {'period': ""Q2 '24"", 'revenue': 157.95, 'unit': 'M', 'net_profit': 4.75}, {'period': ""Q1 '24"", 'revenue': 187.96, 'unit': 'M', 'net_profit': 29.16}, {'period': ""Q4 '23"", 'revenue': 186.51, 'unit': 'M', 'net_profit': 29.01}, {'period': ""Q3 '23"", 'revenue': 138.71, 'unit': 'M', 'net_profit': 39.22}]",0.79,0.79,14408224000,12506873000,1397322000,12811368000,11109551000,0,207266000,288378000,62341000,0,-0.2569633290603674,-0.25471698113207547,"[0.2, 0.1]","['2025-02-03', '1995-01-25']",__nan__,0.8891705181707336
281,NWE,NorthWestern Corporation Common Stock,"NorthWestern Corporation, doing business as NorthWestern Energy, provides electricity and natural gas to residential, commercial, and various industrial customers. The company operates through Electric and Natural Gas segments. It generates, purchases, transmits, and distributes electricity; and produces, purchases, stores, transmits, and distributes natural gas, as well as owns municipal franchises to provide natural gas service in the communities.  The company operates 6,819 miles of electric transmission and 18,177 miles of electric distribution lines with approximately 400 transmission and distribution substations; and 2,166 miles of natural gas transmission and 4,945 miles of natural gas distribution lines with approximately 138 city gate stations in Montana. It also operates 1,308 miles of electric transmission and 2,320 miles of electric distribution lines in South Dakota; and 55 miles of natural gas transmission and 2,517 miles of natural gas distribution lines in South Dakota and Nebraska. The company serves approximately 753,600 customers in Montana, South Dakota, Nebraska, and Yellowstone National Park. NorthWestern Corporation was incorporated in 1923 and is based in Sioux Falls, South Dakota.",Mr. Brian B. Bird,Diversified Utilities,54.76,USD,3358321280,https://images.financialmodelingprep.com/symbol/NWE.png,510170,15,0.04,726762,573980000,224111000,"[{'period': '2024', 'revenue': 1510.0, 'unit': 'M', 'net_profit': 224.11}, {'period': '2023', 'revenue': 1420.0, 'unit': 'M', 'net_profit': 194.13}, {'period': '2022', 'revenue': 1480.0, 'unit': 'M', 'net_profit': 183.01}, {'period': '2021', 'revenue': 1370.0, 'unit': 'M', 'net_profit': 186.84}]","[{'period': ""Q4 '24"", 'revenue': 373.51, 'unit': 'M', 'net_profit': 80.55}, {'period': ""Q3 '24"", 'revenue': 345.16, 'unit': 'M', 'net_profit': 46.82}, {'period': ""Q2 '24"", 'revenue': 319.93, 'unit': 'M', 'net_profit': 31.65}, {'period': ""Q1 '24"", 'revenue': 475.3, 'unit': 'M', 'net_profit': 65.09}, {'period': ""Q4 '23"", 'revenue': 356.01, 'unit': 'M', 'net_profit': 83.14}, {'period': ""Q3 '23"", 'revenue': 321.09, 'unit': 'M', 'net_profit': 29.34}]",3.66,3.65,7997524000,418186000,4283000,5139824000,187764000,0,802200000,4283000,-142503000,0.0909077086528721,0.15443180120640188,0.13664596273291924,"[0.66, 0.33]","['2025-03-14', '2008-03-12']",__nan__,0.6426769085031817
282,NWFL,Norwood Financial Corp. Common Stock,"Norwood Financial Corp. operates as the bank holding company for Wayne Bank that provides various banking products and services. The company accepts a range of deposit products, including interest-bearing and non-interest bearing transaction accounts, and statement savings and money market accounts, as well as certificate of deposits. It also provides various loans, such as commercial loans comprising lines of credit, revolving credit, term loans, mortgages, secured lending products, and letter of credit facilities; municipal finance lending; construction loans for commercial construction projects and single-family residences; land loans; consumer loans; mortgage lending to finance principal residences and second home dwellings; and indirect dealer financing of new and used automobiles, boats, and recreational vehicles. In addition, the company offers investment securities services; trust and investment products; and cash management, direct deposit, remote deposit capture, mobile deposit capture, mobile payment, automated clearing house activity, real estate settlement, and Internet and mobile banking services. Further, it engages in the annuity and mutual fund sale, and discount brokerage activities, as well as insurance agency business. The company serves consumers, businesses, nonprofit organizations, and municipalities. It operates fourteen offices in Northeastern Pennsylvania; and sixteen offices in Delaware, Sullivan, Ontario, Otsego, and Yates Counties, New York, as well as thirty-one automated teller machines. Norwood Financial Corp. was founded in 1870 and is headquartered in Honesdale, Pennsylvania.",Mr. James O. Donnelly,Banks - Regional,22,USD,203776980,https://images.financialmodelingprep.com/symbol/NWFL.png,16042,-1100,-0.31,19737,0,-160000,"[{'period': '2024', 'revenue': 112580.0, 'unit': 'K', 'net_profit': -160.0}, {'period': '2023', 'revenue': 64.64, 'unit': 'M', 'net_profit': 16.76}, {'period': '2022', 'revenue': 78.33, 'unit': 'M', 'net_profit': 29.23}, {'period': '2021', 'revenue': 73.64, 'unit': 'M', 'net_profit': 24.91}]","[{'period': ""Q4 '24"", 'revenue': -1.03, 'unit': 'M', 'net_profit': -12.65}, {'period': ""Q3 '24"", 'revenue': 16.88, 'unit': 'M', 'net_profit': 3.84}, {'period': ""Q2 '24"", 'revenue': 29.86, 'unit': 'M', 'net_profit': 4.21}, {'period': ""Q1 '24"", 'revenue': 28.94, 'unit': 'M', 'net_profit': 4.43}, {'period': ""Q4 '23"", 'revenue': 28190.0, 'unit': 'K', 'net_profit': 354.0}, {'period': ""Q3 '23"", 'revenue': 17.34, 'unit': 'M', 'net_profit': 4.12}]",-0.0199,-0.0199,2317462000,2127669000,425408000,2103954000,1702261000,0,125684000,27562000,22807000,-1,-1.009547109016051,-1.0095673076923075,"[0.31, 0.4679]","['2025-04-15', '1998-05-04']",__nan__,0.9078699025054132
283,NWL,Newell Brands Inc. Common Stock,"Newell Brands Inc. designs, manufactures, sources, and distributes consumer and commercial products worldwide. It operates in five segments: Commercial Solutions, Home Appliances, Home Solutions, Learning and Development, and Outdoor and Recreation. The Commercial Solutions segment provides commercial cleaning and maintenance solutions; closet and garage organization products; hygiene systems and material handling solutions; and home and security, and smoke and carbon monoxide alarms products under the BRK, First Alert, Mapa, Quickie, Rubbermaid, Rubbermaid Commercial Products, and Spontex brands. The Home Appliances segment offers kitchen appliances under the Crock-Pot, Mr. Coffee, Oster, and Sunbeam brands. The Home Solutions segment provides food and home storage; fresh preserving; vacuum sealing; and gourmet cookware, bakeware, cutlery, and home fragrance products under the Ball, Calphalon, Chesapeake Bay Candle, FoodSaver, Rubbermaid, Sistema, WoodWick, and Yankee Candle brands. The Learning and Development segment offers writing instruments, including markers and highlighters, pens, and pencils; art products; activity-based adhesive and cutting products; labeling solutions; and baby gear and infant care products under the Aprica, Baby Jogger, Graco, NUK, Tigex, Dymo, Elmer's, EXPO, Graco, Mr. Sketch, NUK, Paper Mate, Parker, Prismacolor, Sharpie, Waterman, and X-Acto brands. The Outdoor and Recreation segment provides outdoor and outdoor-related products under the Campingaz, Coleman, Contigo, ExOfficio, and Marmot brands. It serves warehouse clubs, department and drug/grocery stores, mass merchants, home centers, office superstores and supply stores, contract stationers, and distributors, e-commerce, sporting goods, specialty, and travel retailers. The company was formerly known as Newell Rubbermaid Inc. and changed its name to Newell Brands Inc. in April 2016. Newell Brands Inc. was founded in 1903 and is based in Atlanta, Georgia.",Mr. Christopher H. Peterson,Household & Personal Products,4.48,USD,1871188480,https://images.financialmodelingprep.com/symbol/NWL.png,9246470,-8.62,-0.41,13393402,358000000,-216000000,"[{'period': '2024', 'revenue': 7580.0, 'unit': 'M', 'net_profit': -216.0}, {'period': '2023', 'revenue': 8130.000000000001, 'unit': 'M', 'net_profit': -388.0}, {'period': '2022', 'revenue': 9460.0, 'unit': 'M', 'net_profit': 197.0}, {'period': '2021', 'revenue': 10590.0, 'unit': 'M', 'net_profit': 622.0}]","[{'period': ""Q4 '24"", 'revenue': 1950.0, 'unit': 'M', 'net_profit': -54.0}, {'period': ""Q3 '24"", 'revenue': 1950.0, 'unit': 'M', 'net_profit': -198.0}, {'period': ""Q2 '24"", 'revenue': 2029.9999999999998, 'unit': 'M', 'net_profit': 45.0}, {'period': ""Q1 '24"", 'revenue': 1650.0, 'unit': 'M', 'net_profit': -9.0}, {'period': ""Q4 '23"", 'revenue': 2080.0, 'unit': 'M', 'net_profit': -86.0}, {'period': ""Q3 '23"", 'revenue': 2050.0, 'unit': 'M', 'net_profit': -218.0}]",-0.52,-0.52,11004000000,2775000000,198000000,8253000000,878000000,0,2437000000,198000000,237000000,2.3457943925233646,0.44329896907216493,0.4468085106382978,"[0.07, 1.4016]","['2025-02-28', '1986-02-10']",__nan__,0.75
284,NWLI,National Western Life Group Inc. Class A Common Stock,"National Western Life Group, Inc., through its subsidiary, National Western Life Insurance Company, operates as a stock life insurance company. It operates through Domestic Life Insurance, International Life Insurance, Annuities, and ONL and Affiliates segments. The company provides life products, including universal life insurance, interest-sensitive whole life, and traditional products, such as term insurance coverage; and annuity products comprising flexible premium and single premium deferred annuities, equity-index annuities, and single premium immediate annuities. The company also engages in the real estate and other investment activities. It markets and distributes its insurance products primarily through independent national marketing organizations. The company was founded in 1956 and is based in Austin, Texas.",Mr. Ross Rankin Moody,Insurance - Life,499.98,USD,1817937280,https://images.financialmodelingprep.com/symbol/NWLI.png,24814,11.35028376844495,0.38,98761,0,94430000,"[{'period': '2023', 'revenue': 698.23, 'unit': 'M', 'net_profit': 94.43}, {'period': '2022', 'revenue': 558.4, 'unit': 'M', 'net_profit': 101.14}, {'period': '2021', 'revenue': 824.09, 'unit': 'M', 'net_profit': 180.68}, {'period': '2020', 'revenue': 694.74, 'unit': 'M', 'net_profit': 92.31}]","[{'period': ""Q1 '24"", 'revenue': 196.15, 'unit': 'M', 'net_profit': 73.61}, {'period': ""Q4 '23"", 'revenue': 205.07, 'unit': 'M', 'net_profit': -12.23}, {'period': ""Q3 '23"", 'revenue': 156.69, 'unit': 'M', 'net_profit': 13.43}, {'period': ""Q2 '23"", 'revenue': 186.18, 'unit': 'M', 'net_profit': 29.63}, {'period': ""Q1 '23"", 'revenue': 152.61, 'unit': 'M', 'net_profit': 12.3}, {'period': ""Q4 '22"", 'revenue': 163.07, 'unit': 'M', 'net_profit': 12.43}]",26.71,26.71,10938627000,1351749000,7590946000,8498903000,0,380629000,-1542424000,482758000,250138000,0,-0.06638060586886024,-0.0660839160839161,"[0.36, 0.34]","['2023-11-03', '2005-10-28']",__nan__,0.7769625017838162
285,NWPX,Northwest Pipe Company Common Stock,"Northwest Pipe Company, together with its subsidiaries, manufactures and supplies water related infrastructure products in North America. It operates in two segments, Engineered Steel Pressure Pipe (SPP) and Precast Infrastructure and Engineered Systems (Precast). The SPP segment offers large-diameter, high-pressure steel pipeline systems for use in water infrastructure applications, which are primarily related to drinking water systems. Its products are also used for hydroelectric power systems, wastewater systems, and other applications. In addition, this segment makes products for industrial plant piping systems and certain structural applications. The Precast segment provides precast and reinforced concrete products, including manholes, box culverts, vaults, catch basins, oil water separators, pump lift stations, biofiltration, and other environmental and engineered solutions. The company sells its water infrastructure products primarily to installation contractors. Northwest Pipe Company was incorporated in 1966 and is headquartered in Vancouver, Washington.",Mr. Scott J. Montross,Manufacturing - Metal Fabrication,39.65,USD,393934645,https://images.financialmodelingprep.com/symbol/NWPX.png,82352,11.66,0.22,93057,48244000,34206000,"[{'period': '2024', 'revenue': 492.55, 'unit': 'M', 'net_profit': 34.21}, {'period': '2023', 'revenue': 444.36, 'unit': 'M', 'net_profit': 21.07}, {'period': '2022', 'revenue': 457.67, 'unit': 'M', 'net_profit': 31.15}, {'period': '2021', 'revenue': 333.31, 'unit': 'M', 'net_profit': 11.52}]","[{'period': ""Q4 '24"", 'revenue': 119.63, 'unit': 'M', 'net_profit': 10.1}, {'period': ""Q3 '24"", 'revenue': 130.2, 'unit': 'M', 'net_profit': 10.25}, {'period': ""Q2 '24"", 'revenue': 129.5, 'unit': 'M', 'net_profit': 8.62}, {'period': ""Q1 '24"", 'revenue': 113.12, 'unit': 'M', 'net_profit': 5.24}, {'period': ""Q4 '23"", 'revenue': 110.26, 'unit': 'M', 'net_profit': 5.44}, {'period': ""Q3 '23"", 'revenue': 118.72, 'unit': 'M', 'net_profit': 5.82}]",3.45,3.4,589653000,262488000,5007000,215650000,170368000,0,75133000,5007000,34252000,-0.03396075290348418,0.6232915717539863,0.6350710900473936,__nan__,__nan__,__nan__,0.36572356962484714
286,NWS,News Corporation Class B Common Stock,"News Corporation, a media and information services company, creates and distributes authoritative and engaging content, and other products and services for consumers and businesses worldwide. It operates in six segments: Digital Real Estate Services, Subscription Video Services, Dow Jones, Book Publishing, News Media, and Other. The company distributes content and data products, including The Wall Street Journal, Barron's, MarketWatch, Investor's Business Daily, Factiva, Dow Jones Risk & Compliance, Dow Jones Newswires, and OPIS through various media channels, such as newspapers, newswires, websites, mobile apps, newsletters, magazines, proprietary databases, live journalism, video, and podcasts. It also owns and operates daily, Sunday, weekly, and bi-weekly newspapers comprising The Australian, The Weekend Australian, The Daily Telegraph, The Sunday Telegraph, Herald Sun, Sunday Herald Sun, The Courier Mail, The Sunday Mail, The Advertiser, Sunday Mail, The Sun, The Sun on Sunday, The Times, The Sunday Times, and New York Post, as well as digital mastheads and other websites. In addition, the company publishes general fiction, nonfiction, children's, and religious books; provides sports, entertainment, and news services to pay-TV and streaming subscribers, and other commercial licensees through cable, satellite, and internet distribution; and broadcasts rights to live sporting events. Further, it offers property and property-related advertising and services on its websites and mobile applications; online real estate services; and financial services. The company was founded in 2012 and is headquartered in New York, New York.",Mr. Robert J. Thomson,Entertainment,27.54,USD,14361190164,https://images.financialmodelingprep.com/symbol/NWS.png,908527,36.72,0.13,1134210,1378000000,266000000,"[{'period': '2024', 'revenue': 10090.0, 'unit': 'M', 'net_profit': 266.0}, {'period': '2023', 'revenue': 9880.0, 'unit': 'M', 'net_profit': 149.0}, {'period': '2022', 'revenue': 10380.0, 'unit': 'M', 'net_profit': 623.0}, {'period': '2021', 'revenue': 9360.0, 'unit': 'M', 'net_profit': 330.0}]","[{'period': ""Q2 '25"", 'revenue': 2240.0, 'unit': 'M', 'net_profit': 215.0}, {'period': ""Q1 '25"", 'revenue': 2580.0, 'unit': 'M', 'net_profit': 264.0}, {'period': ""Q4 '24"", 'revenue': 2580.0, 'unit': 'M', 'net_profit': 50.0}, {'period': ""Q3 '24"", 'revenue': 2420.0, 'unit': 'M', 'net_profit': 30.0}, {'period': ""Q2 '24"", 'revenue': 2590.0, 'unit': 'M', 'net_profit': 156.0}, {'period': ""Q1 '24"", 'revenue': 2500.0, 'unit': 'M', 'net_profit': 30.0}]",0.47,0.46,16684000000,4372000000,1960000000,7673000000,1503000000,430000000,3055000000,1960000000,602000000,0.11398544866612773,0.785234899328859,0.8076923076923075,"[0.1, 0.1]","['2025-03-12', '2015-09-14']",__nan__,0.45990170222968113
287,NWSA,News Corporation Class A Common Stock,"News Corporation, a media and information services company, creates and distributes authoritative and engaging content, and other products and services for consumers and businesses worldwide. It operates in six segments: Digital Real Estate Services, Subscription Video Services, Dow Jones, Book Publishing, News Media, and Other. The company distributes content and data products, including The Wall Street Journal, Barron's, MarketWatch, Investor's Business Daily, Factiva, Dow Jones Risk & Compliance, Dow Jones Newswires, and OPIS through various media channels, such as newspapers, newswires, websites, mobile apps, newsletters, magazines, proprietary databases, live journalism, video, and podcasts. It also owns and operates daily, Sunday, weekly, and bi-weekly newspapers comprising The Australian, The Weekend Australian, The Daily Telegraph, The Sunday Telegraph, Herald Sun, Sunday Herald Sun, The Courier Mail, The Sunday Mail, The Advertiser, Sunday Mail, The Sun, The Sun on Sunday, The Times, The Sunday Times, and New York Post, as well as digital mastheads and other websites. In addition, the company publishes general fiction, nonfiction, children's, and religious books; provides sports, entertainment, and news services to pay-TV and streaming subscribers, and other commercial licensees through cable, satellite, and internet distribution; and broadcasts rights to live sporting events. Further, it offers property and property-related advertising and services on its websites and mobile applications; online real estate services; and financial services. The company was founded in 2012 and is headquartered in New York, New York.",Mr. Robert J. Thomson,Entertainment,23.97,USD,14228105721,https://images.financialmodelingprep.com/symbol/NWSA.png,3538940,31.96,-0.11,4689853,1378000000,266000000,"[{'period': '2024', 'revenue': 10090.0, 'unit': 'M', 'net_profit': 266.0}, {'period': '2023', 'revenue': 9880.0, 'unit': 'M', 'net_profit': 149.0}, {'period': '2022', 'revenue': 10380.0, 'unit': 'M', 'net_profit': 623.0}, {'period': '2021', 'revenue': 9360.0, 'unit': 'M', 'net_profit': 330.0}]","[{'period': ""Q2 '25"", 'revenue': 2240.0, 'unit': 'M', 'net_profit': 215.0}, {'period': ""Q1 '25"", 'revenue': 2580.0, 'unit': 'M', 'net_profit': 264.0}, {'period': ""Q4 '24"", 'revenue': 2580.0, 'unit': 'M', 'net_profit': 50.0}, {'period': ""Q3 '24"", 'revenue': 2420.0, 'unit': 'M', 'net_profit': 30.0}, {'period': ""Q2 '24"", 'revenue': 2590.0, 'unit': 'M', 'net_profit': 156.0}, {'period': ""Q1 '24"", 'revenue': 2500.0, 'unit': 'M', 'net_profit': 30.0}]",0.47,0.46,16684000000,4372000000,1960000000,7673000000,1503000000,430000000,3055000000,1960000000,602000000,0.11398544866612773,0.785234899328859,0.8076923076923075,"[0.1, 0.1]","['2025-03-12', '2015-09-14']",__nan__,0.45990170222968113
288,NXGN,NextGen Healthcare Inc. Common Stock,"NextGen Healthcare, Inc. provides healthcare technology solutions in the United States. The company offers clinical care solutions, including NextGen Enterprise EHR; financial solutions, such as NextGen Enterprise PM; patient engagement solutions comprising NextGen Virtual Visits; integrated clinical care and financial solutions consisting of NextGen Office; interoperability solutions that include NextGen Share and Mirth Connect; data and analytics solutions, which comprise NextGen Health Data Hub; and value based care solutions, including NextGen Population Health Solutions. It also provides managed services, such as revenue cycle management services comprising billing and collections, electronic claims submission and denials management, electronic remittance and payment posting, and accounts receivable follow-up; and client and support services. Further, the company offers professional services consisting of training, project management, installation services, and application managed services; and consulting services that include physician, professional, and technical consulting; assisting clients to optimize their staffing and software solutions; enhancing financial and clinical outcomes; achieving regulatory requirements; and meeting the requirements of healthcare reform. It serves accountable care organizations, independent physician associations, managed service organizations, veterans service organizations, dental service organizations, ambulatory care centers, and community health centers through a direct sales force and reseller channel. The company was formerly known as Quality Systems, Inc. and changed its name to NextGen Healthcare, Inc. in September 2018. NextGen Healthcare, Inc. was incorporated in 1974 and is headquartered in Atlanta, Georgia.",Mr. David William Sides,Medical - Healthcare Information Services,23.94,USD,1606299786,https://images.financialmodelingprep.com/symbol/NXGN.png,1261934,-266,0.03,3124069,48044000,-2654000,"[{'period': '2023', 'revenue': 653.17, 'unit': 'M', 'net_profit': -2.65}, {'period': '2022', 'revenue': 596.35, 'unit': 'M', 'net_profit': 1.62}, {'period': '2021', 'revenue': 556.82, 'unit': 'M', 'net_profit': 9.52}, {'period': '2020', 'revenue': 540.24, 'unit': 'M', 'net_profit': 7.5}]","[{'period': ""Q2 '24"", 'revenue': 176.42, 'unit': 'M', 'net_profit': 5.05}, {'period': ""Q1 '24"", 'revenue': 178.21, 'unit': 'M', 'net_profit': 6.16}, {'period': ""Q4 '23"", 'revenue': 178.55, 'unit': 'M', 'net_profit': -25.24}, {'period': ""Q3 '23"", 'revenue': 161.88, 'unit': 'M', 'net_profit': 7.82}, {'period': ""Q2 '23"", 'revenue': 159.44, 'unit': 'M', 'net_profit': 13.62}, {'period': ""Q1 '23"", 'revenue': 153.3, 'unit': 'M', 'net_profit': 1.15}]",-0.04,-0.0396,896101000,401823000,238331000,495666000,94070000,0,198111000,98719000,6396000,-0.10122532971658404,-2.6402966625463535,-3,"[0.175, 3]","['2015-12-09', '2005-02-22']",__nan__,0.5531363094115507
289,NXPI,NXP Semiconductors N.V. Common Stock,"NXP Semiconductors N.V. offers various semiconductor products. The company's product portfolio includes microcontrollers; application processors, including i.MX application processors, and i.MX 8 and 9 family of applications processors; communication processors; wireless connectivity solutions, such as near field communications, ultra-wideband, Bluetooth low-energy, Zigbee, and Wi-Fi and Wi-Fi/Bluetooth integrated SoCs; analog and interface devices; radio frequency power amplifiers; and security controllers, as well as semiconductor-based environmental and inertial sensors, including pressure, inertial, magnetic, and gyroscopic sensors. The company's product solutions are used in a range of applications, including automotive, industrial and Internet of Things, mobile, and communication infrastructure. The company markets its products to various original equipment manufacturers, contract manufacturers, and distributors. It operates in China, the Netherlands, the United States, Singapore, Germany, Japan, South Korea, Malaysia, and internationally. The company was formerly known as KASLION Acquisition B.V and changed its name to NXP Semiconductors N.V. in May 2010. NXP Semiconductors N.V. was incorporated in 2006 and is headquartered in Eindhoven, the Netherlands.",Mr. Kurt  Sievers,Semiconductors,153.5,USD,38930670000,https://images.financialmodelingprep.com/symbol/NXPI.png,3220088,15.78,-9.79,5083445,4422000000,2510000000,"[{'period': '2024', 'revenue': 12.61, 'unit': 'B', 'net_profit': 2.51}, {'period': '2023', 'revenue': 13.28, 'unit': 'B', 'net_profit': 2.8}, {'period': '2022', 'revenue': 13.21, 'unit': 'B', 'net_profit': 2.79}, {'period': '2021', 'revenue': 11.06, 'unit': 'B', 'net_profit': 1.87}]","[{'period': ""Q4 '24"", 'revenue': 3110.0, 'unit': 'M', 'net_profit': 495.0}, {'period': ""Q3 '24"", 'revenue': 3250.0, 'unit': 'M', 'net_profit': 718.0}, {'period': ""Q2 '24"", 'revenue': 3130.0, 'unit': 'M', 'net_profit': 658.0}, {'period': ""Q1 '24"", 'revenue': 3130.0, 'unit': 'M', 'net_profit': 639.0}, {'period': ""Q4 '23"", 'revenue': 3420.0, 'unit': 'M', 'net_profit': 697.0}, {'period': ""Q3 '23"", 'revenue': 3430.0, 'unit': 'M', 'net_profit': 787.0}]",9.84,9.73,24385000000,7305000000,3292000000,14854000000,1032000000,0,3098000000,3292000000,2782000000,-0.09681372549019608,-0.1026099392205935,-0.09141274238227148,"[1.014, 0.25]","['2025-03-19', '2018-09-24']",__nan__,0.6091449661677261
290,NXST,Nexstar Media Group Inc. Class A Common Stock,"Nexstar Media Group, Inc., a television broadcasting and digital media company, focuses on the acquisition, development, and operation of television stations and interactive community websites and digital media services in the United States. The company offers free programming to television viewing audiences. As of December 31, 2020, it provided sales, programming, and other services through various local service agreements to 37 power television stations owned by independent third parties; and owned, operated, programmed, or provided sales and other services to 198 television stations. The company also offers video and display advertising platforms that are delivered locally or nationally through its own and various third party websites and mobile applications, as well as owns WGN America, a national general entertainment cable network. Its stations are affiliates of ABC, NBC, FOX, CBS, The CW, MyNetworkTV, and other broadcast television networks. The company was formerly known as Nexstar Broadcasting Group, Inc. and changed its name to Nexstar Media Group, Inc. in January 2017. Nexstar Media Group, Inc. was founded in 1996 and is headquartered in Irving, Texas.",Mr. Perry A. Sook,Entertainment,147.79,USD,4508954668,https://images.financialmodelingprep.com/symbol/NXST.png,487263,6.9,-2.88,635024,2223000000,722000000,"[{'period': '2024', 'revenue': 5410.0, 'unit': 'M', 'net_profit': 722.0}, {'period': '2023', 'revenue': 4930.0, 'unit': 'M', 'net_profit': 346.0}, {'period': '2022', 'revenue': 5210.0, 'unit': 'M', 'net_profit': 971.0}, {'period': '2021', 'revenue': 4650.0, 'unit': 'M', 'net_profit': 834.0}]","[{'period': ""Q4 '24"", 'revenue': 1490.0, 'unit': 'M', 'net_profit': 241.0}, {'period': ""Q3 '24"", 'revenue': 1370.0, 'unit': 'M', 'net_profit': 187.0}, {'period': ""Q2 '24"", 'revenue': 1270.0, 'unit': 'M', 'net_profit': 118.0}, {'period': ""Q1 '24"", 'revenue': 1280.0, 'unit': 'M', 'net_profit': 175.0}, {'period': ""Q4 '23"", 'revenue': 1300.0, 'unit': 'M', 'net_profit': 114.0}, {'period': ""Q3 '23"", 'revenue': 1130.0, 'unit': 'M', 'net_profit': 25.0}]",21.73,21.41,11468000000,1297000000,144000000,9200000000,1028000000,877000000,783000000,144000000,1105000000,0.24259362772498602,1.0867052023121386,1.21734693877551,"[1.86, 0.12]","['2025-02-12', '2013-02-13']",__nan__,0.8022322985699337
291,NXTC,NextCure Inc. Common Stock,"NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The company is also developing NC410, which is in Phase I for novel immunomedicine designed to block immune suppression mediated by an immune modulator called Leukocyte-Associated Immunoglobulin-like Receptor 1; NC762, an immunomedicine targeting a molecule called human B7 homolog 4 protein, or B7-H4; and NC525, a novel LAIR-1 antibody which is in Preclinical trails that targets acute myeloid leukemia, blast cells, and leukemic stem cells. Its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules. The company has a license agreement with Yale University. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.",Mr. Michael S. Richman MSBA,Biotechnology,0.3296,USD,9231008,https://images.financialmodelingprep.com/symbol/NXTC.png,85975,-0.17,-0.0562,235533,-54341000,-55654000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -55.65}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -62.72}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -69.43}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -69.39}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.6}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.54}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.4}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -17.11}, {'period': ""Q4 '23"", 'revenue': 6.28, 'unit': 'M', 'net_profit': -14.47}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.3}]",-1.99,-1.99,80860000,71807000,68621000,15388000,0,0,9574000,27727000,-41279000,0.07957451853859314,0.11270187969325447,0.11555555555555556,__nan__,__nan__,__nan__,0.19030422953252535
292,NXTD,Nxt-ID Inc. Common Stock,"Nxt-ID, Inc. provides technology products and services for healthcare applications. It develops and markets solutions for payment, Internet of Things (IoT), and healthcare applications with experience in access control, biometric and behavior-metric identity verification, security and privacy, encryption and data protection, payments, miniaturization, and sensor technologies. The company, through its subsidiary, LogicMark LLC, manufactures and distributes non-monitored and monitored personal emergency response systems sold through healthcare durable medical equipment and monitored security dealers/distributors, and the United States Department of Veterans Affairs. It serves various end markets, including the security, healthcare, financial technology, and the IoT markets. Nxt-ID, Inc. was founded in 2011 and is based in Oxford, Connecticut.",Mr. Vincent Miceli,Security & Protection Services,2.42,USD,57751848,https://images.financialmodelingprep.com/symbol/NXTD.png,2456032,-1.1874386653581943,-0.12999988,249697,-9288986,-11707889,"[{'period': '2021', 'revenue': 10.02, 'unit': 'M', 'net_profit': -11.71}, {'period': '2020', 'revenue': 11.44, 'unit': 'M', 'net_profit': -2.86}, {'period': '2019', 'revenue': 17.14, 'unit': 'M', 'net_profit': -11.79}, {'period': '2018', 'revenue': 17.12, 'unit': 'M', 'net_profit': -7.09}]","[{'period': ""Q4 '21"", 'revenue': 2.42, 'unit': 'M', 'net_profit': -6.29}, {'period': ""Q3 '21"", 'revenue': 2380.0, 'unit': 'K', 'net_profit': -641.7}, {'period': ""Q2 '21"", 'revenue': 2780.0, 'unit': 'K', 'net_profit': -555.75}, {'period': ""Q1 '21"", 'revenue': 2.44, 'unit': 'M', 'net_profit': -4.22}, {'period': ""Q4 '20"", 'revenue': 2580.0, 'unit': 'K', 'net_profit': -1.56}, {'period': ""Q3 '20"", 'revenue': 2.64, 'unit': 'M', 'net_profit': -1.08}]",-1.86,-1.86,30123383,14439765,12044415,1726912,98749,0,1341716,12044415,-5913920,-15.296380896240898,-3.0865460330668513,-1.1136363636363638,__nan__,__nan__,__nan__,0.05732795682344178
293,NYMT,New York Mortgage Trust Inc. Common Stock,"New York Mortgage Trust, Inc. acquires, invests in, finances, and manages mortgage-related single-family and multi-family residential assets in the United States. Its targeted investments include residential loans, second mortgages, and business purpose loans; structured multi-family property investments, such as preferred equity in, and mezzanine loans to owners of multi-family properties, as well as joint venture equity investments in multi-family properties; non-agency residential mortgage-backed securities (RMBS); agency RMBS; commercial mortgage-backed securities (CMBS); and other mortgage, residential housing, and credit-related assets. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was incorporated in 2003 and is headquartered in New York, New York.",Mr. Jason T. Serrano,REIT - Mortgage,5.38,USD,487252612,https://images.financialmodelingprep.com/symbol/NYMT.png,717224,-4.72,-0.11,1061143,254498000,-62029000,"[{'period': '2024', 'revenue': 83.86, 'unit': 'M', 'net_profit': -62.03}, {'period': '2023', 'revenue': 210.0, 'unit': 'M', 'net_profit': -48.66}, {'period': '2022', 'revenue': 8.46, 'unit': 'M', 'net_profit': -340.65}, {'period': '2021', 'revenue': 266.51, 'unit': 'M', 'net_profit': 193.2}]","[{'period': ""Q4 '24"", 'revenue': 26.71, 'unit': 'M', 'net_profit': -31.39}, {'period': ""Q3 '24"", 'revenue': 93.66, 'unit': 'M', 'net_profit': 42.85}, {'period': ""Q2 '24"", 'revenue': 129.74, 'unit': 'M', 'net_profit': -15.59}, {'period': ""Q1 '24"", 'revenue': 115.64, 'unit': 'M', 'net_profit': -57.9}, {'period': ""Q4 '23"", 'revenue': 16.8, 'unit': 'M', 'net_profit': 31.46}, {'period': ""Q3 '23"", 'revenue': 17.39, 'unit': 'M', 'net_profit': -84.51}]",-1.14,-1.14,9217282000,3995966000,3995966000,7806148000,151204000,0,79432000,167422000,4601000,0.23281791935515123,-0.2746121442515155,-0.15151515151515144,"[0.2, 0.16]","['2025-03-31', '2004-10-04']",__nan__,0.8469034580910078
294,NYMTM,New York Mortgage Trust Inc. 7.875% Series E Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock,"New York Mortgage Trust, Inc. acquires, invests in, finances, and manages mortgage-related single-family and multi-family residential assets in the United States. Its targeted investments include residential loans, second mortgages, and business purpose loans; structured multi-family property investments, such as preferred equity in, and mezzanine loans to owners of multi-family properties, as well as joint venture equity investments in multi-family properties; non-agency residential mortgage-backed securities (RMBS); agency RMBS; commercial mortgage-backed securities (CMBS); and other mortgage, residential housing, and credit-related assets. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was incorporated in 2003 and is headquartered in New York, New York.",Mr. Jason T. Serrano,REIT - Mortgage,23.2,USD,2101163680,https://images.financialmodelingprep.com/symbol/NYMTM.png,28708,493.62,0.2,47301,254498000,-62029000,"[{'period': '2024', 'revenue': 83.86, 'unit': 'M', 'net_profit': -62.03}, {'period': '2023', 'revenue': 210.0, 'unit': 'M', 'net_profit': -48.66}, {'period': '2022', 'revenue': 8.46, 'unit': 'M', 'net_profit': -340.65}, {'period': '2021', 'revenue': 266.51, 'unit': 'M', 'net_profit': 193.2}]","[{'period': ""Q4 '24"", 'revenue': 26.71, 'unit': 'M', 'net_profit': -31.39}, {'period': ""Q3 '24"", 'revenue': 93.66, 'unit': 'M', 'net_profit': 42.85}, {'period': ""Q2 '24"", 'revenue': 129.74, 'unit': 'M', 'net_profit': -15.59}, {'period': ""Q1 '24"", 'revenue': 115.64, 'unit': 'M', 'net_profit': -57.9}, {'period': ""Q4 '23"", 'revenue': 16.8, 'unit': 'M', 'net_profit': 31.46}, {'period': ""Q3 '23"", 'revenue': 17.39, 'unit': 'M', 'net_profit': -84.51}]",-1.14,-1.14,9217282000,3995966000,3995966000,7806148000,151204000,0,79432000,167422000,4601000,0.23281791935515123,-0.2746121442515155,-0.15151515151515144,"[0.68704, 0.476]","['2025-04-01', '2019-12-30']",__nan__,0.8469034580910078
295,NYMTN,New York Mortgage Trust Inc. 8.00% Series D Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock,"New York Mortgage Trust, Inc. acquires, invests in, finances, and manages mortgage-related single-family and multi-family residential assets in the United States. Its targeted investments include residential loans, second mortgages, and business purpose loans; structured multi-family property investments, such as preferred equity in, and mezzanine loans to owners of multi-family properties, as well as joint venture equity investments in multi-family properties; non-agency residential mortgage-backed securities (RMBS); agency RMBS; commercial mortgage-backed securities (CMBS); and other mortgage, residential housing, and credit-related assets. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was incorporated in 2003 and is headquartered in New York, New York.",Mr. Jason T. Serrano,REIT - Mortgage,20.5625,USD,503892966,https://images.financialmodelingprep.com/symbol/NYMTN.png,9331,437.5,0.2725,9284,254498000,-62029000,"[{'period': '2024', 'revenue': 83.86, 'unit': 'M', 'net_profit': -62.03}, {'period': '2023', 'revenue': 210.0, 'unit': 'M', 'net_profit': -48.66}, {'period': '2022', 'revenue': 8.46, 'unit': 'M', 'net_profit': -340.65}, {'period': '2021', 'revenue': 266.51, 'unit': 'M', 'net_profit': 193.2}]","[{'period': ""Q4 '24"", 'revenue': 26.71, 'unit': 'M', 'net_profit': -31.39}, {'period': ""Q3 '24"", 'revenue': 93.66, 'unit': 'M', 'net_profit': 42.85}, {'period': ""Q2 '24"", 'revenue': 129.74, 'unit': 'M', 'net_profit': -15.59}, {'period': ""Q1 '24"", 'revenue': 115.64, 'unit': 'M', 'net_profit': -57.9}, {'period': ""Q4 '23"", 'revenue': 16.8, 'unit': 'M', 'net_profit': 31.46}, {'period': ""Q3 '23"", 'revenue': 17.39, 'unit': 'M', 'net_profit': -84.51}]",-1.14,-1.14,9217282000,3995966000,3995966000,7806148000,151204000,0,79432000,167422000,4601000,0.23281791935515123,-0.2746121442515155,-0.15151515151515144,"[0.5, 0.511]","['2025-04-01', '2017-12-28']",__nan__,0.8469034580910078
296,NYMTO,New York Mortgage Trust Inc. 7.875% Series C Cumulative Redeemable Preferred Stock,"New York Mortgage Trust, Inc. acquires, invests in, finances, and manages mortgage-related and residential housing-related assets in the United States. Its investment portfolio includes structured multi-family property investments, such as multi-family commercial mortgage-backed securities and preferred equity in, and mezzanine loans to owners of multi-family properties; residential mortgage loans, including distressed residential mortgage loans, non-qualified mortgage loans, second mortgages, residential bridge loans, and other residential mortgage loans; non-agency residential mortgage-backed securities(RMBS); agency RMBS and CMBS; and other mortgage-related, residential housing-related, and credit-related assets. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2003 and is headquartered in New York, New York.",Mr. Steven R. Mumma CPA,REIT - Mortgage,25.06,USD,1308625657,https://images.financialmodelingprep.com/symbol/NYMTO.png,28147,30.48661800486618,0,4589,254498000,-62029000,"[{'period': '2024', 'revenue': 83.86, 'unit': 'M', 'net_profit': -62.03}, {'period': '2023', 'revenue': 210.0, 'unit': 'M', 'net_profit': -48.66}, {'period': '2022', 'revenue': 8.46, 'unit': 'M', 'net_profit': -340.65}, {'period': '2021', 'revenue': 266.51, 'unit': 'M', 'net_profit': 193.2}]","[{'period': ""Q4 '24"", 'revenue': 26.71, 'unit': 'M', 'net_profit': -31.39}, {'period': ""Q3 '24"", 'revenue': 93.66, 'unit': 'M', 'net_profit': 42.85}, {'period': ""Q2 '24"", 'revenue': 129.74, 'unit': 'M', 'net_profit': -15.59}, {'period': ""Q1 '24"", 'revenue': 115.64, 'unit': 'M', 'net_profit': -57.9}, {'period': ""Q4 '23"", 'revenue': 16.8, 'unit': 'M', 'net_profit': 31.46}, {'period': ""Q3 '23"", 'revenue': 17.39, 'unit': 'M', 'net_profit': -84.51}]",-1.14,-1.14,9217282000,3995966000,3995966000,7806148000,151204000,0,79432000,167422000,4601000,0.23281791935515123,-0.2746121442515155,-0.15151515151515144,"[0.492, 0.454]","['2021-06-30', '2015-06-29']",__nan__,0.8469034580910078
297,NYMTP,New York Mortgage Trust Inc. 7.75% Series B Cumulative Redeemable Preferred Stock,"New York Mortgage Trust, Inc. acquires, invests in, finances, and manages mortgage-related single-family and multi-family residential assets in the United States. Its targeted investments include residential loans, second mortgages, and business purpose loans; structured multi-family property investments, such as preferred equity in, and mezzanine loans to owners of multi-family properties, as well as joint venture equity investments in multi-family properties; non-agency residential mortgage-backed securities (RMBS); agency RMBS; commercial mortgage-backed securities (CMBS); and other mortgage, residential housing, and credit-related assets. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was incorporated in 2003 and is headquartered in New York, New York.",Mr. Steven R. Mumma CPA,REIT - Mortgage,25.3205,USD,0,https://images.financialmodelingprep.com/symbol/NYMTP.png,10412,50.53992015968064,0.00049973,19331,254498000,-62029000,"[{'period': '2024', 'revenue': 83.86, 'unit': 'M', 'net_profit': -62.03}, {'period': '2023', 'revenue': 210.0, 'unit': 'M', 'net_profit': -48.66}, {'period': '2022', 'revenue': 8.46, 'unit': 'M', 'net_profit': -340.65}, {'period': '2021', 'revenue': 266.51, 'unit': 'M', 'net_profit': 193.2}]","[{'period': ""Q4 '24"", 'revenue': 26.71, 'unit': 'M', 'net_profit': -31.39}, {'period': ""Q3 '24"", 'revenue': 93.66, 'unit': 'M', 'net_profit': 42.85}, {'period': ""Q2 '24"", 'revenue': 129.74, 'unit': 'M', 'net_profit': -15.59}, {'period': ""Q1 '24"", 'revenue': 115.64, 'unit': 'M', 'net_profit': -57.9}, {'period': ""Q4 '23"", 'revenue': 16.8, 'unit': 'M', 'net_profit': 31.46}, {'period': ""Q3 '23"", 'revenue': 17.39, 'unit': 'M', 'net_profit': -84.51}]",-1.14,-1.14,9217282000,3995966000,3995966000,7806148000,151204000,0,79432000,167422000,4601000,0.23281791935515123,-0.2746121442515155,-0.15151515151515144,"[0.484, 0.221]","['2021-09-30', '2013-06-27']",__nan__,0.8469034580910078
298,NYMX,Nymox Pharmaceutical Corporation Common Stock (Bahamas),"Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia, and Phase II clinical trials for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. In addition, it offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer's disease, as well as researches and develops drug treatments for Alzheimer's disease. The company was founded in 1989 and is headquartered in Nassau, the Bahamas.","Dr. Paul  Averback DABP, M.D.",Biotechnology,0.1999,USD,18243894,https://images.financialmodelingprep.com/symbol/NYMX.png,134777,-2.855714285714286,-0.0001,881574,-6289000,-6571000,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.57}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.58}, {'period': '2020', 'revenue': 0.005, 'unit': 'M', 'net_profit': -11.78}, {'period': '2019', 'revenue': 0.116, 'unit': 'M', 'net_profit': -13.2}]","[{'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.11}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.39}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.48}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.5}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.46}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.09}]",-0.0735,-0.0735,1625000,1457000,1403000,2107000,10000,0,2107000,1403000,-5205000,0.48627675216467897,0.4774968193384224,0.51,__nan__,__nan__,__nan__,1.2966153846153847
299,OAS,Oasis Petroleum Inc. Common Stock,"As of July 1, 2022, Oasis Petroleum Inc. was acquired by Whiting Petroleum Corporation, in a reverse merger transaction. Oasis Petroleum Inc., an independent exploration and production company, focuses on the acquisition and development of onshore unconventional oil and natural gas resources in the United States. It engages in the acquisition and development of oil and gas properties. As of December 31, 2021, the company had 492,355 net leasehold acres in the Williston Basin. The company sells its crude oil and natural gas to refiners, marketers, and other purchasers that have access to pipeline and rail facilities. Oasis Petroleum Inc. was founded in 2007 and is headquartered in Houston, Texas.",Mr. Thomas Nusz,Oil & Gas Exploration & Production,109.3,USD,4549787380,https://images.financialmodelingprep.com/symbol/OAS.png,0,8.900651465798045,2.6500015,1292714,2276737000,848627000,"[{'period': '2024', 'revenue': 5250.0, 'unit': 'M', 'net_profit': 848.63}, {'period': '2023', 'revenue': 3.9, 'unit': 'B', 'net_profit': 1.02}, {'period': '2022', 'revenue': 3.65, 'unit': 'B', 'net_profit': 1.43}, {'period': '2021', 'revenue': 1580.0, 'unit': 'M', 'net_profit': 188.96}]","[{'period': ""Q4 '24"", 'revenue': 1450.0, 'unit': 'M', 'net_profit': 210.6}, {'period': ""Q3 '24"", 'revenue': 1450.0, 'unit': 'M', 'net_profit': 225.32}, {'period': ""Q2 '24"", 'revenue': 1260.0, 'unit': 'M', 'net_profit': 213.36}, {'period': ""Q1 '24"", 'revenue': 1090.0, 'unit': 'M', 'net_profit': 199.35}, {'period': ""Q4 '23"", 'revenue': 964.68, 'unit': 'M', 'net_profit': 301.63}, {'period': ""Q3 '23"", 'revenue': 1120.0, 'unit': 'M', 'net_profit': 209.08}]",16.32,16.02,13032007000,1579118000,36950000,4329745000,1298973000,142201000,1683978000,36950000,918152000,0.15792586790898272,-0.17108379835882548,-0.33658536585365856,"[1.25, 0.375]","['2022-08-15', '2021-03-05']",__nan__,0.33223930895678616
300,OBAS,Optibase Ltd. Ordinary Shares,"Optibase Ltd., through its subsidiaries, operates in the fixed-income real estate sector in Switzerland, Germany, and the United States. It purchases and operates real estate properties intended for leasing and resale primarily for the purpose of commercial, industrial, office space, parking garage, and warehouse use, as well as for residential purposes. The company was formerly known as Optibase Advanced Systems (1990) Ltd. and changed its name to Optibase Ltd. in November 1993. The company was founded in 1990 and is headquartered in Herzliya, Israel. Optibase Ltd. is a subsidiary of The Capri Family Foundation.",Mr. Amir Philips,Real Estate - Services,12.59,USD,0,https://images.financialmodelingprep.com/symbol/OBAS.png,3033,-31.475,0,312,15013000,6433000,"[{'period': '2020', 'revenue': 14.87, 'unit': 'M', 'net_profit': 6.43}, {'period': '2019', 'revenue': 16.14, 'unit': 'M', 'net_profit': -1.99}, {'period': '2018', 'revenue': 16.61, 'unit': 'M', 'net_profit': -2.78}, {'period': '2017', 'revenue': 16.59, 'unit': 'M', 'net_profit': -1.12}]","[{'period': ""Q3 '21"", 'revenue': 3490.0, 'unit': 'K', 'net_profit': -86.0}, {'period': ""Q2 '21"", 'revenue': 3490.0, 'unit': 'K', 'net_profit': -537.0}, {'period': ""Q1 '21"", 'revenue': 3440.0, 'unit': 'K', 'net_profit': -822.0}, {'period': ""Q4 '20"", 'revenue': 3440.0, 'unit': 'K', 'net_profit': -625.0}, {'period': ""Q3 '20"", 'revenue': 3.54, 'unit': 'M', 'net_profit': 5.16}, {'period': ""Q2 '20"", 'revenue': 3.79, 'unit': 'M', 'net_profit': 1.78}]",1.24,1.24,234697000,33004000,28820000,148036000,747000,9269000,12818000,28820000,5118000,1.3657421998109045,4.227797290516809,4.2631578947368425,__nan__,__nan__,__nan__,0.6307536951899684
301,OBCI,Ocean Bio-Chem Inc. Common Stock,"Ocean Bio-Chem, Inc. manufactures, markets, and distributes appearance, performance, and maintenance products for the marine, automotive, power sports, recreational vehicle, home care, and outdoor power equipment markets in the United States and Canada. The company offers marine products, including polishes, cleaners, protectants, waxes, enzyme fuel treatments, private label products, motor and teak oils, boat washes, vinyl and teak cleaners, bilge and hull cleaners, silicone and polyurethane sealants, polysulfide sealants, gasket materials, lubricants, antifouling additives, and anti-freeze coolants; and brushes, brush handles, tie-downs, and other related accessories. It also manufactures automotive products, such as fuel treatments for gas and diesel engines, motor oils, greases, and related items; anti-freeze and windshield washes; and automotive polishes, cleaners, and other items. In addition, the company offers fuel treatment and other specialty products to the recreational vehicle market; solutions to various problems associated with E-10 fuel; and other specialty recreational vehicle/power sports products, including cleaners, polishes, detergents, fabric cleaners and protectors, silicone sealants, waterproofers, gasket materials, degreasers, vinyl cleaners and protectors, toilet treatment fluids, and anti-freeze/coolants. Further, it provides solutions to rectify operating engine problems in commercial lawn, and other home and garden power equipment; deodorizers, disinfectants, and sanitizers, as well as mildew odor control bags and boat odor sanitizers; blends and packages chemical formulations; and manufactures PVC and HDPE blow molded bottles. The company sells its products under the Star Tron, Performacide, and Star brite brands through retailers and online retailers, as well as to distributors. Ocean Bio-Chem, Inc. was founded in 1973 and is headquartered in Fort Lauderdale, Florida. As of August 9, 2022, Ocean Bio-Chem, Inc. operates as a subsidiary of OneWater Marine Inc.",Mr. Peter Dornau,Conglomerates,13.03,USD,0,https://images.financialmodelingprep.com/symbol/OBCI.png,0,25.54901960784314,-0.010000229,,7735446,13016602,"[{'period': '2021', 'revenue': 64.3, 'unit': 'M', 'net_profit': 13.02}, {'period': '2020', 'revenue': 55.56, 'unit': 'M', 'net_profit': 9.62}, {'period': '2019', 'revenue': 42.26, 'unit': 'M', 'net_profit': 3.5}, {'period': '2018', 'revenue': 41.8, 'unit': 'M', 'net_profit': 2.8}]","[{'period': ""Q2 '22"", 'revenue': 15210.0, 'unit': 'K', 'net_profit': -321.39}, {'period': ""Q1 '22"", 'revenue': 12.74, 'unit': 'M', 'net_profit': 1.3}, {'period': ""Q4 '21"", 'revenue': 14.0, 'unit': 'M', 'net_profit': 3.44}, {'period': ""Q3 '21"", 'revenue': 21.48, 'unit': 'M', 'net_profit': 3.27}, {'period': ""Q2 '21"", 'revenue': 15.69, 'unit': 'M', 'net_profit': 2.6}, {'period': ""Q1 '21"", 'revenue': 13.13, 'unit': 'M', 'net_profit': 1.9}]",1.37,1.37,60277704,42354291,12684935,12841586,9544133,0,4650031,12684935,-1937086,-0.43693517062646686,0.35354383626870095,0.34313725490196084,"[0.04, 0.0329]","['2022-06-07', '1996-04-29']",__nan__,0.21304039715912204
302,OBLG,Oblong Inc. Common Stock,"Oblong Inc., together with its subsidiaries, provides multi-stream collaboration technologies and managed services for video collaboration and network applications in the United States and internationally. The company operates in two segments, Collaboration Products and Managed Services. Its flagship product is Mezzanine that enables visual collaboration across multi-users, multi-screens, multi-devices, and multi-locations for video telepresence, laptop and application sharing, and whiteboard sharing and slides applications. The company also provides managed videoconferencing services; and remote service management, which provides an overlay to enterprise information technology and channel partner support organizations, as well as support and management services for customer video environments. In addition, it offers network services comprising Cloud Connect: Video that allows its customers to outsource the management of their video traffic to them and provides the customer's office locations with a secure, dedicated video network connection to the Oblong Cloud for video communications; Cloud Connect: Converge, which offers customized multiprotocol label switching solutions; and Cloud Connect: Cross Connect that allows the customer to leverage existing carrier for the extension of a Layer 2 private line to its data center. Further, it provides professional services, such as software development, visual and interaction design, engineering, and project support services; and resells video equipment to its customers. Oblong Inc. is based in Conifer, Colorado.",Mr. Peter J. Holst,Software - Application,2.43,USD,2806480,https://images.financialmodelingprep.com/symbol/OBLG.png,24631,-0.15,-0.46,17150,-4033000,-4043000,"[{'period': '2024', 'revenue': 2.38, 'unit': 'M', 'net_profit': -4.04}, {'period': '2023', 'revenue': 3.81, 'unit': 'M', 'net_profit': -4.38}, {'period': '2022', 'revenue': 5.48, 'unit': 'M', 'net_profit': -21.94}, {'period': '2021', 'revenue': 7.74, 'unit': 'M', 'net_profit': -9.05}]","[{'period': ""Q4 '24"", 'revenue': 563.0, 'unit': 'K', 'net_profit': -884.0}, {'period': ""Q3 '24"", 'revenue': 0.578, 'unit': 'M', 'net_profit': -1.04}, {'period': ""Q2 '24"", 'revenue': 611.0, 'unit': 'K', 'net_profit': -983.0}, {'period': ""Q1 '24"", 'revenue': 0.626, 'unit': 'M', 'net_profit': -1.14}, {'period': ""Q4 '23"", 'revenue': 0.9440000000000001, 'unit': 'M', 'net_profit': -1.22}, {'period': ""Q3 '23"", 'revenue': 872.0, 'unit': 'K', 'net_profit': -895.0}]",-15.71,-15.71,5275000,5269000,4965000,1272000,186000,0,1272000,4965000,-3406000,-0.012299196787148595,0.07778284671532847,0.4987236758136566,__nan__,__nan__,__nan__,0.24113744075829383
303,OBLN,Obalon Therapeutics Inc. Common Stock,"Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallow able capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. As of February 27, 2020, it had three company-managed retail treatment centers in California. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.",Dr. Kelly Huang,Medical - Devices,3.05,USD,5472310,https://images.financialmodelingprep.com/symbol/OBLN.png,1508029,-2.2165697674418605,-0.19000006,26469075,-11491000,-12334000,"[{'period': '2020', 'revenue': 1.59, 'unit': 'M', 'net_profit': -12.33}, {'period': '2019', 'revenue': 3.28, 'unit': 'M', 'net_profit': -23.68}, {'period': '2018', 'revenue': 9.1, 'unit': 'M', 'net_profit': -37.38}, {'period': '2017', 'revenue': 9.91, 'unit': 'M', 'net_profit': -34.77}]","[{'period': ""Q2 '21"", 'revenue': 3.53, 'unit': 'K', 'net_profit': -3.9}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.17}, {'period': ""Q4 '20"", 'revenue': 0.061, 'unit': 'M', 'net_profit': -1.32}, {'period': ""Q3 '20"", 'revenue': 0.044, 'unit': 'M', 'net_profit': -1.56}, {'period': ""Q2 '20"", 'revenue': 0.7030000000000001, 'unit': 'M', 'net_profit': -4.19}, {'period': ""Q1 '20"", 'revenue': 0.78, 'unit': 'M', 'net_profit': -5.26}]",-1.59,-1.59,10617000,7835000,3905000,5952000,3150000,0,5046000,3905000,-10580000,0.4956105697480467,0.4790505152897449,0.6838966202783301,__nan__,__nan__,__nan__,0.5606103419044928
304,OBNK,Origin Bancorp Inc. Common Stock,"Origin Bancorp, Inc. operates as a bank holding company for Origin Bank that provides banking and financial services to small and medium-sized businesses, municipalities, high net worth individuals, and retail clients in Texas, Louisiana, and Mississippi. It offers noninterest and interest-bearing checking accounts, savings deposits, money market accounts, and time deposits; and offers commercial real estate, construction and land development, consumer, residential real estate, commercial and industrial, mortgage warehouse, residential mortgage, and paycheck protection program loans. The company also offers personal and commercial property, and casualty insurance products; and Internet banking and voice response information, mobile applications, cash management, overdraft protection, direct deposit, safe deposit box, U.S. savings bonds, and automatic account transfer services; and treasury management, mortgage origination and servicing facilities, peer-to-peer electronic pay solutions, and personal financial management solutions. As of December 31, 2021, it operated 44 banking centers. The company was founded in 1912 and is headquartered in Ruston, Louisiana.",Mr. Drake D. Mills,Banks - Regional,28.61,USD,880644410,https://images.financialmodelingprep.com/symbol/OBNK.png,114230,8.940625,0,136660,0,76492000,"[{'period': '2024', 'revenue': 564.59, 'unit': 'M', 'net_profit': 76.49}, {'period': '2023', 'revenue': 341.14, 'unit': 'M', 'net_profit': 83.8}, {'period': '2022', 'revenue': 332.55, 'unit': 'M', 'net_profit': 87.72}, {'period': '2021', 'revenue': 278.44, 'unit': 'M', 'net_profit': 108.55}]","[{'period': ""Q4 '24"", 'revenue': 77.59, 'unit': 'M', 'net_profit': 14.27}, {'period': ""Q3 '24"", 'revenue': 90.04, 'unit': 'M', 'net_profit': 18.6}, {'period': ""Q2 '24"", 'revenue': 158.76, 'unit': 'M', 'net_profit': 20.99}, {'period': ""Q1 '24"", 'revenue': 155.96, 'unit': 'M', 'net_profit': 22.63}, {'period': ""Q4 '23"", 'revenue': 145.12, 'unit': 'M', 'net_profit': 13.43}, {'period': ""Q3 '23"", 'revenue': 90.07, 'unit': 'M', 'net_profit': 24.31}]",2.46,2.45,9678702000,204634000,204634000,8533457000,0,0,0,132991000,25003000,0,-0.08720763723150358,-0.09558823529411772,"[0.15, 0.0325]","['2023-05-12', '2018-06-14']",__nan__,0.8816736996345171
305,OBSV,ObsEva SA Ordinary Shares,"ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. The company is also involved in developing Ebopiprant, an oral and selective prostaglandin F2a, or PGF2a receptor antagonist, which is in Phase II clinical trial as a once daily treatment for preterm labor in weeks 24 to 34 of gestational age; and Nolasiban, an oral oxytocin receptor antagonist that is in Phase I clinical trial to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. ObsEva SA was founded in 2012 and is headquartered in Geneva, Switzerland.",Mr. William Michael Brown,Biotechnology,0.1018,USD,10996640,https://images.financialmodelingprep.com/symbol/OBSV.png,7950761,-0.13756756756756758,0,8230885,-15110000,-29879000,"[{'period': '2022', 'revenue': 19.64, 'unit': 'M', 'net_profit': -29.88}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -58.38}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -82.97}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -108.79}]","[{'period': ""Q4 '22"", 'revenue': 19.64, 'unit': 'M', 'net_profit': 26.78}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.06}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -32.8}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.8}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -20.05}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 819.0}]",-0.32,-0.32,16544000,15993000,8424000,8061000,252000,0,7186000,8424000,-23143000,0.7190300866525345,0.4881717114617058,0.5897435897435898,__nan__,__nan__,__nan__,0.4872461315280464
306,OCAX,OCA Acquisition Corp. Class A Common Stock,"OCA Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. OCA Acquisition Corp. was incorporated in 2020 and is based in New York, New York.",Mr. David Tao-Wei Shen,Shell Companies,11.6,USD,78136904,https://images.financialmodelingprep.com/symbol/OCAX.png,1183,-50.43,0,100,1025473,-2482005,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.48}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.4}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.59}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -1.27}]","[{'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 911.09}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -257.78}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -510.64}, {'period': ""Q4 '23"", 'revenue': 0.88706, 'unit': 'M', 'net_profit': -2.03}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -64.32}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 595.52}]",-0.3,-0.3,42293226,35672,27767,14226928,0,0,8122478,27767,-511718,1.1267927175665147,-1.3355599852148403,-1.7499999999999998,__nan__,__nan__,__nan__,0.33638786504486556
307,OCAXU,OCA Acquisition Corp. Unit,"OCA Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. OCA Acquisition Corp. was incorporated in 2020 and is based in New York, New York.",Mr. David Tao-Wei Shen,Shell Companies,10.72,USD,78136901,https://images.financialmodelingprep.com/symbol/OCAXU.png,350.33113,32.68,0,879,1025473,-2482005,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.48}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.4}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.59}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -1.27}]","[{'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 911.09}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -257.78}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -510.64}, {'period': ""Q4 '23"", 'revenue': 0.88706, 'unit': 'M', 'net_profit': -2.03}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -64.32}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 595.52}]",-0.3,-0.3,42293226,35672,27767,14226928,0,0,8122478,27767,-511718,1.1267927175665147,-1.3355599852148403,-1.7499999999999998,__nan__,__nan__,__nan__,0.33638786504486556
308,OCAXW,OCA Acquisition Corp. Warrant,"OCA Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York.",Mr. David Tao-Wei Shen,Shell Companies,0.0011,USD,78136904,https://images.financialmodelingprep.com/symbol/OCAXW.png,30473,0,-0.0021,6000,1025473,-2482005,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.48}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.4}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.59}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -1.27}]","[{'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 911.09}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -257.78}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -510.64}, {'period': ""Q4 '23"", 'revenue': 0.88706, 'unit': 'M', 'net_profit': -2.03}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -64.32}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 595.52}]",-0.3,-0.3,42293226,35672,27767,14226928,0,0,8122478,27767,-511718,1.1267927175665147,-1.3355599852148403,-1.7499999999999998,__nan__,__nan__,__nan__,0.33638786504486556
309,OCC,Optical Cable Corporation Common Stock,"Optical Cable Corporation, together with its subsidiaries, manufactures and sells fiber optic and copper data communications cabling and connectivity solutions primarily for the enterprise market in the United States and internationally. The company provides fiber optic and hybrid cables for high bandwidth transmission of data, video, and voice communications; and copper datacom cables, including unshielded and shielded twisted pair constructions. Its fiber optic connectivity products include fiber optic wall mounts, cabinet mount and rack mount enclosures, pre-terminated fiber optic enclosures, fiber optic connectors, splice trays, fiber optic jumpers, plug and play cassette modules, pre-terminated fiber optic cable assemblies, adapters, and accessories; and copper connectivity products comprising category compliant patch panels, jacks, plugs, patch cords, faceplates, surface mounted boxes, distribution and multi-media boxes, copper rack mount and wall mount enclosures, cable assemblies, cable organizers, and other wiring products for equipment rooms, telecommunications closets, data centers, and workstation applications. In addition, it offers network, data storage, and telecommunications management systems, such as data cabinets, wall mount enclosures, horizontal and vertical cable management systems, and open frame relay racks for enterprise and residential use; and datacom wiring products, including various enclosures, and modules and modular outlets for single dwelling and multiple dwelling residential uses. Further, the company provides specialty fiber optic connectors and connectivity components, copper datacom connectors, and related systems and solutions for military, other harsh environment, and special applications. It sells its products to distributors, original equipment manufacturers, value-added resellers, and end-users. Optical Cable Corporation was incorporated in 1983 and is headquartered in Roanoke, Virginia.",Mr. Neil D. Wilkin Jr.,Communication Equipment,2.67,USD,21890209,https://images.financialmodelingprep.com/symbol/OCC.png,49772,-5.34,0.07,72069,-2157028,-4210211,"[{'period': '2024', 'revenue': 66.67, 'unit': 'M', 'net_profit': -4.21}, {'period': '2023', 'revenue': 72.17, 'unit': 'M', 'net_profit': 2.07}, {'period': '2022', 'revenue': 69080.0, 'unit': 'K', 'net_profit': -347.0}, {'period': '2021', 'revenue': 59.14, 'unit': 'M', 'net_profit': 6.61}]","[{'period': ""Q1 '25"", 'revenue': 15.74, 'unit': 'M', 'net_profit': -1.11}, {'period': ""Q4 '24"", 'revenue': 19490.0, 'unit': 'K', 'net_profit': 373.46}, {'period': ""Q3 '24"", 'revenue': 16.22, 'unit': 'M', 'net_profit': -1.56}, {'period': ""Q2 '24"", 'revenue': 16.11, 'unit': 'M', 'net_profit': -1.6}, {'period': ""Q1 '24"", 'revenue': 14.85, 'unit': 'M', 'net_profit': -1.43}, {'period': ""Q4 '23"", 'revenue': 17.33, 'unit': 'M', 'net_profit': -1.27}]",-0.54,-0.54,40358011,30600240,244247,19516095,11011736,0,15143512,244247,-1228475,-1.500327284485138,-3.0373651462522586,-3.076923076923077,"[0.02, 0.01]","['2015-10-28', '2010-11-03']",__nan__,0.4835742524575852
310,OCCI,OFS Credit Company Inc. Common Stock,"OFS Credit Company, Inc. is a fund of OFS Advisor.",Mr. Bilal  Rashid,Asset Management,5.92,USD,138853008,https://images.financialmodelingprep.com/symbol/OCCI.png,377659,6.58,0.28,558906,0,15021613,"[{'period': '2024', 'revenue': 18.69, 'unit': 'M', 'net_profit': 15.02}, {'period': '2023', 'revenue': 1.41, 'unit': 'M', 'net_profit': -1.89}, {'period': '2022', 'revenue': -10.38, 'unit': 'M', 'net_profit': -13.59}, {'period': '2021', 'revenue': 22.97, 'unit': 'M', 'net_profit': 20.31}]","[{'period': ""Q1 '25"", 'revenue': 10.06, 'unit': 'M', 'net_profit': 3.8}, {'period': ""Q4 '24"", 'revenue': 8.59, 'unit': 'M', 'net_profit': 5.3}, {'period': ""Q3 '24"", 'revenue': 7.45, 'unit': 'M', 'net_profit': 3.44}, {'period': ""Q2 '24"", 'revenue': 8070.0, 'unit': 'K', 'net_profit': -650.28}, {'period': ""Q1 '24"", 'revenue': 6.59, 'unit': 'M', 'net_profit': 6.94}, {'period': ""Q4 '23"", 'revenue': 9.08, 'unit': 'M', 'net_profit': 1.99}]",0.9,0.9,240774050,25497171,24696288,92167246,282455,214850657,0,24696288,-30552018,1,8.954850216510737,6.294117647058823,"[0.115, 0.113]","['2025-04-17', '2018-11-02']",__nan__,0.38279559612009684
311,OCCIO,OFS Credit Company Inc. 6.125% Series C Term Preferred Stock,"OFS Credit Company, Inc. is a fund of OFS Advisor.",Mr. Bilal  Rashid,Asset Management,24.36,USD,571361364,https://images.financialmodelingprep.com/symbol/OCCIO.png,634,48.62,-0.12,491,0,15021613,"[{'period': '2024', 'revenue': 18.69, 'unit': 'M', 'net_profit': 15.02}, {'period': '2023', 'revenue': 1.41, 'unit': 'M', 'net_profit': -1.89}, {'period': '2022', 'revenue': -10.38, 'unit': 'M', 'net_profit': -13.59}, {'period': '2021', 'revenue': 22.97, 'unit': 'M', 'net_profit': 20.31}]","[{'period': ""Q1 '25"", 'revenue': 10.06, 'unit': 'M', 'net_profit': 3.8}, {'period': ""Q4 '24"", 'revenue': 8.59, 'unit': 'M', 'net_profit': 5.3}, {'period': ""Q3 '24"", 'revenue': 7.45, 'unit': 'M', 'net_profit': 3.44}, {'period': ""Q2 '24"", 'revenue': 8070.0, 'unit': 'K', 'net_profit': -650.28}, {'period': ""Q1 '24"", 'revenue': 6.59, 'unit': 'M', 'net_profit': 6.94}, {'period': ""Q4 '23"", 'revenue': 9.08, 'unit': 'M', 'net_profit': 1.99}]",0.9,0.9,240774050,25497171,24696288,92167246,282455,214850657,0,24696288,-30552018,1,8.954850216510737,6.294117647058823,"[0.1276, 0.013]","['2025-07-21', '2021-04-27']",__nan__,0.38279559612009684
312,OCCIP,OFS Credit Company Inc. 6.875% Series A Term Preferred Stock,"OFS Credit Company, Inc. is a fund of OFS Advisor.",Mr. Bilal Rashid,Asset Management,25.03,USD,0,https://images.financialmodelingprep.com/symbol/OCCIP.png,1731,6.592046352383461,0,1628,0,15021613,"[{'period': '2024', 'revenue': 18.69, 'unit': 'M', 'net_profit': 15.02}, {'period': '2023', 'revenue': 1.41, 'unit': 'M', 'net_profit': -1.89}, {'period': '2022', 'revenue': -10.38, 'unit': 'M', 'net_profit': -13.59}, {'period': '2021', 'revenue': 22.97, 'unit': 'M', 'net_profit': 20.31}]","[{'period': ""Q1 '25"", 'revenue': 10.06, 'unit': 'M', 'net_profit': 3.8}, {'period': ""Q4 '24"", 'revenue': 8.59, 'unit': 'M', 'net_profit': 5.3}, {'period': ""Q3 '24"", 'revenue': 7.45, 'unit': 'M', 'net_profit': 3.44}, {'period': ""Q2 '24"", 'revenue': 8070.0, 'unit': 'K', 'net_profit': -650.28}, {'period': ""Q1 '24"", 'revenue': 6.59, 'unit': 'M', 'net_profit': 6.94}, {'period': ""Q4 '23"", 'revenue': 9.08, 'unit': 'M', 'net_profit': 1.99}]",0.9,0.9,240774050,25497171,24696288,92167246,282455,214850657,0,24696288,-30552018,1,8.954850216510737,6.294117647058823,"[0.14323, 0.143]","['2022-01-21', '2019-04-22']",__nan__,0.38279559612009684
313,OCDX,Ortho Clinical Diagnostics plc Ordinary Shares,"Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company is also involved in the provision of contract manufacturing and orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. Ortho Clinical Diagnostics Holdings plc was founded in 1939 and is headquartered in Raritan, New Jersey.",,Medical - Diagnostics & Research,17.63,USD,0,https://images.financialmodelingprep.com/symbol/OCDX.png,1007226,-42.278177458033575,0.16,789491,253400000,-54300000,"[{'period': '2021', 'revenue': 2040.0, 'unit': 'M', 'net_profit': -54.3}, {'period': '2020', 'revenue': 1770.0, 'unit': 'M', 'net_profit': -211.9}, {'period': '2019', 'revenue': 1800.0, 'unit': 'M', 'net_profit': -156.9}, {'period': '2018', 'revenue': 1790.0, 'unit': 'M', 'net_profit': -248.8}]","[{'period': ""Q1 '22"", 'revenue': 500.1, 'unit': 'M', 'net_profit': 14.8}, {'period': ""Q4 '21"", 'revenue': 521.0, 'unit': 'M', 'net_profit': -9.9}, {'period': ""Q3 '21"", 'revenue': 522.5, 'unit': 'M', 'net_profit': 14.7}, {'period': ""Q2 '21"", 'revenue': 492.5, 'unit': 'M', 'net_profit': -20.0}, {'period': ""Q1 '21"", 'revenue': 506.8, 'unit': 'M', 'net_profit': -39.1}, {'period': ""Q4 '20"", 'revenue': 516.6, 'unit': 'M', 'net_profit': -40.9}]",-0.22,-0.22,3363800000,1011700000,309700000,2953300000,257200000,0,578500000,309700000,286600000,-0.13129928008227632,0.7437470504955167,0.7755102040816326,__nan__,__nan__,__nan__,0.877965396278019
314,OCFC,OceanFirst Financial Corp. Common Stock,"OceanFirst Financial Corp. operates as the bank holding company for OceanFirst Bank N.A. that provides community banking services. It accepts money market accounts, savings accounts, interest-bearing checking accounts, non-interest-bearing demand deposits, and time deposits to retail, government, and business customers. The company also offers commercial real estate, multi-family, land loans, construction, and commercial and industrial loans; fixed-rate and adjustable-rate mortgage loans that are secured by one-to-four family residences; and consumer loans, such as home equity loans and lines of credit, student loans, overdraft line of credit, loans on savings accounts, and other consumer loans. In addition, it invests in mortgage-backed securities, securities issued by the U.S. Government and agencies, corporate securities, and other investments. Further, the company offers bankcard, wealth management, and trust and asset management services; and sells alternative investment products and life insurance products. As of December 31, 2021, it operated through its branch office in Toms River; administrative office located in Red Bank and Mount Laurel; 46 additional branch offices and four deposit production facilities located throughout central and southern New Jersey; and commercial loan production offices in New Jersey, New York City, the Philadelphia area, Baltimore, and Boston. The company was founded in 1902 and is based in Red Bank, New Jersey.",Mr. Christopher D. Maher,Banks - Regional,14.86,USD,870158506,https://images.financialmodelingprep.com/symbol/OCFC.png,311232,9.01,-0.1,333862,-20000,100065000,"[{'period': '2024', 'revenue': 379.81, 'unit': 'M', 'net_profit': 100.06}, {'period': '2023', 'revenue': 385.68, 'unit': 'M', 'net_profit': 104.03}, {'period': '2022', 'revenue': 431.6, 'unit': 'M', 'net_profit': 146.6}, {'period': '2021', 'revenue': 352.09, 'unit': 'M', 'net_profit': 110.08}]","[{'period': ""Q4 '24"", 'revenue': 94.43, 'unit': 'M', 'net_profit': 21.91}, {'period': ""Q3 '24"", 'revenue': 161.53, 'unit': 'M', 'net_profit': 25.12}, {'period': ""Q2 '24"", 'revenue': 170.41, 'unit': 'M', 'net_profit': 24.37}, {'period': ""Q1 '24"", 'revenue': 173.88, 'unit': 'M', 'net_profit': 28.67}, {'period': ""Q4 '23"", 'revenue': 172.27, 'unit': 'M', 'net_profit': 27.68}, {'period': ""Q3 '23"", 'revenue': 100.6, 'unit': 'M', 'net_profit': 20.67}]",1.79,1.79,13421247000,11052458000,951115000,11718490000,10101343000,0,0,123615000,51845000,0,-0.038104759249824566,0.05294117647058828,"[0.2, 0.2]","['2025-02-03', '1997-05-01']",__nan__,0.8731297471837006
315,OCFCP,OceanFirst Financial Corp. Depositary Shares,"OceanFirst Financial Corp. operates as the bank holding company for OceanFirst Bank N.A. that provides community banking services. It accepts money market accounts, savings accounts, interest-bearing checking accounts, non-interest-bearing demand deposits, and time deposits to retail, government, and business customers. The company also offers commercial real estate, multi-family, land loans, construction, and commercial and industrial loans; fixed-rate and adjustable-rate mortgage loans that are secured by one-to-four family residences; and consumer loans, such as home equity loans and lines of credit, student loans, overdraft line of credit, loans on savings accounts, and other consumer loans. In addition, it invests in mortgage-backed securities, securities issued by the U.S. Government and agencies, corporate securities, and other investments. Further, the company offers bankcard, wealth management, and trust and asset management services; and sells alternative investment products and life insurance products. As of December 31, 2021, it operated through its branch office in Toms River; administrative office located in Red Bank and Mount Laurel; 46 additional branch offices and four deposit production facilities located throughout central and southern New Jersey; and commercial loan production offices in New Jersey, New York City, the Philadelphia area, Baltimore, and Boston. The company was founded in 1902 and is based in Red Bank, New Jersey.",Mr. Christopher D. Maher,Banks - Regional,25.25,USD,1478566775,https://images.financialmodelingprep.com/symbol/OCFCP.png,2644,15.13,-0.02,4309,-20000,100065000,"[{'period': '2024', 'revenue': 379.81, 'unit': 'M', 'net_profit': 100.06}, {'period': '2023', 'revenue': 385.68, 'unit': 'M', 'net_profit': 104.03}, {'period': '2022', 'revenue': 431.6, 'unit': 'M', 'net_profit': 146.6}, {'period': '2021', 'revenue': 352.09, 'unit': 'M', 'net_profit': 110.08}]","[{'period': ""Q4 '24"", 'revenue': 94.43, 'unit': 'M', 'net_profit': 21.91}, {'period': ""Q3 '24"", 'revenue': 161.53, 'unit': 'M', 'net_profit': 25.12}, {'period': ""Q2 '24"", 'revenue': 170.41, 'unit': 'M', 'net_profit': 24.37}, {'period': ""Q1 '24"", 'revenue': 173.88, 'unit': 'M', 'net_profit': 28.67}, {'period': ""Q4 '23"", 'revenue': 172.27, 'unit': 'M', 'net_profit': 27.68}, {'period': ""Q3 '23"", 'revenue': 100.6, 'unit': 'M', 'net_profit': 20.67}]",1.79,1.79,13421247000,11052458000,951115000,11718490000,10101343000,0,0,123615000,51845000,0,-0.038104759249824566,0.05294117647058828,"[0.4375, 0.476]","['2025-01-31', '2020-07-30']",__nan__,0.8731297471837006
316,OCG,Oriental Culture Holding LTD Ordinary Shares,"Oriental Culture Holding LTD, through its subsidiaries, operates an online platform to facilitate e-commerce trading of artwork and collectables in China. The company facilitates trading by individual and institutional customers of various collectibles, artworks, and commodities on its online platforms. It also provides online and offline integrated marketing, storage, and technical maintenance services, as well as industry solutions and related software products, and system development and technical support services. In addition, the company is involved in the development of NFTs for cultural and artwork collections, as well as a metaverse project. Oriental Culture Holding LTD was incorporated in 2018 and is headquartered in Central, Hong Kong.",Mr. Yi  Shao,Specialty Retail,3.19,USD,59236067,https://images.financialmodelingprep.com/symbol/OCG.png,58954,-5.15,-0.1,24088,-3725039,-3598480,"[{'period': '2023', 'revenue': 1.58, 'unit': 'M', 'net_profit': -3.6}, {'period': '2022', 'revenue': 17.81, 'unit': 'M', 'net_profit': 3.24}, {'period': '2021', 'revenue': 37.6, 'unit': 'M', 'net_profit': 11.44}, {'period': '2020', 'revenue': 17.44, 'unit': 'M', 'net_profit': 2.05}]","[{'period': ""Q2 '24"", 'revenue': 0.44726, 'unit': 'M', 'net_profit': -1.87}, {'period': ""Q4 '23"", 'revenue': 0.7806000000000001, 'unit': 'M', 'net_profit': -1.46}, {'period': ""Q2 '23"", 'revenue': 0.7994600000000001, 'unit': 'M', 'net_profit': -2.14}, {'period': ""Q4 '22"", 'revenue': 0.76642, 'unit': 'M', 'net_profit': -2.39}, {'period': ""Q2 '22"", 'revenue': 17.05, 'unit': 'M', 'net_profit': 5.62}, {'period': ""Q4 '21"", 'revenue': 13.14, 'unit': 'M', 'net_profit': 1.36}]",-0.84,-0.84,48630835,37893285,20931367,3081186,360742,917002,3081186,17684018,3389600,-1.9517387894009346,-2.112122746150275,-6.6000000000000005,__nan__,__nan__,__nan__,0.063358690016324
317,OCGN,Ocugen Inc. Common Stock,"Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.","Dr. Shankar  Musunuri M.B.A., Ph.D.",Biotechnology,0.5828,USD,170185759,https://images.financialmodelingprep.com/symbol/OCGN.png,3982719,-2.91,-0.066,3064977,-54757000,-54054000,"[{'period': '2024', 'revenue': 4.05, 'unit': 'M', 'net_profit': -54.05}, {'period': '2023', 'revenue': 6.04, 'unit': 'M', 'net_profit': -63.08}, {'period': '2022', 'revenue': 2.49, 'unit': 'M', 'net_profit': -77.83}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -58.37}]","[{'period': ""Q4 '24"", 'revenue': 0.764, 'unit': 'M', 'net_profit': -13.88}, {'period': ""Q3 '24"", 'revenue': 1.14, 'unit': 'M', 'net_profit': -12.97}, {'period': ""Q2 '24"", 'revenue': 1.14, 'unit': 'M', 'net_profit': -15.28}, {'period': ""Q1 '24"", 'revenue': 1.01, 'unit': 'M', 'net_profit': -11.92}, {'period': ""Q4 '23"", 'revenue': 6.04, 'unit': 'M', 'net_profit': -9.49}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.16}]",-0.2,-0.2,82442000,61682000,58514000,52810000,0,0,21588000,58514000,-45527000,0.15533651102164223,0.1430609721297441,0.23076923076923075,__nan__,__nan__,__nan__,0.6405715533344655
318,OCSL,Oaktree Specialty Lending Corporation Common Stock,"Oaktree Specialty Lending Corporation is a business development company specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity and management buyouts in small and mid-sized companies. It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering, and media and advertising sectors. It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies with enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million. The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million. It primarily invests in North America. The fund seeks to be a lead investor in its portfolio companies.",Mr. Armen  Panossian J.D.,Financial - Credit Services,12.94,USD,1064254182,https://images.financialmodelingprep.com/symbol/OCSL.png,831100,19.31,-0.31,1539320,0,175052000,"[{'period': '2024', 'revenue': 346.25, 'unit': 'M', 'net_profit': 175.05}, {'period': '2023', 'revenue': 379.29, 'unit': 'M', 'net_profit': 117.33}, {'period': '2022', 'revenue': 39.11, 'unit': 'M', 'net_profit': 29.22}, {'period': '2021', 'revenue': 248.31, 'unit': 'M', 'net_profit': 237.26}]","[{'period': ""Q1 '25"", 'revenue': 78.42, 'unit': 'M', 'net_profit': 7.24}, {'period': ""Q4 '24"", 'revenue': 36.47, 'unit': 'M', 'net_profit': 36.91}, {'period': ""Q3 '24"", 'revenue': 25.51, 'unit': 'M', 'net_profit': 1.12}, {'period': ""Q2 '24"", 'revenue': 87.43, 'unit': 'M', 'net_profit': 9.34}, {'period': ""Q1 '24"", 'revenue': 11.83, 'unit': 'M', 'net_profit': 10.54}, {'period': ""Q4 '23"", 'revenue': 49.04, 'unit': 'M', 'net_profit': 45.95}]",0.72,0.72,3198341000,102770000,63966000,1710530000,38804000,3021279000,54994000,63966000,19076000,1,0.4919501240081479,-0.558282208588957,"[0.47, 0.31]","['2025-03-17', '2008-09-08']",__nan__,0.5348178946522588
319,OCUL,Ocular Therapeutix Inc. Common Stock,"Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing OTX-TKI, an axitinib intravitreal implant that is in phase 1 clinical trials for the treatment of wet age-related macular degeneration and other retinal diseases; OTX-TIC, a travoprost intracameral implant, which is in phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension; OTX-CSI, a cyclosporine intracanalicular insert that has completed phase 2 clinical trials for the treatment of dry eye disease; and OTX-DED, a dexamethasone intracanalicular insert, which is in phase 2 clinical trials for the short-term treatment of the signs and symptoms of dry eye disease. The company has a strategic collaboration with Regeneron Pharmaceuticals, Inc. (Regeneron) for the development and commercialization of products using the Company's sustained-release hydrogel in combination with Regeneron's large molecule VEGF-targeting compounds for the treatment of retinal diseases; and AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC, as well as a discovery collaboration with Mosaic Biosciences to identify new targets and therapeutic agents for the treatment of dry age-related macular degeneration (dMAD). Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.",Dr. Pravin U. Dugel M.D.,Biotechnology,6.02,USD,957312440,https://images.financialmodelingprep.com/symbol/OCUL.png,1376954,-4.93,-0.28,1480833,-176143000,-193506000,"[{'period': '2024', 'revenue': 63.72, 'unit': 'M', 'net_profit': -193.51}, {'period': '2023', 'revenue': 58.44, 'unit': 'M', 'net_profit': -80.74}, {'period': '2022', 'revenue': 51.49, 'unit': 'M', 'net_profit': -63.42}, {'period': '2021', 'revenue': 43.52, 'unit': 'M', 'net_profit': -10.8}]","[{'period': ""Q4 '24"", 'revenue': 17.08, 'unit': 'M', 'net_profit': -48.39}, {'period': ""Q3 '24"", 'revenue': 15.43, 'unit': 'M', 'net_profit': -36.49}, {'period': ""Q2 '24"", 'revenue': 16.44, 'unit': 'M', 'net_profit': -43.78}, {'period': ""Q1 '24"", 'revenue': 14.71, 'unit': 'M', 'net_profit': -64.85}, {'period': ""Q4 '23"", 'revenue': 14.8, 'unit': 'M', 'net_profit': -29.22}, {'period': ""Q3 '23"", 'revenue': 14950.0, 'unit': 'K', 'net_profit': -516.0}]",-1.22,-1.22,457935000,440987000,392102000,142591000,32388000,0,41354000,392102000,-135965000,-1.652156892268313,-1.3967746730083235,-0.11926605504587146,__nan__,__nan__,__nan__,0.3113782523720615
320,OCUP,Ocuphire Pharma Inc. Common Stock,"Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical trial for dim light or night vision disturbances; and Phase 2b clinical trial for pharmacologically induced mydriasis, as well as that has completed Phase 2 VEGA-1 trial for presbyopia. The company also develops APX3330, a twice-a-day oral tablet to target pathways relevant to retinal and choroidal vascular diseases, such as diabetic retinopathy and diabetic macular edema; and APX2009 and APX2014 second generation preclinical product candidates and analogs of APX3330. Ocuphire Pharma, Inc. is headquartered in Farmington Hills, Michigan.","Mr. George  Magrath M.B.A., M.D., M.S.",Biotechnology,1.17,USD,31737184,https://images.financialmodelingprep.com/symbol/OCUP.png,139151,-2.1666666666666665,-0.16,675971,-9968000,-9986000,"[{'period': '2023', 'revenue': 19.05, 'unit': 'M', 'net_profit': -9.99}, {'period': '2022', 'revenue': 39.85, 'unit': 'M', 'net_profit': 17.89}, {'period': '2021', 'revenue': 0.589, 'unit': 'M', 'net_profit': -56.53}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -31.48}]","[{'period': ""Q2 '24"", 'revenue': 1.11, 'unit': 'M', 'net_profit': -7.76}, {'period': ""Q1 '24"", 'revenue': 1.71, 'unit': 'M', 'net_profit': -7.11}, {'period': ""Q4 '23"", 'revenue': 1.69, 'unit': 'M', 'net_profit': -4.79}, {'period': ""Q3 '23"", 'revenue': 11.94, 'unit': 'M', 'net_profit': 5.56}, {'period': ""Q2 '23"", 'revenue': 3.67, 'unit': 'M', 'net_profit': -4.96}, {'period': ""Q1 '23"", 'revenue': 1.75, 'unit': 'M', 'net_profit': -5.45}]",-0.46,-0.46,53948000,53948000,50516000,4042000,2333000,0,4042000,50501000,-1112000,-1.5467910038398245,-1.5582513416815742,-1.511111111111111,__nan__,__nan__,__nan__,0.07492400088974568
321,OCX,OncoCyte Corporation Common Stock,"OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.",Mr. Joshua  Riggs,Biotechnology,2.75,USD,78648075,https://images.financialmodelingprep.com/symbol/OCX.png,85291,-0.59,-0.09,29099,-59015000,-60663000,"[{'period': '2024', 'revenue': 1.88, 'unit': 'M', 'net_profit': -60.66}, {'period': '2023', 'revenue': 1.5, 'unit': 'M', 'net_profit': -27.78}, {'period': '2022', 'revenue': 0.9580000000000001, 'unit': 'M', 'net_profit': -73.44}, {'period': '2021', 'revenue': 7.73, 'unit': 'M', 'net_profit': -64.1}]","[{'period': ""Q4 '24"", 'revenue': 1.49, 'unit': 'M', 'net_profit': -33.51}, {'period': ""Q3 '24"", 'revenue': 0.115, 'unit': 'M', 'net_profit': -13.49}, {'period': ""Q2 '24"", 'revenue': 0.10400000000000001, 'unit': 'M', 'net_profit': -4.53}, {'period': ""Q1 '24"", 'revenue': 0.176, 'unit': 'M', 'net_profit': -9.13}, {'period': ""Q4 '23"", 'revenue': 0.314, 'unit': 'M', 'net_profit': -15.99}, {'period': ""Q3 '23"", 'revenue': 0.429, 'unit': 'M', 'net_profit': -6.49}]",-4.64,-4.64,35081000,11759000,8636000,47355000,1613000,0,7275000,8636000,-20713000,-1.5522207326039008,-1.1836147006947193,-0.23733333333333326,__nan__,__nan__,__nan__,1.3498760012542401
322,ODFL,Old Dominion Freight Line Inc. Common Stock,"Old Dominion Freight Line, Inc. operates as a less-than-truckload (LTL) motor carrier in the United States and North America. It provides regional, inter-regional, and national LTL services, including expedited transportation. The company also offers various value-added services, such as container drayage, truckload brokerage, and supply chain consulting. As of December 31, 2021, it owned and operated 10,403 tractors, 27,917 linehaul trailers, and 13,303 pickup and delivery trailers; 3 fleet maintenance centers; and 251 service centers. Old Dominion Freight Line, Inc. was founded in 1934 and is headquartered in Thomasville, North Carolina.",Mr. Kevin M. Freeman,Trucking,148.34,USD,31528925300,https://images.financialmodelingprep.com/symbol/ODFL.png,1858575,27.07,-3.07,1877376,1902377000,1186073000,"[{'period': '2024', 'revenue': 5.81, 'unit': 'B', 'net_profit': 1.19}, {'period': '2023', 'revenue': 5.87, 'unit': 'B', 'net_profit': 1.24}, {'period': '2022', 'revenue': 6.26, 'unit': 'B', 'net_profit': 1.38}, {'period': '2021', 'revenue': 5.26, 'unit': 'B', 'net_profit': 1.03}]","[{'period': ""Q4 '24"", 'revenue': 1390.0, 'unit': 'M', 'net_profit': 263.14}, {'period': ""Q3 '24"", 'revenue': 1470.0, 'unit': 'M', 'net_profit': 308.58}, {'period': ""Q2 '24"", 'revenue': 1500.0, 'unit': 'M', 'net_profit': 322.05}, {'period': ""Q1 '24"", 'revenue': 1460.0, 'unit': 'M', 'net_profit': 292.3}, {'period': ""Q4 '23"", 'revenue': 1500.0, 'unit': 'M', 'net_profit': 322.81}, {'period': ""Q3 '23"", 'revenue': 1520.0, 'unit': 'M', 'net_profit': 339.29}]",5.51,5.48,5491395000,720683000,108676000,1246807000,21135000,0,540529000,108676000,887965000,-0.03564271915137156,-0.04310521483628102,-0.02650176678445236,"[0.28, 0.1]","['2025-03-05', '2017-03-02']",__nan__,0.2270474078080342
323,ODP,The ODP Corporation Common Stock,"The ODP Corporation provides business services and supplies, products, and digital workplace technology solutions for small, medium, and enterprise businesses. The company operates in two divisions, Business Solutions and Retail. The Business Solutions division offers office supply products and services, cleaning and breakroom supplies, technology services, copy and print services, and office furniture products and services through sales forces, catalogs, and telesales, as well as through Internet Websites in the United States, Puerto Rico, the U.S. Virgin Islands, and Canada. The Retail division operates a chain of retail stores, which offer office supplies; technology products and solutions; business machines and related supplies; print, cleaning, breakroom, and facilities products; and furniture, as well as printing, copying, mailing, and shipping services. As of December 31, 2021, this division operated 1,038 retail stores in the United States, Puerto Rico, and the U.S. Virgin Islands. The company offers its products under various brands, including Office Depot, OfficeMax, and Grand&Toy, as well as others. The ODP Corporation was incorporated in 1986 and is headquartered in Boca Raton, Florida.",Mr. Gerry P. Smith,Specialty Retail,12.08,USD,360205064,https://images.financialmodelingprep.com/symbol/ODP.png,756300,3.92,-1.29,935031,266000000,-3000000,"[{'period': '2024', 'revenue': 6990.0, 'unit': 'M', 'net_profit': -3.0}, {'period': '2023', 'revenue': 7830.0, 'unit': 'M', 'net_profit': 139.0}, {'period': '2022', 'revenue': 8490.0, 'unit': 'M', 'net_profit': 166.0}, {'period': '2021', 'revenue': 8460.0, 'unit': 'M', 'net_profit': 187.0}]","[{'period': ""Q4 '24"", 'revenue': 1620.0, 'unit': 'M', 'net_profit': 11.0}, {'period': ""Q3 '24"", 'revenue': 1780.0, 'unit': 'M', 'net_profit': 58.0}, {'period': ""Q2 '24"", 'revenue': 1720.0, 'unit': 'M', 'net_profit': -73.0}, {'period': ""Q1 '24"", 'revenue': 1870.0, 'unit': 'M', 'net_profit': 15.0}, {'period': ""Q4 '23"", 'revenue': 1810.0, 'unit': 'M', 'net_profit': -37.0}, {'period': ""Q3 '23"", 'revenue': 2009.9999999999998, 'unit': 'M', 'net_profit': 70.0}]",-0.08,-0.08,3529000000,1438000000,166000000,2722000000,466000000,0,1543000000,166000000,61000000,-0.20597014925373133,-1.0215827338129497,-1.0224719101123596,"[0.025, 0.025]","['2020-02-28', '2016-08-23']",__nan__,0.7713233210541229
324,ODT,Odonate Therapeutics Inc. Common Stock,"Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York.",Mr. Kevin Tang,Biotechnology,1.12,USD,0,https://images.financialmodelingprep.com/symbol/ODT.png,959817,-0.4131316857248248,-0.04999995,716440,-125905000,-126350000,"[{'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -126.35}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -111.83}, {'period': '2018', 'revenue': 0.0, 'unit': 'M', 'net_profit': -88.96}, {'period': '2017', 'revenue': 0.0, 'unit': 'M', 'net_profit': -32.74}]","[{'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.0}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -22.02}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -33.77}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -32.29}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -30.48}, {'period': ""Q2 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -33.42}]",-3.85,-3.85,167886000,159872000,157265000,31741000,0,0,27073000,157265000,-113562000,-0.12976023832597539,-0.1298904538341158,0.04938271604938265,__nan__,__nan__,__nan__,0.1890628164349618
325,OEG,Orbital Energy Group Inc. Common Stock,"Orbital Energy Group, Inc. provides electric power, telecommunications, and renewables solutions and services in the United States and India. It designs, installs, upgrades, repairs, and maintains electric power transmission and distribution infrastructure, and substation facilities, as well as offers emergency restoration services, including the repair of infrastructure damaged by inclement weather; and provides services to the electric transmission and substation, industrial, telecommunication, and disaster restoration market sectors. The company also offers engineering, design, construction, and maintenance services to the broadband and wireless telecommunication industries; enterprise solutions to the cable and telecommunication industries; and telecommunication services, such as various wireless service capabilities. In addition, it provides engineering, procurement, and construction services that support the development of renewable energy generation focused on utility-scale solar construction. Orbital Energy Group, Inc. was incorporated in 1998 and is headquartered in Houston, Texas.",Mr. James O'Neil,Engineering & Construction,0.6431,USD,107654940,https://images.financialmodelingprep.com/symbol/OEG.png,0,-0.5404201680672269,0.048099995,3024102,-58216000,-49843000,"[{'period': '2021', 'revenue': 82.95, 'unit': 'M', 'net_profit': -49.84}, {'period': '2020', 'revenue': 38.41, 'unit': 'M', 'net_profit': -27.45}, {'period': '2019', 'revenue': 23.49, 'unit': 'M', 'net_profit': -1.13}, {'period': '2018', 'revenue': 96.79, 'unit': 'M', 'net_profit': -17.32}]","[{'period': ""Q2 '22"", 'revenue': 93.91, 'unit': 'M', 'net_profit': -30.09}, {'period': ""Q1 '22"", 'revenue': 70.25, 'unit': 'M', 'net_profit': -36.67}, {'period': ""Q4 '21"", 'revenue': 41.05, 'unit': 'M', 'net_profit': -15.72}, {'period': ""Q3 '21"", 'revenue': 30.92, 'unit': 'M', 'net_profit': -10.15}, {'period': ""Q2 '21"", 'revenue': 16.31, 'unit': 'M', 'net_profit': -8.21}, {'period': ""Q1 '21"", 'revenue': 9.49, 'unit': 'M', 'net_profit': -17.95}]",-0.85,-0.85,412339000,101714000,26865000,316073000,48752000,0,134994000,26865000,-53455000,-1.3811198822037711,-0.8159726017415382,0.07608695652173919,__nan__,__nan__,__nan__,0.7665367573768186
326,OEPW,One Equity Partners Open Water I Corp. Class A Common Stock,"One Equity Partners Open Water I Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. One Equity Partners Open Water I Corp. was incorporated in 2020 and is based in New York, New York.",Mr. R. Todd Bradley,Shell Companies,10.07,USD,0,https://images.financialmodelingprep.com/symbol/OEPW.png,208495,45.77272727272727,-0.01,4022,14696621,30504548,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 30.5}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.01}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.75}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.37}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.99}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.5}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.86}]",0.71,0.71,346859,1816.667,907.893,23231,0,345043,1015.547,907.893,-1427234,0,0,0,__nan__,__nan__,__nan__,0.06697534156530463
327,OEPWU,One Equity Partners Open Water I Corp. Unit,"One Equity Partners Open Water I Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. One Equity Partners Open Water I Corp. was incorporated in 2020 and is based in New York, New York.",,Shell Companies,10.05,USD,0,https://images.financialmodelingprep.com/symbol/OEPWU.png,9707,79.13385826771653,-0.02,16390,14696621,30504548,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 30.5}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.01}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.75}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.37}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.99}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.5}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.86}]",0.71,0.71,346859,1816.667,907.893,23231,0,345043,1015.547,907.893,-1427234,0,0,0,__nan__,__nan__,__nan__,0.06697534156530463
328,OEPWW,One Equity Partners Open Water I Corp. Warrant,"One Equity Partners Open Water I Corp. is a blank check company. One Equity Partners Open Water I Corp. was founded in 2020 and is based in New York, New York.",Mr. R. Todd Bradley,Shell Companies,0.0003,USD,0,https://images.financialmodelingprep.com/symbol/OEPWW.png,0,0,0,145080,14696621,30504548,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 30.5}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.01}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.75}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.37}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.99}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.5}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.86}]",0.71,0.71,346859,1816.667,907.893,23231,0,345043,1015.547,907.893,-1427234,0,0,0,__nan__,__nan__,__nan__,0.06697534156530463
329,OESX,Orion Energy Systems Inc. Common Stock,"Orion Energy Systems, Inc. researches, designs, develops, manufactures, markets, sells, installs, and implements energy management systems for commercial office and retail, exterior area lighting, and industrial applications in North America. The company operates through three segments: Orion Services Group, Orion Distribution Services, and Orion U.S. Markets. It offers interior light emitting diode (LED) high bay fixtures; smart building control systems, which provide lighting control options and data intelligence capabilities for building managers; and LED troffer door retrofit for use in office or retail grid ceilings. The company also offers various other LED and HIF fixtures for lighting and energy management needs comprising fixtures for agribusinesses, parking lots, roadways, retail, mezzanine, outdoor applications, and private label resale. In addition, it provides maintenance, repair, and replacement services; offers lighting-related energy management services, such as site assessment, site field verification, utility incentive and government subsidy management, engineering design, project management, installation, facility design commissioning, and recycling; and sells and distributes replacement lamps and fixture components into the after-market. The company serves customers directly and through independent sales agencies and distributors, national account end-users, federal and state government facilities, regional account end-users, electrical distributors, electrical contractors, and energy service companies. Orion Energy Systems, Inc. was incorporated in 1996 and is headquartered in Manitowoc, Wisconsin.",Mr. Michael H. Jenkins,Electrical Equipment & Parts,0.681,USD,22440380,https://images.financialmodelingprep.com/symbol/OESX.png,52685,-3.1,-0.036,37178,-8288000,-11671000,"[{'period': '2023', 'revenue': 90.58, 'unit': 'M', 'net_profit': -11.67}, {'period': '2022', 'revenue': 77.38, 'unit': 'M', 'net_profit': -34.34}, {'period': '2021', 'revenue': 124.38, 'unit': 'M', 'net_profit': 6.09}, {'period': '2020', 'revenue': 116.84, 'unit': 'M', 'net_profit': 26.13}]","[{'period': ""Q3 '24"", 'revenue': 19.58, 'unit': 'M', 'net_profit': -1.51}, {'period': ""Q2 '24"", 'revenue': 19.36, 'unit': 'M', 'net_profit': -3.62}, {'period': ""Q1 '24"", 'revenue': 19.91, 'unit': 'M', 'net_profit': -3.76}, {'period': ""Q4 '23"", 'revenue': 26.41, 'unit': 'M', 'net_profit': 1.61}, {'period': ""Q3 '23"", 'revenue': 25.97, 'unit': 'M', 'net_profit': -2.26}, {'period': ""Q2 '23"", 'revenue': 20.59, 'unit': 'M', 'net_profit': -4.39}]",-0.36,-0.36,63169000,44822000,5155000,40627000,18561000,0,28053000,5155000,-10929000,0.4092237508019103,0.6601438513729944,0.6666666666666667,__nan__,__nan__,__nan__,0.6431477465212366
330,OFED,Oconee Federal Financial Corp. Common Stock,"Oconee Federal Financial Corp. operates as a holding company for Oconee Federal Savings and Loan Association that provides various banking products and services in the Oconee County area of northwestern South Carolina and the northeast area of Georgia. It offers deposit products, including demand, NOW, money market, savings, certificates of deposit, and individual retirement accounts. The company's loan portfolio comprises one-to-four family and multi-family residential mortgage loans; home equity loans and lines of credit; nonresidential real estate loans; construction and land loans; commercial and industrial loans; agricultural loans; and consumer and other loans. It operates through its executive office and eight branch offices located in Oconee and Pickens Counties, South Carolina; and Stephens and Rabun Counties, Georgia. The company was founded in 1924 and is based in Seneca, South Carolina. Oconee Federal Financial Corp. operates as a subsidiary of Oconee Federal, MHC.",Mr. Curtis T. Evatt,Banks - Regional,12.2,USD,68433094,https://images.financialmodelingprep.com/symbol/OFED.png,131,29.05,0,400,7245000,6250000,"[{'period': '2024', 'revenue': 30.65, 'unit': 'M', 'net_profit': 6.25}, {'period': '2023', 'revenue': 20.95, 'unit': 'M', 'net_profit': 3.35}, {'period': '2022', 'revenue': 16.61, 'unit': 'M', 'net_profit': 4.1}, {'period': '2021', 'revenue': 16.54, 'unit': 'M', 'net_profit': 4.07}]","[{'period': ""Q1 '25"", 'revenue': 7110.0, 'unit': 'K', 'net_profit': 790.0}, {'period': ""Q4 '24"", 'revenue': 8.14, 'unit': 'M', 'net_profit': 1.7}, {'period': ""Q3 '24"", 'revenue': 10.64, 'unit': 'M', 'net_profit': 3.92}, {'period': ""Q2 '24"", 'revenue': 6030.0, 'unit': 'K', 'net_profit': 320.0}, {'period': ""Q1 '24"", 'revenue': 3210.0, 'unit': 'K', 'net_profit': 312.0}, {'period': ""Q4 '23"", 'revenue': 5580.0, 'unit': 'K', 'net_profit': 287.0}]",1.1,1.1,665718000,20113000,0,586947000,0,9533000,74260000,0,926000,0.5043604651162791,0.8684603886397608,0.8333333333333336,"[0.1, 0.1]","['2025-02-06', '2011-04-27']",__nan__,0.8816751237010265
331,OFIX,Orthofix Medical Inc. Common Stock (DE),"Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions, as well as markets regenerative non-tissue biologic solutions derived from synthetic materials. The Global Orthopedics segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.",Mr. Massimo  Calafiore,Medical - Devices,13.96,USD,544754100,https://images.financialmodelingprep.com/symbol/OFIX.png,210470,-4.23,-0.4,311000,-18243000,-123875000,"[{'period': '2024', 'revenue': 799.49, 'unit': 'M', 'net_profit': -123.88}, {'period': '2023', 'revenue': 746.64, 'unit': 'M', 'net_profit': -151.4}, {'period': '2022', 'revenue': 460.71, 'unit': 'M', 'net_profit': -19.75}, {'period': '2021', 'revenue': 464.48, 'unit': 'M', 'net_profit': -38.38}]","[{'period': ""Q4 '24"", 'revenue': 215.66, 'unit': 'M', 'net_profit': -29.15}, {'period': ""Q3 '24"", 'revenue': 196.61, 'unit': 'M', 'net_profit': -27.39}, {'period': ""Q2 '24"", 'revenue': 198.62, 'unit': 'M', 'net_profit': -33.44}, {'period': ""Q1 '24"", 'revenue': 188.61, 'unit': 'M', 'net_profit': -36.02}, {'period': ""Q4 '23"", 'revenue': 200.41, 'unit': 'M', 'net_profit': -22.17}, {'period': ""Q3 '23"", 'revenue': 184.01, 'unit': 'M', 'net_profit': -28.86}]",-3.3,-3.25,893294000,433285000,83238000,390170000,134713000,0,168628000,83238000,-9086000,0.7902741852043456,0.1817761484857492,0.19902912621359228,__nan__,__nan__,__nan__,0.436776693899209
332,OFLX,Omega Flex Inc. Common Stock,"Omega Flex, Inc., together with its subsidiaries, manufactures and sells flexible metal hoses and accessories in North America and internationally. It offers flexible gas piping for use in residential and commercial buildings, as well as its fittings; and corrugated medical tubing for use in hospitals, ambulatory care centers, dental, physician and veterinary clinics, laboratories, and other facilities. The company sells its products under the TracPipe, CounterStrike, AutoSnap, AutoFlare, DoubleTrac, DEF-Trac, and MediTrac brand names. It serves various markets, including construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. The company sells its products through independent sales representatives, distributors, original equipment manufacturers, and direct sales, as well as through its website. The company was formerly known as Tofle America, Inc. and changed its name to Omega Flex, Inc. in 1996. Omega Flex, Inc. was incorporated in 1975 and is based in Exton, Pennsylvania.",Mr. Dean W. Rivest,Industrial - Machinery,31.11,USD,314033673,https://images.financialmodelingprep.com/symbol/OFLX.png,23027,17.48,-1.08,24392,21571000,18014000,"[{'period': '2024', 'revenue': 101.68, 'unit': 'M', 'net_profit': 18.01}, {'period': '2023', 'revenue': 111.47, 'unit': 'M', 'net_profit': 20.76}, {'period': '2022', 'revenue': 125.49, 'unit': 'M', 'net_profit': 23.62}, {'period': '2021', 'revenue': 130.01, 'unit': 'M', 'net_profit': 26.2}]","[{'period': ""Q4 '24"", 'revenue': 26.96, 'unit': 'M', 'net_profit': 4.68}, {'period': ""Q3 '24"", 'revenue': 24.88, 'unit': 'M', 'net_profit': 4.62}, {'period': ""Q2 '24"", 'revenue': 24.62, 'unit': 'M', 'net_profit': 4.5}, {'period': ""Q1 '24"", 'revenue': 25.22, 'unit': 'M', 'net_profit': 4.22}, {'period': ""Q4 '23"", 'revenue': 28.15, 'unit': 'M', 'net_profit': 4.89}, {'period': ""Q3 '23"", 'revenue': 27.5, 'unit': 'M', 'net_profit': 5.58}]",1.78,1.78,105891000,83622000,51699000,22710000,14381000,181000,17438000,51699000,18851000,-0.1980444642724366,-0.13239897895294514,-0.1359223300970874,"[0.34, 0.4]","['2025-04-10', '2006-12-28']",__nan__,0.21446581862481232
333,OFS,OFS Capital Corporation Common Stock,"OFS Capital Corporation is a business development company specializing in direct and fund investments as well as add-on acquisitions. It provides flexible capital solutions primarily through debt capital and to a lesser extent, minority equity investments serving the needs of U.S.-based middle-market companies across a broad array of industries. It does not invest in operational turnarounds or start-up businesses. For direct, it specializes in debt and structured equity investments, recapitalizations and refinancing, management and leveraged buyouts, acquisition financings, shareholder liquidity events, growth capital, independent sponsor transactions, ESOPs, and minority investments in the lower middle market companies. It invests in the aerospace and defense, business services, consumer products and services, food and beverage, health care services, specialty chemicals, transportation and logistics, value added distribution, franchising, and industrial and niche manufacturing sectors. The firm invests in companies based in United States. It seeks to invest between $5 million and $35 million, revenues between $10 million and $200 million, annual EBITDA more than $5 million, and Enterprise value between $10 million and $500 million. The firm seeks to invest in companies with debt investment values between $5 million and $25 million. The fund uses senior secured, unitranche loans, first-lien, second-lien, subordinated/ mezzanine loans, warrants, and preferred equity securities and common equity securities. It prefers to take a minority as well as majority stake in the investments made. It also co-invests with its partners for additional capital.",Mr. Bilal  Rashid,Asset Management,8.15,USD,109194515,https://images.financialmodelingprep.com/symbol/OFS.png,56132,3.84,-0.13,37776,0,28442000,"[{'period': '2024', 'revenue': 41.7, 'unit': 'M', 'net_profit': 28.44}, {'period': '2023', 'revenue': 45590.0, 'unit': 'K', 'net_profit': -465.0}, {'period': '2022', 'revenue': 46.26, 'unit': 'M', 'net_profit': -7.74}, {'period': '2021', 'revenue': 68.23, 'unit': 'M', 'net_profit': 56.86}]","[{'period': ""Q4 '24"", 'revenue': 26.57, 'unit': 'M', 'net_profit': 25.48}, {'period': ""Q3 '24"", 'revenue': -0.188, 'unit': 'M', 'net_profit': 1.69}, {'period': ""Q2 '24"", 'revenue': 6.86, 'unit': 'M', 'net_profit': 10.33}, {'period': ""Q1 '24"", 'revenue': 15.03, 'unit': 'M', 'net_profit': -9.05}, {'period': ""Q4 '23"", 'revenue': 12.37, 'unit': 'M', 'net_profit': -4.11}, {'period': ""Q3 '23"", 'revenue': 3.2, 'unit': 'M', 'net_profit': 1.8}]",2.12,2.12,428123000,7842000,6068000,255898000,1774000,409665000,68350000,6068000,33010000,-1,62.16559139784946,62.09510086455331,"[0.34, 0.17]","['2025-03-21', '2013-01-15']",__nan__,0.5977207484764893
334,OFSSG,OFS Capital Corporation 6.25% Notes Due 2023,,,,,,,,,,,,,,[],"[{'period': ""Q3 '21"", 'revenue': 10140000.0, 'unit': '', 'net_profit': 0.0}]",,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
335,OFSSI,OFS Capital Corporation 5.95% Notes due 2026,"OFS Capital Corporation is a business development company specializing in direct and fund investments as well as add-on acquisitions. It provides flexible capital solutions primarily through debt capital and to a lesser extent, minority equity investments serving the needs of U.S.-based middle-market companies across a broad array of industries. It does not invest in operational turnarounds or start-up businesses. For direct, it specializes in debt and structured equity investments, recapitalizations and refinancing, management and leveraged buyouts, acquisition financings, shareholder liquidity events, growth capital, independent sponsor transactions, ESOPs, and minority investments in the lower middle market companies. It invests in the aerospace and defense, business services, consumer products and services, food and beverage, health care services, specialty chemicals, transportation and logistics, value added distribution, franchising, and industrial and niche manufacturing sectors. The firm invests in companies based in United States. It seeks to invest between $5 million and $35 million, revenues between $10 million and $200 million, annual EBITDA more than $5 million, and Enterprise value between $10 million and $500 million. The firm seeks to invest in companies with debt investment values between $5 million and $25 million. The fund uses senior secured, unitranche loans, first-lien, second-lien, subordinated/ mezzanine loans, warrants, and preferred equity securities and common equity securities. It prefers to take a minority as well as majority stake in the investments made. It also co-invests with its partners for additional capital.",Mr. Bilal  Rashid,Asset Management,25.09,USD,0,https://images.financialmodelingprep.com/symbol/OFSSI.png,5755,0,0.0100002,0,0,28442000,"[{'period': '2024', 'revenue': 41.7, 'unit': 'M', 'net_profit': 28.44}, {'period': '2023', 'revenue': 45590.0, 'unit': 'K', 'net_profit': -465.0}, {'period': '2022', 'revenue': 46.26, 'unit': 'M', 'net_profit': -7.74}, {'period': '2021', 'revenue': 68.23, 'unit': 'M', 'net_profit': 56.86}]","[{'period': ""Q4 '24"", 'revenue': 26.57, 'unit': 'M', 'net_profit': 25.48}, {'period': ""Q3 '24"", 'revenue': -0.188, 'unit': 'M', 'net_profit': 1.69}, {'period': ""Q2 '24"", 'revenue': 6.86, 'unit': 'M', 'net_profit': 10.33}, {'period': ""Q1 '24"", 'revenue': 15.03, 'unit': 'M', 'net_profit': -9.05}, {'period': ""Q4 '23"", 'revenue': 12.37, 'unit': 'M', 'net_profit': -4.11}, {'period': ""Q3 '23"", 'revenue': 3.2, 'unit': 'M', 'net_profit': 1.8}]",2.12,2.12,428123000,7842000,6068000,255898000,1774000,409665000,68350000,6068000,33010000,-1,62.16559139784946,62.09510086455331,"[0.372, 0.438]","['2021-10-14', '2020-01-14']",__nan__,0.5977207484764893
336,OGI,Organigram Holdings Inc. Common Shares,"Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.",Ms. Beena G. Goldenberg,Drug Manufacturers - Specialty & Generic,0.88,USD,111105280,https://images.financialmodelingprep.com/symbol/OGI.png,877331,-2.59,-0.0446,551822,-23592000,-45440000,"[{'period': '2024', 'revenue': 159.84, 'unit': 'M', 'net_profit': -45.44}, {'period': '2023', 'revenue': 149.21, 'unit': 'M', 'net_profit': -229.48}, {'period': '2022', 'revenue': 145.81, 'unit': 'M', 'net_profit': -14.28}, {'period': '2021', 'revenue': 79.16, 'unit': 'M', 'net_profit': -132.55}]","[{'period': ""Q1 '25"", 'revenue': 42.73, 'unit': 'M', 'net_profit': -22.96}, {'period': ""Q4 '24"", 'revenue': 44.7, 'unit': 'M', 'net_profit': -5.43}, {'period': ""Q3 '24"", 'revenue': 41.06, 'unit': 'M', 'net_profit': 2.82}, {'period': ""Q2 '24"", 'revenue': 37.63, 'unit': 'M', 'net_profit': -27.07}, {'period': ""Q1 '24"", 'revenue': 36.45, 'unit': 'M', 'net_profit': -15.75}, {'period': ""Q4 '23"", 'revenue': 46.04, 'unit': 'M', 'net_profit': -32.99}]",-0.44,-0.42,407860000,262219000,107566000,101871000,37153000,40727000,53322000,106745000,-1466000,0.06990801148958498,0.8019852590139794,0.8439716312056738,__nan__,__nan__,__nan__,0.24976952875986858
337,OHPA,Orion Acquisition Corp. Class A common stock,"Orion Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.",Mr. Beau  Garverick,Shell Companies,10.08,USD,0,https://images.financialmodelingprep.com/symbol/OHPA.png,127494,50.4,0.01,23662,10798092,23408871,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 23.41}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.1}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.06}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 11.77}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.58}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.69}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.55}]",0.45,0.45,415590,1535.632,818.897,27224,0,414055,1119.428,818.897,-1490831,0,0,0,__nan__,__nan__,__nan__,0.06550686975143771
338,OHPAU,Orion Acquisition Corp. Unit,"Orion Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.",Mr. Beau  Garverick,Shell Companies,10.075,USD,0,https://images.financialmodelingprep.com/symbol/OHPAU.png,143762,36.63636363636363,0.045,100,10798092,23408871,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 23.41}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.1}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.06}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 11.77}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.58}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.69}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.55}]",0.45,0.45,415590,1535.632,818.897,27224,0,414055,1119.428,818.897,-1490831,0,0,0,__nan__,__nan__,__nan__,0.06550686975143771
339,OHPAW,Orion Acquisition Corp. Warrant,"Orion Acquisition Corp. is a blank check company. The company was incorporated in 2020 and is based in New York, New York.",Mr. Beau  Garverick,Shell Companies,0.0003,USD,0,https://images.financialmodelingprep.com/symbol/OHPAW.png,0,0,0,154,10798092,23408871,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 23.41}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.1}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.06}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 11.77}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.58}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.69}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.55}]",0.45,0.45,415590,1535.632,818.897,27224,0,414055,1119.428,818.897,-1490831,0,0,0,__nan__,__nan__,__nan__,0.06550686975143771
340,OIIM,O2Micro International Limited American Depositary Shares,"O2Micro International Limited, together with its subsidiaries, designs, develops, and markets integrated circuits and solutions for power management components and systems in China, Singapore, Taiwan, Malaysia, Korea, the Philippines, Japan, the United States, and internationally. The company offers analog and mixed-signal integrated circuits that manages and provides power for LCD and LED lighting; controls and monitors battery charging and discharging in portable electronic devices and vehicles; performs DC/DC and AC/DC conversion; and provides select and switch functionality between power sources. Its products are primarily used in the consumer electronics, computer, industrial, communication, and automotive markets for applications, including LCD and LED monitors, LCD and LED televisions, notebook and tablet computers, low/zero emission vehicles, mobile phones, power tools, energy efficient technology relating to batteries, LED lighting, and portable electronics devices. The company sells its products through direct sales force, independent sales representatives, or distributors to OEMs, ODMs, and module makers. It also licenses its proprietary intellectual property to third parties; and provides design and engineering support services. The company was incorporated in 1995 and is headquartered in George Town, the Cayman Islands.",Mr. Sterling  Du,Semiconductors,4.9,USD,143016300,https://images.financialmodelingprep.com/symbol/OIIM.png,215093,27.22222222222222,0,0,12110000,12113000,"[{'period': '2021', 'revenue': 101.1, 'unit': 'M', 'net_profit': 12.11}, {'period': '2020', 'revenue': 78.33, 'unit': 'M', 'net_profit': 6.13}, {'period': '2019', 'revenue': 60.93, 'unit': 'M', 'net_profit': -5.04}, {'period': '2018', 'revenue': 62.71, 'unit': 'M', 'net_profit': 2.09}]","[{'period': ""Q3 '22"", 'revenue': 18.16, 'unit': 'M', 'net_profit': -1.26}, {'period': ""Q2 '22"", 'revenue': 22060.0, 'unit': 'K', 'net_profit': 555.0}, {'period': ""Q1 '22"", 'revenue': 21620.0, 'unit': 'K', 'net_profit': 915.0}, {'period': ""Q4 '21"", 'revenue': 24.39, 'unit': 'M', 'net_profit': 2.79}, {'period': ""Q3 '21"", 'revenue': 27.27, 'unit': 'M', 'net_profit': 3.68}, {'period': ""Q2 '21"", 'revenue': 26.2, 'unit': 'M', 'net_profit': 3.16}]",0.43,0.39,118342000,90399000,49966000,18858000,18784000,992000,16331000,20780000,1608000,0.8191377497371188,0.97698710625102,0.72,__nan__,__nan__,__nan__,0.15935170945226546
341,OKTA,Okta Inc. Class A Common Stock,"Okta, Inc. provides identity solutions for enterprises, small and medium-sized businesses, universities, non-profits, and government agencies in the United States and internationally. The company offers Okta Identity Cloud, a platform that offers a suite of products and services, such as Universal Directory, a cloud-based system of record to store and secure user, application, and device profiles for an organization; Single Sign-On that enables users to access applications in the cloud or on-premise from various devices; Adaptive Multi-Factor Authentication provides a layer of security for cloud, mobile, Web applications, and data; Lifecycle Management that enables IT organizations or developers to manage a user's identity throughout its lifecycle; API Access Management that enables organizations to secure APIs; Access Gateway that enables organizations to extend the Okta Identity Cloud from the cloud to their existing on-premise applications; and Advanced Server Access to secure cloud infrastructure. It also provides Auth0 products, including Universal Login that allows customers to provide login experience across different applications and devices; Attack Protection, a suite of security capabilities that protect from malicious traffics; Adaptive Multi-Factor Authentication that minimizes friction to end users; Passwordless authentication enables users to login without a password and supports in various login methods; Machine to Machine provides standards-based authentication and authorization; private Cloud that allows customers to run a dedicated cloud instance of Auth0; and Organizations that enables customers to independent configurations, login experiences, and security options. It offers customer support, training, and professional services. It sells its products directly to customers through sales force and channel partners. The company was formerly known as Saasure, Inc. Okta, Inc. was incorporated in 2009 and is headquartered in San Francisco, California.",Mr. Todd  McKinnon,Software - Infrastructure,91.39,USD,15154198410,https://images.financialmodelingprep.com/symbol/OKTA.png,3318839,1523.17,0.15,4674608,25000000,28000000,"[{'period': '2025', 'revenue': 2610.0, 'unit': 'M', 'net_profit': 28.0}, {'period': '2024', 'revenue': 2260.0, 'unit': 'M', 'net_profit': -355.0}, {'period': '2023', 'revenue': 1860.0, 'unit': 'M', 'net_profit': -815.0}, {'period': '2022', 'revenue': 1300.0, 'unit': 'M', 'net_profit': -848.41}]","[{'period': ""Q4 '25"", 'revenue': 682.0, 'unit': 'M', 'net_profit': 23.0}, {'period': ""Q3 '25"", 'revenue': 665.0, 'unit': 'M', 'net_profit': 16.0}, {'period': ""Q2 '25"", 'revenue': 646.0, 'unit': 'M', 'net_profit': 29.0}, {'period': ""Q1 '25"", 'revenue': 617.0, 'unit': 'M', 'net_profit': -40.0}, {'period': ""Q4 '24"", 'revenue': 605.0, 'unit': 'M', 'net_profit': -44.0}, {'period': ""Q3 '24"", 'revenue': 584.0, 'unit': 'M', 'net_profit': -81.0}]",0.17,0.06,9437000000,3416000000,2523000000,3032000000,621000000,0,2523000000,409000000,730000000,1.108695652173913,1.0788732394366196,1.0783410138248848,__nan__,__nan__,__nan__,0.32128854508848154
342,OLB,The OLB Group Inc. Common Stock,"The OLB Group, Inc. provides integrated financial and transaction processing services for small- and mid-sized merchants in the United States. The company operates a Crowdfunding platform used to facilitate a capital raise anywhere of various types of securities under Regulation D, Regulation Crowdfunding, Regulation A, and the Securities Act of 1933; a cloud-based business management platform that provides turnkey solutions for merchants to enable them to build and manage their retail businesses; payment processing solutions to merchants, which enable merchants to process credit and debit card-based internet payments for sales of their products; and payment gateway and virtual terminal with proprietary business management tools. It is also involved in the cryptocurrency mining activities; cryptocurrency-related lending and transactional services; and provision of ecommerce development and consulting services. The company was founded in 1993 and is headquartered in New York, New York.",Mr. Ronny  Yakov,Software - Application,1.13,USD,2432167,https://images.financialmodelingprep.com/symbol/OLB.png,40663,-0.16,-0.01,5782,-16397137,-23180663,"[{'period': '2023', 'revenue': 30.57, 'unit': 'M', 'net_profit': -23.18}, {'period': '2022', 'revenue': 30.37, 'unit': 'M', 'net_profit': 15.75}, {'period': '2021', 'revenue': 16.71, 'unit': 'M', 'net_profit': -5.1}, {'period': '2020', 'revenue': 9.77, 'unit': 'M', 'net_profit': -2.82}]","[{'period': ""Q3 '24"", 'revenue': 3.08, 'unit': 'M', 'net_profit': -1.63}, {'period': ""Q2 '24"", 'revenue': 3.52, 'unit': 'M', 'net_profit': -2.65}, {'period': ""Q1 '24"", 'revenue': 3.5, 'unit': 'M', 'net_profit': -2.37}, {'period': ""Q4 '23"", 'revenue': 5.91, 'unit': 'M', 'net_profit': -18.17}, {'period': ""Q3 '23"", 'revenue': 9.69, 'unit': 'M', 'net_profit': -1.8}, {'period': ""Q2 '23"", 'revenue': 8340.0, 'unit': 'K', 'net_profit': -587.82}]",-15.33,-15.33,19728411,1820573,452668,7383539,870889,0,7234500,179006,816809,-16.851420851051785,-2.471945321398768,-2.4287045666356013,__nan__,__nan__,__nan__,0.3742591838744641
343,OLED,Universal Display Corporation Common Stock,"Universal Display Corporation engages in the research, development, and commercialization of organic light emitting diode (OLED) technologies and materials for use in display and solid-state lighting applications. It owns, exclusively licenses, or has sole rights to sublicense approximately 5,500 issued and pending patents worldwide. The company supplies its proprietary UniversalPHOLED materials to display and lighting manufacturers, and others. It is also involved in the research, development, and commercialization of other OLED device and manufacturing technologies, including FOLED that are flexible OLEDs for the fabrication of OLEDs on flexible substrates; OVJP, an organic vapor jet printing technology; thin-film encapsulation technology for the packaging of flexible OLEDs and other thin-film devices, as well as for use as a barrier film for plastic substrates; and UniversalP2OLED, which are printable phosphorescent OLEDs. In addition, the company provides technology development and support services, including third-party collaboration and support to third parties for the commercialization of their OLED products. Further, it provides contract research services in the areas of chemical materials synthesis research, development, and commercialization for non-OLED applications. Universal Display Corporation was founded in 1985 and is headquartered in Ewing, New Jersey.",Mr. Steven V. Abramson,Semiconductors,106.6,USD,5060206060,https://images.financialmodelingprep.com/symbol/OLED.png,782668,22.92,-6.24,1126392,238803000,222079000,"[{'period': '2024', 'revenue': 647.68, 'unit': 'M', 'net_profit': 222.08}, {'period': '2023', 'revenue': 576.43, 'unit': 'M', 'net_profit': 203.01}, {'period': '2022', 'revenue': 616.62, 'unit': 'M', 'net_profit': 210.06}, {'period': '2021', 'revenue': 553.52, 'unit': 'M', 'net_profit': 184.21}]","[{'period': ""Q4 '24"", 'revenue': 162.29, 'unit': 'M', 'net_profit': 46.02}, {'period': ""Q3 '24"", 'revenue': 161.63, 'unit': 'M', 'net_profit': 66.87}, {'period': ""Q2 '24"", 'revenue': 158.5, 'unit': 'M', 'net_profit': 52.34}, {'period': ""Q1 '24"", 'revenue': 165.26, 'unit': 'M', 'net_profit': 56.85}, {'period': ""Q4 '23"", 'revenue': 158.32, 'unit': 'M', 'net_profit': 61.98}, {'period': ""Q3 '23"", 'revenue': 141.08, 'unit': 'M', 'net_profit': 51.52}]",4.66,4.65,1832333000,899831000,492670000,215808000,113648000,457593000,125410000,98980000,211103000,-0.08360994815630625,0.09392594489953747,0.09647058823529416,"[0.45, 0.03]","['2025-03-17', '2017-03-13']",__nan__,0.1177777183514132
344,OLK,Olink Holding AB (publ) American Depositary Shares,"Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. The company's products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and bioinformatics services. In addition, it provides Olink normalized protein expression (NPX) Manager, a purpose-built software that enable users to import data, validate data quality, and normalize for subsequent statistical analysis; and Olink Insight, a cloud platform for data visualization and statistical analysis of NPX data. Olink Holding AB (publ) sells its products and services through its own direct sales force in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. The company was founded in 2004 and is headquartered in Uppsala, Sweden. Olink Holding AB (publ) is a subsidiary of Summa Equity Holding AB.",Mr. Jon  Heimer,Medical - Diagnostics & Research,26.08,USD,3242865440,https://images.financialmodelingprep.com/symbol/OLK.png,545957,-96.5925925925926,0.08,1885999,-30905350,-31657721,"[{'period': '2023', 'revenue': 169.91, 'unit': 'M', 'net_profit': -31.66}, {'period': '2022', 'revenue': 139.85, 'unit': 'M', 'net_profit': -12.85}, {'period': '2021', 'revenue': 94.97, 'unit': 'M', 'net_profit': -38.34}, {'period': '2020', 'revenue': 54.07, 'unit': 'M', 'net_profit': -6.78}]","[{'period': ""Q1 '24"", 'revenue': 28.59, 'unit': 'M', 'net_profit': -15.97}, {'period': ""Q4 '23"", 'revenue': 69.27, 'unit': 'M', 'net_profit': -7.63}, {'period': ""Q3 '23"", 'revenue': 44.15, 'unit': 'M', 'net_profit': -1.82}, {'period': ""Q2 '23"", 'revenue': 29.44, 'unit': 'M', 'net_profit': -8.27}, {'period': ""Q1 '23"", 'revenue': 27.46, 'unit': 'M', 'net_profit': -13.96}, {'period': ""Q4 '22"", 'revenue': 57.88, 'unit': 'M', 'net_profit': 5.43}]",-0.26,-0.26,602267089,263472601,120960030,99556494,66239659,1794044,55488390,120960030,-51336601,-1.662188819019726,-1.4634441677690453,-1.3636363636363638,__nan__,__nan__,__nan__,0.165302896037874
345,OLLI,Ollie's Bargain Outlet Holdings Inc. Common Stock,"Ollie's Bargain Outlet Holdings, Inc. operates as a retailer of brand name merchandise. The company offers housewares, bed and bath, food, floor coverings, health and beauty aids, books and stationery, toys, and electronics; and other products, including hardware, candy, clothing, sporting goods, pet and lawn, and garden products. It provides its products primarily under the Ollie's, Ollie's Bargain Outlet, Good Stuff Cheap, Ollie's Army, Real Brands Real Cheap!, Real Brands! Real Bargains, Sarasota Breeze, Steelton Tools, American Way, and Middleton Home names. As of August 3, 2022, it operated 450 stores in 29 states throughout half of the United States. The company was formerly known as Bargain Holdings, Inc. and changed its name to Ollie's Bargain Outlet Holdings, Inc. in March 2015. Ollie's Bargain Outlet Holdings, Inc. was founded in 1982 and is headquartered in Harrisburg, Pennsylvania.",Mr. Eric  van der Valk,Discount Stores,103.49,USD,6338865990,https://images.financialmodelingprep.com/symbol/OLLI.png,1156416,32.04,-4.58,1611774,293461000,199762000,"[{'period': '2024', 'revenue': 2270.0, 'unit': 'M', 'net_profit': 199.76}, {'period': '2023', 'revenue': 2100.0, 'unit': 'M', 'net_profit': 181.44}, {'period': '2022', 'revenue': 1830.0, 'unit': 'M', 'net_profit': 102.79}, {'period': '2021', 'revenue': 1750.0, 'unit': 'M', 'net_profit': 157.46}]","[{'period': ""Q4 '24"", 'revenue': 667.08, 'unit': 'M', 'net_profit': 68.55}, {'period': ""Q3 '24"", 'revenue': 517.43, 'unit': 'M', 'net_profit': 35.88}, {'period': ""Q2 '24"", 'revenue': 578.38, 'unit': 'M', 'net_profit': 48.98}, {'period': ""Q1 '24"", 'revenue': 508.82, 'unit': 'M', 'net_profit': 46.34}, {'period': ""Q4 '23"", 'revenue': 648.95, 'unit': 'M', 'net_profit': 76.47}, {'period': ""Q3 '23"", 'revenue': 480.05, 'unit': 'M', 'net_profit': 31.8}]",3.26,3.23,2561145000,993791000,428669000,865835000,2352000,0,304341000,205123000,106900000,0.05781826177542435,0.10098710861501661,0.10884353741496594,__nan__,__nan__,__nan__,0.3380655917568119
346,OLMA,Olema Pharmaceuticals Inc. Common Stock,"Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.","Dr. Sean P. Bohen M.D., Ph.D.",Biotechnology,3.06,USD,209099286,https://images.financialmodelingprep.com/symbol/OLMA.png,1029978,-1.39,-0.12,763796,-142258000,-129474000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -129.47}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -96.66}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -102.59}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -70.89}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -33.57}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -34.55}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -30.38}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -30.97}, {'period': ""Q4 '23"", 'revenue': 1.88, 'unit': 'M', 'net_profit': -26.77}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.5}]",-2.2,-2.2,450979000,438473000,434086000,42015000,0,0,41758000,139480000,-104351000,-0.36022718580279967,-0.33954787646784956,-0.028037383177570117,__nan__,__nan__,__nan__,0.09316398324533959
347,OM,Outset Medical Inc. Common Stock,"Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.",Ms. Leslie L. Trigg,Medical - Devices,9.485,USD,167880668,https://images.financialmodelingprep.com/symbol/OM.png,90707,-0.26,-0.095,248169,-97886000,-127976000,"[{'period': '2024', 'revenue': 113.69, 'unit': 'M', 'net_profit': -127.98}, {'period': '2023', 'revenue': 130.38, 'unit': 'M', 'net_profit': -172.8}, {'period': '2022', 'revenue': 115.38, 'unit': 'M', 'net_profit': -162.96}, {'period': '2021', 'revenue': 102.6, 'unit': 'M', 'net_profit': -131.94}]","[{'period': ""Q4 '24"", 'revenue': 29.47, 'unit': 'M', 'net_profit': -25.64}, {'period': ""Q3 '24"", 'revenue': 28.67, 'unit': 'M', 'net_profit': -27.94}, {'period': ""Q2 '24"", 'revenue': 27.39, 'unit': 'M', 'net_profit': -34.45}, {'period': ""Q1 '24"", 'revenue': 28.17, 'unit': 'M', 'net_profit': -39.94}, {'period': ""Q4 '23"", 'revenue': 30.51, 'unit': 'M', 'net_profit': -38.6}, {'period': ""Q3 '23"", 'revenue': 30.36, 'unit': 'M', 'net_profit': -46.18}]",-2.46,-2.46,275795000,258221000,158685000,248976000,35619000,0,45378000,124014000,-117215000,0.36350454193732973,0.25938529025388174,0.2931034482758621,__nan__,__nan__,__nan__,0.9027574829130333
348,OMAB,Grupo Aeroportuario del Centro Norte S.A.B. de C.V. ADS,"Grupo Aeroportuario del Centro Norte, S.A.B. de C.V., together with its subsidiaries, holds concessions to develop, operate, and maintain airports in Mexico. The company operates 13 international airports in Monterrey, Acapulco, Mazatlán, Zihuatanejo, Ciudad Juárez, Reynosa, Chihuahua, Culiacán, Durango, San Luis Potosí, Tampico, Torreón, and Zacatecas cities. It also operates the NH Collection Hotel in Terminal 2 of the Mexico City International Airport; and a hotel under the Hilton Garden Inn name at the Monterrey International Airport. In addition, the company provides aeronautical services, which include passenger, aircraft landing and parking, boarding and unloading, passenger walkway, and airport security services. Further, it offers complementary services that comprise leasing of space to airlines, cargo handling, baggage-screening, permanent and non-permanent ground transportation, and access rights services; non-aeronautical services, such as leasing of space at its airports to retailers, restaurants, and other commercial tenants, as well as maintaining of parking facilities and advertising; and diversification services, which consists of operation and lease of the industrial park and real estate services, as well as hotel and air cargo logistics services. Additionally, the company provides construction services. It has a strategic alliance with VYNMSA Desarrollo Inmobiliario, S.A. de C.V. to build and operate an industrial park at the Monterrey airport. The company was founded in 1998 and is headquartered in Mexico City, Mexico.",Mr. Ricardo  Duenas Espriu,"Airlines, Airports & Air Services",72.48,USD,3797154503,https://images.financialmodelingprep.com/symbol/OMAB.png,70280,14.53,-0.79,90922,8840195000,4928804000,"[{'period': '2024', 'revenue': 15.07, 'unit': 'B', 'net_profit': 4.93}, {'period': '2023', 'revenue': 14.46, 'unit': 'B', 'net_profit': 5.01}, {'period': '2022', 'revenue': 11.93, 'unit': 'B', 'net_profit': 3.9}, {'period': '2021', 'revenue': 8.72, 'unit': 'B', 'net_profit': 2.86}]","[{'period': ""Q4 '24"", 'revenue': 4.12, 'unit': 'B', 'net_profit': 1.19}, {'period': ""Q3 '24"", 'revenue': 3.7, 'unit': 'B', 'net_profit': 1.38}, {'period': ""Q2 '24"", 'revenue': 3.5, 'unit': 'B', 'net_profit': 1.29}, {'period': ""Q1 '24"", 'revenue': 3.76, 'unit': 'B', 'net_profit': 1.08}, {'period': ""Q4 '23"", 'revenue': 3.71, 'unit': 'B', 'net_profit': 1.25}, {'period': ""Q3 '23"", 'revenue': 3.91, 'unit': 'B', 'net_profit': 1.41}]",12.76,12.76,27233060000,4292531000,1656365000,16688823000,1866241000,0,3267300000,1656365000,5875331000,-0.014542534315514003,-0.016568359497366437,-0.01694915254237293,"[2.19047, 0.199]","['2024-11-19', '2007-07-11']",__nan__,0.6128148287412432
349,OMCL,Omnicell Inc. Common Stock ($0.001 par value),"Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.",Mr. Randall A. Lipps,Medical - Healthcare Information Services,30.52,USD,1429666672,https://images.financialmodelingprep.com/symbol/OMCL.png,511613,113.04,-1.08,947276,337000,12531000,"[{'period': '2024', 'revenue': 1110.0, 'unit': 'M', 'net_profit': 12.53}, {'period': '2023', 'revenue': 1150.0, 'unit': 'M', 'net_profit': -20.37}, {'period': '2022', 'revenue': 1300.0, 'unit': 'M', 'net_profit': 5.65}, {'period': '2021', 'revenue': 1130.0, 'unit': 'M', 'net_profit': 77.85}]","[{'period': ""Q4 '24"", 'revenue': 306.88, 'unit': 'M', 'net_profit': 15.84}, {'period': ""Q3 '24"", 'revenue': 282.42, 'unit': 'M', 'net_profit': 8.63}, {'period': ""Q2 '24"", 'revenue': 276.79, 'unit': 'M', 'net_profit': 3.73}, {'period': ""Q1 '24"", 'revenue': 246.15, 'unit': 'M', 'net_profit': -15.68}, {'period': ""Q4 '23"", 'revenue': 258.85, 'unit': 'M', 'net_profit': -14.38}, {'period': ""Q3 '23"", 'revenue': 298.66, 'unit': 'M', 'net_profit': 5.55}]",0.27,0.27,2120960000,815493000,381676000,877647000,256398000,52744000,595678000,369201000,151259000,-0.9944471906409623,1.6151391684257033,1.5999999999999999,__nan__,__nan__,__nan__,0.4137970541641521
350,OMEG,Omega Alpha SPAC Class A Ordinary Shares,"Omega Alpha SPAC does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded in 2004 and is headquartered in Boston, Massachusetts.",Dr. Otello  Stampacchia,Shell Companies,10.1,USD,0,https://images.financialmodelingprep.com/symbol/OMEG.png,41930,0,0.02,33020,0,0,"[{'period': '2021', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -32.46}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.63}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 367.25}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -251.03}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 651.7}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -170.17}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -200.47}]",0,0,138926,913.239,517.445,4885.135,0,138013,55.135,517.445,-1262410,1,1,1,__nan__,__nan__,__nan__,0.03516357629241467
351,OMER,Omeros Corporation Common Stock,"Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical programs include Narsoplimab (OMS721/MASP-2) that has completed pivotal studies for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (HSCT-TMA); that is in Phase III clinical trial for immunoglobulin A nephropathy (IgAN) and atypical hemolytic uremic syndrome (aHUS); and Phase II clinical trial to treat COVID-19. Its clinical programs also consist of PPAR? (OMS405) that is in Phase II to treat opioid and nicotine addiction; PDE7 (OMS527), which is in Phase I trial for treating addiction and compulsive disorders, and movement disorders; and MASP-3 (OMS906) that is in Phase I trial for paroxysmal nocturnal hemoglobinuria (PNH) and other alternative pathway disorders. The company's preclinical programs comprise MASP-2-small-molecule inhibitors used for the treatment of aHUS, IgAN, HSCT-TMA, and age-related macular degeneration; longer-acting second generation antibody targeting MASP-2; and MASP-3-small-molecule inhibitors to treat PNH and other alternative pathway disorders. Its preclinical programs also include GPR174 Inhibitors and Chimeric Antigen Receptor (CAR) T-Cell and Adoptive T-Cell Therapies for various cancers; and G protein-coupled receptor targets for treating immunologic, immuno-oncologic, metabolic, CNS, cardiovascular, musculoskeletal, and other disorders. The company was incorporated in 1994 and is headquartered in Seattle, Washington.",Dr. Gregory A. Demopulos M.D.,Biotechnology,6.03,USD,350125317,https://images.financialmodelingprep.com/symbol/OMER.png,586049,-1.92,-0.865,1193604,-157004000,-156815000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -156.81}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -117.81}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 28.78}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 194.24}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -31.36}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -32.23}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -56.04}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -37.18}, {'period': ""Q4 '23"", 'revenue': 1.37, 'unit': 'M', 'net_profit': -9.07}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -37.75}]",-2.7,-2.7,277079000,134120000,90132000,459688000,36822000,0,79526000,3400000,-148968000,0.040376505103600024,-0.3310500538989755,-0.43617021276595763,__nan__,__nan__,__nan__,1.659050306952169
352,OMEX,Odyssey Marine Exploration Inc. Common Stock,"Odyssey Marine Exploration, Inc., together with its subsidiaries, discovers, validates, and develops seafloor resources worldwide. The company provides specialized mineral exploration, project development, and marine services to clients. It also offers resource assessment, project planning, research, and project management services. The company was founded in 1986 and is headquartered in Tampa, Florida.",Mr. Mark D. Gordon,Specialty Business Services,0.3,USD,8748540,https://images.financialmodelingprep.com/symbol/OMEX.png,427172,4.29,0.0035,770776,-12004927000,15657934,"[{'period': '2024', 'revenue': 768.68, 'unit': 'M', 'net_profit': 15.66}, {'period': '2023', 'revenue': 0.8038, 'unit': 'M', 'net_profit': 5.35}, {'period': '2022', 'revenue': 1.33, 'unit': 'M', 'net_profit': -23.14}, {'period': '2021', 'revenue': 0.9212400000000001, 'unit': 'M', 'net_profit': -9.96}]","[{'period': ""Q4 '24"", 'revenue': 0.13615000000000002, 'unit': 'M', 'net_profit': -5.0}, {'period': ""Q3 '24"", 'revenue': 0.2139, 'unit': 'M', 'net_profit': 18.69}, {'period': ""Q2 '24"", 'revenue': 0.21556, 'unit': 'M', 'net_profit': -1.53}, {'period': ""Q1 '24"", 'revenue': 0.20306000000000002, 'unit': 'M', 'net_profit': 3.5}, {'period': ""Q4 '23"", 'revenue': 0.17124, 'unit': 'M', 'net_profit': -2.77}, {'period': ""Q3 '23"", 'revenue': 0.17124, 'unit': 'M', 'net_profit': -2.77}]",746.41,551.78,18491890000,5761133000,4791743000,75107703000,285764,9885779,22467358000,4791743000,557991000,-7614.600300360103,1.929005639734529,2763.4814814814813,__nan__,__nan__,__nan__,4.061656380175309
353,OMP,Oasis Midstream Partners LP Common Units Representing Limited Partner Interests,"Oasis Midstream Partners LP, together with its subsidiaries, provides crude oil, natural gas, and water-related midstream services in North America. It offers natural gas gathering, compression, processing, and gas lift supply services; crude oil gathering, stabilization, blending, and storage services; produced and flowback water gathering and disposal services; freshwater distribution services; and crude oil transportation services from the Wild Basin operating area to Johnson's Corner. OMP GP LLC serves as the general partner of the company. The company was founded in 2013 and is based in Houston, Texas. As of February 1, 2022, Oasis Midstream Partners LP operates as a subsidiary of Crestwood Equity Partners LP.",Mr. Taylor L. Reid,Oil & Gas Midstream,23.86,USD,0,https://images.financialmodelingprep.com/symbol/OMP.png,153574,8.101867572156197,0,1698447,76095000,23075000,"[{'period': '2020', 'revenue': 347.86, 'unit': 'M', 'net_profit': 23.07}, {'period': '2019', 'revenue': 410.19, 'unit': 'M', 'net_profit': 117.66}, {'period': '2018', 'revenue': 271.62, 'unit': 'M', 'net_profit': 50.05}, {'period': '2017', 'revenue': 182.22, 'unit': 'M', 'net_profit': 11.64}]","[{'period': ""Q3 '21"", 'revenue': 105.38, 'unit': 'M', 'net_profit': 37.62}, {'period': ""Q2 '21"", 'revenue': 95.26, 'unit': 'M', 'net_profit': 35.15}, {'period': ""Q1 '21"", 'revenue': 100.37, 'unit': 'M', 'net_profit': 25.9}, {'period': ""Q4 '20"", 'revenue': 90.61, 'unit': 'M', 'net_profit': 55.34}, {'period': ""Q3 '20"", 'revenue': 84.56, 'unit': 'M', 'net_profit': 27.26}, {'period': ""Q2 '20"", 'revenue': 66.06, 'unit': 'M', 'net_profit': 11.87}]",0.68,0.68,1030693000,87055000,5147000,507035000,70578000,0,50007000,5147000,157037000,-0.5564318690542809,-0.8038774053171959,-0.8045977011494252,"[0.56, 0.0245]","['2021-11-12', '2018-02-15']",__nan__,0.49193600810328586
